assays_SASI,assays_CHEI,assays_ASI,assays_BFO,assays_AST,assays_ASSUBCFRAC,assays_VARII,assays_ASTI,assays_ASSTI,assays_ASOR,assays_ASST,assays_Descr,assays_CUB,assays_CONSC,assays_ASCETY,assays_RELT,assays_Ti,assays_TISI,assays_ASSCA,assays_DOI,assays_ASTTY,assays_CI,assays_SI
,CHEMBL618647,7524,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL618648,7525,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL618649,7526,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL618650,7527,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL618651,7528,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL876497,7529,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL618652,7530,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,1,,N,50597,2048.0,,9866,In vivo,,1
,CHEMBL618653,7531,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Intermediate,1,,N,50597,2048.0,,9866,In vivo,,1
,CHEMBL618654,7532,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,1,,N,50597,2048.0,,9866,In vivo,,1
,CHEMBL618655,7533,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Intermediate,1,,N,50597,,,6351,,,1
,CHEMBL618656,7534,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for solubility in water,Intermediate,1,,N,50597,,,1465,,,1
,CHEMBL618657,7535,BAO_0000100,P,,,,,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),Intermediate,0,,U,22229,,,5182,,,1
,CHEMBL618658,7536,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Solubility was determined,Intermediate,1,,N,50597,,,17847,,,1
,CHEMBL618659,7537,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,solubility in water (ug/mL) at 37 degree C.,Intermediate,1,,N,50597,,,15339,,,1
,CHEMBL618660,7538,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Intermediate,1,,N,50597,,,5202,,,1
,CHEMBL618661,7539,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Intermediate,1,,N,50597,,,1088,,,1
,CHEMBL873807,7540,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats,Intermediate,1,,N,50597,,,3169,,,1
,CHEMBL618662,7541,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in Dawley rat,Intermediate,1,,N,50597,,,5353,,,1
,CHEMBL618663,7542,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after 3 mg/kg iv administration,Intermediate,1,,N,50597,,,2864,In vivo,,1
,CHEMBL618664,7543,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after 3 mg/kg iv administration in rat,Intermediate,1,,N,50597,,,2864,In vivo,,1
,CHEMBL618665,7544,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after 3 mg/kg iv administration in the rat,Intermediate,1,,N,50597,,,2864,In vivo,,1
,CHEMBL876498,7545,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in female Sprague-Dawley rats,Intermediate,1,,N,50597,,,6362,,,1
,CHEMBL618666,7546,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat,Intermediate,1,,N,50597,,,6249,,,1
,CHEMBL620440,7547,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rats was determined,Intermediate,1,,N,50597,,,3169,,,1
,CHEMBL620441,7548,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rats with metabolic oxidation,Intermediate,1,,N,50597,,,3169,,,1
,CHEMBL620442,7549,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rats,Intermediate,1,,N,50597,,,3169,,,1
,CHEMBL620443,7550,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL620444,7551,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL620445,7552,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL620446,7553,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL620447,7554,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biological half-life measured in plasma of rat,Intermediate,1,,N,50597,1969.0,,2879,,,1
,CHEMBL621129,7555,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biological half-life measured in plasma of rat; 22-25,Intermediate,1,,N,50597,1969.0,,2879,,,1
,CHEMBL621130,7556,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biological half-life measured in plasma of rat; 9-16,Intermediate,1,,N,50597,1969.0,,2879,,,1
,CHEMBL873808,7557,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for its half life when administered intravenously in rat,Intermediate,1,,N,50597,,,3184,In vivo,,1
,CHEMBL876598,7558,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Intermediate,1,,N,50597,,,4891,In vivo,,1
,CHEMBL621131,7559,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Intermediate,1,,N,50597,,,429,In vivo,,1
,CHEMBL621132,7560,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life (T1/2) after oral administration in rat,Intermediate,1,,N,50597,,,5656,In vivo,,1
,CHEMBL621133,7561,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound after iv administration of 20 mg/kg dose in rat,Intermediate,1,,N,50597,,,4413,In vivo,,1
,CHEMBL621312,7562,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,,,3598,In vivo,,1
,CHEMBL621313,7563,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound was determined in rat,Intermediate,1,,N,50597,,,17267,,,1
,CHEMBL621314,7564,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Half life of compound was determined in rat blood,Intermediate,1,,N,50597,178.0,,4727,,,1
,CHEMBL621315,7565,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life at 1 mg/kg was determined in rat,Intermediate,1,,N,50597,,,17651,In vivo,,1
,CHEMBL621316,7566,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life at 10 mg/kg was determined in rat,Intermediate,1,,N,50597,,,17651,In vivo,,1
,CHEMBL621317,7567,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats,Intermediate,1,,N,50597,,,401,,,1
,CHEMBL621318,7568,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats in hours,Intermediate,1,,N,50597,,,4942,,,1
,CHEMBL621319,7569,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,1,,N,50597,,,17735,In vivo,,1
,CHEMBL621377,7570,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,1,,N,50597,,,6056,In vivo,,1
,CHEMBL621378,7571,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was determined,Intermediate,1,,N,50597,,,5213,,,1
,CHEMBL876599,7572,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after i.v. administration,Intermediate,1,,N,50597,,,6616,In vivo,,1
,CHEMBL621379,7573,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,1,,N,50597,,,5937,In vivo,,1
,CHEMBL621380,7574,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat plasma,Intermediate,1,,N,50597,1969.0,,5819,,,1
,CHEMBL621381,7575,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat plasma; Not detected,Intermediate,1,,N,50597,1969.0,,5819,,,1
,CHEMBL618515,7576,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats,Intermediate,1,,N,50597,,,6803,,,1
,CHEMBL618516,7577,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period of compound was determined after peroral administration,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL618517,7578,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL618518,7579,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat,Intermediate,1,,N,50597,,,5948,,,1
,CHEMBL618519,7580,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,1,,N,50597,,,1916,In vivo,,1
,CHEMBL618698,7581,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,1,,N,50597,,,1916,In vivo,,1
,CHEMBL618862,7582,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Intermediate,1,,N,50597,,,1916,In vivo,,1
,CHEMBL618863,7583,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,,,4890,In vivo,,1
,CHEMBL618864,7584,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,1,,N,50597,,,17764,In vivo,,1
,CHEMBL618865,7585,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life time in rat the dose of 2 mg/kg,Intermediate,1,,N,50597,,,4727,In vivo,,1
,CHEMBL618866,7586,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life 24 hr after 10 mg/kg iv administration in rats,Intermediate,1,,N,50597,,,17509,In vivo,,1
,CHEMBL618867,7587,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life 24 hr after 2 mg/kg iv administration in rats,Intermediate,1,,N,50597,,,17509,In vivo,,1
,CHEMBL875828,7588,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life consistent with the observed metabolic steady state in rats,Intermediate,1,,N,50597,,,6597,,,1
,CHEMBL618868,7589,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,1,,N,50597,,,17735,In vivo,,1
,CHEMBL618869,7590,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life for oxidative metabolic stability was determined using male human,Intermediate,1,,N,50597,,,6597,,,1
,CHEMBL618870,7591,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,1,,N,50597,,,17670,In vivo,,1
,CHEMBL618871,7592,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in rat plasma,Intermediate,1,,N,50597,1969.0,,1696,,,1
,CHEMBL618872,7593,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in rat plasma was determined,Intermediate,1,,N,50597,1969.0,,1742,,,1
,CHEMBL873816,7594,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rats was determined,Intermediate,1,,N,50597,,,17800,,,1
,CHEMBL618873,7595,BAO_0000218,A,,,,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,Autocuration,0,,U,22224,,,12923,,,1
,CHEMBL621602,7596,BAO_0000019,A,,,,,,,Area under curve after oral dose of 0.1 mg//kg,Autocuration,0,,U,22224,,,11954,,,1
,CHEMBL621603,7597,BAO_0000218,A,,,,,,,Area under curve after oral dose of 0.3 mg/kg,Autocuration,0,,U,22224,,,11954,,,1
,CHEMBL621604,7598,BAO_0000218,A,,,,,,,Area under curve after oral dose of 1 mg/kg,Autocuration,0,,U,22224,,,11954,,,1
,CHEMBL621605,7599,BAO_0000218,A,,,,,,,Area under curve after oral dose of 10 mg/kg,Autocuration,0,,U,22224,,,11954,,,1
,CHEMBL621606,7600,BAO_0000218,A,,,,,,,Area under curve after oral dose of 23.4 mg/kg,Autocuration,0,,U,22224,,,11954,,,1
,CHEMBL621607,7601,BAO_0000218,A,,,,,,,Area under curve after oral dose of 3 mg/kg,Autocuration,0,,U,22224,,,11954,,,1
,CHEMBL621608,7602,BAO_0000218,A,,,,,,,Area under curve after oral dose of 3.87 mg/kg,Autocuration,0,,U,22224,,,11954,,,1
,CHEMBL621609,7603,BAO_0000019,A,,,,,,,Area under curve was determined,Autocuration,0,,U,22224,,,5237,,,1
,CHEMBL621610,7604,BAO_0000218,A,,,,,,,Area under curve at a dose of 10 mg/kg,Autocuration,0,,U,22224,,,4026,,,1
,CHEMBL621611,7605,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined; ND=No data,Intermediate,1,,N,50597,,,5237,,,1
,CHEMBL621612,7606,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622308,7607,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622309,7608,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622310,7609,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622311,7610,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622312,7611,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622931,7612,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622932,7613,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Intermediate,1,,N,50597,,,14793,,,1
,CHEMBL622736,7614,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622737,7615,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622738,7616,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622739,7617,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622740,7618,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622741,7619,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622742,7620,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622743,7621,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Intermediate,1,,N,50597,1969.0,,14793,,,1
,CHEMBL622744,7622,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,AUC in mice,Intermediate,1,,N,50594,1969.0,,11637,,,1
,CHEMBL624134,7623,BAO_0000019,A,,,,,,,Area under curve was measured from the graph obtained from concentration Vs time,Autocuration,0,,U,22224,,,11149,,,1
,CHEMBL624135,7624,BAO_0000019,A,,,,,,,Area under curve value of compound per hour after oral administration,Autocuration,0,,U,22224,,,10016,,,1
,CHEMBL624136,7625,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined after oral administration in rats,Intermediate,1,,N,50597,,,17796,,,1
,CHEMBL624137,7626,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined after oral administration in rats; No data,Intermediate,1,,N,50597,,,17796,,,1
,CHEMBL624320,7627,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined after oral administration in rats;No data,Intermediate,1,,N,50597,,,17796,,,1
,CHEMBL624321,7628,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,1,,N,50588,,,12923,,,1
,CHEMBL624322,7629,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL624323,7630,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound after iv dose of 5.06 in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL624324,7631,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL624325,7632,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL624326,7633,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL624327,7634,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL624328,7635,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL627848,7636,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve was determined in Dogs after peroral administration,Intermediate,1,,N,50588,,,14169,,,1
,CHEMBL627849,7637,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in Rats after peroral administration,Intermediate,1,,N,50597,,,14169,,,1
,CHEMBL627850,7638,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in carotid blood of rat when administered intradermally,Intermediate,1,,N,50597,,,14258,,,1
,CHEMBL627851,7639,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in portal blood of rat when administered intradermally,Intermediate,1,,N,50597,,,14258,,,1
,CHEMBL627852,7640,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL627853,7641,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL627854,7642,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL627855,7643,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL627856,7644,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL875339,7645,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL627857,7646,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL627858,7647,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Intermediate,1,,N,50597,2106.0,,11195,In vivo,,1
,CHEMBL627859,7648,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Intermediate,1,,N,50597,178.0,,10130,,,1
,CHEMBL627860,7649,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Intermediate,1,,N,50597,955.0,,10130,,,1
,CHEMBL627019,7650,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Intermediate,1,,N,50597,948.0,,10130,,,1
,CHEMBL627020,7651,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Intermediate,1,,N,50597,2107.0,,10130,,,1
,CHEMBL627021,7652,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Intermediate,1,,N,50597,2048.0,,10130,,,1
,CHEMBL627022,7653,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Intermediate,1,,N,50597,2385.0,,10130,,,1
,CHEMBL627023,7654,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Intermediate,1,,N,50597,,,10130,,,1
,CHEMBL627024,7655,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Intermediate,1,,N,50597,2106.0,,10130,,,1
,CHEMBL627025,7656,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,1,,N,50597,2046.0,,10130,,,1
,CHEMBL627026,7657,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Intermediate,1,,N,50597,2113.0,,10130,,,1
,CHEMBL627027,7658,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Intermediate,1,,N,50597,178.0,,10130,,,1
,CHEMBL627028,7659,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Intermediate,1,,N,50597,955.0,,10130,,,1
,CHEMBL627029,7660,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Intermediate,1,,N,50597,948.0,,10130,,,1
,CHEMBL627030,7661,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Intermediate,1,,N,50597,2113.0,,10130,,,1
,CHEMBL627031,7662,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Intermediate,1,,N,50597,2107.0,,10130,,,1
,CHEMBL627032,7663,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Intermediate,1,,N,50597,2048.0,,10130,,,1
,CHEMBL627033,7664,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Intermediate,1,,N,50597,2385.0,,10130,,,1
,CHEMBL627034,7665,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Intermediate,1,,N,50597,,,10130,,,1
,CHEMBL627035,7666,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Intermediate,1,,N,50597,2106.0,,10130,,,1
,CHEMBL627036,7667,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,1,,N,50597,2046.0,,10130,,,1
,CHEMBL875340,7668,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Intermediate,1,,N,50597,178.0,,10130,,,1
,CHEMBL627037,7669,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Intermediate,1,,N,50597,948.0,,10130,,,1
,CHEMBL627038,7670,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Intermediate,1,,N,50597,2113.0,,10130,,,1
,CHEMBL627039,7671,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Intermediate,1,,N,50597,2107.0,,10130,,,1
,CHEMBL627040,7672,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Intermediate,1,,N,50597,2385.0,,10130,,,1
,CHEMBL624663,7673,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Intermediate,1,,N,50597,2106.0,,10130,,,1
,CHEMBL625963,7674,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,1,,N,50597,2046.0,,10130,,,1
,CHEMBL876799,7675,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Intermediate,1,,N,50597,955.0,,10130,,,1
,CHEMBL626133,7676,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Intermediate,1,,N,50597,2048.0,,10130,,,1
,CHEMBL626134,7677,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Intermediate,1,,N,50597,,,10130,,,1
,CHEMBL626135,7678,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6295,,,1
,CHEMBL626136,7679,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6296,,,1
,CHEMBL626137,7680,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Intermediate,1,,N,50597,,,6296,,,1
,CHEMBL626138,7681,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6295,,,1
,CHEMBL626139,7682,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6296,,,1
,CHEMBL626140,7683,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL626141,7684,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL626142,7685,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,C24h in rat p.o. at 20 mg/kg concentration,Intermediate,1,,N,50597,,,17686,,,1
,CHEMBL627930,7686,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL627931,7687,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL627932,7688,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL627933,7689,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL627934,7690,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL627935,7691,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL627936,7692,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627937,7693,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627938,7694,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627939,7695,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627940,7696,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627941,7697,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL876800,7698,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627942,7699,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627943,7700,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627944,7701,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627945,7702,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL628584,7703,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL628585,7704,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL628586,7705,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL628587,7706,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL628588,7707,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL628589,7708,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL625304,7709,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL625305,7710,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL625306,7711,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL625307,7712,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL625308,7713,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627740,7714,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627741,7715,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627742,7716,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627743,7717,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627744,7718,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Intermediate,1,,N,50597,178.0,,9866,In vivo,,1
,CHEMBL627745,7719,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL627746,7720,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL627747,7721,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL876810,7722,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL627748,7723,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL627749,7724,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL627750,7725,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618728,7726,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618729,7727,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618730,7728,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618731,7729,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618732,7730,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618733,7731,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618734,7732,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618735,7733,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL876602,7734,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618736,7735,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618737,7736,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618738,7737,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618739,7738,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618740,7739,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618741,7740,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618742,7741,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618743,7742,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Intermediate,1,,N,50597,10000001.0,,9866,In vivo,,1
,CHEMBL618744,7743,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life from rat plasma at a single oral dose of 25 mg/kg,Intermediate,1,,N,50597,1969.0,,17752,In vivo,,1
,CHEMBL618745,7744,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in male rat,Intermediate,1,,N,50597,,,5610,,,1
,CHEMBL620479,7745,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat after peroral administration at 10 mg/kg concentration,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL620480,7746,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat after peroral administration at 5 mg/kg concentration,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL620481,7747,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat at a dose of 3 mg/kg,Intermediate,1,,N,50597,,,17771,In vivo,,1
,CHEMBL620482,7748,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was evaluated in rats,Intermediate,1,,N,50597,,,1974,,,1
,CHEMBL876603,7749,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was measured in rat,Intermediate,1,,N,50597,,,4239,,,1
,CHEMBL620483,7750,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period for the compound was determined in rats at 50 mg/kg dose,Intermediate,1,,N,50597,,,6681,In vivo,,1
,CHEMBL620484,7751,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period in rats after intravenous administration at 5 mg/kg,Intermediate,1,,N,50597,,,17752,In vivo,,1
,CHEMBL620485,7752,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period in rat at 10 mg/kg,Intermediate,1,,N,50597,,,6046,In vivo,,1
,CHEMBL620486,7753,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL620487,7754,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL620488,7755,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL620489,7756,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life time in rat the dose of 2 mg/kg,Intermediate,1,,N,50597,,,4727,In vivo,,1
,CHEMBL620490,7757,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Intermediate,1,,N,50597,,,1088,In vivo,,1
,CHEMBL620491,7758,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Intermediate,1,,N,50597,,,5610,In vivo,,1
,CHEMBL876604,7759,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,1,,N,50597,1969.0,,3032,In vivo,,1
,CHEMBL620492,7760,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral half life was determined,Intermediate,1,,N,50597,,,5199,In vivo,,1
,CHEMBL620493,7761,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,1,,N,50597,,,14941,In vivo,,1
,CHEMBL620494,7762,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (t1/2) in rat,Intermediate,1,,N,50597,,,4408,In vivo,,1
,CHEMBL620495,7763,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma elimination half-life was determined,Intermediate,1,,N,50597,1969.0,,2552,,,1
,CHEMBL620496,7764,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,1,,N,50597,1969.0,,5199,In vivo,,1
,CHEMBL620497,7765,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half life was observed after intravenous administration in rat,Intermediate,1,,N,50597,1969.0,,15662,In vivo,,1
,CHEMBL620498,7766,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life was determined,Intermediate,1,,N,50597,1969.0,,1465,,,1
,CHEMBL620499,7767,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life following oral administration in Fisher rats,Intermediate,1,,N,50597,1969.0,,1446,In vivo,,1
,CHEMBL620500,7768,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life in rat,Intermediate,1,,N,50597,1969.0,,6824,,,1
,CHEMBL873809,7769,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasmatic Half-life after intravenous administration to rat,Intermediate,1,,N,50597,1969.0,,17533,In vivo,,1
,CHEMBL620501,7770,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,1,,N,50597,,,5979,In vivo,,1
,CHEMBL620502,7771,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Terminal half life after intravenous administration (1 mg/kg) in rat,Intermediate,1,,N,50597,,,4689,In vivo,,1
,CHEMBL620503,7772,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Terminal half life in Rat at a oral dose of 5 mg/kg,Intermediate,1,,N,50597,,,4689,In vivo,,1
,CHEMBL620504,7773,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,1,,N,50597,,,2463,In vivo,,1
,CHEMBL876605,7774,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Intermediate,1,,N,50597,,,4883,In vivo,,1
,CHEMBL620505,7775,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Intermediate,1,,N,50597,,,4883,In vivo,,1
,CHEMBL873811,7776,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,plasma half life was observed after intravenous administration in rat,Intermediate,1,,N,50597,1969.0,,15662,In vivo,,1
,CHEMBL624016,7777,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,,,3598,In vivo,,1
,CHEMBL624017,7778,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound determined in rat,Intermediate,1,,N,50597,,,4576,,,1
,CHEMBL624018,7779,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean residence time determined in rat,Intermediate,1,,N,50597,,,4576,,,1
,CHEMBL624019,7780,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma half life determined in rat,Intermediate,1,,N,50597,,,4576,,,1
,CHEMBL624020,7781,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Intermediate,1,,N,50597,955.0,,4910,In vivo,,1
,CHEMBL624201,7782,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for pharmacokinetic parameter maximum time period,Intermediate,1,,N,50597,,,4891,In vivo,,1
,CHEMBL872528,7783,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,1,,N,50597,,,429,In vivo,,1
,CHEMBL624202,7784,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL624203,7785,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL624350,7786,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL621320,7787,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL621321,7788,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL621322,7789,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum time (Tmax) required to reach Cmax in rats,Intermediate,1,,N,50597,,,4026,,,1
,CHEMBL621323,7790,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,,,4890,In vivo,,1
,CHEMBL621324,7791,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum time of clearance of compound in rats after peroral administration,Intermediate,1,,N,50597,,,6571,In vivo,,1
,CHEMBL621325,7792,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum time at the dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,4727,,,1
,CHEMBL875837,7793,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Intermediate,1,,N,50597,1969.0,,17651,In vivo,,1
,CHEMBL621326,7794,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Intermediate,1,,N,50597,1969.0,,17651,In vivo,,1
,CHEMBL621327,7795,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax in Guinea pig (PO dose),Intermediate,1,,N,50597,,,14465,In vivo,,1
,CHEMBL621328,7796,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,1,,N,50597,,,14941,In vivo,,1
,CHEMBL621329,7797,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (Tmax) in rat,Intermediate,1,,N,50597,,,5960,In vivo,,1
,CHEMBL621330,7798,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (Tmax) was estimated,Intermediate,1,,N,50597,,,5022,In vivo,,1
,CHEMBL621331,7799,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Tmax) in rat,Intermediate,1,,N,50597,,,4408,In vivo,,1
,CHEMBL621332,7800,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,1,,N,50597,,,5983,In vivo,,1
,CHEMBL621333,7801,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T max in Rat at a oral dose of 5 mg/kg,Intermediate,1,,N,50597,,,4689,In vivo,,1
,CHEMBL621334,7802,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T max was determined at 10 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL621335,7803,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,1,,N,50594,,,15011,,,1
,CHEMBL621336,7804,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Intermediate,1,,N,50588,,,14180,,,1
,CHEMBL621337,7805,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Intermediate,1,,N,50597,,,14180,,,1
,CHEMBL621338,7806,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve was measured after i.v. administration into Beagle dog.,Intermediate,1,,N,50588,,,14599,,,1
,CHEMBL875838,7807,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve was measured after iv administration into Beagle dog,Intermediate,1,,N,50588,,,14599,,,1
,CHEMBL621339,7808,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve was measured after po administration into Beagle dog,Intermediate,1,,N,50588,,,14599,,,1
,CHEMBL621340,7809,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve was measured after po administration into Beagle dog.,Intermediate,1,,N,50588,,,14599,,,1
,CHEMBL621341,7810,BAO_0000218,A,,,,,,,Area under curve was measured at peroral dose of 3 mg/kg,Autocuration,0,,U,22224,,,15675,,,1
,CHEMBL621342,7811,BAO_0000019,A,,,,,,,Area under curve was measured by using concentration Vs time,Autocuration,0,,U,22224,,,12706,,,1
,CHEMBL621343,7812,BAO_0000019,A,,,,,,,Area under curve was measured by using concentration Vs time; not tested,Autocuration,0,,U,22224,,,12706,,,1
,CHEMBL621344,7813,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Intermediate,1,,N,50594,,,9750,,,1
,CHEMBL621345,7814,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve(AUC) was measured in mice after oral administration.,Intermediate,1,,N,50594,,,9750,,,1
,CHEMBL621346,7815,BAO_0000019,A,,,,,,,Area under curve(AUC) value of the compound,Autocuration,0,,U,22224,,,14691,,,1
,CHEMBL621347,7816,BAO_0000218,A,,,,,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,Autocuration,0,,U,22224,,,14691,,,1
,CHEMBL621348,7817,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Intermediate,1,,N,50588,,,14691,,,1
,CHEMBL621349,7818,BAO_0000019,A,,,,Blood,,,Area under curve(carotid artery) was determined by the availability in blood,Autocuration,0,,U,22224,178.0,,2939,,,1
,CHEMBL621350,7819,BAO_0000019,A,,,,Blood,,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,Autocuration,0,,U,22224,178.0,,2939,,,1
,CHEMBL875839,7820,BAO_0000019,A,,,,Blood,,,Area under curve(carotid artery) was determined by the availability in blood; No data,Autocuration,0,,U,22224,178.0,,2939,,,1
,CHEMBL620211,7821,BAO_0000019,A,,,,Blood,,,Area under curve(portal vein) was determined by the availability in blood,Autocuration,0,,U,22224,178.0,,2939,,,1
,CHEMBL620212,7822,BAO_0000019,A,,,,Blood,,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,Autocuration,0,,U,22224,178.0,,2939,,,1
,CHEMBL620213,7823,BAO_0000019,A,,,,Blood,,,Area under curve(portal vein) was determined by the availability in blood; No data,Autocuration,0,,U,22224,178.0,,2939,,,1
,CHEMBL620214,7824,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,1,,N,50797,1969.0,,9552,,,1
,CHEMBL620215,7825,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,1,,N,50797,1969.0,,9552,,,1
,CHEMBL620216,7826,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Intermediate,1,,N,50797,1969.0,,9552,,,1
,CHEMBL620888,7827,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Intermediate,1,,N,50588,1969.0,,9552,,,1
,CHEMBL620889,7828,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Intermediate,1,,N,50588,1969.0,,9552,,,1
,CHEMBL620890,7829,BAO_0000019,A,,,,Plasma,,,Area under plasma concentration vs time curve observed in rats for 0-3 h,Autocuration,0,,U,22224,1969.0,,9552,,,1
,CHEMBL620891,7830,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under plasma time curve determined in male rat,Intermediate,1,,N,50597,1969.0,,11911,,,1
,CHEMBL620892,7831,BAO_0000019,A,,,,,,,Area under the MAP curve measured over 5 min.,Autocuration,0,,U,22224,,,16618,,,1
,CHEMBL621079,7832,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Intermediate,1,,N,50594,,,14387,,,1
,CHEMBL621080,7833,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Intermediate,1,,N,50594,,,14387,,,1
,CHEMBL621081,7834,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Intermediate,1,,N,50588,,,12836,,,1
,CHEMBL621082,7835,BAO_0000218,A,,,10026.0,,Cricetinae,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Intermediate,1,,N,100712,,,12836,,,1
,CHEMBL621083,7836,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Intermediate,1,,N,50597,,,12836,,,1
,CHEMBL621084,7837,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Intermediate,1,,N,50588,,,14339,,,1
,CHEMBL621085,7838,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Intermediate,1,,N,50588,,,14339,,,1
,CHEMBL621086,7839,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Intermediate,1,,N,50588,,,14339,,,1
,CHEMBL621087,7840,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,1,,N,50588,,,10524,,,1
,CHEMBL622607,7841,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Intermediate,1,,N,50588,,,9994,,,1
,CHEMBL622608,7842,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Serum AUC in marmosets (IV dose),Intermediate,1,,N,50588,,,11325,,,1
,CHEMBL624481,7843,BAO_0000019,A,,,,,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,Autocuration,0,,U,22224,,,12536,,,1
,CHEMBL624482,7844,BAO_0000019,A,,,,,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,Autocuration,0,,U,22224,,,12536,,,1
,CHEMBL624483,7845,BAO_0000019,A,,,,,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,Autocuration,0,,U,22224,,,12536,,,1
,CHEMBL624484,7846,BAO_0000019,A,,,,,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,Autocuration,0,,U,22224,,,12536,,,1
,CHEMBL624485,7847,BAO_0000019,A,,,,,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,Autocuration,0,,U,22224,,,12536,,,1
,CHEMBL624486,7848,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve for fumarate salt was evaluated in F344 Rats.,Intermediate,1,,N,50597,,,15556,,,1
,CHEMBL624487,7849,BAO_0000019,A,,,,,,,Area under the curve for the compound was calculated.,Autocuration,0,,U,22224,,,2809,,,1
,CHEMBL624488,7850,BAO_0000019,A,,,,,,,Area under the curve in concentration/ time,Autocuration,0,,U,22224,,,9511,,,1
,CHEMBL624489,7851,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve administered intraintestinal in rats.,Intermediate,1,,N,50597,,,12818,,,1
,CHEMBL625184,7852,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve administered intravenously in rats.,Intermediate,1,,N,50597,,,12818,,,1
,CHEMBL625185,7853,BAO_0000019,A,,,,,,,Area under the curve during intravenous administration,Autocuration,0,,U,22224,,,15118,,,1
,CHEMBL875954,7854,BAO_0000019,A,,,,,,,Area under the curve during intravenous administration; Not determined,Autocuration,0,,U,22224,,,15118,,,1
,CHEMBL625186,7855,BAO_0000019,A,,,,,,,Area under the curve during systemic administration,Autocuration,0,,U,22224,,,15118,,,1
,CHEMBL625187,7856,BAO_0000019,A,,,,,,,Area under the curve during systemic administration; Not determined,Autocuration,0,,U,22224,,,15118,,,1
,CHEMBL625188,7857,BAO_0000019,A,,,,,,,Area under the curve was calculated for the compound.,Autocuration,0,,U,22224,,,2632,,,1
,CHEMBL625189,7858,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Intermediate,1,,N,50588,,,14346,,,1
,CHEMBL625190,7859,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Intermediate,1,,N,50588,,,14346,,,1
,CHEMBL621733,7860,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL621734,7861,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL621735,7862,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Intermediate,1,,N,50597,,,11149,,,1
,CHEMBL621736,7863,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Clearance of the drug was measured in the plasma of rat; No data,Intermediate,1,,N,50597,1969.0,,17796,,,1
,CHEMBL621737,7864,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The pharmacokinetic parameter plasma clearance in vivo in rats,Intermediate,1,,N,50597,1969.0,,5247,,,1
,CHEMBL621738,7865,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance at the dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,4727,,,1
,CHEMBL622806,7866,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL623519,7867,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL623520,7868,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL623521,7869,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,1,,N,50597,,,17065,In vivo,,1
,CHEMBL623522,7870,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,1,,N,50597,,,17671,In vivo,,1
,CHEMBL623523,7871,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rate in rat,Intermediate,1,,N,50597,,,6672,In vivo,,1
,CHEMBL623690,7872,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rate in rat,Intermediate,1,,N,50597,,,6673,In vivo,,1
,CHEMBL623691,7873,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL623692,7874,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL623693,7875,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL623694,7876,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL623695,7877,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance of compound after iv administration of 20 mg/kg dose in rat,Intermediate,1,,N,50597,,,4413,In vivo,,1
,CHEMBL623696,7878,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL623697,7879,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL623698,7880,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,0,,U,22224,1969.0,,5005,In vivo,,1
,CHEMBL623699,7881,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Intermediate,0,,U,22224,1969.0,,5005,In vivo,,1
,CHEMBL623700,7882,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean (%CV) PK parameters for CL(mL/min/kg).,Intermediate,1,,N,50597,,,15765,In vivo,,1
,CHEMBL623701,7883,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Intermediate,1,,N,50597,,,3747,In vivo,,1
,CHEMBL623702,7884,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Intermediate,1,,N,50597,1969.0,,16366,In vivo,,1
,CHEMBL623703,7885,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Intermediate,1,,N,50597,,,4199,In vivo,,1
,CHEMBL623704,7886,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat was determined,Intermediate,1,,N,50597,,,17267,In vivo,,1
,CHEMBL623705,7887,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL623706,7888,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL623707,7889,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined,Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL623708,7890,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,5960,In vivo,,1
,CHEMBL623709,7891,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,1,,N,50597,,,5937,In vivo,,1
,CHEMBL623710,7892,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat by iv administration,Intermediate,1,,N,50597,,,5871,In vivo,,1
,CHEMBL623711,7893,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Intermediate,1,,N,50597,,,5874,In vivo,,1
,CHEMBL623712,7894,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat p.o.,Intermediate,1,,N,50597,,,6504,In vivo,,1
,CHEMBL623713,7895,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rats,Intermediate,1,,N,50597,,,6803,In vivo,,1
,CHEMBL623714,7896,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined; ND denotes no data,Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL623715,7897,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined; ND denotes not determined,Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL623716,7898,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,1,,N,50597,,,1916,In vivo,,1
,CHEMBL622980,7899,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,1,,N,50597,,,5199,In vivo,,1
,CHEMBL622981,7900,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma administration to rats,Intermediate,1,,N,50597,,,16367,In vivo,,1
,CHEMBL622982,7901,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance of the compound in female Sprague-Dawley rats,Intermediate,1,,N,50597,,,6362,In vivo,,1
,CHEMBL622983,7902,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was observed after intravenous administration in rat,Intermediate,1,,N,50597,,,15662,In vivo,,1
,CHEMBL622984,7903,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,1,,N,50597,,,6215,In vivo,,1
,CHEMBL622985,7904,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,1,,N,50597,,,1466,In vivo,,1
,CHEMBL623631,7905,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,plasma clearance was observed after intravenous administration in rat,Intermediate,1,,N,50597,1969.0,,15662,In vivo,,1
,CHEMBL623632,7906,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo CL/F determined,Intermediate,1,,N,50597,,,4723,In vivo,,1
,CHEMBL623633,7907,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,1969.0,,2792,In vivo,,1
,CHEMBL623634,7908,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,1969.0,,2792,In vivo,,1
,CHEMBL623635,7909,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for the lower blood clearance in rat,Intermediate,1,,N,50597,,,5213,In vivo,,1
,CHEMBL621195,7910,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for the low clearance in rat (in vivo),Intermediate,1,,N,50597,,,4687,In vivo,,1
,CHEMBL621196,7911,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (CLb)of the compound was determined in rat,Intermediate,1,,N,50597,,,3371,In vivo,,1
,CHEMBL875287,7912,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Rapid clearance after intravenous administration in rat was determined,Intermediate,1,,N,50597,,,4690,In vivo,,1
,CHEMBL621197,7913,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance measured in rat,Intermediate,1,,N,50597,,,5702,In vivo,,1
,CHEMBL621198,7914,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for plasma clearance in rat,Intermediate,1,,N,50597,1969.0,,740,In vivo,,1
,CHEMBL621199,7915,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Low plasma clearance was calculated in rat,Intermediate,1,,N,50597,1969.0,,4853,In vivo,,1
,CHEMBL621200,7916,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Clp) in rat,Intermediate,1,,N,50597,,,5789,In vivo,,1
,CHEMBL621201,7917,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,In vivo,,1
,CHEMBL621202,7918,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,In vivo,,1
,CHEMBL621203,7919,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL621204,7920,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after IV dosing at 1 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL621205,7921,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621206,7922,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621207,7923,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621208,7924,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621209,7925,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL876484,7926,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621210,7927,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621211,7928,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621212,7929,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621213,7930,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621214,7931,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621215,7932,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621216,7933,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621217,7934,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621218,7935,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621219,7936,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621220,7937,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621221,7938,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621222,7939,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621223,7940,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL876485,7941,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621224,7942,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621225,7943,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621226,7944,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Intermediate,1,,N,50597,948.0,,9866,In vivo,,1
,CHEMBL621227,7945,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621228,7946,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621229,7947,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621230,7948,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621231,7949,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621232,7950,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621233,7951,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621234,7952,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621235,7953,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621236,7954,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL621237,7955,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL876486,7956,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Intermediate,1,,N,50597,2113.0,,9866,In vivo,,1
,CHEMBL622436,7957,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Intermediate,1,,N,50597,160.0,,9866,In vivo,,1
,CHEMBL622437,7958,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,1,,N,50597,160.0,,9866,In vivo,,1
,CHEMBL622438,7959,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,1,,N,50597,160.0,,9866,In vivo,,1
,CHEMBL622439,7960,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622440,7961,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622441,7962,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622442,7963,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622443,7964,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622444,7965,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622445,7966,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622446,7967,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622447,7968,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622448,7969,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622449,7970,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622450,7971,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622451,7972,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622452,7973,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622453,7974,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622454,7975,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622455,7976,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL876024,7977,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL622456,7978,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,T max was determined at 3 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL622457,7979,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,In vivo,,1
,CHEMBL622458,7980,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,In vivo,,1
,CHEMBL622459,7981,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL873343,7982,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL622460,7983,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL622461,7984,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time for maximum plasma concentration determined in rat,Intermediate,1,,N,50597,1969.0,,4576,,,1
,CHEMBL622462,7985,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,1,,N,50597,1969.0,,6681,In vivo,,1
,CHEMBL622463,7986,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL622464,7987,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL622465,7988,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL622466,7989,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL622467,7990,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL622468,7991,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time of maximum plasma concentration in rat,Intermediate,1,,N,50597,1969.0,,6824,,,1
,CHEMBL876025,7992,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,1,,N,50597,1969.0,,6685,,,1
,CHEMBL622469,7993,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,1,,N,50597,1969.0,,6685,,,1
,CHEMBL622470,7994,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,1,,N,50597,1969.0,,6685,,,1
,CHEMBL622471,7995,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,1,,N,50597,,,15662,In vivo,,1
,CHEMBL622472,7996,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time required to reach maximum concentration in rat plasma,Intermediate,1,,N,50597,1969.0,,1742,,,1
,CHEMBL622473,7997,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,1,,N,50597,1969.0,,2774,In vivo,,1
,CHEMBL624282,7998,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,1,,N,50597,1969.0,,5199,In vivo,,1
,CHEMBL624283,7999,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,1,,N,50597,1969.0,,12873,In vivo,,1
,CHEMBL624284,8000,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,1,,N,50597,1969.0,,12873,In vivo,,1
,CHEMBL624285,8001,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,1,,N,50597,1969.0,,1916,In vivo,,1
,CHEMBL624286,8002,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time to reach Cmax after oral administration to rats,Intermediate,1,,N,50597,,,16367,In vivo,,1
,CHEMBL624287,8003,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Intermediate,1,,N,50597,,,16366,In vivo,,1
,CHEMBL624288,8004,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Intermediate,1,,N,50597,,,216,,,1
,CHEMBL624289,8005,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,1,,N,50597,1969.0,,6410,In vivo,,1
,CHEMBL873344,8006,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Intermediate,1,,N,50597,1969.0,,6410,In vivo,,1
,CHEMBL619623,8007,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax after peroral administration (10 mg/kg) was determined in rat,Intermediate,1,,N,50597,,,6215,In vivo,,1
,CHEMBL621399,8008,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,,,3598,In vivo,,1
,CHEMBL621400,8009,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,In vivo,,1
,CHEMBL621401,8010,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,1,,N,50597,,,17670,In vivo,,1
,CHEMBL621402,8011,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax was determined,Intermediate,1,,N,50597,,,1465,,,1
,CHEMBL621403,8012,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax was determined,Intermediate,1,,N,50597,,,2552,,,1
,CHEMBL621121,8013,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax after oral administration in rat,Intermediate,1,,N,50597,,,5656,In vivo,,1
,CHEMBL872525,8014,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax after peroral administration in rats at 2.4 uM/kg,Intermediate,1,,N,50597,,,17764,In vivo,,1
,CHEMBL621122,8015,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax in male rat,Intermediate,1,,N,50597,,,5610,,,1
,CHEMBL621123,8016,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax in rat at 10 mg/kg,Intermediate,1,,N,50597,,,6046,In vivo,,1
,CHEMBL621124,8017,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax in rat by po administration at a dose of 40 mg/kg,Intermediate,1,,N,50597,,,5874,In vivo,,1
,CHEMBL621125,8018,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax in rats,Intermediate,1,,N,50597,,,17596,,,1
,CHEMBL621126,8019,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax was measured in rats after peroral administration at 5 mg/kg,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL621127,8020,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,1,,N,50597,,,1908,In vivo,,1
,CHEMBL621128,8021,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,1,,N,50597,,,2959,In vivo,,1
,CHEMBL618263,8022,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax value at a dose of 10 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,In vivo,,1
,CHEMBL618264,8023,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax value at a dose of 100 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,In vivo,,1
,CHEMBL618265,8024,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax value at a dose of 50 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,In vivo,,1
,CHEMBL618266,8025,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,1,,N,50597,1969.0,,4186,In vivo,,1
,CHEMBL618267,8026,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,1,,N,50597,,,15662,In vivo,,1
,CHEMBL618450,8027,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Intermediate,1,,N,50597,1088.0,,429,,,1
,CHEMBL618451,8028,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Intermediate,1,,N,50597,1088.0,,429,,,1
,CHEMBL618452,8029,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,1,,N,50597,,,5546,,,1
,CHEMBL618453,8030,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Intermediate,1,,N,50597,1088.0,,3173,,,1
,CHEMBL618454,8031,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Intermediate,1,,N,50597,1088.0,,3173,,,1
,CHEMBL618455,8032,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Intermediate,1,,N,50597,1088.0,,3173,,,1
,CHEMBL618456,8033,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Intermediate,1,,N,50597,,,4257,In vivo,,1
,CHEMBL618457,8034,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound distribution in rat tissues was determined,Intermediate,1,,N,50597,,,6011,In vivo,,1
,CHEMBL618458,8035,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was evaluated in rat,Intermediate,1,,N,50597,,,5472,In vivo,,1
,CHEMBL618459,8036,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL876733,8037,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL618460,8038,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Intermediate,1,,N,50588,,,14346,,,1
,CHEMBL618461,8039,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL618462,8040,BAO_0000019,A,,,,,,,Area under the curve was determined after oral administration (300 uM/Kg),Autocuration,0,,U,22224,,,15469,,,1
,CHEMBL618463,8041,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL618464,8042,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL618465,8043,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL618466,8044,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL618467,8045,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Intermediate,1,,N,50597,,,14346,,,1
,CHEMBL618468,8046,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,1,,N,50597,,,15372,,,1
,CHEMBL618469,8047,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Intermediate,1,,N,50588,1969.0,,12935,,,1
,CHEMBL618470,8048,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Intermediate,1,,N,50588,1969.0,,12935,,,1
,CHEMBL618471,8049,BAO_0000218,A,,,,,,,Plasma drug AUC in rat (PO dose),Autocuration,0,,U,22224,,,14813,,,1
,CHEMBL618472,8050,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Intermediate,1,,N,50594,,,15792,,,1
,CHEMBL618473,8051,BAO_0000218,A,,,,,,,Area under was determined at a dose of 30 mg/kg,Autocuration,0,,U,22224,,,3579,,,1
,CHEMBL621699,8052,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Intermediate,1,,N,50506,,,12487,,,1
,CHEMBL621700,8053,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Intermediate,1,,N,50597,,,12487,,,1
,CHEMBL621701,8054,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Intermediate,1,,N,50597,,,12487,,,1
,CHEMBL621702,8055,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Intermediate,1,,N,50506,,,12487,,,1
,CHEMBL621703,8056,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,1,,N,50588,,,12487,,,1
,CHEMBL621704,8057,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Intermediate,1,,N,50588,,,12487,,,1
,CHEMBL624259,8058,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL624260,8059,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL624430,8060,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL624431,8061,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL624432,8062,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL624433,8063,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL624434,8064,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL624435,8065,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL618570,8066,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL618571,8067,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL618572,8068,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL618573,8069,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL619267,8070,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL619431,8071,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL619432,8072,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL619433,8073,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL619434,8074,BAO_0000218,A,,,,Plasma,,,AUC in mice after oral dose (50 mg/kg),Autocuration,0,,U,22224,1969.0,,13298,,,1
,CHEMBL619435,8075,BAO_0000218,A,,,10090.0,Serum,Mus musculus,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Intermediate,1,,N,50594,1977.0,,12226,,,1
,CHEMBL619436,8076,BAO_0000019,A,,,,Plasma,,,AUC (0-4 hr) ug/ml/h,Autocuration,0,,U,22224,1969.0,,12634,,,1
,CHEMBL619437,8077,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Intermediate,1,,N,50597,,,14810,,,1
,CHEMBL619438,8078,BAO_0000218,A,,,,,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,Autocuration,0,,U,22224,,,13889,,,1
,CHEMBL619439,8079,BAO_0000218,A,,,10090.0,,Mus musculus,,Compound was evaluated for Area under curve in mice,Intermediate,1,,N,50594,,,10018,,,1
,CHEMBL619440,8080,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,1,,N,50597,,,8758,,,1
,CHEMBL619441,8081,BAO_0000218,F,,,,,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Autocuration,0,,U,22224,,,8758,,,1
,CHEMBL619442,8082,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,1,,N,50597,,,8758,,,1
,CHEMBL875156,8083,BAO_0000019,A,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,Autocuration,0,,U,22224,,,2249,,,1
,CHEMBL619443,8084,BAO_0000019,A,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,Autocuration,0,,U,22224,,,2249,,,1
,CHEMBL619444,8085,BAO_0000019,A,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,Autocuration,0,,U,22224,,,2249,,,1
,CHEMBL623464,8086,BAO_0000019,A,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,Autocuration,0,,U,22224,,,2249,,,1
,CHEMBL623465,8087,BAO_0000218,A,,,10090.0,,Mus musculus,,Compound was evaluated for area under curve when administered through oral route in mouse,Intermediate,1,,N,50594,,,15115,,,1
,CHEMBL623466,8088,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL623467,8089,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL623468,8090,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,6249,In vivo,,1
,CHEMBL622660,8091,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,1,,N,50597,,,2463,In vivo,,1
,CHEMBL622661,8092,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance rate in Sprague-Dawley rats,Intermediate,1,,N,50597,,,4969,In vivo,,1
,CHEMBL622662,8093,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,,,17720,In vivo,,1
,CHEMBL622663,8094,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (total body clearance) in rat,Intermediate,1,,N,50597,,,3457,In vivo,,1
,CHEMBL622664,8095,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,1,,N,50597,,,5983,In vivo,,1
,CHEMBL622665,8096,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6295,,,1
,CHEMBL622666,8097,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6296,,,1
,CHEMBL621615,8098,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cl in rat i.v. at 2 mg/kg concentration,Intermediate,1,,N,50597,,,17686,In vivo,,1
,CHEMBL621616,8099,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance of compound after intravenous administration in rats at 24 uM/kg,Intermediate,1,,N,50597,,,17764,In vivo,,1
,CHEMBL621617,8100,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance was determined,Intermediate,1,,N,50597,,,5503,In vivo,,1
,CHEMBL621618,8101,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance by intravenous administration of 3.4 mg/kg in rat,Intermediate,1,,N,50597,,,4368,In vivo,,1
,CHEMBL621619,8102,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,1,,N,50597,,,6005,In vivo,,1
,CHEMBL621620,8103,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rate after i.v. administration in rats,Intermediate,1,,N,50597,,,5031,In vivo,,1
,CHEMBL621786,8104,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,,,4890,In vivo,,1
,CHEMBL621787,8105,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,1,,N,50597,,,5182,In vivo,,1
,CHEMBL621788,8106,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Intermediate,1,,N,50597,,,5979,In vivo,,1
,CHEMBL621789,8107,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance (Cl) after oral administration in rat,Intermediate,1,,N,50597,,,5656,In vivo,,1
,CHEMBL621790,8108,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL621791,8109,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma clearance in rat,Intermediate,1,,N,50597,1969.0,,4839,In vivo,,1
,CHEMBL621792,8110,BAO_0000218,A,Microsomes,,10116.0,,Rattus norvegicus,,In vitro microsome metabolism clearance in rat was determined,Intermediate,1,,N,50597,,,5041,In vitro,,1
,CHEMBL621793,8111,BAO_0000218,A,Microsomes,,10116.0,,Rattus norvegicus,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Intermediate,1,,N,50597,,,5041,In vitro,,1
,CHEMBL621794,8112,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL621795,8113,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,In vivo plasma clearance was determined,Intermediate,1,,N,50597,1969.0,,5496,In vivo,,1
,CHEMBL621796,8114,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Intermediate,1,,N,50597,,,5739,In vivo,,1
,CHEMBL621797,8115,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Intermediate,1,Hepatocyte,N,50597,2107.0,,5676,In vivo,401.0,1
,CHEMBL621798,8116,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Plasma clearance) was measured in rat,Intermediate,1,,N,50597,,,4239,In vivo,,1
,CHEMBL621799,8117,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (clearance) in rat i.v.,Intermediate,1,,N,50597,,,5676,In vivo,,1
,CHEMBL621800,8118,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma Clearance was evaluated in rats, iv",Intermediate,1,,N,50597,,,1918,In vivo,,1
,CHEMBL621801,8119,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance (in vivo) in rats was determined,Intermediate,1,,N,50597,,,17800,In vivo,,1
,CHEMBL621802,8120,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,1,,N,50597,,,6056,In vivo,,1
,CHEMBL618596,8121,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined,Intermediate,1,,N,50597,,,5496,In vivo,,1
,CHEMBL618597,8122,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL618598,8123,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL618599,8124,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rats,Intermediate,1,,N,50597,,,17752,In vivo,,1
,CHEMBL618600,8125,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance rate determined in rat,Intermediate,1,,N,50597,,,4576,In vivo,,1
,CHEMBL618601,8126,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined in rat,Intermediate,1,,N,50597,,,6011,In vivo,,1
,CHEMBL618602,8127,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined,Intermediate,1,,N,50597,,,5510,In vivo,,1
,CHEMBL618603,8128,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance value in rat,Intermediate,1,,N,50597,,,5948,In vivo,,1
,CHEMBL618604,8129,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,1,,N,50597,2107.0,,6125,Ex vivo,,1
,CHEMBL618605,8130,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in rat,Intermediate,1,,N,50597,,,4839,In vivo,,1
,CHEMBL618606,8131,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total body clearance in rat i.v. at 2 mg/kg concentration,Intermediate,1,,N,50597,,,17686,In vivo,,1
,CHEMBL618607,8132,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance of compound in rats after intravenous administration,Intermediate,1,,N,50597,,,6571,In vivo,,1
,CHEMBL618608,8133,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance after iv administration to rats,Intermediate,1,,N,50597,,,3364,In vivo,,1
,CHEMBL618609,8134,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618610,8135,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618611,8136,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618612,8137,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618613,8138,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL621076,8139,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL621077,8140,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL621078,8141,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,1,,N,50597,,,17670,In vivo,,1
,CHEMBL621251,8142,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in rat,Intermediate,1,,N,50597,,,5970,In vivo,,1
,CHEMBL621252,8143,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in rat after oral administration at 10 mg/kg,Intermediate,1,,N,50597,,,6495,In vivo,,1
,CHEMBL621253,8144,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in rat.,Intermediate,1,,N,50597,,,4590,In vivo,,1
,CHEMBL621254,8145,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rate following an oral dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,6193,In vivo,,1
,CHEMBL621255,8146,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Intermediate,1,,N,50597,,,2832,In vivo,,1
,CHEMBL621256,8147,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Intermediate,1,,N,50597,1969.0,,1052,In vivo,,1
,CHEMBL621257,8148,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621258,8149,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621259,8150,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621260,8151,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL876494,8152,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621261,8153,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621262,8154,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621263,8155,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621264,8156,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Intermediate,1,,N,50597,2107.0,,9866,In vivo,,1
,CHEMBL621265,8157,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621266,8158,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621267,8159,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621268,8160,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621269,8161,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621270,8162,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621271,8163,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621272,8164,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621273,8165,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621274,8166,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL876495,8167,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621275,8168,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621276,8169,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621277,8170,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Intermediate,1,,N,50597,2385.0,,9866,In vivo,,1
,CHEMBL621278,8171,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,1,,N,50597,160.0,,9866,In vivo,,1
,CHEMBL621279,8172,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,1,,N,50597,160.0,,9866,In vivo,,1
,CHEMBL621280,8173,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Intermediate,1,,N,50597,160.0,,9866,In vivo,,1
,CHEMBL621281,8174,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL621282,8175,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL621283,8176,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL621284,8177,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL621285,8178,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL621286,8179,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL623220,8180,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL623221,8181,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL876029,8182,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Intermediate,1,,N,50597,2106.0,,9866,In vivo,,1
,CHEMBL623222,8183,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Intermediate,1,,N,50597,945.0,,9866,In vivo,,1
,CHEMBL623223,8184,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Intermediate,1,,N,50597,945.0,,9866,In vivo,,1
,CHEMBL621445,8185,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Intermediate,1,,N,50597,945.0,,9866,In vivo,,1
,CHEMBL621446,8186,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,178.0,,13950,In vivo,,1
,CHEMBL621447,8187,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,178.0,,13950,In vivo,,1
,CHEMBL619681,8188,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,178.0,,13950,In vivo,,1
,CHEMBL619682,8189,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,178.0,,13950,In vivo,,1
,CHEMBL619683,8190,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,178.0,,13950,In vivo,,1
,CHEMBL619684,8191,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,955.0,,13950,In vivo,,1
,CHEMBL619685,8192,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,955.0,,13950,In vivo,,1
,CHEMBL619686,8193,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,955.0,,13950,In vivo,,1
,CHEMBL619687,8194,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,955.0,,13950,In vivo,,1
,CHEMBL619688,8195,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,955.0,,13950,In vivo,,1
,CHEMBL619689,8196,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,948.0,,13950,In vivo,,1
,CHEMBL619690,8197,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,948.0,,13950,In vivo,,1
,CHEMBL619691,8198,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,948.0,,13950,In vivo,,1
,CHEMBL619692,8199,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,1,,N,50597,,,6062,In vivo,,1
,CHEMBL619693,8200,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,,,3598,,,1
,CHEMBL619694,8201,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Vc value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,1,,N,50597,,,1908,In vivo,,1
,CHEMBL619695,8202,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Intermediate,1,,N,50597,,,17596,In vivo,,1
,CHEMBL619696,8203,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for pharmacokinetic parameter volume of distribution,Intermediate,1,,N,50597,,,4891,In vivo,,1
,CHEMBL619697,8204,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for volume of distribution in rat,Intermediate,1,,N,50597,,,740,In vivo,,1
,CHEMBL619698,8205,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume distribution was determined; steady state(ss),Intermediate,1,,N,50597,,,16366,In vivo,,1
,CHEMBL619699,8206,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume of distribution after iv administration to rats,Intermediate,1,,N,50597,,,3364,In vivo,,1
,CHEMBL619700,8207,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume of distribution dosing at 3 mg/kg iv,Intermediate,1,,N,50597,,,2552,In vivo,,1
,CHEMBL619701,8208,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was evaluated for volume of distribution in rat,Intermediate,1,,N,50597,,,406,In vivo,,1
,CHEMBL619702,8209,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for volume of distribution in rat,Intermediate,1,,N,50597,,,12500,In vivo,,1
,CHEMBL620335,8210,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Intermediate,1,,N,50597,,,12500,In vivo,,1
,CHEMBL620336,8211,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution (VD) after oral administration in rat,Intermediate,1,,N,50597,,,5656,In vivo,,1
,CHEMBL620337,8212,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,1,,N,50597,,,17671,In vivo,,1
,CHEMBL620520,8213,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat,Intermediate,1,,N,50597,,,1094,In vivo,,1
,CHEMBL620521,8214,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat,Intermediate,1,,N,50597,,,5833,In vivo,,1
,CHEMBL875825,8215,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat after peroral administration at 10 mg/kg,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL620522,8216,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat after peroral administration at 5 mg/kg,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL620523,8217,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,1,,N,50597,,,6005,In vivo,,1
,CHEMBL620524,8218,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rat.,Intermediate,1,,N,50597,,,1696,In vivo,,1
,CHEMBL620525,8219,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rat,Intermediate,1,,N,50597,,,6672,In vivo,,1
,CHEMBL620526,8220,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rat,Intermediate,1,,N,50597,,,6673,In vivo,,1
,CHEMBL620527,8221,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rat by iv administration,Intermediate,1,,N,50597,,,5871,In vivo,,1
,CHEMBL620528,8222,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rats,Intermediate,1,,N,50597,,,6803,In vivo,,1
,CHEMBL620529,8223,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,1,,N,50597,,,5199,In vivo,,1
,CHEMBL620530,8224,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution at the dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,4727,,,1
,CHEMBL620531,8225,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume of distribution was determined,Intermediate,1,,N,50597,,,16367,In vivo,,1
,CHEMBL620532,8226,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,0,,U,22224,,,5005,In vivo,,1
,CHEMBL620533,8227,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Intermediate,0,,U,22224,,,5005,In vivo,,1
,CHEMBL620534,8228,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Intermediate,0,,U,22224,,,5005,In vivo,,1
,CHEMBL620535,8229,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean (%CV) PK parameters for Vdss(mL/kg).,Intermediate,1,,N,50597,,,15765,In vivo,,1
,CHEMBL875826,8230,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL620536,8231,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL620537,8232,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL618526,8233,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL618527,8234,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Intermediate,1,,N,50597,,,5739,In vivo,,1
,CHEMBL618528,8235,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Vdss) in rat,Intermediate,1,,N,50597,,,5789,In vivo,,1
,CHEMBL618529,8236,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (vdss) was measured in rat,Intermediate,1,,N,50597,,,4239,In vivo,,1
,CHEMBL618530,8237,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Intermediate,1,,N,50597,,,4709,In vivo,,1
,CHEMBL618531,8238,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rat,Intermediate,1,,N,50597,,,6642,In vivo,,1
,CHEMBL618532,8239,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The pharmacokinetic parameter volume of distribution in vivo in rats,Intermediate,1,,N,50597,,,5247,In vivo,,1
,CHEMBL618533,8240,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,,,17720,In vivo,,1
,CHEMBL618534,8241,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Vdss in rat i.v. at 2 mg/kg concentration,Intermediate,1,,N,50597,,,17686,In vivo,,1
,CHEMBL618535,8242,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution after intravenous administration (1 mg/kg) in rat,Intermediate,1,,N,50597,,,4689,In vivo,,1
,CHEMBL618536,8243,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL618537,8244,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL618538,8245,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution at a dose of 10 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,In vivo,,1
,CHEMBL618539,8246,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,1,,N,50597,,,4521,In vivo,,1
,CHEMBL618540,8247,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution was calculated in rat,Intermediate,1,,N,50597,,,6057,In vivo,,1
,CHEMBL618541,8248,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution was determined,Intermediate,1,,N,50597,,,5510,In vivo,,1
,CHEMBL618542,8249,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution after intravenous administration was evaluated in rat,Intermediate,1,,N,50597,,,2938,In vivo,,1
,CHEMBL622544,8250,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,1,,N,50597,,,6679,In vivo,,1
,CHEMBL622545,8251,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL622546,8252,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL622547,8253,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL622548,8254,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in steady state was determined in rat,Intermediate,1,,N,50597,,,5145,In vivo,,1
,CHEMBL622549,8255,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,1,,N,50597,,,6467,In vivo,,1
,CHEMBL622550,8256,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,1,,N,50597,,,6467,In vivo,,1
,CHEMBL622551,8257,BAO_0000218,A,,,10090.0,,Mus musculus,,Compound was evaluated for area under curve when administered through oral route to mouse,Intermediate,1,,N,50594,,,15115,,,1
,CHEMBL622552,8258,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,1,,N,50597,,,8758,,,1
,CHEMBL622553,8259,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,1,,N,50597,,,8758,,,1
,CHEMBL622554,8260,BAO_0000218,F,,,,,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,Autocuration,0,,U,22224,,,8267,In vivo,,1
,CHEMBL622555,8261,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Intermediate,1,,N,50588,,,8267,,,1
,CHEMBL622556,8262,BAO_0000218,A,,,10090.0,,Mus musculus,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Intermediate,1,,N,50594,,,14239,,,1
,CHEMBL622557,8263,BAO_0000218,A,,,10090.0,,Mus musculus,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Intermediate,1,,N,50594,,,14239,,,1
,CHEMBL622558,8264,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Intermediate,1,,N,50594,178.0,,10754,,,1
,CHEMBL622559,8265,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Intermediate,1,,N,50594,178.0,,10754,,,1
,CHEMBL622560,8266,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Intermediate,1,,N,50588,,,10754,,,1
,CHEMBL622561,8267,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,1,,N,50597,,,14681,,,1
,CHEMBL622562,8268,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Intermediate,1,,N,50597,,,14681,,,1
,CHEMBL622563,8269,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,1,,N,50597,,,14681,,,1
,CHEMBL622564,8270,BAO_0000019,A,,,,,,,Concentration of compound in Central nervous system,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622565,8271,BAO_0000019,A,,,,,,,Concentration of compound in Central nervous system; Not detectable,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622566,8272,BAO_0000218,A,,,10090.0,,Mus musculus,,"Concentration of diester in the blood, following oral administration in mice",Intermediate,1,,N,50594,,,13318,,,1
,CHEMBL624515,8273,BAO_0000218,A,,,10090.0,,Mus musculus,,"Concentration of monoester in the blood, following oral administration in mice",Intermediate,1,,N,50594,,,13318,,,1
,CHEMBL624516,8274,BAO_0000218,A,,,10090.0,,Mus musculus,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Intermediate,1,,N,50594,,,13318,,,1
,CHEMBL624517,8275,BAO_0000019,A,,,,,,,Evaluated for Pharmacokinetic property: Area under the curve,Autocuration,0,,U,22224,,,15692,,,1
,CHEMBL624518,8276,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL624519,8277,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL624520,8278,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL624521,8279,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL624522,8280,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL624523,8281,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL624409,8282,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL624410,8283,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL624411,8284,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL623531,8285,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL623532,8286,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL623533,8287,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL623534,8288,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,1,,N,100710,,,14839,,,1
,CHEMBL623535,8289,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623536,8290,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623537,8291,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623538,8292,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623539,8293,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623540,8294,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623541,8295,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623542,8296,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623543,8297,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623544,8298,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623545,8299,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623546,8300,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623547,8301,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,1969.0,,5408,In vivo,,1
,CHEMBL623548,8302,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,High i.v. clearance in Dawley rats,Intermediate,1,,N,50597,,,6827,In vivo,,1
,CHEMBL623549,8303,BAO_0000218,A,Microsomes,,10116.0,Liver,Rattus norvegicus,,In vitro clearance in rat liver microsomes,Intermediate,1,,N,50597,2107.0,,17538,In vitro,,1
,CHEMBL623550,8304,BAO_0000218,A,Microsomes,,10116.0,Liver,Rattus norvegicus,,Intrinsic clearance in rat liver microsomes was determined,Intermediate,1,,N,50597,2107.0,,6331,In vitro,,1
,CHEMBL875276,8305,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Intrinsic clearance in rat hepatocytes was determined,Intermediate,1,Hepatocyte,N,50597,2107.0,,5948,In vitro,401.0,1
,CHEMBL621872,8306,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma Clearance was determined,Intermediate,1,,N,50597,,,4026,In vivo,,1
,CHEMBL621873,8307,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Intermediate,1,,N,50597,,,6647,In vivo,,1
,CHEMBL621874,8308,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat.,Intermediate,1,,N,50597,,,1696,In vivo,,1
,CHEMBL621875,8309,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rats,Intermediate,1,,N,50597,,,6597,In vivo,,1
,CHEMBL621876,8310,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Intermediate,1,,N,50597,,,347,In vivo,,1
,CHEMBL621877,8311,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Intermediate,1,,N,50597,,,16423,In vivo,,1
,CHEMBL621878,8312,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was measured in rat,Intermediate,1,,N,50597,,,2879,In vivo,,1
,CHEMBL621879,8313,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,1,,N,50597,,,4883,In vivo,,1
,CHEMBL621880,8314,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Intermediate,1,,N,50597,1969.0,,5328,In vivo,,1
,CHEMBL621881,8315,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Intermediate,1,,N,50597,,,5160,In vivo,,1
,CHEMBL621882,8316,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL875283,8317,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total clearance at 1 mg/kg was determined in rat,Intermediate,1,,N,50597,,,17651,In vivo,,1
,CHEMBL621883,8318,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total clearance at 10 mg/kg was determined in rat,Intermediate,1,,N,50597,,,17651,In vivo,,1
,CHEMBL621884,8319,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in rat,Intermediate,1,,N,50597,,,6596,In vivo,,1
,CHEMBL621885,8320,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance rate determined in rats,Intermediate,1,,N,50597,,,4796,In vivo,,1
,CHEMBL621886,8321,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance of compound in rat was evaluated,Intermediate,1,,N,50597,,,6850,In vivo,,1
,CHEMBL621887,8322,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,5932,In vivo,,1
,CHEMBL621888,8323,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (blood clearance) in rat,Intermediate,1,,N,50597,,,3371,In vivo,,1
,CHEMBL621889,8324,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,2083,In vivo,,1
,CHEMBL621890,8325,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rats,Intermediate,1,,N,50597,,,4942,In vivo,,1
,CHEMBL621891,8326,BAO_0000218,A,Microsomes,,10116.0,Liver,Rattus norvegicus,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Intermediate,1,,N,50597,2107.0,,6838,In vitro,,1
,CHEMBL621892,8327,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in Dawley rat,Intermediate,1,,N,50597,,,5353,In vivo,,1
,CHEMBL621893,8328,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rat,Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL621894,8329,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL621895,8330,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rat; Not determined,Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL875284,8331,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL618699,8332,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL618700,8333,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL618701,8334,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,1,,N,50597,,,6211,In vivo,,1
,CHEMBL876600,8335,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,1,,N,50597,1969.0,,12873,In vivo,,1
,CHEMBL618702,8336,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance of compound in rat after 1 mg/kg i.v. administration,Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL618703,8337,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for Hepatic clearance in rat,Intermediate,1,,N,50597,,,3341,In vivo,,1
,CHEMBL618704,8338,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo clearance after 5 mg/kg dose,Intermediate,1,,N,50597,,,4891,In vivo,,1
,CHEMBL618705,8339,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma clearance in rats,Intermediate,1,,N,50597,1969.0,,1094,In vivo,,1
,CHEMBL618706,8340,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Hepatic clearance after intravenous administration was evaluated in rat,Intermediate,1,,N,50597,,,2938,In vivo,,1
,CHEMBL618707,8341,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Lower clearance in rat (i.v.) at 0.5 mpk,Intermediate,1,,N,50597,,,17853,In vivo,,1
,CHEMBL618708,8342,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Pharmacokinetic parameter expressed as plasma clearance in rat,Intermediate,1,,N,50597,1969.0,,6049,In vivo,,1
,CHEMBL618709,8343,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Clp) in rat,Intermediate,1,,N,50597,,,5789,In vivo,,1
,CHEMBL618710,8344,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in Sprague-Dawley rats,Intermediate,1,,N,50597,,,4514,In vivo,,1
,CHEMBL618711,8345,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance (Clp) in rat,Intermediate,1,,N,50597,,,6448,In vivo,,1
,CHEMBL618712,8346,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Intermediate,1,,N,50597,,,6062,In vivo,,1
,CHEMBL618713,8347,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Intermediate,1,,N,50597,,,5710,In vivo,,1
,CHEMBL618714,8348,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after intravenous administration of 1 mg/kg in rat,Intermediate,1,,N,50597,,,4709,In vivo,,1
,CHEMBL618715,8349,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,1,,N,50597,,,4521,In vivo,,1
,CHEMBL618716,8350,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat was determined,Intermediate,1,,N,50597,,,1742,In vivo,,1
,CHEMBL876601,8351,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance measured in rat,Intermediate,1,,N,50597,,,6057,In vivo,,1
,CHEMBL618717,8352,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was calculated in rat,Intermediate,1,,N,50597,,,6057,In vivo,,1
,CHEMBL618718,8353,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,5145,In vivo,,1
,CHEMBL618719,8354,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,5833,In vivo,,1
,CHEMBL618720,8355,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,6453,In vivo,,1
,CHEMBL618721,8356,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,6640,In vivo,,1
,CHEMBL621477,8357,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rats,Intermediate,1,,N,50597,,,6305,In vivo,,1
,CHEMBL621478,8358,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,6642,In vivo,,1
,CHEMBL621479,8359,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was evaluated in rat,Intermediate,1,,N,50597,,,5472,In vivo,,1
,CHEMBL621480,8360,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was evaluated in rat; Not tested,Intermediate,1,,N,50597,,,5472,In vivo,,1
,CHEMBL621481,8361,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance rate was determined for the compound in rat,Intermediate,1,,N,50597,,,5144,In vivo,,1
,CHEMBL621482,8362,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL621483,8363,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL621484,8364,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL621485,8365,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,948.0,,13950,In vivo,,1
,CHEMBL621486,8366,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,948.0,,13950,In vivo,,1
,CHEMBL621487,8367,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,160.0,,13950,In vivo,,1
,CHEMBL621488,8368,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,160.0,,13950,In vivo,,1
,CHEMBL621489,8369,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,160.0,,13950,In vivo,,1
,CHEMBL621490,8370,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,160.0,,13950,In vivo,,1
,CHEMBL621491,8371,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,160.0,,13950,In vivo,,1
,CHEMBL621492,8372,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2113.0,,13950,In vivo,,1
,CHEMBL621493,8373,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2113.0,,13950,In vivo,,1
,CHEMBL621494,8374,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2113.0,,13950,In vivo,,1
,CHEMBL621495,8375,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2113.0,,13950,In vivo,,1
,CHEMBL621496,8376,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2113.0,,13950,In vivo,,1
,CHEMBL621497,8377,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2107.0,,13950,In vivo,,1
,CHEMBL621498,8378,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2107.0,,13950,In vivo,,1
,CHEMBL621499,8379,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2107.0,,13950,In vivo,,1
,CHEMBL618634,8380,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2107.0,,13950,In vivo,,1
,CHEMBL618635,8381,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2107.0,,13950,In vivo,,1
,CHEMBL618636,8382,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2048.0,,13950,In vivo,,1
,CHEMBL619737,8383,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2048.0,,13950,In vivo,,1
,CHEMBL619738,8384,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2048.0,,13950,In vivo,,1
,CHEMBL624329,8385,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2048.0,,13950,In vivo,,1
,CHEMBL624330,8386,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2048.0,,13950,In vivo,,1
,CHEMBL624331,8387,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2385.0,,13950,In vivo,,1
,CHEMBL624332,8388,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2385.0,,13950,In vivo,,1
,CHEMBL624333,8389,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2385.0,,13950,In vivo,,1
,CHEMBL624334,8390,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2385.0,,13950,In vivo,,1
,CHEMBL624335,8391,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2385.0,,13950,In vivo,,1
,CHEMBL620016,8392,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2106.0,,13950,In vivo,,1
,CHEMBL620169,8393,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2106.0,,13950,In vivo,,1
,CHEMBL620170,8394,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2106.0,,13950,In vivo,,1
,CHEMBL620171,8395,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2106.0,,13950,In vivo,,1
,CHEMBL620172,8396,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2106.0,,13950,In vivo,,1
,CHEMBL620173,8397,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,945.0,,13950,In vivo,,1
,CHEMBL620174,8398,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,945.0,,13950,In vivo,,1
,CHEMBL620175,8399,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,945.0,,13950,In vivo,,1
,CHEMBL620176,8400,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,945.0,,13950,In vivo,,1
,CHEMBL620177,8401,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,945.0,,13950,In vivo,,1
,CHEMBL620178,8402,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2037.0,,13950,,,1
,CHEMBL620179,8403,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2037.0,,13950,,,1
,CHEMBL620180,8404,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,,,13950,,,1
,CHEMBL620181,8405,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL620182,8406,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution of compound in rats after intravenous administration,Intermediate,1,,N,50597,,,6571,In vivo,,1
,CHEMBL620183,8407,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rat,Intermediate,1,,N,50597,,,6453,In vivo,,1
,CHEMBL620184,8408,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL620185,8409,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL620186,8410,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL620187,8411,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was determined in Dawley rat,Intermediate,1,,N,50597,,,5353,In vivo,,1
,CHEMBL620188,8412,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL620189,8413,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was reported in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL620190,8414,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volumes of distribution in rat after peroral administration,Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL620191,8415,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volumes of distribution in rat after po administration,Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL620192,8416,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volumes of distribution in rat after po administration; Not determined,Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL620193,8417,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,1,,N,50597,,,5676,In vivo,,1
,CHEMBL620194,8418,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Intermediate,1,,N,50597,,,6410,In vivo,,1
,CHEMBL876730,8419,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,1,,N,50597,,,17670,In vivo,,1
,CHEMBL620195,8420,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat after oral administration at 10 mg/kg,Intermediate,1,,N,50597,,,6495,In vivo,,1
,CHEMBL620196,8421,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,,,5408,In vivo,,1
,CHEMBL620197,8422,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,1,,N,50597,,,4883,In vivo,,1
,CHEMBL620198,8423,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Intermediate,1,,N,50597,,,6647,In vivo,,1
,CHEMBL620199,8424,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rats,Intermediate,1,,N,50597,,,6495,In vivo,,1
,CHEMBL620200,8425,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL620201,8426,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL620202,8427,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL620203,8428,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL620204,8429,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL620205,8430,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL624664,8431,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (Vss) in rat,Intermediate,1,,N,50597,,,5960,In vivo,,1
,CHEMBL624665,8432,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,1,,N,50597,,,5676,In vivo,,1
,CHEMBL624666,8433,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Vss) in rat,Intermediate,1,,N,50597,,,5948,,,1
,CHEMBL624667,8434,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,1,,N,50597,,,5979,In vivo,,1
,CHEMBL624668,8435,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL624669,8436,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL624670,8437,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL624671,8438,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL624672,8439,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume distribution in rat,Intermediate,1,,N,50597,,,6448,In vivo,,1
,CHEMBL624673,8440,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Intermediate,1,,N,50597,1969.0,,12873,In vivo,,1
,CHEMBL624674,8441,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state volume of distribution determined in rat,Intermediate,1,,N,50597,,,4576,In vivo,,1
,CHEMBL624675,8442,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL621728,8443,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,1,,N,50597,,,1466,In vivo,,1
,CHEMBL621729,8444,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Intermediate,1,,N,50597,,,5182,,,1
,CHEMBL621730,8445,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Intermediate,1,,N,50597,,,5182,,,1
,CHEMBL621731,8446,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL621732,8447,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL621908,8448,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume in steady state distribution value was determined,Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL875347,8449,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume in steady state distribution value was determined; ND denotes no data,Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL621909,8450,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume in steady state distribution value was determined; ND denotes not determined,Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL621910,8451,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,1,,N,50597,,,17065,In vivo,,1
,CHEMBL621911,8452,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution at steady state was evaluated in rats,Intermediate,1,,N,50597,,,6597,In vivo,,1
,CHEMBL621912,8453,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,1,,N,50597,,,15662,In vivo,,1
,CHEMBL621913,8454,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in steady state was determined in rat,Intermediate,1,,N,50597,,,6485,In vivo,,1
,CHEMBL621914,8455,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in steady state was determined in rat,Intermediate,1,,N,50597,,,17655,In vivo,,1
,CHEMBL621915,8456,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution after i.v. administration,Intermediate,1,,N,50597,,,6616,In vivo,,1
,CHEMBL621916,8457,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,1,,N,50597,,,1916,In vivo,,1
,CHEMBL621917,8458,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,1,,N,50594,2107.0,,16438,In vivo,,1
,CHEMBL621918,8459,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,1,,N,50594,2107.0,,16438,In vivo,,1
,CHEMBL621919,8460,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of compound (oxidized form) in spleen tissue,Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL621920,8461,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL621921,8462,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL622401,8463,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL875348,8464,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL622402,8465,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL622403,8466,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Intermediate,1,,N,50594,178.0,,16438,In vivo,,1
,CHEMBL622404,8467,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,1,,N,50594,178.0,,16438,In vivo,,1
,CHEMBL622405,8468,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Intermediate,1,,N,50594,955.0,,16438,In vivo,,1
,CHEMBL622406,8469,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,1,,N,50594,955.0,,16438,In vivo,,1
,CHEMBL622407,8470,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,1,,N,50594,955.0,,16438,In vivo,,1
,CHEMBL622408,8471,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Intermediate,1,,N,50594,948.0,,16438,In vivo,,1
,CHEMBL622409,8472,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,1,,N,50594,948.0,,16438,In vivo,,1
,CHEMBL622410,8473,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,1,,N,50594,948.0,,16438,In vivo,,1
,CHEMBL622411,8474,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Intermediate,1,,N,50594,2113.0,,16438,In vivo,,1
,CHEMBL627864,8475,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,1,,N,50594,2113.0,,16438,In vivo,,1
,CHEMBL627865,8476,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,1,,N,50594,2113.0,,16438,In vivo,,1
,CHEMBL627866,8477,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Intermediate,1,,N,50594,2107.0,,16438,In vivo,,1
,CHEMBL627751,8478,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,1,,N,50594,2107.0,,16438,In vivo,,1
,CHEMBL627752,8479,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL627753,8480,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL627754,8481,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,1,,N,50594,2106.0,,16438,In vivo,,1
,CHEMBL627755,8482,BAO_0000218,A,,,10090.0,,Mus musculus,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Intermediate,1,,N,50594,,,12467,,,1
,CHEMBL627756,8483,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,955.0,,17208,In vivo,,1
,CHEMBL627757,8484,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,955.0,,17208,In vivo,,1
,CHEMBL627758,8485,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,955.0,,17208,In vivo,,1
,CHEMBL627759,8486,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,955.0,,17208,In vivo,,1
,CHEMBL627760,8487,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,955.0,,17208,In vivo,,1
,CHEMBL627761,8488,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,955.0,,17208,In vivo,,1
,CHEMBL876811,8489,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,948.0,,17208,In vivo,,1
,CHEMBL627762,8490,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,948.0,,17208,In vivo,,1
,CHEMBL627763,8491,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,948.0,,17208,In vivo,,1
,CHEMBL627764,8492,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,948.0,,17208,In vivo,,1
,CHEMBL627765,8493,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,948.0,,17208,In vivo,,1
,CHEMBL627766,8494,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,948.0,,17208,In vivo,,1
,CHEMBL627767,8495,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2113.0,,17208,In vivo,,1
,CHEMBL627768,8496,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2113.0,,17208,In vivo,,1
,CHEMBL628422,8497,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2113.0,,17208,In vivo,,1
,CHEMBL628423,8498,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2113.0,,17208,In vivo,,1
,CHEMBL628424,8499,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Intermediate,1,,N,50597,,,5089,In vivo,,1
,CHEMBL628425,8500,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Intermediate,1,,N,50597,,,5089,In vivo,,1
,CHEMBL628426,8501,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Intermediate,1,,N,50597,,,4257,In vivo,,1
,CHEMBL628427,8502,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,1,,N,50597,,,6679,In vivo,,1
,CHEMBL626938,8503,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,1,,N,50597,,,5546,In vivo,,1
,CHEMBL626939,8504,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,1,,N,50597,,,6141,In vivo,,1
,CHEMBL626940,8505,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL626941,8506,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL626942,8507,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was reported in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL876812,8508,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after intravenous administration (1 mg/kg) in rat,Intermediate,1,,N,50597,,,4689,In vivo,,1
,CHEMBL626943,8509,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance of compound in rats was evaluated,Intermediate,1,,N,50597,,,6848,In vivo,,1
,CHEMBL626944,8510,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Intermediate,1,,N,50597,,,6848,In vivo,,1
,CHEMBL626945,8511,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,1,,N,50597,,,6467,In vivo,,1
,CHEMBL626946,8512,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,1,,N,50597,,,6467,In vivo,,1
,CHEMBL626856,8513,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance rate in Sprague-Dawley rats,Intermediate,1,,N,50597,,,4956,In vivo,,1
,CHEMBL626857,8514,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,1,,N,50597,,,5529,In vivo,,1
,CHEMBL626858,8515,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The compound was evaluated for plasma clearance in rat,Intermediate,1,,N,50597,1969.0,,406,In vivo,,1
,CHEMBL627018,8516,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance in rat,Intermediate,1,,N,50597,1969.0,,17655,In vivo,,1
,CHEMBL625331,8517,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Intermediate,1,,N,50597,178.0,,3293,In vivo,,1
,CHEMBL625332,8518,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Intermediate,1,,N,50597,178.0,,4075,In vivo,,1
,CHEMBL877590,8519,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,C max was determined at 10 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL625333,8520,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,C max was determined at 3 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL625334,8521,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,1,,N,50597,,,17594,In vivo,,1
,CHEMBL625335,8522,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after single intravenous bolus of 1 mg/kg in rats,Intermediate,1,,N,50597,,,17594,In vivo,,1
,CHEMBL625336,8523,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax of compound at 5 mg/kg after po administration was determined in rat,Intermediate,1,,N,50597,,,4762,In vivo,,1
,CHEMBL625337,8524,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax 24 hr after 10 mg/kg oral administration in rats,Intermediate,1,,N,50597,,,17509,In vivo,,1
,CHEMBL625338,8525,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax 24 hr after 2 mg/kg oral administration in rats,Intermediate,1,,N,50597,,,17509,In vivo,,1
,CHEMBL625339,8526,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,1,,N,50597,1969.0,,1466,In vivo,,1
,CHEMBL625340,8527,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat after administration of 2 mg/kg iv,Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL625341,8528,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat after administration of 2 mg/kg iv,Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL622687,8529,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Intermediate,1,,N,50597,,,3169,In vivo,,1
,CHEMBL622688,8530,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Intermediate,1,,N,50597,1969.0,,6515,In vivo,,1
,CHEMBL622689,8531,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Intermediate,1,,N,50597,178.0,,11149,In vivo,,1
,CHEMBL620295,8532,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Intermediate,1,,N,50597,178.0,,11149,In vivo,,1
,CHEMBL620296,8533,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after 10 mg/kg oral administration in rat,Intermediate,1,,N,50597,,,17858,In vivo,,1
,CHEMBL620297,8534,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL620298,8535,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after IV dosing at 1 mg/kg in rat; no data,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL620299,8536,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after oral administration at 20 mpk in rats,Intermediate,1,,N,50597,,,4426,In vivo,,1
,CHEMBL620300,8537,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after oral administration at 20 mpk in rats; Not performed.,Intermediate,1,,N,50597,,,4426,In vivo,,1
,CHEMBL620301,8538,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after oral administration at 20 mpk in rats d; Not performed.,Intermediate,1,,N,50597,,,4426,In vivo,,1
,CHEMBL620302,8539,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after oral administration in rat,Intermediate,1,,N,50597,,,5656,In vivo,,1
,CHEMBL620303,8540,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after oral administration at a dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL620304,8541,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after oral administration at a dose of 4 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL620305,8542,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rats after 20 mg/kg oral dose,Intermediate,1,,N,50597,,,6113,In vivo,,1
,CHEMBL620306,8543,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after peroral administration in rats at 2.4 uM/kg,Intermediate,1,,N,50597,,,17764,In vivo,,1
,CHEMBL620307,8544,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,1,,N,50597,,,4756,In vivo,,1
,CHEMBL620308,8545,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,1,,N,50597,,,4756,In vivo,,1
,CHEMBL620309,8546,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax by administering at 20 mg/kg p.o. in rats,Intermediate,1,,N,50597,,,6402,In vivo,,1
,CHEMBL620310,8547,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in male rat,Intermediate,1,,N,50597,,,5610,In vivo,,1
,CHEMBL620311,8548,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat,Intermediate,1,,N,50597,,,5207,In vivo,,1
,CHEMBL620312,8549,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat,Intermediate,1,,N,50597,,,6011,In vivo,,1
,CHEMBL620313,8550,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat,Intermediate,1,,N,50597,,,6504,In vivo,,1
,CHEMBL620314,8551,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat at 10 mg/kg,Intermediate,1,,N,50597,,,6046,In vivo,,1
,CHEMBL620315,8552,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat at the dose of 1 mg/kg i.v.,Intermediate,1,,N,50597,,,6504,In vivo,,1
,CHEMBL620316,8553,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat by po administration at a dose of 40 mg/kg,Intermediate,1,,N,50597,,,5874,In vivo,,1
,CHEMBL620317,8554,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat p.o. at 20 mg/kg concentration,Intermediate,1,,N,50597,,,17686,In vivo,,1
,CHEMBL620318,8555,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rats,Intermediate,1,,N,50597,,,5836,In vivo,,1
,CHEMBL620319,8556,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rats,Intermediate,1,,N,50597,,,17596,In vivo,,1
,CHEMBL620320,8557,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax was evaluated after 20 uM/kg of peroral administration,Intermediate,1,,N,50597,,,16423,In vivo,,1
,CHEMBL620321,8558,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax was measured in rats after peroral administration at 3 mg/kg,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL620322,8559,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,1,,N,50597,,,1908,In vivo,,1
,CHEMBL620323,8560,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,,,13950,,,1
,CHEMBL620324,8561,BAO_0000218,A,,,10116.0,Frontal cortex,Rattus norvegicus,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,1870.0,,13950,,,1
,CHEMBL620325,8562,BAO_0000218,A,,,10116.0,Frontal cortex,Rattus norvegicus,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,1870.0,,13950,,,1
,CHEMBL620326,8563,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,10000000.0,,13950,,,1
,CHEMBL620327,8564,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,10000000.0,,13950,,,1
,CHEMBL620328,8565,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,,,13950,,,1
,CHEMBL620329,8566,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,,,13950,,,1
,CHEMBL620330,8567,BAO_0000218,A,,,10116.0,Midbrain,Rattus norvegicus,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,1891.0,,13950,,,1
,CHEMBL875286,8568,BAO_0000218,A,,,10116.0,Midbrain,Rattus norvegicus,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,1891.0,,13950,,,1
,CHEMBL620331,8569,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,,,13950,,,1
,CHEMBL620332,8570,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,,,13950,,,1
,CHEMBL620333,8571,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2435.0,,13950,,,1
,CHEMBL620334,8572,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,1,,N,50597,2435.0,,13950,,,1
,CHEMBL621015,8573,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL621016,8574,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL621191,8575,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL621192,8576,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL621193,8577,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL621194,8578,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL624204,8579,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL624205,8580,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL624206,8581,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624207,8582,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624208,8583,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624209,8584,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624210,8585,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624211,8586,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624212,8587,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624213,8588,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL876611,8589,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL624214,8590,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL624215,8591,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,178.0,,16434,,,1
,CHEMBL624216,8592,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624217,8593,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624218,8594,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624219,8595,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624220,8596,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624221,8597,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,178.0,,16435,,,1
,CHEMBL624222,8598,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL624223,8599,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL624224,8600,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL624225,8601,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622420,8602,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Intermediate,1,,N,50597,,,17764,In vivo,,1
,CHEMBL622421,8603,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of steady state distribution after i.v. administration in rats,Intermediate,1,,N,50597,,,5031,In vivo,,1
,CHEMBL622422,8604,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,1,,N,50597,,,6215,In vivo,,1
,CHEMBL622423,8605,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,1,,N,50597,,,17671,In vivo,,1
,CHEMBL622424,8606,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Vss was determined,Intermediate,1,,N,50597,,,17752,In vivo,,1
,CHEMBL622425,8607,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Vss in rat,Intermediate,1,,N,50597,,,6596,In vivo,,1
,CHEMBL876612,8608,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Vss was evaluated after 10 uM/kg of intra arterial administration,Intermediate,1,,N,50597,,,16423,In vivo,,1
,CHEMBL622426,8609,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,1,,N,50597,,,15662,In vivo,,1
,CHEMBL622427,8610,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,1,,N,50597,,,6062,In vivo,,1
,CHEMBL622428,8611,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic (PK) parameter Vz in rat,Intermediate,1,,N,50597,,,5874,In vivo,,1
,CHEMBL622429,8612,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume distribution in rats,Intermediate,1,,N,50597,,,4942,In vivo,,1
,CHEMBL622430,8613,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in rat; No data,Intermediate,1,,N,50597,,,17796,In vivo,,1
,CHEMBL622431,8614,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,,,4890,In vivo,,1
,CHEMBL622432,8615,BAO_0000218,A,,,10116.0,Ileum,Rattus norvegicus,,% absorption predicted from in vitro rat ileum transport studies,Intermediate,1,,N,50597,2116.0,,15765,,,1
,CHEMBL622433,8616,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL622434,8617,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL622435,8618,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618748,8619,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618749,8620,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618750,8621,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618751,8622,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618752,8623,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,1,,N,50597,,,13569,In vivo,,1
,CHEMBL618753,8624,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4576,In vivo,,1
,CHEMBL618754,8625,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Intermediate,1,,N,50597,1969.0,,750,In vivo,,1
,CHEMBL618755,8626,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,750,In vivo,,1
,CHEMBL618756,8627,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4590,In vivo,,1
,CHEMBL618757,8628,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,1716,In vivo,,1
,CHEMBL618758,8629,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,1974,In vivo,,1
,CHEMBL621088,8630,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,1,,N,50597,,,4502,In vivo,,1
,CHEMBL621089,8631,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (cLogP) in rat,Intermediate,1,,N,50597,,,3371,,,1
,CHEMBL621090,8632,BAO_0000218,F,,,10116.0,Blood,Rattus norvegicus,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Intermediate,1,,N,50597,178.0,,9099,,,1
,CHEMBL621091,8633,BAO_0000218,F,,,10116.0,Blood,Rattus norvegicus,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Intermediate,1,,N,50597,178.0,,9099,,,1
,CHEMBL876731,8634,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in rat.,Intermediate,1,,N,50597,,,4590,In vivo,,1
,CHEMBL621092,8635,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for its clearance when administered intravenously in rat,Intermediate,1,,N,50597,,,3184,In vivo,,1
,CHEMBL621093,8636,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,16456,In vivo,,1
,CHEMBL621094,8637,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Blood: Brain distribution ratio is determined in rat,Intermediate,1,,N,50597,,,4199,,,1
,CHEMBL621095,8638,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Intermediate,1,,N,50597,,,4199,,,1
,CHEMBL621096,8639,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Intermediate,1,,N,50597,,,4199,,,1
,CHEMBL621097,8640,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2113.0,,8677,In vivo,,1
,CHEMBL621098,8641,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent dose excreted in 0-48 hours administered ip to male rat,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL621099,8642,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2037.0,,11977,,,1
,CHEMBL621100,8643,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2037.0,,11977,,,1
,CHEMBL621101,8644,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2037.0,,11977,,,1
,CHEMBL621102,8645,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2037.0,,11977,,,1
,CHEMBL876732,8646,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2037.0,,11977,,,1
,CHEMBL621103,8647,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL621104,8648,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL621105,8649,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL621106,8650,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL621107,8651,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL621108,8652,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL621109,8653,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL621110,8654,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2113.0,,17208,In vivo,,1
,CHEMBL621111,8655,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2113.0,,17208,In vivo,,1
,CHEMBL622541,8656,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2107.0,,17208,In vivo,,1
,CHEMBL622542,8657,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2107.0,,17208,In vivo,,1
,CHEMBL622543,8658,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2107.0,,17208,In vivo,,1
,CHEMBL624412,8659,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2107.0,,17208,In vivo,,1
,CHEMBL624413,8660,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2107.0,,17208,In vivo,,1
,CHEMBL624414,8661,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2107.0,,17208,In vivo,,1
,CHEMBL624415,8662,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2048.0,,17208,In vivo,,1
,CHEMBL624416,8663,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2048.0,,17208,In vivo,,1
,CHEMBL624417,8664,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2048.0,,17208,In vivo,,1
,CHEMBL624418,8665,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2048.0,,17208,In vivo,,1
,CHEMBL624419,8666,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2048.0,,17208,In vivo,,1
,CHEMBL624420,8667,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2048.0,,17208,In vivo,,1
,CHEMBL624421,8668,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2385.0,,17208,In vivo,,1
,CHEMBL624422,8669,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2385.0,,17208,In vivo,,1
,CHEMBL624423,8670,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2385.0,,17208,In vivo,,1
,CHEMBL625123,8671,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2385.0,,17208,In vivo,,1
,CHEMBL625124,8672,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2385.0,,17208,In vivo,,1
,CHEMBL625125,8673,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2385.0,,17208,In vivo,,1
,CHEMBL625126,8674,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,14.0,,17208,In vivo,,1
,CHEMBL626947,8675,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,14.0,,17208,In vivo,,1
,CHEMBL626948,8676,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,14.0,,17208,In vivo,,1
,CHEMBL626949,8677,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,14.0,,17208,In vivo,,1
,CHEMBL626950,8678,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,14.0,,17208,In vivo,,1
,CHEMBL626951,8679,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,14.0,,17208,In vivo,,1
,CHEMBL626952,8680,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2106.0,,17208,In vivo,,1
,CHEMBL626953,8681,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2106.0,,17208,In vivo,,1
,CHEMBL626954,8682,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2106.0,,17208,In vivo,,1
,CHEMBL626955,8683,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2106.0,,17208,In vivo,,1
,CHEMBL626956,8684,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2106.0,,17208,In vivo,,1
,CHEMBL626957,8685,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,2106.0,,17208,In vivo,,1
,CHEMBL626958,8686,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,178.0,,17208,In vivo,,1
,CHEMBL626959,8687,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,178.0,,17208,In vivo,,1
,CHEMBL626960,8688,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,178.0,,17208,In vivo,,1
,CHEMBL626961,8689,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,178.0,,17208,In vivo,,1
,CHEMBL627589,8690,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,178.0,,17208,In vivo,,1
,CHEMBL627590,8691,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,1,,N,50594,178.0,,17208,In vivo,,1
,CHEMBL627591,8692,BAO_0000218,A,,,10090.0,,Mus musculus,,Time taken for EC90 was determined when tested in mouse,Intermediate,1,,N,50594,,,3132,,,1
,CHEMBL627592,8693,BAO_0000218,A,,,10090.0,,Mus musculus,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Intermediate,1,,N,50594,,,3132,,,1
,CHEMBL627593,8694,BAO_0000218,A,,,10090.0,,Mus musculus,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Intermediate,1,,N,50594,,,16597,In vivo,,1
,CHEMBL627594,8695,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in mice,Intermediate,1,,N,50594,,,5727,,,1
,CHEMBL876813,8696,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life period in mouse after 10 mg/Kg dose,Intermediate,1,,N,50594,,,5302,In vivo,,1
,CHEMBL627595,8697,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life period in mouse after 10 mg/kg dose,Intermediate,1,,N,50594,,,5302,In vivo,,1
,CHEMBL627596,8698,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Intermediate,1,,N,50594,,,6348,In vivo,,1
,CHEMBL627597,8699,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value at 5 mg/kg po was determined in rat,Intermediate,1,,N,50597,,,5964,In vivo,,1
,CHEMBL627598,8700,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value evaluated in rat,Intermediate,1,,N,50597,,,6078,In vivo,,1
,CHEMBL627599,8701,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Intermediate,1,,N,50597,955.0,,5206,In vivo,,1
,CHEMBL627600,8702,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,1,,N,50597,,,2959,In vivo,,1
,CHEMBL627601,8703,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value at 1 mg/kg po in rat,Intermediate,1,,N,50597,,,5964,In vivo,,1
,CHEMBL627776,8704,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value at 5 mg/kg po in rat,Intermediate,1,,N,50597,,,5964,In vivo,,1
,CHEMBL627777,8705,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value at a dose of 10 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,In vivo,,1
,CHEMBL627778,8706,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value at a dose of 100 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,In vivo,,1
,CHEMBL627779,8707,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value at a dose of 50 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,In vivo,,1
,CHEMBL876814,8708,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value in rats at 10 mg/kg,Intermediate,1,,N,50597,,,17617,In vivo,,1
,CHEMBL627780,8709,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value was evaluated in rats at a dose of 20 mg/kg,Intermediate,1,,N,50597,,,1445,In vivo,,1
,CHEMBL627781,8710,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value was determined after peroral administration of 20 mg/kg in rat,Intermediate,1,,N,50597,,,6082,In vivo,,1
,CHEMBL627782,8711,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,1,,N,50597,,,1446,In vivo,,1
,CHEMBL627783,8712,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Intermediate,1,,N,50597,1969.0,,5407,In vivo,,1
,CHEMBL627784,8713,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Intermediate,1,,N,50597,1969.0,,2690,In vivo,,1
,CHEMBL627785,8714,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL627786,8715,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL627787,8716,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Intermediate,1,,N,50597,1969.0,,4891,In vivo,,1
,CHEMBL627788,8717,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Intermediate,1,,N,50597,1969.0,,2807,In vivo,,1
,CHEMBL626579,8718,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Intermediate,1,,N,50597,1969.0,,2807,In vivo,,1
,CHEMBL626580,8719,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Intermediate,1,,N,50597,1969.0,,2807,In vivo,,1
,CHEMBL876815,8720,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Intermediate,1,,N,50597,,,3634,In vivo,,1
,CHEMBL626581,8721,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Intermediate,1,,N,50597,1969.0,,1881,In vivo,,1
,CHEMBL626582,8722,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Intermediate,1,,N,50597,1969.0,,1881,In vivo,,1
,CHEMBL626583,8723,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Intermediate,1,,N,50597,,,429,In vivo,,1
,CHEMBL626205,8724,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL626206,8725,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL626207,8726,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL623882,8727,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL623883,8728,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL623884,8729,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL623885,8730,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,1,,N,50597,1969.0,,3032,In vivo,,1
,CHEMBL623886,8731,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Intermediate,1,,N,50597,1969.0,,6295,In vivo,,1
,CHEMBL623887,8732,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximal concentration in rat was determined,Intermediate,1,,N,50597,,,6619,In vivo,,1
,CHEMBL623888,8733,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximal concentration after i.v. administration,Intermediate,1,,N,50597,,,6616,In vivo,,1
,CHEMBL623889,8734,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Intermediate,1,,N,50597,1969.0,,3249,In vivo,,1
,CHEMBL623890,8735,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Intermediate,1,,N,50597,1969.0,,17791,In vivo,,1
,CHEMBL623891,8736,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax in rat plasma after oral dose (50 mg/Kg),Intermediate,1,,N,50597,1969.0,,17791,In vivo,,1
,CHEMBL623892,8737,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximal plasma concentration was determined.,Intermediate,1,,N,50597,1969.0,,1360,In vivo,,1
,CHEMBL623893,8738,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximal plasma drug concentration was determined,Intermediate,1,,N,50597,1969.0,,2552,In vivo,,1
,CHEMBL877616,8739,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximal concentration in rats after peroral administration,Intermediate,1,,N,50597,,,6571,In vivo,,1
,CHEMBL623894,8740,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL623895,8741,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Intermediate,1,,N,50597,1969.0,,6567,In vivo,,1
,CHEMBL623896,8742,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration of compound in rat was evaluated.,Intermediate,1,,N,50597,,,3031,In vivo,,1
,CHEMBL623897,8743,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,3436,In vivo,,1
,CHEMBL623898,8744,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,3436,In vivo,,1
,CHEMBL623899,8745,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,1,,N,50597,,,2083,In vivo,,1
,CHEMBL623900,8746,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,3436,In vivo,,1
,CHEMBL623901,8747,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,In vivo,,1
,CHEMBL623902,8748,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration was evaluated in rats,Intermediate,1,,N,50597,,,1974,In vivo,,1
,CHEMBL623903,8749,BAO_0000218,A,,,10116.0,Cerebrospinal fluid,Rattus norvegicus,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,1,,N,50597,1359.0,,3307,In vivo,,1
,CHEMBL623904,8750,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,1,,N,50597,1969.0,,3307,In vivo,,1
,CHEMBL877617,8751,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,1,,N,50597,1969.0,,1916,In vivo,,1
,CHEMBL623905,8752,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Intermediate,1,,N,50597,,,1500,In vivo,,1
,CHEMBL623906,8753,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Intermediate,1,,N,50597,,,1500,In vivo,,1
,CHEMBL623907,8754,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,1,,N,50597,1969.0,,4186,In vivo,,1
,CHEMBL623908,8755,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623909,8756,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623910,8757,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623911,8758,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623912,8759,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL624616,8760,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL624617,8761,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL624618,8762,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL624619,8763,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL624794,8764,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL624795,8765,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623921,8766,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623922,8767,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623923,8768,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623924,8769,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623925,8770,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623926,8771,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623927,8772,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623928,8773,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623929,8774,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623930,8775,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623931,8776,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL622165,8777,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL621249,8778,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL621250,8779,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL621448,8780,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL621449,8781,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL621450,8782,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL621451,8783,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL621452,8784,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL621453,8785,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL621454,8786,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL621455,8787,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL621456,8788,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625145,8789,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL875847,8790,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625146,8791,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625147,8792,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL625148,8793,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL625149,8794,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,955.0,,16434,,,1
,CHEMBL625150,8795,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625151,8796,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625152,8797,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625153,8798,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625154,8799,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625155,8800,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,955.0,,16435,,,1
,CHEMBL625156,8801,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL624354,8802,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL624355,8803,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,10000000.0,,11977,,,1
,CHEMBL624356,8804,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,10000000.0,,11977,,,1
,CHEMBL624357,8805,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,10000000.0,,11977,,,1
,CHEMBL624358,8806,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,10000000.0,,11977,,,1
,CHEMBL624359,8807,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2435.0,,11977,,,1
,CHEMBL624360,8808,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2435.0,,11977,,,1
,CHEMBL624361,8809,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2435.0,,11977,,,1
,CHEMBL624362,8810,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2435.0,,11977,,,1
,CHEMBL624363,8811,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2435.0,,11977,,,1
,CHEMBL624364,8812,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,178.0,,11977,In vivo,,1
,CHEMBL624365,8813,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,178.0,,11977,In vivo,,1
,CHEMBL624366,8814,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,178.0,,11977,In vivo,,1
,CHEMBL624367,8815,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,178.0,,11977,In vivo,,1
,CHEMBL624368,8816,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,955.0,,11977,In vivo,,1
,CHEMBL624369,8817,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,955.0,,11977,In vivo,,1
,CHEMBL624370,8818,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,955.0,,11977,In vivo,,1
,CHEMBL625069,8819,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,955.0,,11977,In vivo,,1
,CHEMBL625070,8820,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,955.0,,11977,In vivo,,1
,CHEMBL626051,8821,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,948.0,,11977,In vivo,,1
,CHEMBL626052,8822,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,948.0,,11977,In vivo,,1
,CHEMBL626053,8823,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,948.0,,11977,In vivo,,1
,CHEMBL626054,8824,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,948.0,,11977,In vivo,,1
,CHEMBL626055,8825,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,948.0,,11977,In vivo,,1
,CHEMBL626056,8826,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2113.0,,11977,In vivo,,1
,CHEMBL626057,8827,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2113.0,,11977,In vivo,,1
,CHEMBL625193,8828,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2113.0,,11977,In vivo,,1
,CHEMBL625194,8829,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2113.0,,11977,In vivo,,1
,CHEMBL625195,8830,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2107.0,,11977,In vivo,,1
,CHEMBL625196,8831,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2107.0,,11977,In vivo,,1
,CHEMBL625197,8832,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2107.0,,11977,In vivo,,1
,CHEMBL625198,8833,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2107.0,,11977,In vivo,,1
,CHEMBL627929,8834,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2107.0,,11977,In vivo,,1
,CHEMBL627074,8835,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2048.0,,11977,In vivo,,1
,CHEMBL627075,8836,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2048.0,,11977,In vivo,,1
,CHEMBL627076,8837,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2048.0,,11977,In vivo,,1
,CHEMBL627077,8838,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2048.0,,11977,In vivo,,1
,CHEMBL627078,8839,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2048.0,,11977,In vivo,,1
,CHEMBL627079,8840,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2385.0,,11977,In vivo,,1
,CHEMBL873824,8841,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Intermediate,1,,N,50594,,,4573,In vivo,,1
,CHEMBL627080,8842,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Half life in mouse plasma was determined at dose 25 mg/kg,Intermediate,1,,N,50594,1969.0,,3132,In vivo,,1
,CHEMBL627081,8843,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life was determined,Intermediate,1,,N,50594,,,17718,,,1
,CHEMBL627082,8844,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,1,,N,50594,,,17728,In vivo,,1
,CHEMBL627083,8845,BAO_0000218,A,,,10090.0,,Mus musculus,,Half-life in male mice after 1 mg/kg intravenous dose,Intermediate,1,,N,50594,,,5961,In vivo,,1
,CHEMBL627085,8847,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Half life in mice plasma,Intermediate,1,,N,50594,1969.0,,17731,,,1
,CHEMBL627086,8848,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in mouse,Intermediate,1,,N,50594,,,17592,,,1
,CHEMBL627087,8849,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Half life in mouse plasma at dose 25 mg/kg,Intermediate,1,,N,50594,1969.0,,3132,In vivo,,1
,CHEMBL627088,8850,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Intermediate,1,,N,50594,,,17729,In vivo,,1
,CHEMBL627089,8851,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Intermediate,1,,N,50594,,,17729,In vivo,,1
,CHEMBL627090,8852,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Intermediate,1,,N,50594,,,17729,In vivo,,1
,CHEMBL627091,8853,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Intermediate,1,,N,50594,,,3277,In vivo,,1
,CHEMBL627092,8854,BAO_0000218,A,,,10090.0,,Mus musculus,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Intermediate,1,,N,50594,,,3760,In vivo,,1
,CHEMBL876785,8855,BAO_0000218,A,,,10090.0,,Mus musculus,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Intermediate,1,,N,50594,,,3760,In vivo,,1
,CHEMBL627093,8856,BAO_0000218,A,,,10090.0,,Mus musculus,,Half-life by iv administration in mouse,Intermediate,1,,N,50594,,,2862,In vivo,,1
,CHEMBL627094,8857,BAO_0000218,A,,,10090.0,,Mus musculus,,Half-life by oral administration in mouse,Intermediate,1,,N,50594,,,2862,In vivo,,1
,CHEMBL627095,8858,BAO_0000218,A,,,10090.0,,Mus musculus,,Half-life in mice,Intermediate,1,,N,50594,,,5980,,,1
,CHEMBL627096,8859,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Half-life using mouse brain homogenate,Intermediate,1,,N,50594,955.0,,6159,,,1
,CHEMBL627097,8860,BAO_0000218,A,,,10090.0,,Mus musculus,,Half-life was measured in mice,Intermediate,1,,N,50594,,,6254,,,1
,CHEMBL627098,8861,BAO_0000218,A,,,10090.0,,Mus musculus,,Half-life was measured in mouse after an iv dose of 1 mg/kg,Intermediate,1,,N,50594,,,6062,In vivo,,1
,CHEMBL627099,8862,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Half-life period was determined in mouse blood,Intermediate,1,,N,50594,178.0,,1574,,,1
,CHEMBL627100,8863,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Intermediate,1,,N,50594,955.0,,56,,,1
,CHEMBL627101,8864,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Plasma half life in mouse,Intermediate,1,,N,50594,1969.0,,993,,,1
,CHEMBL627102,8865,BAO_0000218,A,,,10090.0,,Mus musculus,,Stability of the peptide in the presence of mouse serum,Intermediate,1,,N,50594,,,6652,,,1
,CHEMBL627103,8866,BAO_0000218,A,,,10090.0,,Mus musculus,,Terminal half life of compound was determined in mouse,Intermediate,1,,N,50594,,,17852,,,1
,CHEMBL627104,8867,BAO_0000218,A,,,10090.0,,Mus musculus,,Terminal half life was evaluated in mice after intravenous administration,Intermediate,1,,N,50594,,,2675,In vivo,,1
,CHEMBL627105,8868,BAO_0000218,A,,,10090.0,,Mus musculus,,Terminal half life was evaluated in mice after oral administration,Intermediate,1,,N,50594,,,2675,In vivo,,1
,CHEMBL876786,8869,BAO_0000218,A,,,10090.0,,Mus musculus,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Intermediate,1,,N,50594,,,499,,,1
,CHEMBL873825,8870,BAO_0000218,A,,,10090.0,,Mus musculus,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Intermediate,1,,N,50594,,,499,,,1
,CHEMBL627106,8871,BAO_0000218,A,,,10090.0,,Mus musculus,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Intermediate,1,,N,50594,,,499,,,1
,CHEMBL626336,8872,BAO_0000218,A,,,10090.0,,Mus musculus,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Intermediate,1,,N,50594,,,14239,In vivo,,1
,CHEMBL877462,8873,BAO_0000218,A,,,10090.0,,Mus musculus,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Intermediate,1,,N,50594,,,5506,In vivo,,1
,CHEMBL626337,8874,BAO_0000218,A,,,10090.0,,Mus musculus,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Intermediate,1,,N,50594,,,5506,In vivo,,1
,CHEMBL626338,8875,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life after intraperitoneal administration of 100 mg/kg in mice,Intermediate,1,,N,50594,,,17734,,,1
,CHEMBL626339,8876,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Intermediate,1,,N,50594,,,17728,In vivo,,1
,CHEMBL626340,8877,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,1,,N,50594,,,17728,In vivo,,1
,CHEMBL625377,8878,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Intermediate,1,,N,50594,,,17728,In vivo,,1
,CHEMBL625378,8879,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Intermediate,1,,N,50594,,,17728,In vivo,,1
,CHEMBL625379,8880,BAO_0000218,A,,,10090.0,,Mus musculus,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Intermediate,1,,N,50594,,,17728,In vivo,,1
,CHEMBL625380,8881,BAO_0000251,A,Microsomes,,9823.0,,Sus scrofa,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,0,,U,22224,,,14294,,,1
,CHEMBL625381,8882,BAO_0000251,A,Microsomes,,9823.0,,Sus scrofa,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Autocuration,0,,U,22224,,,14294,,,1
,CHEMBL625382,8883,BAO_0000019,A,,,9823.0,,Sus scrofa,,Stability to porcine renal DHP-I,Autocuration,0,,U,22224,,,6056,,,1
,CHEMBL873828,8884,BAO_0000218,A,,,9823.0,,Sus scrofa,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Autocuration,0,,U,22224,,,1317,In vivo,,1
,CHEMBL625383,8885,BAO_0000218,A,,,9823.0,,Sus scrofa,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Autocuration,0,,U,22224,,,1317,In vivo,,1
,CHEMBL625384,8886,BAO_0000019,A,,,9823.0,,Sus scrofa,,Half-life of the parent prodrug in porcine esterase solution,Autocuration,0,,U,22224,,,5229,,,1
,CHEMBL625385,8887,BAO_0000019,A,,,9823.0,,Sus scrofa,,"First order rate constant, k was determined in in pig liver Esterase",Autocuration,0,,U,22224,,,4231,,,1
,CHEMBL625386,8888,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Half life of the in pig liver Esterase,Autocuration,0,,U,22224,2107.0,,4231,,,1
,CHEMBL623571,8889,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Autocuration,0,,U,22224,2107.0,,5318,,,1
,CHEMBL623572,8890,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Autocuration,0,,U,22224,2107.0,,5318,,,1
,CHEMBL623573,8891,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Autocuration,0,,U,22224,2107.0,,5318,,,1
,CHEMBL623574,8892,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Autocuration,0,,U,22224,2107.0,,3305,,,1
,CHEMBL623575,8893,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Autocuration,0,,U,22224,2107.0,,3305,,,1
,CHEMBL623749,8894,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Autocuration,0,,U,22224,2107.0,,2842,,,1
,CHEMBL623750,8895,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Autocuration,0,,U,22224,2107.0,,2842,,,1
,CHEMBL623751,8896,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Half-life in vitro in pig liver,Autocuration,0,,U,22224,2107.0,,889,In vitro,,1
,CHEMBL623752,8897,BAO_0000221,A,,,9823.0,Liver,Sus scrofa,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Autocuration,0,,U,22224,2107.0,,1904,,,1
,CHEMBL623753,8898,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Intermediate,1,,N,50597,1969.0,,4186,In vivo,,1
,CHEMBL623754,8899,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,1,,N,50597,1969.0,,2774,In vivo,,1
,CHEMBL623755,8900,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in rat plasma was determined,Intermediate,1,,N,50597,1969.0,,1742,In vivo,,1
,CHEMBL623756,8901,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration in rats,Intermediate,1,,N,50597,,,3169,In vivo,,1
,CHEMBL623757,8902,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration in rats at 1-2 hours,Intermediate,1,,N,50597,,,3169,In vivo,,1
,CHEMBL623758,8903,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Intermediate,1,,N,50597,,,2081,In vivo,,1
,CHEMBL623759,8904,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,1,,N,50597,955.0,,3307,In vivo,,1
,CHEMBL623760,8905,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at the dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,4727,In vivo,,1
,CHEMBL623761,8906,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration was evaluated in rats,Intermediate,1,,N,50597,,,6597,In vivo,,1
,CHEMBL623762,8907,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,1,,N,50597,1969.0,,16365,In vivo,,1
,CHEMBL877594,8908,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Intermediate,1,,N,50597,1969.0,,16365,In vivo,,1
,CHEMBL623763,8909,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Intermediate,1,,N,50597,1969.0,,16365,In vivo,,1
,CHEMBL623764,8910,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Intermediate,1,,N,50597,1969.0,,16365,In vivo,,1
,CHEMBL623765,8911,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,1,,N,50597,1969.0,,16365,In vivo,,1
,CHEMBL623766,8912,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Intermediate,1,,N,50597,178.0,,2591,In vivo,,1
,CHEMBL623767,8913,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Intermediate,1,,N,50597,178.0,,2591,In vivo,,1
,CHEMBL623768,8914,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Intermediate,1,,N,50597,178.0,,2591,In vivo,,1
,CHEMBL623769,8915,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5978,In vivo,,1
,CHEMBL623770,8916,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5978,In vivo,,1
,CHEMBL623771,8917,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5978,In vivo,,1
,CHEMBL623772,8918,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5978,In vivo,,1
,CHEMBL623773,8919,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5978,In vivo,,1
,CHEMBL623774,8920,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5978,In vivo,,1
,CHEMBL623775,8921,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5978,In vivo,,1
,CHEMBL623776,8922,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat (PO dose),Intermediate,1,,N,50597,,,14465,In vivo,,1
,CHEMBL622191,8923,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,1969.0,,4723,In vivo,,1
,CHEMBL622192,8924,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,1969.0,,4723,In vivo,,1
,CHEMBL622193,8925,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration determined in rat,Intermediate,1,,N,50597,1969.0,,4576,In vivo,,1
,CHEMBL622194,8926,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,1,,N,50597,1969.0,,12873,In vivo,,1
,CHEMBL622195,8927,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,1,,N,50597,1969.0,,12873,In vivo,,1
,CHEMBL622196,8928,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration in rat,Intermediate,1,,N,50597,1969.0,,6824,In vivo,,1
,CHEMBL622197,8929,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,1,,N,50597,1969.0,,17065,In vivo,,1
,CHEMBL622198,8930,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Intermediate,1,,N,50597,1969.0,,2932,In vivo,,1
,CHEMBL622199,8931,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Intermediate,1,,N,50597,1969.0,,2932,In vivo,,1
,CHEMBL622200,8932,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration of compound was measured in rat,Intermediate,1,,N,50597,1969.0,,2879,In vivo,,1
,CHEMBL622201,8933,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration after 20 mg/kg oral administration in rat,Intermediate,1,,N,50597,1969.0,,2864,In vivo,,1
,CHEMBL623990,8934,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration after oral administration to rats,Intermediate,1,,N,50597,1969.0,,16367,In vivo,,1
,CHEMBL623991,8935,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,1,,N,50597,1969.0,,17717,In vivo,,1
,CHEMBL623992,8936,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Intermediate,1,,N,50597,1969.0,,17717,In vivo,,1
,CHEMBL623993,8937,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,1,,N,50597,1969.0,,17717,In vivo,,1
,CHEMBL623994,8938,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,1,,N,50597,1969.0,,17717,In vivo,,1
,CHEMBL623995,8939,BAO_0000218,F,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,1969.0,,17720,In vivo,,1
,CHEMBL623996,8940,BAO_0000218,F,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,1969.0,,17720,In vivo,,1
,CHEMBL623997,8941,BAO_0000218,F,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,1969.0,,17720,In vivo,,1
,CHEMBL623998,8942,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration dosed orally in rats,Intermediate,1,,N,50597,1969.0,,4516,In vivo,,1
,CHEMBL623999,8943,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration dosed orally in rats after 6 hours,Intermediate,1,,N,50597,1969.0,,4516,In vivo,,1
,CHEMBL624000,8944,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Intermediate,1,,N,50597,1969.0,,4516,In vivo,,1
,CHEMBL624001,8945,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,1,,N,50597,1969.0,,5199,In vivo,,1
,CHEMBL624002,8946,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration in rat after po administration,Intermediate,1,,N,50597,1969.0,,17538,In vivo,,1
,CHEMBL624003,8947,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Intermediate,1,,N,50597,1969.0,,6685,In vivo,,1
,CHEMBL624004,8948,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Intermediate,1,,N,50597,1969.0,,6685,In vivo,,1
,CHEMBL624005,8949,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624006,8950,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624007,8951,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624008,8952,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624009,8953,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL874387,8954,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624010,8955,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624011,8956,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624012,8957,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624013,8958,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624736,8959,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624737,8960,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624738,8961,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624739,8962,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624740,8963,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,948.0,,16434,,,1
,CHEMBL624896,8964,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624897,8965,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624108,8966,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624109,8967,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624110,8968,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624111,8969,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624112,8970,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL624113,8971,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL619709,8972,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL619710,8973,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,948.0,,16435,,,1
,CHEMBL619711,8974,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619712,8975,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619713,8976,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619714,8977,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619715,8978,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619716,8979,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619717,8980,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619718,8981,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619719,8982,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL875329,8983,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619720,8984,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619721,8985,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619722,8986,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619723,8987,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619724,8988,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619725,8989,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619726,8990,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619727,8991,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619728,8992,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,2113.0,,16434,,,1
,CHEMBL619729,8993,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL619730,8994,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2385.0,,11977,In vivo,,1
,CHEMBL619731,8995,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2385.0,,11977,In vivo,,1
,CHEMBL619732,8996,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2385.0,,11977,In vivo,,1
,CHEMBL619733,8997,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2385.0,,11977,In vivo,,1
,CHEMBL619734,8998,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2385.0,,11977,In vivo,,1
,CHEMBL619735,8999,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,14.0,,11977,In vivo,,1
,CHEMBL875330,9000,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,14.0,,11977,In vivo,,1
,CHEMBL628465,9001,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,14.0,,11977,In vivo,,1
,CHEMBL628466,9002,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,14.0,,11977,In vivo,,1
,CHEMBL628467,9003,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,14.0,,11977,In vivo,,1
,CHEMBL628468,9004,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2106.0,,11977,In vivo,,1
,CHEMBL628469,9005,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2106.0,,11977,In vivo,,1
,CHEMBL628470,9006,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2106.0,,11977,In vivo,,1
,CHEMBL628471,9007,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2106.0,,11977,In vivo,,1
,CHEMBL628472,9008,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2106.0,,11977,In vivo,,1
,CHEMBL625191,9009,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2046.0,,11977,In vivo,,1
,CHEMBL625192,9010,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2046.0,,11977,In vivo,,1
,CHEMBL875337,9011,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,1,,N,50597,2046.0,,11977,In vivo,,1
,CHEMBL626341,9012,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2046.0,,11977,In vivo,,1
,CHEMBL626342,9013,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2046.0,,11977,In vivo,,1
,CHEMBL621943,9014,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,1,,N,50597,2107.0,,11977,In vivo,,1
,CHEMBL621944,9015,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats,Intermediate,1,,N,50597,,,3748,,,1
,CHEMBL621945,9016,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Intermediate,1,,N,50597,,,15765,,,1
,CHEMBL621946,9017,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Intermediate,1,,N,50597,,,4871,,,1
,CHEMBL621947,9018,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,1,,N,50597,,,4871,,,1
,CHEMBL621948,9019,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Intermediate,1,,N,50597,,,4872,,,1
,CHEMBL621949,9020,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,1,,N,50597,,,4872,,,1
,CHEMBL621950,9021,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Intermediate,1,,N,50597,,,5413,,,1
,CHEMBL621951,9022,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Intermediate,1,,N,50597,,,5413,,,1
,CHEMBL621952,9023,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Intermediate,1,,N,50597,178.0,,15272,In vivo,,1
,CHEMBL621953,9024,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Stability (%) in rat liver microsomes,Intermediate,1,,N,50597,2107.0,,4689,,,1
,CHEMBL621954,9025,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was calculated after intravenous administration,Intermediate,1,,N,50597,,,6057,,,1
,CHEMBL621955,9026,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was calculated after iv administration in rat,Intermediate,1,,N,50597,,,6057,,,1
,CHEMBL621956,9027,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was calculated in rat after peroral administration,Intermediate,1,,N,50597,,,6057,,,1
,CHEMBL621957,9028,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,1,,N,50597,,,6211,,,1
,CHEMBL621958,9029,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Intermediate,1,,N,50597,,,5710,,,1
,CHEMBL621959,9030,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Intermediate,1,,N,50597,,,5710,,,1
,CHEMBL621960,9031,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Intermediate,1,,N,50597,,,17853,,,1
,CHEMBL621961,9032,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Intermediate,1,,N,50597,,,17853,,,1
,CHEMBL621962,9033,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,p value of the compound,Intermediate,1,,N,50597,,,15765,,,1
,CHEMBL876787,9034,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,p value of the compound,Intermediate,1,,N,50597,,,15765,,,1
,CHEMBL621963,9035,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,p value of the compound,Intermediate,1,,N,50597,,,15765,,,1
,CHEMBL622637,9036,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,1,,N,50597,945.0,,6175,,,1
,CHEMBL622638,9037,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,1,,N,50597,945.0,,6175,,,1
,CHEMBL626561,9038,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,1,,N,50597,945.0,,6175,,,1
,CHEMBL626562,9039,BAO_0000019,F,,,9986.0,,Oryctolagus cuniculus,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Autocuration,0,,U,22224,,,7991,,,1
,CHEMBL626563,9040,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Autocuration,0,,U,22224,,,429,,,1
,CHEMBL626564,9041,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Autocuration,0,,U,22224,,,429,,,1
,CHEMBL626565,9042,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,0,,U,22224,,,6253,In vivo,,1
,CHEMBL626566,9043,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,0,,U,22224,,,6253,In vivo,,1
,CHEMBL626567,9044,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Clearance rate in rabbits,Autocuration,0,,U,22224,,,3615,In vivo,,1
,CHEMBL626568,9045,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,0,,U,22224,,,4059,In vivo,,1
,CHEMBL626569,9046,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,0,,U,22224,,,5124,In vivo,,1
,CHEMBL626570,9047,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,0,,U,22224,,,5124,In vivo,,1
,CHEMBL626571,9048,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,0,,U,22224,,,5124,In vivo,,1
,CHEMBL626572,9049,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Autocuration,0,,U,22224,,,429,In vivo,,1
,CHEMBL626573,9050,BAO_0000218,A,,,9986.0,Plasma,Oryctolagus cuniculus,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,0,,U,22224,1969.0,,4059,In vivo,,1
,CHEMBL626574,9051,BAO_0000251,A,Microsomes,,9986.0,Liver,Oryctolagus cuniculus,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Autocuration,0,,U,22224,2107.0,,9659,,,1
,CHEMBL626575,9052,BAO_0000251,A,Microsomes,,9986.0,Liver,Oryctolagus cuniculus,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Autocuration,0,,U,22224,2107.0,,9659,,,1
,CHEMBL626576,9053,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Autocuration,0,,U,22224,,,3639,,,1
,CHEMBL626577,9054,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Dose at which bioavailability of perorally administered compound was tested in rabbit,Autocuration,0,,U,22224,,,3639,,,1
,CHEMBL626578,9055,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,The compound was tested for its bioavailability in rabbit (by oral dosage).,Autocuration,0,,U,22224,,,3639,In vivo,,1
,CHEMBL625263,9056,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,0,,U,22224,,,5124,In vivo,,1
,CHEMBL625264,9057,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,0,,U,22224,,,5124,In vivo,,1
,CHEMBL625265,9058,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,0,,U,22224,,,5124,In vivo,,1
,CHEMBL625266,9059,BAO_0000251,A,Microsomes,,9986.0,,Oryctolagus cuniculus,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,0,,U,22224,,,14294,,,1
,CHEMBL876796,9060,BAO_0000251,A,Microsomes,,9986.0,,Oryctolagus cuniculus,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Autocuration,0,,U,22224,,,14294,,,1
,CHEMBL625267,9061,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Autocuration,0,,U,22224,,,429,In vivo,,1
,CHEMBL625268,9062,BAO_0000218,A,,,9986.0,Plasma,Oryctolagus cuniculus,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,0,,U,22224,1969.0,,5124,In vivo,,1
,CHEMBL625269,9063,BAO_0000218,A,,,9986.0,Plasma,Oryctolagus cuniculus,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,0,,U,22224,1969.0,,5124,In vivo,,1
,CHEMBL624689,9064,BAO_0000218,A,,,9986.0,Plasma,Oryctolagus cuniculus,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,0,,U,22224,1969.0,,5124,In vivo,,1
,CHEMBL624690,9065,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Autocuration,0,,U,22224,,,429,In vivo,,1
,CHEMBL624691,9066,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Autocuration,0,,U,22224,1088.0,,429,,,1
,CHEMBL624692,9067,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Autocuration,0,,U,22224,1088.0,,429,,,1
,CHEMBL624693,9068,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,0,,U,22224,,,4059,In vivo,,1
,CHEMBL624694,9069,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Autocuration,0,,U,22224,,,4137,In vivo,,1
,CHEMBL877596,9070,BAO_0000221,A,,,9986.0,,Oryctolagus cuniculus,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Autocuration,0,,U,22224,,,11672,In vitro,,1
,CHEMBL624695,9071,BAO_0000019,A,,,9986.0,,Oryctolagus cuniculus,,Time within which only 10% of the drug was degraded,Autocuration,0,,U,22224,,,12886,,,1
,CHEMBL624696,9072,BAO_0000221,A,,,9986.0,Liver,Oryctolagus cuniculus,,Half life period in rabbit liver homogenate,Autocuration,0,,U,22224,2107.0,,3853,,,1
,CHEMBL624697,9073,BAO_0000019,A,,,9986.0,,Oryctolagus cuniculus,,Half life value in rabbits,Autocuration,0,,U,22224,,,3615,,,1
,CHEMBL624698,9074,BAO_0000218,A,,,9986.0,Blood,Oryctolagus cuniculus,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,0,,U,22224,178.0,,6253,In vivo,,1
,CHEMBL624699,9075,BAO_0000218,A,,,9986.0,Blood,Oryctolagus cuniculus,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,0,,U,22224,178.0,,6253,In vivo,,1
,CHEMBL624700,9076,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Half-life period in rabbits following intravenous administration at 2 mg/kg,Autocuration,0,,U,22224,,,6077,In vivo,,1
,CHEMBL622903,9077,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC 0-8 hr value in rats at 10 mg/kg,Intermediate,1,,N,50597,1969.0,,17617,,,1
,CHEMBL622904,9078,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC after administration at 2000 mg/kg/day in rats,Intermediate,1,,N,50597,1969.0,,17594,,,1
,CHEMBL622905,9079,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Intermediate,1,,N,50597,1969.0,,6149,,,1
,CHEMBL622906,9080,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,1,,N,50597,1969.0,,17260,,,1
,CHEMBL622907,9081,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,1,,N,50597,1969.0,,17260,,,1
,CHEMBL622908,9082,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat after oral administration at 10.5 mg/kg dose,Intermediate,1,,N,50597,1969.0,,6644,,,1
,CHEMBL622909,9083,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat after oral administration at 11.2 mg/kg dose,Intermediate,1,,N,50597,1969.0,,6644,,,1
,CHEMBL622910,9084,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat after oral administration at 9.7 mg/kg dose,Intermediate,1,,N,50597,1969.0,,6644,,,1
,CHEMBL622911,9085,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,AUC in rat brain after oral administration at 10 mg/kg,Intermediate,1,,N,50597,955.0,,6495,,,1
,CHEMBL622912,9086,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat p.o.,Intermediate,1,,N,50597,1969.0,,6504,,,1
,CHEMBL622913,9087,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat p.o. at 20 mg/kg concentration,Intermediate,1,,N,50597,1969.0,,17686,,,1
,CHEMBL622914,9088,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat plasma after oral administration at 10 mg/kg,Intermediate,1,,N,50597,1969.0,,6495,,,1
,CHEMBL622915,9089,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rats,Intermediate,1,,N,50597,1969.0,,216,,,1
,CHEMBL622916,9090,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,1,,N,50597,1969.0,,1908,,,1
,CHEMBL622917,9091,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,1,,N,50597,1969.0,,1908,,,1
,CHEMBL622918,9092,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,1,,N,50597,1969.0,,6685,In vivo,,1
,CHEMBL622919,9093,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Intermediate,1,,N,50597,1969.0,,216,In vivo,,1
,CHEMBL622920,9094,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration was evaluated in rat,Intermediate,1,,N,50597,1969.0,,6049,In vivo,,1
,CHEMBL622921,9095,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,1,,N,50597,1969.0,,2463,In vivo,,1
,CHEMBL622922,9096,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Intermediate,1,,N,50597,1969.0,,6679,In vivo,,1
,CHEMBL622923,9097,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,1,,N,50597,1969.0,,6681,In vivo,,1
,CHEMBL877604,9098,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,1969.0,,4890,In vivo,,1
,CHEMBL622924,9099,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,1,,N,50597,1969.0,,6410,In vivo,,1
,CHEMBL622925,9100,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,1,,N,50597,1969.0,,6410,In vivo,,1
,CHEMBL622926,9101,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Intermediate,1,,N,50597,1969.0,,16366,In vivo,,1
,CHEMBL623625,9102,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,1,,N,50597,1969.0,,6227,In vivo,,1
,CHEMBL623626,9103,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,1969.0,,3598,In vivo,,1
,CHEMBL623627,9104,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma drug concentration was determined,Intermediate,1,,N,50597,1969.0,,1465,In vivo,,1
,CHEMBL623628,9105,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Intermediate,1,,N,50597,,,4368,In vivo,,1
,CHEMBL623629,9106,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,1,,N,50597,1969.0,,15662,In vivo,,1
,CHEMBL623630,9107,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Mean peak plasma concentration was observed after oral administration in rat,Intermediate,1,,N,50597,1969.0,,15662,In vivo,,1
,CHEMBL623804,9108,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Intermediate,1,,N,50597,,,5355,In vivo,,1
,CHEMBL623805,9109,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,5355,In vivo,,1
,CHEMBL623806,9110,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak oral plasma concentration was determined in rats by oral administration,Intermediate,1,,N,50597,1969.0,,1567,In vivo,,1
,CHEMBL623807,9111,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration (Cmax) was determined,Intermediate,1,,N,50597,1969.0,,4026,In vivo,,1
,CHEMBL623808,9112,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,6193,In vivo,,1
,CHEMBL623809,9113,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration (Cmax) in rats,Intermediate,1,,N,50597,1969.0,,4026,In vivo,,1
,CHEMBL623810,9114,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration at 1 mg/kg peroral administration,Intermediate,1,,N,50597,1969.0,,6485,In vivo,,1
,CHEMBL623811,9115,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration in rat,Intermediate,1,,N,50597,1969.0,,17655,In vivo,,1
,CHEMBL623812,9116,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,1,,N,50597,1969.0,,14941,In vivo,,1
,CHEMBL877605,9117,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Intermediate,1,,N,50597,,,5394,In vivo,,1
,CHEMBL623813,9118,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Cmax) in rat,Intermediate,1,,N,50597,,,4408,In vivo,,1
,CHEMBL623814,9119,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,1,,N,50597,,,5983,In vivo,,1
,CHEMBL623815,9120,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat after 3mg/kg oral dose,Intermediate,1,,N,50597,,,4878,In vivo,,1
,CHEMBL623816,9121,BAO_0000218,A,,,10116.0,,Rattus norvegicus,Sprague-Dawley,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Intermediate,1,,N,50597,,,5862,In vivo,,1
,CHEMBL623145,9122,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rats after 20 mg/kg oral dose,Intermediate,1,,N,50597,,,4517,In vivo,,1
,CHEMBL623146,9123,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,5932,In vivo,,1
,CHEMBL623147,9124,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma concentration after oral administration of 100 mg/kg to rats,Intermediate,1,,N,50597,1969.0,,5436,In vivo,,1
,CHEMBL623042,9125,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,1,,N,50597,955.0,,4910,In vivo,,1
,CHEMBL623043,9126,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for the Cmax in rat at 10 mg/kg per orally,Intermediate,1,,N,50597,,,4950,In vivo,,1
,CHEMBL623044,9127,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,In vivo,,1
,CHEMBL623045,9128,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,In vivo,,1
,CHEMBL623046,9129,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability as oral Cmax in rats at 30 mins,Intermediate,1,,N,50597,,,3360,In vivo,,1
,CHEMBL623226,9130,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability as oral Cmax in rats at 6hr,Intermediate,1,,N,50597,,,3360,In vivo,,1
,CHEMBL623227,9131,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,1,,N,50597,,,15022,In vivo,,1
,CHEMBL623228,9132,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,1,,N,50597,,,15022,In vivo,,1
,CHEMBL623229,9133,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,1,,N,50597,,,15022,In vivo,,1
,CHEMBL623230,9134,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma levels for the compounds were determined by LC-MS.,Intermediate,1,,N,50597,1969.0,,5160,In vivo,,1
,CHEMBL623231,9135,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,1,,N,50597,1969.0,,15662,In vivo,,1
,CHEMBL623232,9136,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,mean peak plasma concentration was observed after oral administration in rat,Intermediate,1,,N,50597,1969.0,,15662,In vivo,,1
,CHEMBL623233,9137,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Intermediate,1,,N,50597,,,4709,,,1
,CHEMBL623234,9138,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Intermediate,1,,N,50597,,,3535,,,1
,CHEMBL623235,9139,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in plasma (portal) following oral dose in rats at 1 hr,Intermediate,1,,N,50597,,,3535,,,1
,CHEMBL623236,9140,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in plasma (portal) following oral dose in rats at 2 hr,Intermediate,1,,N,50597,,,3535,,,1
,CHEMBL623237,9141,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Intermediate,1,,N,50597,,,3535,,,1
,CHEMBL623238,9142,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Intermediate,1,,N,50597,,,3535,,,1
,CHEMBL623239,9143,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Intermediate,1,,N,50597,,,3535,,,1
,CHEMBL623240,9144,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Intermediate,0,,U,22224,1969.0,,5005,In vivo,,1
,CHEMBL623241,9145,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Intermediate,1,,N,50597,1898.0,,6326,,,1
,CHEMBL623242,9146,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Intermediate,1,,N,50597,1898.0,,6326,,,1
,CHEMBL874394,9147,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Intermediate,1,,N,50597,,,6326,,,1
,CHEMBL623243,9148,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Intermediate,1,,N,50597,,,6326,,,1
,CHEMBL623244,9149,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL623245,9150,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL623246,9151,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL623247,9152,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL623248,9153,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL623249,9154,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,2113.0,,16435,,,1
,CHEMBL625072,9155,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625073,9156,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625074,9157,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625075,9158,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625076,9159,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625077,9160,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625078,9161,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL874395,9162,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625079,9163,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625080,9164,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625081,9165,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625082,9166,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625083,9167,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625084,9168,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625085,9169,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625086,9170,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL625087,9171,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL625088,9172,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL622205,9173,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,2107.0,,16434,,,1
,CHEMBL622206,9174,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL622207,9175,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL622366,9176,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL622367,9177,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL875331,9178,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL622368,9179,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,2107.0,,16435,,,1
,CHEMBL622369,9180,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622370,9181,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622371,9182,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622372,9183,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622373,9184,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622374,9185,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622375,9186,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622376,9187,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622377,9188,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622378,9189,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622379,9190,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622380,9191,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622381,9192,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622382,9193,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622383,9194,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL875332,9195,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,1,,N,50597,945.0,,6175,,,1
,CHEMBL622384,9196,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,1,,N,50597,945.0,,6175,,,1
,CHEMBL622385,9197,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,1,,N,50597,945.0,,6175,,,1
,CHEMBL622386,9198,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,1,,N,50597,945.0,,6175,,,1
,CHEMBL622387,9199,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for the plasma binding in rat,Intermediate,1,,N,50597,,,10839,,,1
,CHEMBL622388,9200,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Intermediate,1,,N,50597,,,16459,,,1
,CHEMBL622389,9201,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Intermediate,1,,N,50597,,,16459,,,1
,CHEMBL622390,9202,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Intermediate,1,,N,50597,,,16459,,,1
,CHEMBL622391,9203,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Intermediate,1,,N,50597,,,16459,,,1
,CHEMBL622392,9204,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Intermediate,1,,N,50597,,,16459,,,1
,CHEMBL622393,9205,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Intermediate,1,,N,50597,,,16459,,,1
,CHEMBL622394,9206,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma level at 2 hr after administration of the compound,Intermediate,1,,N,50597,,,3278,,,1
,CHEMBL622395,9207,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,plasma level at 2 hr after administration of the compound,Intermediate,1,,N,50597,,,3278,,,1
,CHEMBL622396,9208,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 1 min,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624894,9209,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 10 min,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624895,9210,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 10 mins,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624058,9211,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 2 hr,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624059,9212,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 3 min,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624060,9213,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 3 mins,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624061,9214,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 5 min,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624062,9215,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Stability in rat serum measured as % recovery at 5 mins,Intermediate,1,,N,50597,1977.0,,4684,,,1
,CHEMBL624063,9216,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,16456,In vivo,,1
,CHEMBL624064,9217,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,16456,In vivo,,1
,CHEMBL624065,9218,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Intermediate,1,,N,50597,1969.0,,723,,,1
,CHEMBL624066,9219,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Intermediate,1,,N,50597,1969.0,,723,,,1
,CHEMBL877490,9220,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life tested in mature male rat at a dose of 30 mg/kg,Intermediate,1,,N,50597,,,5160,In vivo,,1
,CHEMBL874442,9221,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after intravenous administration of 1 mg/kg in rat,Intermediate,1,,N,50597,,,4709,In vivo,,1
,CHEMBL626890,9222,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after administration (30 mg/kg) in rat,Intermediate,1,,N,50597,,,5633,In vivo,,1
,CHEMBL626891,9223,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat after 5 mg/Kg dose,Intermediate,1,,N,50597,,,5302,In vivo,,1
,CHEMBL626892,9224,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat after 5 mg/kg dose,Intermediate,1,,N,50597,,,5302,In vivo,,1
,CHEMBL626893,9225,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was determined,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL626894,9226,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was evaluated in rat,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL626895,9227,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was evaluated in rat; 0.5-1.0,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL626896,9228,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was evaluated in rat; 5.9-7.5,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL626897,9229,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in rat plasma,Intermediate,1,,N,50597,1969.0,,14512,,,1
,CHEMBL626898,9230,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life time in rat was determined,Intermediate,1,,N,50597,,,6230,,,1
,CHEMBL626899,9231,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Terminal half-life after iv administration to rats,Intermediate,1,,N,50597,,,3364,In vivo,,1
,CHEMBL626900,9232,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Intermediate,1,,N,50597,,,6874,In vivo,,1
,CHEMBL626901,9233,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Intermediate,1,,N,50597,,,857,,,1
,CHEMBL626902,9234,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Intermediate,1,,N,50597,,,858,In vivo,,1
,CHEMBL626903,9235,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Intermediate,1,,N,50597,,,858,In vivo,,1
,CHEMBL874443,9236,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Intermediate,1,,N,50597,,,5355,In vivo,,1
,CHEMBL626904,9237,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,5355,In vivo,,1
,CHEMBL626905,9238,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats,Intermediate,1,,N,50597,,,6305,,,1
,CHEMBL873830,9239,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,1,,N,50597,1969.0,,13501,In vivo,,1
,CHEMBL626906,9240,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Intermediate,1,,N,50597,,,17594,In vivo,,1
,CHEMBL631076,9241,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,1,,N,50597,1969.0,,4186,In vivo,,1
,CHEMBL631077,9242,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biological half-life was measured in plasma of rats,Intermediate,1,,N,50597,1969.0,,2932,,,1
,CHEMBL631078,9243,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,1,,N,50597,,,17065,In vivo,,1
,CHEMBL631079,9244,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Intermediate,1,,N,50597,,,15765,In vivo,,1
,CHEMBL631080,9245,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Intermediate,1,,N,50597,,,2713,In vivo,,1
,CHEMBL631081,9246,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL631239,9247,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL631240,9248,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated for plasma half life in rat,Intermediate,1,,N,50597,1969.0,,740,,,1
,CHEMBL631241,9249,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC value at a dose of 5 mg/kg (p.o.) in rats,Intermediate,1,,N,50597,1969.0,,6597,,,1
,CHEMBL631242,9250,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC value after administration of 20 mg/Kg oral dose in rat,Intermediate,1,,N,50597,1969.0,,2959,,,1
,CHEMBL631243,9251,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,17594,,,1
,CHEMBL874444,9252,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC0-96 after administration at 50 mg/kg,Intermediate,1,,N,50597,1969.0,,17596,,,1
,CHEMBL631244,9253,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,17594,,,1
,CHEMBL631245,9254,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Intermediate,1,,N,50597,,,3293,,,1
,CHEMBL627162,9255,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,,,1
,CHEMBL627163,9256,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,,,1
,CHEMBL627164,9257,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Intermediate,1,,N,50597,,,6757,,,1
,CHEMBL627165,9258,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Intermediate,1,,N,50597,2113.0,,5979,,,1
,CHEMBL627166,9259,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Intermediate,1,,N,50597,,,5979,,,1
,CHEMBL627167,9260,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Intermediate,1,,N,50597,,,5979,,,1
,CHEMBL627822,9261,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (AUC) at a dose of 30 mg/kg in rats,Intermediate,1,,N,50597,,,4026,,,1
,CHEMBL627823,9262,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,5355,,,1
,CHEMBL627824,9263,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Intermediate,1,,N,50597,,,5355,,,1
,CHEMBL627825,9264,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,1,,N,50597,,,5355,,,1
,CHEMBL627826,9265,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Intermediate,1,,N,50597,,,5633,,,1
,CHEMBL627827,9266,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (Pharmacokinetic property) was determined,Intermediate,1,,N,50597,,,1716,,,1
,CHEMBL627828,9267,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (Pharmacokinetic property) of the compound; Not determined,Intermediate,1,,N,50597,,,1716,,,1
,CHEMBL627829,9268,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve after intravenous administration (1 mg/kg) in rat,Intermediate,1,,N,50597,,,4689,,,1
,CHEMBL627830,9269,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,,,1
,CHEMBL627831,9270,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,,,1
,CHEMBL627832,9271,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in male SD rats was observed after oral administration in rat,Intermediate,1,,N,50597,,,15662,,,1
,CHEMBL627833,9272,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Intermediate,1,,N,50597,,,4413,,,1
,CHEMBL627834,9273,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,,,3598,,,1
,CHEMBL628004,9274,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,,,3598,,,1
,CHEMBL628005,9275,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve at 5 mg/kg po was determined in rat,Intermediate,1,,N,50597,,,5964,,,1
,CHEMBL628006,9276,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in Rat at a oral dose of 5 mg/kg,Intermediate,1,,N,50597,,,4689,,,1
,CHEMBL628007,9277,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,1,,N,50597,,,4186,,,1
,CHEMBL625676,9278,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined,Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL631309,9279,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Intermediate,1,,N,50597,,,17858,,,1
,CHEMBL631310,9280,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve after intravenous administration at 3 mg/kg,Intermediate,1,,N,50597,,,17804,,,1
,CHEMBL631311,9281,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Intermediate,1,,N,50597,,,6106,,,1
,CHEMBL631312,9282,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve at 4 hr in rat,Intermediate,1,,N,50597,,,5964,,,1
,CHEMBL631313,9283,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve at a dose of 30 mg/kg,Intermediate,1,,N,50597,,,4026,,,1
,CHEMBL631314,9284,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Intermediate,1,,N,50597,,,4756,,,1
,CHEMBL631315,9285,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Intermediate,1,,N,50597,,,4756,,,1
,CHEMBL631316,9286,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve for a 2-mpk po dose in SD rats,Intermediate,1,,N,50597,,,5862,,,1
,CHEMBL631317,9287,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in SD rats,Intermediate,1,,N,50597,,,5862,,,1
,CHEMBL874471,9288,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat after oral administration at 13 mg/kg dose,Intermediate,1,,N,50597,,,6644,,,1
,CHEMBL631318,9289,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat by po administration at 0-24 hr,Intermediate,1,,N,50597,,,5871,,,1
,CHEMBL631319,9290,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under curve in rat plasma,Intermediate,1,,N,50597,1969.0,,5919,,,1
,CHEMBL631320,9291,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Intermediate,1,,N,50597,,,5939,,,1
,CHEMBL631321,9292,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Intermediate,1,,N,50597,,,5939,,,1
,CHEMBL631322,9293,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Intermediate,1,,N,50597,,,10,,,1
,CHEMBL631323,9294,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Intermediate,1,,N,50597,,,11149,,,1
,CHEMBL631324,9295,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve value in rat at a dose of 5 mg/kg,Intermediate,1,,N,50597,,,5302,,,1
,CHEMBL631325,9296,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined after oral administration in rats,Intermediate,1,,N,50597,,,17796,,,1
,CHEMBL631326,9297,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,,,4890,,,1
,CHEMBL631327,9298,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined after peroral administration in rat,Intermediate,1,,N,50597,,,6011,,,1
,CHEMBL631328,9299,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined at a dose 30 mpk administered orally.,Intermediate,1,,N,50597,,,5375,,,1
,CHEMBL631329,9300,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,1,,N,50597,,,17764,,,1
,CHEMBL627217,9301,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Intermediate,1,,N,50597,,,4368,,,1
,CHEMBL626352,9302,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in male rat,Intermediate,1,,N,50597,,,5610,,,1
,CHEMBL626353,9303,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in rat after PO administration,Intermediate,1,,N,50597,,,5833,,,1
,CHEMBL626354,9304,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in rat after a 3 mg/kg of oral dose,Intermediate,1,,N,50597,,,4257,,,1
,CHEMBL626355,9305,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,1,,N,50597,,,5937,,,1
,CHEMBL626356,9306,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Intermediate,1,,N,50597,,,5932,,,1
,CHEMBL626357,9307,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Intermediate,1,,N,50597,,,5932,,,1
,CHEMBL626358,9308,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL626359,9309,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL626360,9310,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration in rat at a dose of 3 mg/kg,Intermediate,1,,N,50597,1969.0,,17771,,,1
,CHEMBL626361,9311,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration at 2 hr in rats was evaluated.,Intermediate,1,,N,50597,,,1628,,,1
,CHEMBL626362,9312,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration at 2 hr in rats was evaluated; Not available,Intermediate,1,,N,50597,,,1628,,,1
,CHEMBL626363,9313,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL626970,9314,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL626971,9315,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL626972,9316,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,1969.0,,4910,,,1
,CHEMBL626973,9317,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,1969.0,,4910,,,1
,CHEMBL626974,9318,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,1969.0,,4910,,,1
,CHEMBL874592,9319,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,1969.0,,4910,,,1
,CHEMBL626975,9320,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL626976,9321,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL626977,9322,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL626978,9323,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL626979,9324,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,PK study was carried to determine the relative absorption ranking in rat.,Intermediate,1,,N,50597,,,16427,,,1
,CHEMBL626980,9325,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Intermediate,1,,N,50597,1969.0,,4689,In vivo,,1
,CHEMBL626981,9326,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Intermediate,1,,N,50597,178.0,,11450,,,1
,CHEMBL626982,9327,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Intermediate,1,,N,50597,178.0,,11450,,,1
,CHEMBL626983,9328,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Intermediate,1,,N,50597,178.0,,11450,,,1
,CHEMBL622522,9329,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Intermediate,1,,N,50597,178.0,,11450,,,1
,CHEMBL622523,9330,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Intermediate,1,,N,50597,178.0,,11450,,,1
,CHEMBL622524,9331,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Intermediate,1,,N,50597,178.0,,11450,,,1
,CHEMBL622525,9332,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Intermediate,1,,N,50597,955.0,,11450,,,1
,CHEMBL622526,9333,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Intermediate,1,,N,50597,955.0,,11450,,,1
,CHEMBL619849,9334,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Intermediate,1,,N,50597,955.0,,11450,,,1
,CHEMBL619850,9335,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Intermediate,1,,N,50597,955.0,,11450,,,1
,CHEMBL623864,9336,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Intermediate,1,,N,50597,955.0,,11450,,,1
,CHEMBL623865,9337,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Intermediate,1,,N,50597,955.0,,11450,,,1
,CHEMBL623866,9338,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Intermediate,1,,N,50597,948.0,,11450,,,1
,CHEMBL623867,9339,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Intermediate,1,,N,50597,948.0,,11450,,,1
,CHEMBL877615,9340,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Intermediate,1,,N,50597,948.0,,11450,,,1
,CHEMBL623868,9341,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Intermediate,1,,N,50597,948.0,,11450,,,1
,CHEMBL623869,9342,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Intermediate,1,,N,50597,948.0,,11450,,,1
,CHEMBL623870,9343,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Intermediate,1,,N,50597,948.0,,11450,,,1
,CHEMBL623871,9344,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL623872,9345,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,2048.0,,16434,,,1
,CHEMBL622129,9346,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622130,9347,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622131,9348,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622132,9349,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622133,9350,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622134,9351,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622135,9352,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622136,9353,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,2048.0,,16435,,,1
,CHEMBL622137,9354,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL622138,9355,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL623017,9356,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL623018,9357,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL623019,9358,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL623020,9359,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL623021,9360,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL623022,9361,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL623023,9362,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL623024,9363,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL623025,9364,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620545,9365,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620546,9366,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620547,9367,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620548,9368,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620549,9369,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620550,9370,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL620551,9371,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL620552,9372,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,2385.0,,16434,,,1
,CHEMBL620553,9373,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620554,9374,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL875845,9375,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620555,9376,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620556,9377,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620557,9378,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,2385.0,,16435,,,1
,CHEMBL620558,9379,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL620559,9380,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622939,9381,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622940,9382,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622941,9383,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622942,9384,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622943,9385,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622944,9386,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622945,9387,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622946,9388,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622947,9389,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for terminal half life in rat,Intermediate,1,,N,50597,,,3341,,,1
,CHEMBL622948,9390,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Intermediate,1,,N,50597,1969.0,,3634,In vivo,,1
,CHEMBL622949,9391,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Intermediate,1,,N,50597,1969.0,,3634,In vivo,,1
,CHEMBL622950,9392,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for its half life in rat,Intermediate,1,,N,50597,,,4839,,,1
,CHEMBL622951,9393,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Intermediate,0,,U,22224,1969.0,,5005,In vivo,,1
,CHEMBL622952,9394,BAO_0000366,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for its plasma half life in Sprague Dawley rats,Intermediate,0,,U,22224,1969.0,,5005,,,1
,CHEMBL622953,9395,BAO_0000366,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Intermediate,0,,U,22224,1969.0,,5005,,,1
,CHEMBL873818,9396,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma half-life period in rat,Intermediate,1,,N,50597,1969.0,,1094,,,1
,CHEMBL622954,9397,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Elimination half life after i.v. administration of compound in rats,Intermediate,1,,N,50597,,,5031,In vivo,,1
,CHEMBL622955,9398,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL875229,9399,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Elimination half-life after IV dosing at 1 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL622956,9400,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL622957,9401,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL622958,9402,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,1,,N,50597,955.0,,5408,In vivo,,1
,CHEMBL622959,9403,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,1,,N,50597,1969.0,,5408,In vivo,,1
,CHEMBL622960,9404,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,1,,N,50597,955.0,,5408,In vivo,,1
,CHEMBL622961,9405,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,1,,N,50597,1969.0,,5408,In vivo,,1
,CHEMBL622962,9406,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for the half life in rat (in vivo),Intermediate,1,,N,50597,,,4687,In vivo,,1
,CHEMBL622963,9407,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Hafl life in rat,Intermediate,1,,N,50597,,,6640,,,1
,CHEMBL622964,9408,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Hafl life rat,Intermediate,1,,N,50597,,,6640,,,1
,CHEMBL622965,9409,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Hafl life rat,Intermediate,1,,N,50597,,,6641,,,1
,CHEMBL622966,9410,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Hafl life rat; Not determined,Intermediate,1,,N,50597,,,6640,,,1
,CHEMBL622967,9411,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Hafl life rat; Not determined,Intermediate,1,,N,50597,,,6641,,,1
,CHEMBL622968,9412,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,2113.0,,17411,In vivo,,1
,CHEMBL622969,9413,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,2107.0,,17411,In vivo,,1
,CHEMBL875327,9414,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,2048.0,,17411,In vivo,,1
,CHEMBL628638,9415,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat after 1 mg/kg i.v. administration,Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL628639,9416,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat after 2 mg/kg peroral administration,Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL625840,9417,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,In vivo,,1
,CHEMBL625841,9418,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of 10 mg/kg oral dose determined in rats,Intermediate,1,,N,50597,,,4722,In vivo,,1
,CHEMBL625842,9419,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL625843,9420,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL625844,9421,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL873822,9422,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL625845,9423,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL627059,9424,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL627060,9425,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL627061,9426,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL627709,9427,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound at 5 mg/kg after po administration was determined in rat,Intermediate,1,,N,50597,,,4762,In vivo,,1
,CHEMBL627710,9428,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound determined after intravenous administration to rat,Intermediate,1,,N,50597,,,5327,In vivo,,1
,CHEMBL627711,9429,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life of compound was determined in rat,Intermediate,1,,N,50597,,,4847,,,1
,CHEMBL627712,9430,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,1969.0,,17720,In vivo,,1
,CHEMBL627713,9431,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,In vivo,,1
,CHEMBL627714,9432,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,In vivo,,1
,CHEMBL627889,9433,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Intermediate,0,,U,22224,,,4256,In vivo,,1
,CHEMBL627890,9434,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life determined in rat by intravenous administration,Intermediate,0,,U,22224,,,4256,In vivo,,1
,CHEMBL627891,9435,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life determined in rats after iv administration,Intermediate,1,,N,50597,,,4722,In vivo,,1
,CHEMBL627892,9436,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,1,,N,50597,1969.0,,6535,In vivo,,1
,CHEMBL627893,9437,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,1,,N,50597,1969.0,,6535,In vivo,,1
,CHEMBL627894,9438,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat plasma was determined,Intermediate,1,,N,50597,1969.0,,1435,,,1
,CHEMBL627895,9439,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat plasma was determined; NA means not applicable,Intermediate,1,,N,50597,1969.0,,1435,,,1
,CHEMBL627896,9440,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat was tested,Intermediate,1,,N,50597,,,5206,,,1
,CHEMBL627897,9441,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life measured in rat plasma,Intermediate,1,,N,50597,1969.0,,6080,,,1
,CHEMBL627898,9442,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life recorded in rats,Intermediate,1,,N,50597,,,4449,,,1
,CHEMBL627899,9443,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was calculated,Intermediate,1,,N,50597,,,6057,,,1
,CHEMBL873823,9444,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was calculated in rat,Intermediate,1,,N,50597,,,6057,,,1
,CHEMBL627900,9445,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was determined,Intermediate,1,,N,50597,,,3747,,,1
,CHEMBL627901,9446,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after 10 mg/kg oral administration in rat,Intermediate,1,,N,50597,,,17858,In vivo,,1
,CHEMBL627902,9447,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL627903,9448,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after administering orally a dose of 30 mg/kg,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL627904,9449,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Intermediate,1,,N,50597,,,5031,,,1
,CHEMBL627905,9450,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Intermediate,1,,N,50597,,,4722,,,1
,CHEMBL627906,9451,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Intermediate,1,,N,50597,,,6078,,,1
,CHEMBL627907,9452,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Intermediate,1,,N,50597,,,6078,,,1
,CHEMBL876783,9453,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,6078,,,1
,CHEMBL627908,9454,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Intermediate,1,,N,50597,,,6078,,,1
,CHEMBL627909,9455,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,1,,N,50597,,,17065,,,1
,CHEMBL627910,9456,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Intermediate,1,,N,50597,,,1353,,,1
,CHEMBL627911,9457,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Intermediate,1,,N,50597,,,1353,,,1
,CHEMBL627912,9458,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Intermediate,1,,N,50597,,,1353,,,1
,CHEMBL627913,9459,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Intermediate,1,,N,50597,,,1353,,,1
,CHEMBL627914,9460,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Intermediate,1,,N,50597,,,1353,,,1
,CHEMBL627915,9461,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Intermediate,1,,N,50597,,,16423,,,1
,CHEMBL627916,9462,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was evaluated after 20 uM/kg of peroral administration,Intermediate,1,,N,50597,,,16423,,,1
,CHEMBL627917,9463,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Intermediate,1,,N,50597,,,6062,,,1
,CHEMBL627918,9464,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Intermediate,1,,N,50597,,,6056,,,1
,CHEMBL627919,9465,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Intermediate,1,,N,50597,,,5182,,,1
,CHEMBL627920,9466,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Intermediate,1,,N,50597,,,6410,,,1
,CHEMBL627921,9467,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve was evaluated at an oral dose of 30 mg/kg,Intermediate,1,,N,50597,,,6410,,,1
,CHEMBL627922,9468,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,,,1
,CHEMBL876784,9469,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,,,1
,CHEMBL627923,9470,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,,,1
,CHEMBL626208,9471,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,,,1
,CHEMBL626209,9472,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,,,1
,CHEMBL626210,9473,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,,,1
,CHEMBL627994,9474,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,1,,N,50597,1969.0,,2463,,,1
,CHEMBL627995,9475,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Intermediate,1,,N,50597,,,4709,,,1
,CHEMBL627996,9476,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Intermediate,1,,N,50597,,,4075,,,1
,CHEMBL627997,9477,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Intermediate,1,,N,50597,,,5394,,,1
,CHEMBL627998,9478,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,,,1
,CHEMBL628640,9479,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,,,1
,CHEMBL628641,9480,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,,,1
,CHEMBL628642,9481,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,,,1
,CHEMBL628643,9482,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for area under the curve expressed as (h*ug/ml),Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL628644,9483,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for area under curve in rat,Intermediate,1,,N,50597,,,2591,,,1
,CHEMBL628645,9484,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Intermediate,1,,N,50597,,,6567,,,1
,CHEMBL628646,9485,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,1,,N,50597,,,6211,,,1
,CHEMBL628647,9486,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Intermediate,1,,N,50597,,,5529,,,1
,CHEMBL628648,9487,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,1,,N,50597,,,5408,,,1
,CHEMBL625358,9488,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,1,,N,50597,,,5408,,,1
,CHEMBL625359,9489,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,1,,N,50597,,,5408,,,1
,CHEMBL625360,9490,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,1,,N,50597,,,5408,,,1
,CHEMBL625361,9491,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Intermediate,1,,N,50597,,,429,,,1
,CHEMBL625362,9492,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Intermediate,1,,N,50597,,,429,,,1
,CHEMBL625363,9493,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Intermediate,1,,N,50597,,,429,,,1
,CHEMBL625364,9494,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,1,,N,50597,,,4796,,,1
,CHEMBL625365,9495,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,,,1
,CHEMBL625366,9496,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,,,1
,CHEMBL625367,9497,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,,,1
,CHEMBL625368,9498,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Intermediate,1,,N,50597,2113.0,,11450,,,1
,CHEMBL625369,9499,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Intermediate,1,,N,50597,2113.0,,11450,,,1
,CHEMBL625370,9500,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Intermediate,1,,N,50597,2113.0,,11450,,,1
,CHEMBL625371,9501,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Intermediate,1,,N,50597,2113.0,,11450,,,1
,CHEMBL625372,9502,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Intermediate,1,,N,50597,2113.0,,11450,,,1
,CHEMBL625373,9503,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Intermediate,1,,N,50597,2113.0,,11450,,,1
,CHEMBL625374,9504,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Intermediate,1,,N,50597,2107.0,,11450,,,1
,CHEMBL877593,9505,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Intermediate,1,,N,50597,2107.0,,11450,,,1
,CHEMBL625375,9506,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Intermediate,1,,N,50597,2107.0,,11450,,,1
,CHEMBL625376,9507,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Intermediate,1,,N,50597,2107.0,,11450,,,1
,CHEMBL621973,9508,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Intermediate,1,,N,50597,2107.0,,11450,,,1
,CHEMBL621974,9509,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Intermediate,1,,N,50597,2107.0,,11450,,,1
,CHEMBL621975,9510,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Intermediate,1,,N,50597,2048.0,,11450,,,1
,CHEMBL622166,9511,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Intermediate,1,,N,50597,2048.0,,11450,,,1
,CHEMBL622167,9512,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Intermediate,1,,N,50597,2048.0,,11450,,,1
,CHEMBL622168,9513,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Intermediate,1,,N,50597,2048.0,,11450,,,1
,CHEMBL622169,9514,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Intermediate,1,,N,50597,2048.0,,11450,,,1
,CHEMBL622170,9515,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Intermediate,1,,N,50597,2048.0,,11450,,,1
,CHEMBL622171,9516,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622172,9517,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622173,9518,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622174,9519,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622175,9520,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622176,9521,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622177,9522,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622178,9523,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622179,9524,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622180,9525,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622181,9526,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622182,9527,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622183,9528,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622184,9529,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622185,9530,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622186,9531,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622187,9532,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL625002,9533,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622090,9534,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622091,9535,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622092,9536,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622093,9537,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622094,9538,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622095,9539,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622264,9540,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622265,9541,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL622266,9542,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL622267,9543,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL622268,9544,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL622269,9545,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL625071,9546,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL621621,9547,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL621622,9548,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL621623,9549,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621624,9550,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621625,9551,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621626,9552,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621627,9553,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621628,9554,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL875328,9555,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621629,9556,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621630,9557,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL621631,9558,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL621632,9559,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,2106.0,,16434,,,1
,CHEMBL621633,9560,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621634,9561,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621635,9562,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621636,9563,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621637,9564,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL621638,9565,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,2106.0,,16435,,,1
,CHEMBL618883,9566,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL618884,9567,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL628627,9568,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL628628,9569,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL628629,9570,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL628630,9571,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after administering orally a dose of 3 mg/kg,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL628631,9572,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL628632,9573,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after administering intravenously a dose of 1 mg/kg,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL628633,9574,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after oral dosing in rats,Intermediate,1,,N,50597,,,526,In vivo,,1
,CHEMBL628634,9575,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL627789,9576,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life by intravenous administration of 3.4 mg/kg in rat,Intermediate,1,,N,50597,,,4368,In vivo,,1
,CHEMBL627790,9577,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat,Intermediate,1,,N,50597,,,3371,,,1
,CHEMBL627791,9578,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat,Intermediate,1,,N,50597,,,6448,,,1
,CHEMBL627792,9579,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat,Intermediate,1,,N,50597,,,6453,,,1
,CHEMBL627793,9580,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat after intravenous administration of the compound,Intermediate,1,,N,50597,,,4353,In vivo,,1
,CHEMBL627794,9581,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,1,,N,50597,1969.0,,4353,In vivo,,1
,CHEMBL627795,9582,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat after po administration of the compound,Intermediate,1,,N,50597,,,4353,In vivo,,1
,CHEMBL627796,9583,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat after po administration of the compound; ND means Not determined,Intermediate,1,,N,50597,,,4353,In vivo,,1
,CHEMBL875335,9584,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Intermediate,1,,N,50597,1969.0,,4353,In vivo,,1
,CHEMBL627797,9585,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,1,,N,50597,1969.0,,4353,In vivo,,1
,CHEMBL627798,9586,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat i.v.,Intermediate,1,,N,50597,,,5789,In vivo,,1
,CHEMBL627799,9587,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat i.v. at 2 mg/kg concentration,Intermediate,1,,N,50597,,,17686,In vivo,,1
,CHEMBL627800,9588,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats,Intermediate,1,,N,50597,,,6495,,,1
,CHEMBL627801,9589,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats after intravenous administration,Intermediate,1,,N,50597,,,484,In vivo,,1
,CHEMBL627802,9590,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,1,,N,50597,,,6467,In vivo,,1
,CHEMBL627803,9591,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat,Expert,1,,N,50597,,,6642,,,1
,CHEMBL873820,9592,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was evaluated after intravenous administration to rats,Intermediate,1,,N,50597,,,16367,In vivo,,1
,CHEMBL627804,9593,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Intermediate,1,,N,50597,,,1369,,,1
,CHEMBL627805,9594,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was evaluated in rat,Intermediate,1,,N,50597,,,5472,,,1
,CHEMBL627806,9595,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was evaluated in rat,Intermediate,1,,N,50597,,,6049,,,1
,CHEMBL627107,9596,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was evaluated in rat; Not tested,Intermediate,1,,N,50597,,,5472,,,1
,CHEMBL627108,9597,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Intermediate,1,,N,50597,,,16366,In vivo,,1
,CHEMBL627109,9598,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Intermediate,1,,N,50597,,,11149,In vivo,,1
,CHEMBL627110,9599,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Intermediate,1,,N,50597,178.0,,11149,In vivo,,1
,CHEMBL627111,9600,BAO_0000218,A,,,9443.0,,Primates,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL627112,9601,BAO_0000218,A,,,9443.0,,Primates,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL627113,9602,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was measured in rat at dose of 30 mg/kg by iv administration,Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL627114,9603,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was measured in rat at dose of 30 mg/kg by po administration,Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL627115,9604,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life (t1/2) was determined,Intermediate,1,,N,50597,,,4026,,,1
,CHEMBL627116,9605,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period at a dose of 10 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,,,1
,CHEMBL627117,9606,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Intermediate,1,,N,50597,,,4527,In vivo,,1
,CHEMBL627118,9607,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was determined,Intermediate,1,,N,50597,,,5503,,,1
,CHEMBL627119,9608,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after intravenous administration at 20 mpk in rats,Intermediate,1,,N,50597,,,4426,In vivo,,1
,CHEMBL627120,9609,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Intermediate,1,,N,50597,,,4426,In vivo,,1
,CHEMBL626922,9610,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after intravenous administration in rat,Intermediate,1,,N,50597,,,6109,In vivo,,1
,CHEMBL626923,9611,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL626924,9612,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL626925,9613,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in 80% rat plasma at 37 degree Centigrade,Intermediate,1,,N,50597,1969.0,,4755,,,1
,CHEMBL626926,9614,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in SD rats,Intermediate,1,,N,50597,,,5862,,,1
,CHEMBL626927,9615,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL626928,9616,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL626929,9617,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL626930,9618,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL626931,9619,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat,Intermediate,1,,N,50597,,,5960,,,1
,CHEMBL626932,9620,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat,Intermediate,1,,N,50597,,,6103,,,1
,CHEMBL626933,9621,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat,Intermediate,1,,N,50597,,,6317,,,1
,CHEMBL873826,9622,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat after oral administration at 10.5 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL626934,9623,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat after oral administration at 11.2 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL626935,9624,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat after oral administration at 13 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL626936,9625,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat after oral administration at 9.7 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL626937,9626,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,,,1
,CHEMBL625906,9627,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6295,,,1
,CHEMBL625907,9628,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,1,,N,50597,,,6296,,,1
,CHEMBL625908,9629,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,PK study was carried to determine AUC (area under curve) value in rat,Intermediate,1,,N,50597,,,16427,,,1
,CHEMBL625909,9630,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC after intravenous administration to rats,Intermediate,1,,N,50597,,,16367,,,1
,CHEMBL625910,9631,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC after oral administration to rats,Intermediate,1,,N,50597,,,16367,,,1
,CHEMBL625911,9632,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Intermediate,1,,N,50597,,,16365,,,1
,CHEMBL625912,9633,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Intermediate,1,,N,50597,,,16365,,,1
,CHEMBL626538,9634,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Intermediate,1,,N,50597,,,16365,,,1
,CHEMBL876794,9635,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Intermediate,1,,N,50597,,,16365,,,1
,CHEMBL626539,9636,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Intermediate,1,,N,50597,,,16365,,,1
,CHEMBL626540,9637,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Intermediate,1,,N,50597,,,16365,,,1
,CHEMBL626541,9638,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Intermediate,1,,N,50597,,,5394,,,1
,CHEMBL626542,9639,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Intermediate,1,,N,50597,,,5394,,,1
,CHEMBL626543,9640,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,,,1
,CHEMBL626544,9641,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,,,2792,,,1
,CHEMBL626545,9642,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,,,1
,CHEMBL626546,9643,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,,,2792,,,1
,CHEMBL626547,9644,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter area under curve was reported,Intermediate,1,,N,50597,,,5334,,,1
,CHEMBL626548,9645,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (AUC) in rat,Intermediate,1,,N,50597,,,4408,,,1
,CHEMBL626549,9646,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,1,,N,50597,,,5983,,,1
,CHEMBL626550,9647,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Intermediate,1,,N,50597,,,4397,,,1
,CHEMBL626551,9648,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Intermediate,1,,N,50597,,,4397,,,1
,CHEMBL623777,9649,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property was determined,Intermediate,1,,N,50597,,,5491,,,1
,CHEMBL623778,9650,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Intermediate,1,,N,50597,,,5491,,,1
,CHEMBL623779,9651,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Intermediate,1,,N,50597,,,5491,,,1
,CHEMBL623780,9652,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,1,,N,50597,1969.0,,4199,,,1
,CHEMBL622015,9653,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,1,,N,50597,1969.0,,4199,,,1
,CHEMBL622016,9654,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,1,,N,50597,1969.0,,4199,,,1
,CHEMBL622017,9655,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Intermediate,1,,N,50597,,,5173,,,1
,CHEMBL622018,9656,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Intermediate,1,,N,50597,,,5173,,,1
,CHEMBL622019,9657,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Intermediate,1,,N,50597,,,5173,,,1
,CHEMBL622020,9658,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Intermediate,1,,N,50597,,,5173,,,1
,CHEMBL622021,9659,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Intermediate,1,,N,50597,,,16366,,,1
,CHEMBL622022,9660,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Intermediate,1,,N,50597,,,16366,,,1
,CHEMBL622023,9661,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Intermediate,1,,N,50597,,,5327,,,1
,CHEMBL622024,9662,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Intermediate,1,,N,50597,,,6681,,,1
,CHEMBL622693,9663,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Intermediate,1,,N,50597,,,12873,,,1
,CHEMBL622694,9664,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Intermediate,1,,N,50597,,,12873,,,1
,CHEMBL622695,9665,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,6685,,,1
,CHEMBL622696,9666,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,1,,N,50597,,,6685,,,1
,CHEMBL622697,9667,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Intermediate,1,,N,50597,,,6685,,,1
,CHEMBL622874,9668,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Intermediate,1,,N,50597,,,6619,,,1
,CHEMBL622875,9669,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Intermediate,1,,N,50597,,,6619,,,1
,CHEMBL622876,9670,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,1,,N,50597,,,10363,,,1
,CHEMBL622877,9671,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,1,,N,50597,,,4796,,,1
,CHEMBL622878,9672,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL622879,9673,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Intermediate,1,,N,50597,1969.0,,4910,,,1
,CHEMBL877602,9674,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Intermediate,1,,N,50597,,,4839,,,1
,CHEMBL622880,9675,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL622881,9676,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL622882,9677,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL622883,9678,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL622884,9679,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622885,9680,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Intermediate,1,,N,50597,2046.0,,11450,,,1
,CHEMBL622886,9681,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL622887,9682,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL622888,9683,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,1,,N,50597,1088.0,,8151,,,1
,CHEMBL622889,9684,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,178.0,,8677,In vivo,,1
,CHEMBL622890,9685,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,178.0,,8677,In vivo,,1
,CHEMBL622891,9686,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,178.0,,8677,In vivo,,1
,CHEMBL877603,9687,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,178.0,,8677,In vivo,,1
,CHEMBL622892,9688,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,955.0,,8677,In vivo,,1
,CHEMBL622893,9689,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,955.0,,8677,In vivo,,1
,CHEMBL622894,9690,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,955.0,,8677,In vivo,,1
,CHEMBL622895,9691,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,955.0,,8677,In vivo,,1
,CHEMBL622896,9692,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Intermediate,1,,N,50597,955.0,,8677,In vivo,,1
,CHEMBL622897,9693,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,948.0,,8677,In vivo,,1
,CHEMBL622898,9694,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,948.0,,8677,In vivo,,1
,CHEMBL622899,9695,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,948.0,,8677,In vivo,,1
,CHEMBL622900,9696,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2113.0,,8677,In vivo,,1
,CHEMBL624114,9697,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2113.0,,8677,In vivo,,1
,CHEMBL624115,9698,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2113.0,,8677,In vivo,,1
,CHEMBL624116,9699,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2113.0,,8677,In vivo,,1
,CHEMBL624117,9700,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2107.0,,8677,In vivo,,1
,CHEMBL624118,9701,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2107.0,,8677,In vivo,,1
,CHEMBL624119,9702,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2107.0,,8677,In vivo,,1
,CHEMBL624120,9703,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2107.0,,8677,In vivo,,1
,CHEMBL624121,9704,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2048.0,,8677,In vivo,,1
,CHEMBL624122,9705,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2048.0,,8677,In vivo,,1
,CHEMBL624123,9706,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2048.0,,8677,In vivo,,1
,CHEMBL624124,9707,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2048.0,,8677,In vivo,,1
,CHEMBL624125,9708,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2385.0,,8677,In vivo,,1
,CHEMBL624126,9709,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2385.0,,8677,In vivo,,1
,CHEMBL624127,9710,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2385.0,,8677,In vivo,,1
,CHEMBL624128,9711,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2385.0,,8677,In vivo,,1
,CHEMBL624129,9712,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,14.0,,8677,In vivo,,1
,CHEMBL624130,9713,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,14.0,,8677,In vivo,,1
,CHEMBL622340,9714,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,14.0,,8677,In vivo,,1
,CHEMBL622341,9715,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,14.0,,8677,In vivo,,1
,CHEMBL622342,9716,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,160.0,,8677,In vivo,,1
,CHEMBL622343,9717,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,160.0,,8677,In vivo,,1
,CHEMBL622344,9718,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,160.0,,8677,In vivo,,1
,CHEMBL622345,9719,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,160.0,,8677,In vivo,,1
,CHEMBL622346,9720,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2106.0,,8677,In vivo,,1
,CHEMBL622347,9721,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2106.0,,8677,In vivo,,1
,CHEMBL622348,9722,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2106.0,,8677,In vivo,,1
,CHEMBL622349,9723,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2106.0,,8677,In vivo,,1
,CHEMBL622350,9724,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622351,9725,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622352,9726,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622353,9727,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622354,9728,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622355,9729,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622356,9730,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622357,9731,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622358,9732,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622359,9733,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL874393,9734,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL622872,9735,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL622873,9736,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623047,9737,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL623048,9738,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623049,9739,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623050,9740,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623051,9741,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL623052,9742,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL626343,9743,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL626344,9744,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL626345,9745,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL626346,9746,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL626347,9747,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL626348,9748,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL626349,9749,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,1,,N,50597,,,16434,,,1
,CHEMBL626350,9750,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL626351,9751,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL627650,9752,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL627651,9753,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL627652,9754,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL627653,9755,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,1,,N,50597,,,16435,,,1
,CHEMBL627654,9756,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627835,9757,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627836,9758,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627837,9759,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627838,9760,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL875338,9761,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627839,9762,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627840,9763,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627841,9764,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627842,9765,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627843,9766,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627844,9767,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627845,9768,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL627846,9769,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period in rat by iv administration at a dose of 3 mg/kg,Intermediate,1,,N,50597,,,5874,In vivo,,1
,CHEMBL627847,9770,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL873821,9771,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL626079,9772,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL626080,9773,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,1,,N,50597,1969.0,,1515,,,1
,CHEMBL626081,9774,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period was evaluated in rat plasma,Intermediate,1,,N,50597,1969.0,,5491,,,1
,CHEMBL875344,9775,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life period was evaluated in rat plasma; Not tested,Intermediate,1,,N,50597,1969.0,,5491,,,1
,CHEMBL626082,9776,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was evaluated in rats,Intermediate,1,,N,50597,,,1918,,,1
,CHEMBL626250,9777,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Half life period was evaluated in rats, iv",Intermediate,1,,N,50597,,,1918,In vivo,,1
,CHEMBL626251,9778,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period after intravenous administration at 5 mg/kg in rat,Intermediate,1,,N,50597,,,6113,In vivo,,1
,CHEMBL626252,9779,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,1,,N,50597,,,5546,In vivo,,1
,CHEMBL626253,9780,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Intermediate,1,,N,50597,,,5553,In vivo,,1
,CHEMBL626254,9781,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life stability of compound was evaluated in rat plasma,Intermediate,1,,N,50597,1969.0,,4188,,,1
,CHEMBL626255,9782,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,1,,N,50597,,,6215,In vivo,,1
,CHEMBL626256,9783,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,1,,N,50597,,,6141,In vivo,,1
,CHEMBL626257,9784,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,1,,N,50597,,,5182,In vivo,,1
,CHEMBL626258,9785,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Intermediate,1,,N,50597,,,5182,In vivo,,1
,CHEMBL626259,9786,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Intermediate,1,,N,50597,,,5710,In vivo,,1
,CHEMBL626260,9787,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half in rat i.v.,Intermediate,1,,N,50597,,,5789,In vivo,,1
,CHEMBL875345,9788,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half period in rat after intravenous administration,Intermediate,1,,N,50597,,,6011,In vivo,,1
,CHEMBL626261,9789,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,1,,N,50597,,,17594,In vivo,,1
,CHEMBL626262,9790,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Half-life measured in in vitro Cathepsin B assay in rat liver,Intermediate,1,,N,50597,2107.0,,12357,In vitro,,1
,CHEMBL626263,9791,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life of compound was determined in rats,Intermediate,1,,N,50597,,,5210,,,1
,CHEMBL625270,9792,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life at 10 mg/kg in rat upon intravenous administration,Intermediate,1,,N,50597,,,17596,In vivo,,1
,CHEMBL625271,9793,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life determined in rat,Intermediate,1,,N,50597,,,6672,,,1
,CHEMBL625272,9794,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life determined in rat,Intermediate,1,,N,50597,,,6673,,,1
,CHEMBL625273,9795,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,1,,N,50597,955.0,,4910,In vivo,,1
,CHEMBL625274,9796,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Intermediate,1,,N,50597,1969.0,,3741,,,1
,CHEMBL625275,9797,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,1,,N,50597,,,17671,In vivo,,1
,CHEMBL625276,9798,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Intermediate,1,,N,50597,1969.0,,4910,In vivo,,1
,CHEMBL625277,9799,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in rat plasma,Intermediate,1,,N,50597,1969.0,,17537,,,1
,CHEMBL625278,9800,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in rat plasma was determined,Intermediate,1,,N,50597,1969.0,,4965,,,1
,CHEMBL625279,9801,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in rat plasma; Not tested,Intermediate,1,,N,50597,1969.0,,17537,,,1
,CHEMBL625280,9802,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Half-life in rat serum,Intermediate,1,,N,50597,1977.0,,6124,,,1
,CHEMBL876797,9803,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Half-life in rat serum; na is not available,Intermediate,1,,N,50597,1977.0,,6124,,,1
,CHEMBL625281,9804,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was calculated in rat,Intermediate,1,,N,50597,,,6078,,,1
,CHEMBL873827,9805,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life was calculated in rat plasma,Intermediate,1,,N,50597,1969.0,,17668,,,1
,CHEMBL625282,9806,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was determined,Intermediate,1,,N,50597,,,3185,,,1
,CHEMBL625283,9807,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was determined,Intermediate,1,,N,50597,,,4883,,,1
,CHEMBL625284,9808,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life after administration of 20 mg/Kg oral dose in rat,Intermediate,1,,N,50597,,,2959,In vivo,,1
,CHEMBL625285,9809,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life after administration of 3.2 mg/kg intravenously in male rat,Intermediate,1,,N,50597,,,4029,In vivo,,1
,CHEMBL625286,9810,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life after intravenous administration in female rat,Intermediate,1,,N,50597,,,4029,In vivo,,1
,CHEMBL625287,9811,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life after intravenous administration in male rat,Intermediate,1,,N,50597,,,4029,In vivo,,1
,CHEMBL625288,9812,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life after intravenous dose in rat,Intermediate,1,,N,50597,,,6180,In vivo,,1
,CHEMBL625289,9813,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Half-life in a rat liver homogenate preparation,Intermediate,1,,N,50597,2107.0,,1557,,,1
,CHEMBL625290,9814,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in plasma of rat,Intermediate,1,,N,50597,1969.0,,12500,,,1
,CHEMBL876798,9815,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in plasma of rat at dose of 3-10 mgkg,Intermediate,1,,N,50597,1969.0,,12500,,,1
,CHEMBL625291,9816,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat,Intermediate,1,,N,50597,,,5064,,,1
,CHEMBL625292,9817,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat,Intermediate,1,,N,50597,,,5145,,,1
,CHEMBL625293,9818,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat,Intermediate,1,,N,50597,,,5147,,,1
,CHEMBL622832,9819,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat,Intermediate,1,,N,50597,,,5833,,,1
,CHEMBL622833,9820,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat,Intermediate,1,,N,50597,,,6596,,,1
,CHEMBL622834,9821,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat,Intermediate,1,,N,50597,,,17655,,,1
,CHEMBL622835,9822,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat after oral administration at 10 mg/kg,Intermediate,1,,N,50597,,,6495,In vivo,,1
,CHEMBL622836,9823,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat after po administration at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,17538,In vivo,,1
,CHEMBL622837,9824,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,1,,N,50597,,,17538,In vivo,,1
,CHEMBL622838,9825,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat at 3 mg/kg dose administered intravenously,Intermediate,1,,N,50597,,,10,In vivo,,1
,CHEMBL622839,9826,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Half-life in rat brain homogenate,Intermediate,1,,N,50597,955.0,,17669,,,1
,CHEMBL622840,9827,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in rat plasma,Intermediate,1,,N,50597,1969.0,,17065,,,1
,CHEMBL622841,9828,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rats,Intermediate,1,,N,50597,,,4333,,,1
,CHEMBL622842,9829,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in Dawley rats,Intermediate,1,,N,50597,,,6827,,,1
,CHEMBL622843,9830,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in vitro in rat plasma,Intermediate,1,,N,50597,1969.0,,889,In vitro,,1
,CHEMBL622844,9831,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Intermediate,1,,N,50597,1969.0,,889,In vitro,,1
,CHEMBL622845,9832,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Intermediate,1,,N,50597,,,3747,,,1
,CHEMBL622846,9833,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The area under the curve of compound was measured at the dose of 100 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL622847,9834,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The area under the curve of compound was measured at the dose of 300 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL622848,9835,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The area under the curve of compound was measured at the dose of 30 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL622849,9836,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability as oral AUC in rats,Intermediate,1,,N,50597,,,3360,In vivo,,1
,CHEMBL622850,9837,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The plasma concentration versus time curve (AUC) was determined,Intermediate,1,,N,50597,1969.0,,5334,,,1
,CHEMBL876807,9838,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL622851,9839,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL622852,9840,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL622853,9841,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Intermediate,1,,N,50597,,,6570,,,1
,CHEMBL622854,9842,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Intermediate,1,,N,50597,,,6570,,,1
,CHEMBL622855,9843,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,1,,N,50597,,,17411,,,1
,CHEMBL622856,9844,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,1,,N,50597,1969.0,,14941,,,1
,CHEMBL622857,9845,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,1,,N,50597,1969.0,,14941,,,1
,CHEMBL622858,9846,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat after po administration at a dose of 10 mg/kg,Intermediate,1,,N,50597,1969.0,,17538,,,1
,CHEMBL622859,9847,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Intermediate,1,,N,50597,1969.0,,17752,,,1
,CHEMBL622860,9848,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Intermediate,1,,N,50597,,,17509,,,1
,CHEMBL622861,9849,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Intermediate,1,,N,50597,,,17509,,,1
,CHEMBL622862,9850,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Intermediate,1,,N,50597,,,17509,,,1
,CHEMBL622863,9851,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Intermediate,1,,N,50597,,,17509,,,1
,CHEMBL623817,9852,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve value 6 hr after po administration in rat,Intermediate,1,,N,50597,,,17509,,,1
,CHEMBL623818,9853,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,1,,N,50597,,,17717,,,1
,CHEMBL623819,9854,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Intermediate,1,,N,50597,,,17717,,,1
,CHEMBL623820,9855,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,1,,N,50597,,,17717,,,1
,CHEMBL623821,9856,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,1,,N,50597,,,17717,,,1
,CHEMBL623822,9857,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC normalized for dose (AUCN) in rat,Intermediate,1,,N,50597,1969.0,,6642,,,1
,CHEMBL623823,9858,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat after p.o. administration,Intermediate,1,,N,50597,,,6640,,,1
,CHEMBL623824,9859,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat after p.o. administration,Intermediate,1,,N,50597,,,6641,,,1
,CHEMBL623825,9860,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat after p.o. administration; Not determined,Intermediate,1,,N,50597,,,6641,,,1
,CHEMBL622070,9861,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in rat after peroral administration,Intermediate,1,,N,50597,,,6641,,,1
,CHEMBL622071,9862,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (carotid artery) value of the compound,Intermediate,1,,N,50597,,,3603,,,1
,CHEMBL622072,9863,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability expressed as the area under curve of rat carotid artery,Intermediate,1,,N,50597,,,3550,,,1
,CHEMBL622073,9864,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve in male SD rats was observed after intravenous administration in rat,Intermediate,1,,N,50597,,,15662,,,1
,CHEMBL622074,9865,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve of the compound was determined,Intermediate,1,,N,50597,,,17720,,,1
,CHEMBL622075,9866,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Intermediate,1,,N,50597,,,5407,,,1
,CHEMBL622076,9867,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Intermediate,1,,N,50597,1969.0,,17752,,,1
,CHEMBL622077,9868,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Intermediate,1,,N,50597,1969.0,,17752,,,1
,CHEMBL622078,9869,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve (portal vein) value of the compound,Intermediate,1,,N,50597,,,3603,,,1
,CHEMBL622079,9870,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability expressed as the area under curve of rat portal vein,Intermediate,1,,N,50597,,,3550,,,1
,CHEMBL622080,9871,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Area Under plasma concentration time curve in rat upon peroral administration,Intermediate,1,,N,50597,1969.0,,17655,,,1
,CHEMBL877612,9872,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Intermediate,1,,N,50597,,,17582,,,1
,CHEMBL622081,9873,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Intermediate,1,,N,50597,,,17582,,,1
,CHEMBL622082,9874,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for oral bioavailability in rats,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL622083,9875,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for oral bioavailability in rats after iv administration,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL622084,9876,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for oral bioavailability in rats; 30-80,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL622085,9877,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for oral bioavailability in rats; 50-60,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL622086,9878,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for oral bioavailability in rats; no data,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL622087,9879,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for oral bioavailability in rats; peptide,Intermediate,1,,N,50597,,,17791,,,1
,CHEMBL622088,9880,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Intermediate,1,,N,50597,178.0,,7768,,,1
,CHEMBL622089,9881,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Intermediate,1,,N,50597,178.0,,7768,,,1
,CHEMBL623685,9882,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Intermediate,1,,N,50597,178.0,,7768,,,1
,CHEMBL623686,9883,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Intermediate,1,,N,50597,178.0,,7768,,,1
,CHEMBL623687,9884,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,945.0,,8677,In vivo,,1
,CHEMBL623688,9885,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,945.0,,8677,In vivo,,1
,CHEMBL623689,9886,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,945.0,,8677,In vivo,,1
,CHEMBL622485,9887,BAO_0000218,A,,,10116.0,Stomach,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,945.0,,8677,In vivo,,1
,CHEMBL622486,9888,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2046.0,,8677,In vivo,,1
,CHEMBL877613,9889,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2046.0,,8677,In vivo,,1
,CHEMBL622487,9890,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2046.0,,8677,In vivo,,1
,CHEMBL622488,9891,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,2046.0,,8677,In vivo,,1
,CHEMBL622489,9892,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,1,,N,50597,948.0,,8677,In vivo,,1
,CHEMBL622490,9893,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,1,,N,50597,1088.0,,6899,,,1
,CHEMBL622491,9894,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,1,,N,50597,1088.0,,6899,,,1
,CHEMBL622492,9895,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Intermediate,1,,N,50597,2107.0,,6899,,,1
,CHEMBL622493,9896,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,1,,N,50597,1088.0,,6899,,,1
,CHEMBL622494,9897,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,1,,N,50597,1088.0,,6899,,,1
,CHEMBL622495,9898,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,1,,N,50597,2385.0,,8677,,,1
,CHEMBL622496,9899,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Intermediate,1,,N,50597,,,6899,,,1
,CHEMBL622497,9900,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,1,,N,50597,1088.0,,6899,,,1
,CHEMBL622498,9901,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Intermediate,1,,N,50597,,,2189,,,1
,CHEMBL624918,9902,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Intermediate,1,,N,50597,1088.0,,2189,,,1
,CHEMBL624919,9903,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Intermediate,1,,N,50597,1088.0,,2189,,,1
,CHEMBL624920,9904,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of compound in rat blood after 5 min of administration,Intermediate,1,,N,50597,178.0,,10839,In vivo,,1
,CHEMBL624921,9905,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of compound in rat blood after 5 min of administration.,Intermediate,1,,N,50597,178.0,,10839,In vivo,,1
,CHEMBL624922,9906,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of compound in rat brain after 5 min of administration,Intermediate,1,,N,50597,955.0,,10839,In vivo,,1
,CHEMBL624923,9907,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of compound in rat heart after 5 min of administration,Intermediate,1,,N,50597,948.0,,10839,In vivo,,1
,CHEMBL624924,9908,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of compound in rat heart after 5 min of administration.,Intermediate,1,,N,50597,948.0,,10839,In vivo,,1
,CHEMBL624925,9909,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of compound in rat kidney after 5 min of administration,Intermediate,1,,N,50597,2113.0,,10839,In vivo,,1
,CHEMBL624926,9910,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of compound in rat kidney after 5 min of administration.,Intermediate,1,,N,50597,2113.0,,10839,In vivo,,1
,CHEMBL624927,9911,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of compound in rat liver after 5 min of administration,Intermediate,1,,N,50597,2107.0,,10839,In vivo,,1
,CHEMBL874402,9912,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of compound in rat liver after 5 min of administration.,Intermediate,1,,N,50597,2107.0,,10839,In vivo,,1
,CHEMBL624928,9913,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of compound in rat lung after 5 min of administration,Intermediate,1,,N,50597,2048.0,,10839,In vivo,,1
,CHEMBL624929,9914,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of compound in rat lung after 5 min of administration.,Intermediate,1,,N,50597,2048.0,,10839,In vivo,,1
,CHEMBL624930,9915,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of compound in rat muscle after 5 min of administration,Intermediate,1,,N,50597,2385.0,,10839,In vivo,,1
,CHEMBL624931,9916,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of compound in rat muscle after 5 min of administration.,Intermediate,1,,N,50597,2385.0,,10839,In vivo,,1
,CHEMBL624932,9917,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,948.0,,4043,,,1
,CHEMBL624933,9918,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,948.0,,4043,,,1
,CHEMBL624934,9919,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,2107.0,,4043,,,1
,CHEMBL624935,9920,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,2107.0,,4043,,,1
,CHEMBL624936,9921,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,,,4043,,,1
,CHEMBL624937,9922,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,,,4043,,,1
,CHEMBL624938,9923,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,2106.0,,4043,,,1
,CHEMBL624939,9924,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,2106.0,,4043,,,1
,CHEMBL624940,9925,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,,,4043,,,1
,CHEMBL874403,9926,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,1,,N,50597,,,4043,,,1
,CHEMBL624941,9927,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Intermediate,1,,N,50597,,,1446,,,1
,CHEMBL624942,9928,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Intermediate,1,,N,50597,1088.0,,9971,,,1
,CHEMBL624943,9929,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Intermediate,1,,N,50597,1088.0,,9971,,,1
,CHEMBL624944,9930,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% Bioavailability after 1 day of the drug administration in rats,Intermediate,1,,N,50597,,,5765,In vivo,,1
,CHEMBL624945,9931,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% Bioavailability after 4 day of the drug administration in rats,Intermediate,1,,N,50597,,,5765,In vivo,,1
,CHEMBL624946,9932,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Absolute bioavailability was evaluated in rat,Intermediate,1,,N,50597,,,4257,In vivo,,1
,CHEMBL624947,9933,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL624948,9934,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL624949,9935,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL622025,9936,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Intermediate,1,,N,50597,2113.0,,13091,,,1
,CHEMBL622026,9937,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Intermediate,1,,N,50597,2113.0,,13091,,,1
,CHEMBL622027,9938,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Intermediate,1,,N,50597,2113.0,,13091,,,1
,CHEMBL622028,9939,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Intermediate,1,,N,50597,2113.0,,13091,,,1
,CHEMBL622029,9940,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Intermediate,1,,N,50597,2107.0,,13091,,,1
,CHEMBL622208,9941,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Intermediate,1,,N,50597,2107.0,,13091,,,1
,CHEMBL622209,9942,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Intermediate,1,,N,50597,2107.0,,13091,,,1
,CHEMBL622210,9943,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Intermediate,1,,N,50597,2107.0,,13091,,,1
,CHEMBL622211,9944,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL622212,9945,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL622213,9946,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL874404,9947,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL620452,9948,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL620453,9949,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL620454,9950,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL624067,9951,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL624068,9952,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL624069,9953,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Intermediate,1,,N,50597,992.0,,13091,,,1
,CHEMBL624070,9954,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Intermediate,1,,N,50597,992.0,,13091,,,1
,CHEMBL624071,9955,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Intermediate,1,,N,50597,992.0,,13091,,,1
,CHEMBL624072,9956,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Intermediate,1,,N,50597,995.0,,13091,,,1
,CHEMBL624073,9957,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Intermediate,1,,N,50597,995.0,,13091,,,1
,CHEMBL624788,9958,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Intermediate,1,,N,50597,995.0,,13091,,,1
,CHEMBL624789,9959,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Intermediate,1,,N,50597,995.0,,13091,,,1
,CHEMBL624790,9960,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL624791,9961,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL624792,9962,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL624793,9963,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Intermediate,1,,N,50597,,,13091,,,1
,CHEMBL877491,9964,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL624957,9965,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL624958,9966,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL624959,9967,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Intermediate,1,,N,50597,2385.0,,13091,,,1
,CHEMBL624960,9968,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dissociation constant was determined,Intermediate,1,,N,50597,,,11977,,,1
,CHEMBL624961,9969,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,1,,N,50597,,,14941,,,1
,CHEMBL624962,9970,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL624963,9971,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL624964,9972,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Intermediate,1,,N,50597,,,4755,,,1
,CHEMBL624965,9973,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,LogP value was evaluated in the in situ rat gut perfusion assay,Intermediate,1,,N,50597,,,589,,,1
,CHEMBL624966,9974,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL624967,9975,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Intermediate,1,,N,50597,,,5031,In vivo,,1
,CHEMBL624968,9976,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Intermediate,1,,N,50597,,,17764,In vivo,,1
,CHEMBL624969,9977,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,,,17720,,,1
,CHEMBL624970,9978,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Expert,1,,N,50597,,,2862,,,1
,CHEMBL624971,9979,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was evaluated after 10 uM/kg of intra arterial administration,Intermediate,1,,N,50597,,,16423,,,1
,CHEMBL624972,9980,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was evaluated after 20 uM/kg of peroral administration,Intermediate,1,,N,50597,,,16423,In vivo,,1
,CHEMBL624973,9981,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,1,,N,50597,,,6005,In vivo,,1
,CHEMBL624974,9982,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life was evaluated in plasma of rat,Intermediate,1,,N,50597,1969.0,,2938,,,1
,CHEMBL624975,9983,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,1,,N,50597,,,6410,In vivo,,1
,CHEMBL877492,9984,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,1,,N,50597,,,6410,In vivo,,1
,CHEMBL624976,9985,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was measured in rat after an iv dose of 1 mg/kg,Intermediate,1,,N,50597,,,6062,In vivo,,1
,CHEMBL624977,9986,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period of compound in rats after peroral administration,Intermediate,1,,N,50597,,,6571,In vivo,,1
,CHEMBL626848,9987,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life period of compound was measured in rat plasma.,Intermediate,1,,N,50597,1969.0,,3136,,,1
,CHEMBL626849,9988,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life period of compound was measured in rat plasma; ND is not determined,Intermediate,1,,N,50597,1969.0,,3136,,,1
,CHEMBL626850,9989,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half-life period of compound was measured in rat plasma; not determined,Intermediate,1,,N,50597,1969.0,,3136,,,1
,CHEMBL626851,9990,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,1,,N,50597,,,4521,In vivo,,1
,CHEMBL626852,9991,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period in rat by iv administration,Intermediate,1,,N,50597,,,5871,In vivo,,1
,CHEMBL626853,9992,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period in rats following intravenous administration at 2 mg/kg,Intermediate,1,,N,50597,,,6077,In vivo,,1
,CHEMBL626854,9993,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,1,,N,50597,,,6679,In vivo,,1
,CHEMBL627486,9994,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period was determined for the compound in rat,Intermediate,1,,N,50597,,,5144,,,1
,CHEMBL627487,9995,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,1,,N,50597,,,4498,In vivo,,1
,CHEMBL627488,9996,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Intermediate,1,,N,50597,,,4498,In vivo,,1
,CHEMBL627489,9997,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,1,,N,50597,,,1908,In vivo,,1
,CHEMBL627490,9998,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,1,,N,50597,,,6211,In vivo,,1
,CHEMBL873829,9999,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,1,,N,50597,,,5529,In vivo,,1
,CHEMBL627655,10000,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was determined in rat at a dose of 1 mpk i.v.,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL625994,10001,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL625995,10002,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,1,,N,50597,,,6444,In vivo,,1
,CHEMBL625996,10003,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life in rat,Intermediate,1,,N,50597,,,5207,,,1
,CHEMBL625850,10004,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,In vitro half life in rat plasma,Intermediate,1,,N,50597,1969.0,,530,In vitro,,1
,CHEMBL625851,10005,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Intermediate,1,,N,50597,1969.0,,1116,In vitro,,1
,CHEMBL625852,10006,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro half life in rat,Intermediate,1,,N,50597,,,3219,In vitro,,1
,CHEMBL625853,10007,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo half life period after intravenous administration in rat,Intermediate,1,,N,50597,,,6109,In vivo,,1
,CHEMBL625854,10008,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL874450,10009,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL625855,10010,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL625856,10011,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL625857,10012,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL873831,10013,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL625858,10014,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Longer half-life in rat (i.v.) at 0.5 mpk,Intermediate,1,,N,50597,,,17853,In vivo,,1
,CHEMBL625859,10015,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Longer half-life in rat (p.o.) at 2.0 mpk,Intermediate,1,,N,50597,,,17853,In vivo,,1
,CHEMBL625860,10016,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (half life) in rat,Intermediate,1,,N,50597,,,3457,,,1
,CHEMBL625861,10017,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL625862,10018,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL625863,10019,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL625864,10020,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL625865,10021,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Intermediate,1,,N,50597,,,5739,In vivo,,1
,CHEMBL625866,10022,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic half time was determined intravenously in rats.,Intermediate,1,,N,50597,,,15765,In vivo,,1
,CHEMBL625867,10023,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Intermediate,1,,N,50597,1969.0,,6567,In vivo,,1
,CHEMBL625868,10024,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half life of hydrolysis of the compound,Intermediate,1,,N,50597,1969.0,,2448,,,1
,CHEMBL625869,10025,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Intermediate,1,,N,50597,1969.0,,5423,In vivo,,1
,CHEMBL874451,10026,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half life period was calculated in rat,Intermediate,1,,N,50597,1969.0,,4853,,,1
,CHEMBL625870,10027,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life in Sprague-Dawley rats,Intermediate,1,,N,50597,1969.0,,4514,,,1
,CHEMBL625871,10028,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life in Sprague-Dawley rats; Not determined,Intermediate,1,,N,50597,1969.0,,4514,,,1
,CHEMBL625872,10029,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life in rats,Intermediate,1,,N,50597,1969.0,,1500,,,1
,CHEMBL625873,10030,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life in rats; <MQL,Intermediate,1,,N,50597,1969.0,,1500,,,1
,CHEMBL625874,10031,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life period (0-8 h) was determined,Intermediate,1,,N,50597,1969.0,,5334,,,1
,CHEMBL625875,10032,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5334,,,1
,CHEMBL625876,10033,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5334,In vivo,,1
,CHEMBL631258,10034,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,1,,N,50597,1969.0,,5334,In vivo,,1
,CHEMBL631259,10035,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Intermediate,1,,N,50597,1969.0,,4956,,,1
,CHEMBL631260,10036,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Intermediate,1,,N,50597,1969.0,,4956,,,1
,CHEMBL631261,10037,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Intermediate,1,,N,50597,178.0,,7768,,,1
,CHEMBL631262,10038,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Intermediate,1,,N,50597,178.0,,7768,,,1
,CHEMBL631263,10039,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Intermediate,1,,N,50597,178.0,,7768,,,1
,CHEMBL631264,10040,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Intermediate,1,,N,50597,,,7768,,,1
,CHEMBL631265,10041,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Intermediate,1,,N,50597,,,7768,,,1
,CHEMBL631266,10042,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Intermediate,1,,N,50597,,,7768,,,1
,CHEMBL631267,10043,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Intermediate,1,,N,50597,,,7768,,,1
,CHEMBL631268,10044,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Intermediate,1,,N,50597,,,7768,,,1
,CHEMBL631269,10045,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Intermediate,1,,N,50597,,,7768,,,1
,CHEMBL631270,10046,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Intermediate,1,,N,50597,,,7768,,,1
,CHEMBL631271,10047,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,1,,N,50597,948.0,,7768,,,1
,CHEMBL631272,10048,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Intermediate,1,,N,50597,948.0,,7768,,,1
,CHEMBL631273,10049,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Intermediate,1,,N,50597,948.0,,7768,,,1
,CHEMBL631274,10050,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Intermediate,1,,N,50597,948.0,,7768,,,1
,CHEMBL631275,10051,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Intermediate,1,,N,50597,948.0,,7768,,,1
,CHEMBL626984,10052,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Intermediate,1,,N,50597,948.0,,7768,,,1
,CHEMBL626985,10053,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Intermediate,1,,N,50597,948.0,,7768,,,1
,CHEMBL626986,10054,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,1,,N,50597,2107.0,,7768,,,1
,CHEMBL626987,10055,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Intermediate,1,,N,50597,2107.0,,7768,,,1
,CHEMBL626988,10056,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Intermediate,1,,N,50597,2107.0,,7768,,,1
,CHEMBL626989,10057,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Intermediate,1,,N,50597,2107.0,,7768,,,1
,CHEMBL626990,10058,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Intermediate,1,,N,50597,2107.0,,7768,,,1
,CHEMBL626991,10059,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Intermediate,1,,N,50597,2107.0,,7768,,,1
,CHEMBL626992,10060,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Intermediate,1,,N,50597,2107.0,,7768,,,1
,CHEMBL626993,10061,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Intermediate,1,,N,50597,2048.0,,7768,,,1
,CHEMBL874593,10062,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Intermediate,1,,N,50597,2048.0,,7768,,,1
,CHEMBL626994,10063,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Intermediate,1,,N,50597,2048.0,,7768,,,1
,CHEMBL626995,10064,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Intermediate,1,,N,50597,2048.0,,7768,,,1
,CHEMBL626190,10065,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Intermediate,1,,N,50597,2048.0,,7768,,,1
,CHEMBL626191,10066,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Intermediate,1,,N,50597,2048.0,,7768,,,1
,CHEMBL626364,10067,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Intermediate,1,,N,50597,2048.0,,7768,,,1
,CHEMBL626365,10068,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Intermediate,1,,N,50597,2046.0,,7768,,,1
,CHEMBL626366,10069,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Intermediate,1,,N,50597,2046.0,,7768,,,1
,CHEMBL626367,10070,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Intermediate,1,,N,50597,2046.0,,7768,,,1
,CHEMBL626368,10071,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Intermediate,1,,N,50597,2046.0,,7768,,,1
,CHEMBL626369,10072,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Intermediate,1,,N,50597,2046.0,,7768,,,1
,CHEMBL626370,10073,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Intermediate,1,,N,50597,2046.0,,7768,,,1
,CHEMBL626371,10074,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,1,,N,50597,,,4498,In vivo,,1
,CHEMBL626372,10075,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Intermediate,1,,N,50597,,,4498,In vivo,,1
,CHEMBL626373,10076,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after a dose of 10 mg/kg p.o.,Intermediate,1,,N,50597,,,3603,In vivo,,1
,CHEMBL626374,10077,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Intermediate,1,,N,50597,,,6215,In vivo,,1
,CHEMBL626375,10078,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Intermediate,1,,N,50597,,,5710,In vivo,,1
,CHEMBL626376,10079,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Intermediate,1,,N,50597,,,5710,In vivo,,1
,CHEMBL626377,10080,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat po was determined,Intermediate,1,,N,50597,,,5676,In vivo,,1
,CHEMBL626378,10081,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability of compound at 10 mg/kg in rat after oral administration,Intermediate,1,,N,50597,,,17667,In vivo,,1
,CHEMBL626379,10082,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Intermediate,1,,N,50597,,,17667,In vivo,,1
,CHEMBL626380,10083,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,1,,N,50597,,,6848,In vivo,,1
,CHEMBL626381,10084,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,1,,N,50597,,,6848,In vivo,,1
,CHEMBL626382,10085,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,17267,In vivo,,1
,CHEMBL626383,10086,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Sprague-Dawley) (female),Intermediate,1,,N,50597,,,6362,In vivo,,1
,CHEMBL874652,10087,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,1,,N,50597,,,17671,In vivo,,1
,CHEMBL626384,10088,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Intermediate,1,,N,50597,,,17671,In vivo,,1
,CHEMBL626385,10089,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Intermediate,1,,N,50597,,,4333,In vivo,,1
,CHEMBL626386,10090,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat at an oral dose of 2 mg/kg,Intermediate,1,,N,50597,,,6077,In vivo,,1
,CHEMBL626387,10091,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,3278,In vivo,,1
,CHEMBL626388,10092,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,5964,In vivo,,1
,CHEMBL626389,10093,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,4884,In vivo,,1
,CHEMBL626390,10094,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,4905,In vivo,,1
,CHEMBL626391,10095,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Intermediate,1,,N,50597,,,4884,In vivo,,1
,CHEMBL626392,10096,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,6850,In vivo,,1
,CHEMBL626393,10097,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,2864,In vivo,,1
,CHEMBL623026,10098,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was determined in rat,Intermediate,1,,N,50597,,,5780,In vivo,,1
,CHEMBL623027,10099,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability,Intermediate,1,,N,50597,,,1465,In vivo,,1
,CHEMBL623028,10100,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability,Intermediate,1,,N,50597,,,5199,In vivo,,1
,CHEMBL623029,10101,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after 1 day dosing,Intermediate,1,,N,50597,,,5765,In vivo,,1
,CHEMBL623030,10102,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after 4 day dosing,Intermediate,1,,N,50597,,,5765,In vivo,,1
,CHEMBL623031,10103,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL623032,10104,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL623033,10105,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL623034,10106,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Intermediate,1,,N,50597,,,6518,In vivo,,1
,CHEMBL623035,10107,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,1,,N,50597,,,2083,In vivo,,1
,CHEMBL623036,10108,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,1,,N,50597,,,17260,In vivo,,1
,CHEMBL623037,10109,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,1,,N,50597,,,4956,In vivo,,1
,CHEMBL623038,10110,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Intermediate,1,,N,50597,,,4368,In vivo,,1
,CHEMBL874385,10111,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Intermediate,1,,N,50597,1969.0,,17752,In vivo,,1
,CHEMBL623039,10112,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Fisher) (fasted),Intermediate,1,,N,50597,,,1446,In vivo,,1
,CHEMBL623040,10113,BAO_0000218,A,,,9443.0,,Primates,,Bioavailability in monkey after po administration of 10 mg/kg dose,Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL623041,10114,BAO_0000218,A,,,9443.0,,Primates,,Oral bioavailability in monkey (dose 10 mg/kg),Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL623741,10115,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,6672,In vivo,,1
,CHEMBL623742,10116,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,6673,In vivo,,1
,CHEMBL623743,10117,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,17655,In vivo,,1
,CHEMBL623744,10118,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,17796,In vivo,,1
,CHEMBL623745,10119,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 2.0 mg/kg p.o.),Intermediate,1,,N,50597,,,17853,In vivo,,1
,CHEMBL623746,10120,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Intermediate,1,,N,50597,,,4521,In vivo,,1
,CHEMBL623747,10121,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 5 mg/kg p.o.),Intermediate,1,,N,50597,,,4940,In vivo,,1
,CHEMBL623748,10122,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL623916,10123,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,0,,U,22224,,,2891,In vivo,,1
,CHEMBL623917,10124,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,1,,N,50597,,,4521,In vivo,,1
,CHEMBL623918,10125,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 2 mg/kg i.v.),Intermediate,1,,N,50597,,,17686,In vivo,,1
,CHEMBL874386,10126,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,17796,In vivo,,1
,CHEMBL623919,10127,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Bioavailability in rat; Only traces detected in rat plasma,Intermediate,1,,N,50597,1969.0,,17796,In vivo,,1
,CHEMBL623920,10128,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,5064,In vivo,,1
,CHEMBL623148,10129,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability upon oral administration of compound,Intermediate,1,,N,50597,,,5147,In vivo,,1
,CHEMBL623149,10130,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Intermediate,1,,N,50597,,,1916,In vivo,,1
,CHEMBL623150,10131,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,6049,In vivo,,1
,CHEMBL623151,10132,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Intermediate,1,,N,50597,,,1445,In vivo,,1
,CHEMBL623152,10133,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Intermediate,1,,N,50597,,,1445,In vivo,,1
,CHEMBL623153,10134,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Expert,1,,N,50597,,,2862,,,1
,CHEMBL623154,10135,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Expert,1,,N,50597,,,2862,,,1
,CHEMBL623155,10136,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro and metabolic stability was determined,Intermediate,1,,N,50597,,,4194,,,1
,CHEMBL623156,10137,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro metabolic stability in rat hepatocytes,Intermediate,1,,N,50597,,,4194,,,1
,CHEMBL623157,10138,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Intermediate,1,,N,50597,,,5486,,,1
,CHEMBL623158,10139,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Metabolic rate for compound was observed in rat hepatocytes,Intermediate,1,Hepatocyte,N,50597,2107.0,,17582,In vitro,401.0,1
,CHEMBL623159,10140,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Intermediate,1,,N,50597,,,5600,,,1
,CHEMBL874390,10141,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Intermediate,1,,N,50597,,,14294,,,1
,CHEMBL623160,10142,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Intermediate,1,,N,50597,,,14294,,,1
,CHEMBL623161,10143,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Metabolism of compound in rat S9 microsomes; Trace,Intermediate,1,,N,50597,,,14294,,,1
,CHEMBL623162,10144,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Intermediate,1,,N,50597,,,17847,,,1
,CHEMBL623163,10145,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623164,10146,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623165,10147,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623166,10148,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL624983,10149,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL624984,10150,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL624985,10151,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622970,10152,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622971,10153,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622972,10154,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622973,10155,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622974,10156,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622975,10157,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622976,10158,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622977,10159,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL624351,10160,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL624352,10161,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL624353,10162,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622397,10163,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622398,10164,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622399,10165,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL622400,10166,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628428,10167,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628590,10168,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628591,10169,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628592,10170,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628593,10171,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL875333,10172,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628594,10173,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628595,10174,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Intermediate,1,,N,50597,1969.0,,4969,,,1
,CHEMBL628596,10175,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Stability in rat plasma was determined,Intermediate,1,,N,50597,1969.0,,6737,,,1
,CHEMBL628597,10176,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Stability in rat plasma was determined; ND= no data,Intermediate,1,,N,50597,1969.0,,6737,,,1
,CHEMBL628598,10177,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tested for plasma half life period in rat (0-8 hr),Intermediate,1,,N,50597,1969.0,,5089,,,1
,CHEMBL628599,10178,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tested for plasma half life period in rat (0-8 hr); Not determined,Intermediate,1,,N,50597,1969.0,,5089,,,1
,CHEMBL628600,10179,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,1,,N,50597,,,1466,In vivo,,1
,CHEMBL628601,10180,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,1,,N,50597,,,1466,In vivo,,1
,CHEMBL628602,10181,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for the half life in rat,Intermediate,1,,N,50597,,,4950,,,1
,CHEMBL628603,10182,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Intermediate,1,,N,50597,,,2412,In vitro,,1
,CHEMBL628604,10183,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Intermediate,1,,N,50597,,,2412,In vitro,,1
,CHEMBL628605,10184,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Intermediate,1,,N,50597,,,2412,In vitro,,1
,CHEMBL628606,10185,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Intermediate,1,,N,50597,,,2412,In vitro,,1
,CHEMBL628607,10186,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Intermediate,1,,N,50597,,,2412,In vitro,,1
,CHEMBL628608,10187,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The biological half life the compound was measured at the dose of 100 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL628609,10188,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The biological half life the compound was measured at the dose of 30 umol/kg,Intermediate,1,,N,50597,,,15022,,,1
,CHEMBL628610,10189,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The compound was evaluated for plasma half life period in rat,Intermediate,1,,N,50597,1969.0,,406,,,1
,CHEMBL873819,10190,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,In vivo,,1
,CHEMBL628611,10191,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,In vivo,,1
,CHEMBL628612,10192,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The pharmacokinetic parameter half-life period in vivo in rats,Intermediate,1,,N,50597,,,5247,In vivo,,1
,CHEMBL628613,10193,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The pharmacokinetic property, Half-life was determined",Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL628614,10194,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The pharmacokinetic property, Half-life in rat in vivo",Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL628615,10195,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL628616,10196,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Intermediate,1,,N,50597,,,5041,In vivo,,1
,CHEMBL627924,10197,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The plasma half life period in rats,Intermediate,1,,N,50597,1969.0,,3918,,,1
,CHEMBL627925,10198,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Intermediate,1,,N,50597,2107.0,,2906,,,1
,CHEMBL627926,10199,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,1,,N,50597,,,6467,In vivo,,1
,CHEMBL627927,10200,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,t1/2 (apparent elimination)of the compound was determined,Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL627928,10201,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,t1/2 value in rat,Intermediate,1,,N,50597,,,3788,,,1
,CHEMBL627539,10202,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life in rat,Intermediate,1,,N,50597,,,17796,,,1
,CHEMBL876790,10203,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,1,,N,50597,1969.0,,12873,In vivo,,1
,CHEMBL858186,10204,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,1,,N,50597,,,5983,In vivo,,1
,CHEMBL627540,10205,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half-life period in fasted rats,Intermediate,1,,N,50597,,,15765,,,1
,CHEMBL627541,10206,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL627715,10207,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL627716,10208,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,1,,N,50597,,,429,In vivo,,1
,CHEMBL627717,10209,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum time required to achieve Cmax was determined in rat,Intermediate,1,,N,50597,,,17655,,,1
,CHEMBL627718,10210,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL627719,10211,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL627720,10212,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL627721,10213,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL627722,10214,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL627723,10215,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL626058,10216,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL626059,10217,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL626060,10218,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL626061,10219,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,1969.0,,17720,In vivo,,1
,CHEMBL876791,10220,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,In vivo,,1
,CHEMBL626062,10221,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,1,,N,50597,,,4723,In vivo,,1
,CHEMBL626063,10222,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,1,,N,50597,,,4756,In vivo,,1
,CHEMBL626064,10223,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,1,,N,50597,,,4756,In vivo,,1
,CHEMBL626065,10224,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,1969.0,,17720,In vivo,,1
,CHEMBL626066,10225,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,1,,N,50597,1969.0,,17720,In vivo,,1
,CHEMBL626067,10226,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,1,,N,50597,,,1466,In vivo,,1
,CHEMBL626068,10227,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626069,10228,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626070,10229,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of 3-methoxyacetaminophen glucuronide,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626071,10230,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of N-methoxyacetaminophen glucuronide,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626072,10231,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of N-methoxyacetaminophen sulfate,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626073,10232,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of acetaminophen,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626741,10233,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Intermediate,1,,N,50597,2046.0,,7768,,,1
,CHEMBL626742,10234,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Intermediate,1,,N,50597,,,17655,,,1
,CHEMBL626743,10235,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Intermediate,1,,N,50597,,,17735,,,1
,CHEMBL876792,10236,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Intermediate,1,,N,50597,,,5960,,,1
,CHEMBL626744,10237,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,1,,N,50597,,,17735,,,1
,CHEMBL626745,10238,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for antidiuretic activity in rats,Intermediate,1,,N,50597,,,7116,,,1
,CHEMBL626746,10239,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rat after 3mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,4878,In vivo,,1
,CHEMBL626747,10240,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Intermediate,1,,N,50597,,,5939,,,1
,CHEMBL626748,10241,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Intermediate,1,,N,50597,,,5939,,,1
,CHEMBL626749,10242,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability administered orally at a dose of 10 mg/kg to rats,Intermediate,1,,N,50597,,,16367,,,1
,CHEMBL626750,10243,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral Bioavailability was determined,Intermediate,1,,N,50597,,,16366,,,1
,CHEMBL626751,10244,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4426,,,1
,CHEMBL626913,10245,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat; Not performed.,Intermediate,1,,N,50597,,,4426,,,1
,CHEMBL626914,10246,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability,Intermediate,1,,N,50597,,,5041,,,1
,CHEMBL626915,10247,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was determined; ND denotes no data,Intermediate,1,,N,50597,,,5041,,,1
,CHEMBL626916,10248,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Intermediate,1,,N,50597,,,1500,,,1
,CHEMBL626917,10249,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Intermediate,1,,N,50597,,,1500,,,1
,CHEMBL626918,10250,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Binding towards rat plasma protein at 10 uM,Intermediate,1,,N,50597,,,17409,,,1
,CHEMBL626919,10251,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Binding towards rat plasma protein at 100 uM,Intermediate,1,,N,50597,,,17409,,,1
,CHEMBL626920,10252,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,1,,N,50597,,,2959,In vivo,,1
,CHEMBL621976,10253,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,1,,N,50597,,,13501,In vivo,,1
,CHEMBL877599,10254,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after 5 mg/kg oral gavage,Intermediate,1,,N,50597,,,6567,In vivo,,1
,CHEMBL621977,10255,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,6571,In vivo,,1
,CHEMBL621978,10256,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 1 mg/kg i.v.),Intermediate,1,,N,50597,,,6715,In vivo,,1
,CHEMBL621979,10257,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 3 mg/kg p.o.),Intermediate,1,,N,50597,,,6715,In vivo,,1
,CHEMBL621980,10258,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,2932,In vivo,,1
,CHEMBL621981,10259,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability of the compound in rats after administration of 30 mg/kg,Intermediate,1,,N,50597,,,4171,In vivo,,1
,CHEMBL621982,10260,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after administration of 10 mg/kg in rats,Intermediate,1,,N,50597,,,17509,In vivo,,1
,CHEMBL882953,10261,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability after administration of 2 mg/kg in rats,Intermediate,1,,N,50597,,,17509,In vivo,,1
,CHEMBL621983,10262,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,1,,N,50597,,,4527,In vivo,,1
,CHEMBL621984,10263,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in dogs was determined; high,Intermediate,1,,N,50597,,,4026,In vivo,,1
,CHEMBL621985,10264,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in monkey after intravenous administration at 1 mpk,Intermediate,1,,N,50597,,,6659,In vivo,,1
,CHEMBL621986,10265,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in monkey after peroral administration at 10 mpk,Intermediate,1,,N,50597,,,6659,In vivo,,1
,CHEMBL621987,10266,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after intravenous administration at 1 mpk,Intermediate,1,,N,50597,,,6659,In vivo,,1
,CHEMBL877600,10267,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after intravenous administration at 2 mpk,Intermediate,1,,N,50597,,,6659,In vivo,,1
,CHEMBL621988,10268,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after peroral administration at 30 mpk,Intermediate,1,,N,50597,,,6659,In vivo,,1
,CHEMBL621989,10269,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after peroral administration at at 100 mpk,Intermediate,1,,N,50597,,,6659,In vivo,,1
,CHEMBL621990,10270,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rats was evaluated,Intermediate,1,,N,50597,,,6597,In vivo,,1
,CHEMBL621991,10271,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Intermediate,1,,N,50597,,,1202,In vivo,,1
,CHEMBL621992,10272,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Intermediate,1,,N,50597,,,1202,In vivo,,1
,CHEMBL621993,10273,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Intermediate,1,,N,50597,,,1202,In vivo,,1
,CHEMBL621994,10274,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Intermediate,1,,N,50597,,,1202,In vivo,,1
,CHEMBL621995,10275,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,5207,In vivo,,1
,CHEMBL621996,10276,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,5970,In vivo,,1
,CHEMBL621997,10277,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,1,,N,50597,,,17538,In vivo,,1
,CHEMBL621998,10278,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,1,,N,50597,,,17538,In vivo,,1
,CHEMBL621999,10279,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,1,,N,50597,,,1466,In vivo,,1
,CHEMBL622000,10280,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,2879,In vivo,,1
,CHEMBL622001,10281,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was measured in rat after oral administration; 2-4,Intermediate,1,,N,50597,,,2879,In vivo,,1
,CHEMBL622002,10282,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was measured in rat after oral administration; 3-7,Intermediate,1,,N,50597,,,2879,In vivo,,1
,CHEMBL622003,10283,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (intraduodenal administration),Intermediate,1,,N,50597,,,3777,In vivo,,1
,CHEMBL877601,10284,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (intraduodenal administration),Intermediate,1,,N,50597,,,3777,In vivo,,1
,CHEMBL624871,10285,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,3777,In vivo,,1
,CHEMBL622004,10286,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,3777,In vivo,,1
,CHEMBL882954,10287,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Intermediate,1,,N,50597,,,5423,In vivo,,1
,CHEMBL622005,10288,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL622006,10289,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Intermediate,1,,N,50597,,,16365,In vivo,,1
,CHEMBL622007,10290,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was measured in rat,Intermediate,1,,N,50597,,,4239,In vivo,,1
,CHEMBL622008,10291,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was reported,Intermediate,1,,N,50597,,,5438,In vivo,,1
,CHEMBL622009,10292,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL622010,10293,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL622011,10294,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,1,,N,50597,,,4199,In vivo,,1
,CHEMBL622012,10295,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Intermediate,1,,N,50597,,,4199,In vivo,,1
,CHEMBL622013,10296,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Intermediate,1,,N,50597,,,4199,In vivo,,1
,CHEMBL622014,10297,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,1,,N,50597,,,4890,In vivo,,1
,CHEMBL624749,10298,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was determined at 3 mg/kg po dose in rats,Intermediate,1,,N,50597,,,2792,In vivo,,1
,CHEMBL624750,10299,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,1,,N,50597,,,5529,In vivo,,1
,CHEMBL624751,10300,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL624752,10301,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL624753,10302,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,1,,N,50597,,,6685,In vivo,,1
,CHEMBL624754,10303,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Intermediate,1,,N,50597,,,6005,In vivo,,1
,CHEMBL624755,10304,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,1,,N,50597,,,6410,In vivo,,1
,CHEMBL624756,10305,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,1,,N,50597,,,6410,In vivo,,1
,CHEMBL624757,10306,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,6103,In vivo,,1
,CHEMBL624758,10307,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,1,,N,50597,,,6410,In vivo,,1
,CHEMBL622270,10308,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,1,,N,50597,,,6410,In vivo,,1
,CHEMBL622271,10309,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Sprague-Dawley),Intermediate,1,,N,50597,,,5353,In vivo,,1
,CHEMBL622272,10310,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat at the dose of 2 mg/kg,Intermediate,1,,N,50597,,,4727,In vivo,,1
,CHEMBL622273,10311,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL622274,10312,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (cannulated) (dose 2 mg/kg),Intermediate,1,,N,50597,,,5809,In vivo,,1
,CHEMBL622275,10313,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability value of compound in rats was determined after peroral administration,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL622276,10314,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,1,,N,50597,,,3634,In vivo,,1
,CHEMBL622277,10315,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,3341,In vivo,,1
,CHEMBL622278,10316,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,1,,N,50597,,,2690,In vivo,,1
,CHEMBL622279,10317,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,3184,In vivo,,1
,CHEMBL622280,10318,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,740,In vivo,,1
,CHEMBL624083,10319,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for oral bioavailability in rats; 15-27 %,Intermediate,1,,N,50597,,,1806,In vivo,,1
,CHEMBL624084,10320,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Intermediate,1,,N,50597,,,4891,In vivo,,1
,CHEMBL624085,10321,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Intermediate,1,,N,50597,,,3634,In vivo,,1
,CHEMBL624086,10322,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for bioavailability in rats,Intermediate,1,,N,50597,,,64,In vivo,,1
,CHEMBL624087,10323,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,4839,In vivo,,1
,CHEMBL624088,10324,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,1094,In vivo,,1
,CHEMBL624089,10325,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Intermediate,0,,U,22224,,,5005,In vivo,,1
,CHEMBL624090,10326,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,0,,U,22224,,,5005,In vivo,,1
,CHEMBL624091,10327,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Evaluated for the bioavailability in rat (in vivo),Intermediate,1,,N,50597,,,4687,In vivo,,1
,CHEMBL624092,10328,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,F value of compound in rats was determined after peroral administration,Intermediate,1,,N,50597,,,17804,In vivo,,1
,CHEMBL624093,10329,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL624094,10330,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL624095,10331,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL624096,10332,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,1,,N,50597,,,5974,In vivo,,1
,CHEMBL624097,10333,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Intermediate,1,,N,50597,,,1088,In vivo,,1
,CHEMBL624098,10334,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum fall in carotid flow in rat,Intermediate,1,,N,50597,,,1742,In vivo,,1
,CHEMBL874392,10335,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Intermediate,1,,N,50597,,,4689,In vivo,,1
,CHEMBL624099,10336,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,1,,N,50597,,,2463,In vivo,,1
,CHEMBL624100,10337,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL624101,10338,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,1,,N,50597,,,5654,In vivo,,1
,CHEMBL624102,10339,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (male Wistar),Intermediate,1,,N,50597,,,6874,In vivo,,1
,CHEMBL624103,10340,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability after administration (30 mg/kg) in rat; good,Intermediate,1,,N,50597,,,5633,In vivo,,1
,CHEMBL624104,10341,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability at the dose of 2 mg/kg in rat,Intermediate,1,,N,50597,,,5496,In vivo,,1
,CHEMBL624105,10342,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability determined in rats,Intermediate,1,,N,50597,,,2358,In vivo,,1
,CHEMBL624106,10343,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Intermediate,1,,N,50597,,,16456,In vivo,,1
,CHEMBL624107,10344,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,1,,N,50597,,,5302,In vivo,,1
,CHEMBL623943,10345,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,1,,N,50597,,,5302,In vivo,,1
,CHEMBL623944,10346,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 5 mg/kg,Intermediate,1,,N,50597,,,5302,In vivo,,1
,CHEMBL623945,10347,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623946,10348,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623947,10349,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623948,10350,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623949,10351,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623950,10352,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL874398,10353,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623951,10354,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623952,10355,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623953,10356,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623954,10357,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623955,10358,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL623956,10359,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627807,10360,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627808,10361,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627809,10362,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627810,10363,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627811,10364,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627812,10365,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627813,10366,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627814,10367,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL875336,10368,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627815,10369,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627816,10370,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627817,10371,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627818,10372,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627819,10373,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627820,10374,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL627821,10375,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL628464,10376,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626239,10377,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626240,10378,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626241,10379,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626242,10380,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626243,10381,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626244,10382,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626907,10383,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626908,10384,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626909,10385,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL626910,10386,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL875342,10387,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of acetaminophen cysteine conjugate,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626911,10388,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of acetaminophen glucuronide,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL626912,10389,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of acetaminophen sulfate,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL627065,10390,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,Percent total excretion of acetaminophen-mercapturic acid,Intermediate,1,,N,50597,,,7449,,,1
,CHEMBL627066,10391,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Intermediate,1,,N,50597,1088.0,,3172,,,1
,CHEMBL627067,10392,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,16456,In vivo,,1
,CHEMBL627068,10393,BAO_0000218,A,,,8656.0,Muscle tissue,ratrat,,Biodistribution of compound in rat muscle after 5 min of administration,Autocuration,0,,U,22224,2385.0,,10839,In vivo,,1
,CHEMBL627069,10394,BAO_0000218,A,,,8656.0,Muscle tissue,ratrat,,Biodistribution of compound in rat muscle after 5 min of administration.,Autocuration,0,,U,22224,2385.0,,10839,In vivo,,1
,CHEMBL627070,10395,BAO_0000218,A,,,9940.0,,Ovis aries,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,,,5334,In vivo,,1
,CHEMBL627071,10396,BAO_0000218,A,,,9940.0,,Ovis aries,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,,,5334,In vivo,,1
,CHEMBL627072,10397,BAO_0000218,A,,,9940.0,,Ovis aries,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,,,5334,In vivo,,1
,CHEMBL627073,10398,BAO_0000218,A,,,9940.0,,Ovis aries,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,,,5334,In vivo,,1
,CHEMBL625387,10399,BAO_0000218,A,,,9940.0,,Ovis aries,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,,,5334,In vivo,,1
,CHEMBL625388,10400,BAO_0000218,A,,,9940.0,,Ovis aries,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,,,5334,In vivo,,1
,CHEMBL625389,10401,BAO_0000218,A,,,9940.0,Plasma,Ovis aries,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,1969.0,,5334,In vivo,,1
,CHEMBL875343,10402,BAO_0000218,A,,,9940.0,Plasma,Ovis aries,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,0,,U,22224,1969.0,,5334,In vivo,,1
,CHEMBL876795,10403,BAO_0000218,A,,,8570.0,,Serpentes,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Intermediate,1,,N,50497,,,1735,,,1
,CHEMBL626552,10404,BAO_0000218,A,,,8570.0,,Serpentes,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Intermediate,1,,N,50497,,,1469,,,1
,CHEMBL626553,10405,BAO_0000218,A,,,8570.0,,Serpentes,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Intermediate,1,,N,50497,,,1336,,,1
,CHEMBL626554,10406,BAO_0000366,A,,,9606.0,Plasma,Homo sapiens,,The human biological plasma half life of the compound,Autocuration,0,,U,22224,1969.0,,12403,,,1
,CHEMBL626555,10407,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,1,,N,50597,1088.0,,8151,,,1
,CHEMBL626556,10408,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL626557,10409,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL626558,10410,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL626559,10411,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL626560,10412,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL876803,10413,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627964,10414,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627965,10415,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627966,10416,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627967,10417,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627968,10418,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627969,10419,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627970,10420,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,1,,N,50597,,,8004,,,1
,CHEMBL627971,10421,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Intermediate,1,,N,50597,178.0,,8004,,,1
,CHEMBL627972,10422,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Intermediate,1,,N,50597,178.0,,8004,,,1
,CHEMBL856029,10423,BAO_0000357,B,,,9606.0,,Homo sapiens,,Dissociation constant against binding to human cyclophilin A,Expert,9,,D,180,,,15917,,,1
,CHEMBL627973,10424,BAO_0000019,B,,,9913.0,,Bos taurus,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Expert,8,,H,11591,,,12396,,,1
,CHEMBL627974,10425,BAO_0000019,A,,,,,,,-Log C was determined by performing the electroshock minimum test,Autocuration,0,,U,22224,,,7065,,,1
,CHEMBL627975,10426,BAO_0000019,A,,,,,,,-Log C was determined by performing the foot shock test,Autocuration,0,,U,22224,,,7065,,,1
,CHEMBL627976,10427,BAO_0000019,A,,,,,,,-Log C was determined by performing the incl screen test,Autocuration,0,,U,22224,,,7065,,,1
,CHEMBL627977,10428,BAO_0000019,A,,,,,,,-Log C was determined by performing the maximum electroshock test,Autocuration,0,,U,22224,,,7065,,,1
,CHEMBL627978,10429,BAO_0000019,A,,,,,,,-Log C was determined by performing the pentylenetetrazole test,Autocuration,0,,U,22224,,,7065,,,1
,CHEMBL627979,10430,BAO_0000019,A,,,,,,,Tested for experimental arotinoid inhibitory dose,Autocuration,0,,U,22224,,,12415,,,1
,CHEMBL876804,10431,BAO_0000019,A,,,,,,,Negative log transformed activity,Autocuration,0,,U,22224,,,10256,,,1
,CHEMBL627980,10432,BAO_0000019,A,,,,,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",Autocuration,0,,U,22224,,,7991,,,1
,CHEMBL627981,10433,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Intermediate,1,,N,50512,,,14342,,,1
,CHEMBL627982,10434,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Intermediate,1,,N,50512,,,14342,,,1
,CHEMBL627983,10435,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Intermediate,1,,N,50512,,,14342,,,1
,CHEMBL627984,10436,BAO_0000218,A,,,10141.0,Ileum,Cavia porcellus,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Intermediate,1,,N,50512,2116.0,,14342,,,1
,CHEMBL627985,10437,BAO_0000100,P,,,,,,,Solubility in water was determined; values expressed as -log,Autocuration,0,,U,22229,,,6047,,,1
,CHEMBL627986,10438,BAO_0000019,A,,,,,,,Ratio of Kcat to that of Km was determined,Autocuration,0,,U,22224,,,17269,,,1
,CHEMBL627987,10439,BAO_0000019,A,,,,,,,Observed first order rate constant,Autocuration,0,,U,22224,,,10026,,,1
,CHEMBL627988,10440,BAO_0000019,A,,,,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,Autocuration,0,,U,22224,,,14583,,,1
,CHEMBL627989,10441,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL627990,10442,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,1,,N,50597,,,2661,In vivo,,1
,CHEMBL876805,10443,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral Bioavailability after administration of 10 mg/kg in male rat,Intermediate,1,,N,50597,,,4029,In vivo,,1
,CHEMBL627991,10444,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Intermediate,1,,N,50597,,,17735,In vivo,,1
,CHEMBL627992,10445,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4576,In vivo,,1
,CHEMBL627993,10446,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,1,,N,50597,,,17582,In vivo,,1
,CHEMBL622817,10447,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability at 1 mg/kg was determined in rat,Intermediate,1,,N,50597,,,17651,In vivo,,1
,CHEMBL622818,10448,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability at 10 mg/kg was determined in rat,Intermediate,1,,N,50597,,,17651,In vivo,,1
,CHEMBL622819,10449,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Intermediate,1,,N,50597,,,17670,In vivo,,1
,CHEMBL872267,10450,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5045,In vivo,,1
,CHEMBL622820,10451,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,1696,In vivo,,1
,CHEMBL622821,10452,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Intermediate,1,,N,50597,,,17764,In vivo,,1
,CHEMBL622822,10453,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6448,In vivo,,1
,CHEMBL622823,10454,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6596,In vivo,,1
,CHEMBL622824,10455,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,17547,In vivo,,1
,CHEMBL622825,10456,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat at a dose of 3 mg/kg,Intermediate,1,,N,50597,,,17771,In vivo,,1
,CHEMBL622901,10457,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after oral administration at 10 mg/kg,Intermediate,1,,N,50597,,,6495,In vivo,,1
,CHEMBL622902,10458,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4558,In vivo,,1
,CHEMBL621844,10459,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,17596,In vivo,,1
,CHEMBL621845,10460,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in Dawley rats,Intermediate,1,,N,50597,,,6827,In vivo,,1
,CHEMBL621846,10461,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,4026,In vivo,,1
,CHEMBL621847,10462,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,1,,N,50597,,,10,In vivo,,1
,CHEMBL877609,10463,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL621848,10464,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL621849,10465,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL622030,10466,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL622031,10467,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent oral bioavailability determined in rats,Intermediate,1,,N,50597,,,4796,In vivo,,1
,CHEMBL622032,10468,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,1,,N,50597,,,4883,In vivo,,1
,CHEMBL622033,10469,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was evaluated for bioavailability in rats; 32-51,Intermediate,1,,N,50597,,,2137,In vivo,,1
,CHEMBL622034,10470,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,1,,N,50597,,,2959,In vivo,,1
,CHEMBL622035,10471,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,1361,In vivo,,1
,CHEMBL882966,10472,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability percent in rat at the dose of 2 mg/kg,Intermediate,1,,N,50597,,,4727,In vivo,,1
,CHEMBL622036,10473,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated after 20 uM/kg of peroral administration,Intermediate,1,,N,50597,,,16423,In vivo,,1
,CHEMBL622037,10474,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5206,In vivo,,1
,CHEMBL622038,10475,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6448,In vivo,,1
,CHEMBL622039,10476,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rats,Intermediate,1,,N,50597,,,17723,In vivo,,1
,CHEMBL622040,10477,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,1,,N,50597,178.0,,17738,In vivo,,1
,CHEMBL622041,10478,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,178.0,,17738,In vivo,,1
,CHEMBL622042,10479,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,178.0,,17738,In vivo,,1
,CHEMBL622043,10480,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,178.0,,17738,In vivo,,1
,CHEMBL622044,10481,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,178.0,,17738,In vivo,,1
,CHEMBL622045,10482,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,10000001.0,,17738,In vivo,,1
,CHEMBL622046,10483,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,10000001.0,,17738,In vivo,,1
,CHEMBL622047,10484,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,10000001.0,,17738,In vivo,,1
,CHEMBL877610,10485,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,10000001.0,,17738,In vivo,,1
,CHEMBL622048,10486,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,955.0,,17738,In vivo,,1
,CHEMBL622049,10487,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,955.0,,17738,In vivo,,1
,CHEMBL622050,10488,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,955.0,,17738,In vivo,,1
,CHEMBL622051,10489,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,955.0,,17738,In vivo,,1
,CHEMBL622052,10490,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,,,17738,In vivo,,1
,CHEMBL622053,10491,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,,,17738,In vivo,,1
,CHEMBL622054,10492,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,,,17738,In vivo,,1
,CHEMBL622055,10493,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,,,17738,In vivo,,1
,CHEMBL622056,10494,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rats was determined; High,Intermediate,1,,N,50597,,,5237,In vivo,,1
,CHEMBL622057,10495,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in the rat was determined,Intermediate,1,,N,50597,,,5503,In vivo,,1
,CHEMBL628008,10496,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Intermediate,1,,N,50597,,,15765,In vivo,,1
,CHEMBL622058,10497,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Intermediate,1,,N,50597,,,15660,In vivo,,1
,CHEMBL622059,10498,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL622060,10499,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL622061,10500,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL622062,10501,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,1,,N,50597,,,5978,In vivo,,1
,CHEMBL622063,10502,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Intermediate,1,,N,50597,,,5656,In vivo,,1
,CHEMBL877611,10503,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,1,,N,50597,,,3598,In vivo,,1
,CHEMBL622064,10504,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound in Sprague Dawley rats,Intermediate,1,,N,50597,,,4216,In vivo,,1
,CHEMBL622065,10505,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound in rat,Intermediate,1,,N,50597,,,17839,In vivo,,1
,CHEMBL622066,10506,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,1,,N,50597,,,6570,In vivo,,1
,CHEMBL622067,10507,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound in rat was determined,Intermediate,1,,N,50597,,,5334,In vivo,,1
,CHEMBL622068,10508,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound in rats,Intermediate,1,,N,50597,,,6886,In vivo,,1
,CHEMBL622069,10509,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound was determined in rats,Intermediate,1,,N,50597,,,5210,In vivo,,1
,CHEMBL624796,10510,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability at a dose of 30 mg/kg in rats,Intermediate,1,,N,50597,,,4170,In vivo,,1
,CHEMBL624797,10511,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,1,,N,50597,,,6028,In vivo,,1
,CHEMBL623053,10512,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,1,,N,50597,,,6028,In vivo,,1
,CHEMBL623054,10513,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability evaluated in rat,Intermediate,1,,N,50597,,,6078,In vivo,,1
,CHEMBL623055,10514,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in fasted rat,Intermediate,1,,N,50597,,,6168,In vivo,,1
,CHEMBL623056,10515,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in fed rat,Intermediate,1,,N,50597,,,6168,In vivo,,1
,CHEMBL623057,10516,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Intermediate,1,,N,50597,,,5160,In vivo,,1
,CHEMBL623058,10517,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6057,In vivo,,1
,CHEMBL623059,10518,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL623060,10519,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after administration of 10 mg/kg po,Intermediate,1,,N,50597,,,6535,In vivo,,1
,CHEMBL623061,10520,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4194,In vivo,,1
,CHEMBL623062,10521,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6230,In vivo,,1
,CHEMBL623063,10522,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6619,In vivo,,1
,CHEMBL623064,10523,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,17607,In vivo,,1
,CHEMBL623065,10524,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in ratrs,Intermediate,1,,N,50597,,,4942,In vivo,,1
,CHEMBL623066,10525,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4942,In vivo,,1
,CHEMBL623067,10526,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6646,In vivo,,1
,CHEMBL623068,10527,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rats was determined; High,Intermediate,1,,N,50597,,,5237,In vivo,,1
,CHEMBL623069,10528,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6646,In vivo,,1
,CHEMBL623070,10529,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4449,In vivo,,1
,CHEMBL623071,10530,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was calculated in rat,Intermediate,1,,N,50597,,,6057,In vivo,,1
,CHEMBL623072,10531,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,2552,In vivo,,1
,CHEMBL623073,10532,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,5496,In vivo,,1
,CHEMBL623074,10533,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,6484,In vivo,,1
,CHEMBL623075,10534,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,6485,In vivo,,1
,CHEMBL623076,10535,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability after i.v. administration,Intermediate,1,,N,50597,,,6616,In vivo,,1
,CHEMBL623077,10536,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,1,,N,50597,,,4969,In vivo,,1
,CHEMBL623078,10537,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley),Intermediate,1,,N,50597,,,5862,In vivo,,1
,CHEMBL623079,10538,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in Sprague-Dawley rats,Intermediate,1,,N,50597,,,4514,In vivo,,1
,CHEMBL623080,10539,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,1,,N,50597,,,4514,In vivo,,1
,CHEMBL623081,10540,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,1,,N,50597,,,4514,In vivo,,1
,CHEMBL623082,10541,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Intermediate,1,,N,50597,,,5546,In vivo,,1
,CHEMBL874400,10542,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in fasted rat,Intermediate,1,,N,50597,,,6168,In vivo,,1
,CHEMBL623083,10543,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in fed rat,Intermediate,1,,N,50597,,,6168,In vivo,,1
,CHEMBL623084,10544,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,3624,In vivo,,1
,CHEMBL623085,10545,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5213,In vivo,,1
,CHEMBL623086,10546,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5496,In vivo,,1
,CHEMBL623087,10547,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5553,In vivo,,1
,CHEMBL623088,10548,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5833,In vivo,,1
,CHEMBL623089,10549,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5836,In vivo,,1
,CHEMBL623090,10550,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5865,In vivo,,1
,CHEMBL623091,10551,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5960,In vivo,,1
,CHEMBL623092,10552,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6249,In vivo,,1
,CHEMBL623093,10553,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6448,In vivo,,1
,CHEMBL874401,10554,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6453,In vivo,,1
,CHEMBL623094,10555,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6640,In vivo,,1
,CHEMBL623095,10556,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,17607,In vivo,,1
,CHEMBL623096,10557,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after peroral administration at 10 mg/kg,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL624913,10558,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after peroral administration at 5 mg/kg,Intermediate,1,,N,50597,,,5939,In vivo,,1
,CHEMBL624914,10559,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Intermediate,1,,N,50597,,,6281,In vivo,,1
,CHEMBL624915,10560,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Intermediate,1,,N,50597,,,5874,In vivo,,1
,CHEMBL624916,10561,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat; Not measured,Intermediate,1,,N,50597,,,5213,In vivo,,1
,CHEMBL624917,10562,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4964,In vivo,,1
,CHEMBL625157,10563,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Intermediate,1,,N,50597,,,11020,,,1
,CHEMBL625158,10564,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,In vitro metabolic potential in rat liver microsomes,Intermediate,1,,N,50597,2107.0,,6251,,,1
,CHEMBL625159,10565,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Intermediate,1,,N,50597,,,1568,In vivo,,1
,CHEMBL625160,10566,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Intermediate,1,,N,50597,,,3032,In vivo,,1
,CHEMBL625161,10567,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Intermediate,1,,N,50597,,,3748,In vivo,,1
,CHEMBL625162,10568,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,401,In vivo,,1
,CHEMBL625163,10569,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6512,In vivo,,1
,CHEMBL625164,10570,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rats at 10 mg/kg,Intermediate,1,,N,50597,,,17617,In vivo,,1
,CHEMBL625165,10571,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,1,,N,50597,,,6679,In vivo,,1
,CHEMBL625166,10572,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6742,In vivo,,1
,CHEMBL625167,10573,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Intermediate,1,,N,50597,,,589,,,1
,CHEMBL625168,10574,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Intermediate,1,,N,50597,,,589,,,1
,CHEMBL625169,10575,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance of the compound,Intermediate,1,,N,50597,,,3185,In vivo,,1
,CHEMBL626264,10576,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Intermediate,1,,N,50597,,,17596,In vivo,,1
,CHEMBL626265,10577,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Intermediate,1,,N,50597,,,2713,In vivo,,1
,CHEMBL626266,10578,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The compound was tested for plasma clearance in rat,Intermediate,1,,N,50597,1969.0,,12500,In vivo,,1
,CHEMBL626267,10579,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Intermediate,1,,N,50597,1969.0,,12500,In vivo,,1
,CHEMBL626268,10580,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration upon oral administration of 1 mg/Kg in rats,Intermediate,1,,N,50597,,,2713,,,1
,CHEMBL626269,10581,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Intermediate,1,,N,50597,,,1446,,,1
,CHEMBL626270,10582,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Intermediate,1,,N,50597,,,6227,,,1
,CHEMBL626271,10583,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Intermediate,1,,N,50597,,,4709,,,1
,CHEMBL626272,10584,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL626273,10585,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL875346,10586,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL626274,10587,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Intermediate,1,,N,50597,,,5510,,,1
,CHEMBL626275,10588,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for protein binding in rat plasma,Intermediate,1,,N,50597,,,4514,,,1
,CHEMBL624646,10589,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Intermediate,1,,N,50597,,,2713,,,1
,CHEMBL624647,10590,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Intermediate,1,,N,50597,,,2713,,,1
,CHEMBL624648,10591,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Intermediate,1,,N,50597,2107.0,,5340,,,1
,CHEMBL624649,10592,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve ratio was determined (po/iv) in rat,Intermediate,1,,N,50597,,,12058,,,1
,CHEMBL624650,10593,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Intermediate,1,,N,50597,,,11195,,,1
,CHEMBL624651,10594,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Intermediate,1,,N,50597,,,11195,,,1
,CHEMBL624652,10595,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Intermediate,1,,N,50597,,,11195,,,1
,CHEMBL624653,10596,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Intermediate,1,,N,50597,,,6495,,,1
,CHEMBL624654,10597,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Ratio of AUCbrain to AUCplasma,Intermediate,1,,N,50597,,,6078,,,1
,CHEMBL624655,10598,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Ratio of brain to plasma,Intermediate,1,,N,50597,,,5656,,,1
,CHEMBL624656,10599,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL624657,10600,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL624658,10601,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL624659,10602,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Intermediate,1,,N,50597,,,10130,,,1
,CHEMBL624660,10603,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Intermediate,1,,N,50597,,,10130,,,1
,CHEMBL624661,10604,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Intermediate,1,,N,50597,,,10130,,,1
,CHEMBL624662,10605,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Steady state brain :blood ratio was determined,Intermediate,1,,N,50597,,,5213,,,1
,CHEMBL625199,10606,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL625200,10607,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL625201,10608,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL625202,10609,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,1,,N,50597,,,4910,,,1
,CHEMBL625203,10610,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percentage recovery after 3h incubation with rat hapatocytes was determined,Intermediate,1,,N,50597,,,2083,,,1
,CHEMBL625204,10611,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,1,,N,50597,,,2082,,,1
,CHEMBL625205,10612,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,1,,N,50597,,,2082,,,1
,CHEMBL625206,10613,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Intermediate,1,,N,50597,,,6351,,,1
,CHEMBL625207,10614,BAO_0000019,A,,,,,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",Autocuration,0,,U,22224,,,14583,,,1
,CHEMBL625208,10615,BAO_0000019,A,,,,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,Autocuration,0,,U,22224,,,14583,,,1
,CHEMBL625209,10616,BAO_0000218,A,,,9606.0,,Homo sapiens,,In vivo absorption in Caco-2 cell line monolayers was determined,Intermediate,1,Caco-2,N,50587,,,4608,,495.0,1
,CHEMBL625210,10617,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13668,,,1
,CHEMBL625211,10618,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determine after peroral administration at 10 mpk in Rat,Intermediate,1,,N,50597,,,5669,,,1
,CHEMBL625212,10619,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Intermediate,1,,N,50797,,,5669,,,1
,CHEMBL625213,10620,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determine after peroral administration at 160 mpk in Rat,Intermediate,1,,N,50597,,,5669,,,1
,CHEMBL625214,10621,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determine after peroral administration at 20 mpk in Rat,Intermediate,1,,N,50597,,,5669,,,1
,CHEMBL874542,10622,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve was determine after peroral administration at 50 mpk in Rat,Intermediate,1,,N,50597,,,5669,,,1
,CHEMBL625215,10623,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (AlogP),Autocuration,0,,U,22229,,,6472,,,1
,CHEMBL625216,10624,BAO_0000019,A,,,,,,,Activated partial thromboplastin time measured,Autocuration,0,,U,22224,,,15106,,,1
,CHEMBL625217,10625,BAO_0000100,P,,,,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),Autocuration,0,,U,22224,,,15207,,,1
,CHEMBL625218,10626,BAO_0000100,P,,,,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),Autocuration,0,,U,22224,,,15207,,,1
,CHEMBL622864,10627,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Intermediate,1,,N,50588,1969.0,,13941,,,1
,CHEMBL622865,10628,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Intermediate,1,,N,50597,1969.0,,13941,,,1
,CHEMBL622866,10629,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Intermediate,1,,N,50597,1969.0,,13941,,,1
,CHEMBL622867,10630,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Intermediate,1,,N,50588,1969.0,,13941,,,1
,CHEMBL876808,10631,BAO_0000218,A,,,10141.0,Plasma,Cavia porcellus,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,1,,N,50512,1969.0,,15240,,,1
,CHEMBL627725,10632,BAO_0000019,A,,,,Brain,,,AUC in brain,Autocuration,0,,U,22224,955.0,,10655,,,1
,CHEMBL627726,10633,BAO_0000019,A,,,,Serum,,,AUC in serum,Autocuration,0,,U,22224,1977.0,,10655,,,1
,CHEMBL627727,10634,BAO_0000019,A,,,,Plasma,,,AUC was determined,Autocuration,0,,U,22224,1969.0,,6504,,,1
,CHEMBL627728,10635,BAO_0000019,A,,,,Plasma,,,AUC of the compound.,Autocuration,0,,U,22224,1969.0,,10615,,,1
,CHEMBL627729,10636,BAO_0000019,A,,,,Plasma,,,AUC value (0-4 hr),Autocuration,0,,U,22224,1969.0,,10353,,,1
,CHEMBL627730,10637,BAO_0000019,A,,,,Plasma,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",Autocuration,0,,U,22224,1969.0,,14907,,,1
,CHEMBL627731,10638,BAO_0000019,A,,,,Plasma,,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,Autocuration,0,,U,22224,1969.0,,14907,,,1
,CHEMBL627732,10639,BAO_0000019,A,,,,Plasma,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",Autocuration,0,,U,22224,1969.0,,14907,,,1
,CHEMBL627733,10640,BAO_0000019,A,,,,Plasma,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",Autocuration,0,,U,22224,1969.0,,14907,,,1
,CHEMBL627734,10641,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC(area under curve) was determined after intravenous administration in rats,Intermediate,1,,N,50597,1969.0,,16359,,,1
,CHEMBL627735,10642,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC(area under curve) was determined after oral administration in rats,Intermediate,1,,N,50597,1969.0,,16359,,,1
,CHEMBL627736,10643,BAO_0000218,A,,,10141.0,Plasma,Cavia porcellus,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,1,,N,50512,1969.0,,15240,,,1
,CHEMBL876809,10644,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Intermediate,1,,N,50597,1969.0,,15240,,,1
,CHEMBL627737,10645,BAO_0000019,A,,,,,,,Area Under Curve after oral dosing of 100 uM/Kg,Autocuration,0,,U,22224,,,15469,,,1
,CHEMBL627738,10646,BAO_0000019,A,,,,,,,Area Under Curve after oral dosing of 30 uM/Kg,Autocuration,0,,U,22224,,,15469,,,1
,CHEMBL627739,10647,BAO_0000019,A,,,,,,,Area Under Curve was measured by ploting the graph between concentration verses time,Autocuration,0,,U,22224,,,13520,,,1
,CHEMBL626143,10648,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Intermediate,1,,N,50588,,,17025,,,1
,CHEMBL626144,10649,BAO_0000218,A,,,314293.0,,Simiiformes,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Autocuration,0,,U,22224,,,17025,,,1
,CHEMBL626145,10650,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Intermediate,1,,N,50592,,,17025,,,1
,CHEMBL626146,10651,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Intermediate,1,,N,50597,,,17025,,,1
,CHEMBL626147,10652,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Intermediate,1,,N,50597,178.0,,12032,,,1
,CHEMBL626148,10653,BAO_0000019,A,,,,,,,Area under curve (AUC) was determined,Autocuration,0,,U,22224,,,10291,,,1
,CHEMBL626149,10654,BAO_0000218,A,,,,,,,Area under curve (AUC) following ip administration at 1 mg/kg,Autocuration,0,,U,22224,,,5767,,,1
,CHEMBL626150,10655,BAO_0000019,A,,,,,,,Area under curve (AUC) was determined; ND is Not determined,Autocuration,0,,U,22224,,,1434,,,1
,CHEMBL626151,10656,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Intermediate,1,,N,50588,,,14925,,,1
,CHEMBL626152,10657,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Intermediate,1,,N,50588,,,14925,,,1
,CHEMBL626153,10658,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Intermediate,1,,N,50588,,,14925,,,1
,CHEMBL626154,10659,BAO_0000019,A,,,,,,,Area under curve (AUR) was determined,Autocuration,0,,U,22224,,,1434,,,1
,CHEMBL626155,10660,BAO_0000019,A,,,,,,,Area under curve at 1 uM/dg administered intravenously,Autocuration,0,,U,22224,,,11883,,,1
,CHEMBL626156,10661,BAO_0000019,A,,,,,,,Area under curve at 10 uM/dg administered perorally,Autocuration,0,,U,22224,,,11883,,,1
,CHEMBL626157,10662,BAO_0000019,A,,,,,,,Area under curve at 2 uM/dg administered intravenously,Autocuration,0,,U,22224,,,11883,,,1
,CHEMBL626158,10663,BAO_0000019,A,,,,,,,Area under curve at 20 uM/dg administered perorally,Autocuration,0,,U,22224,,,11883,,,1
,CHEMBL626159,10664,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve at a peroral dose of 3 mg/kg in dog,Intermediate,1,,N,50588,,,15233,,,1
,CHEMBL626160,10665,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve at a peroral dose of 3 mg/kg in rat,Intermediate,1,,N,50597,,,15233,,,1
,CHEMBL626161,10666,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve at an iv dose of 1 mg/kg in dog,Intermediate,1,,N,50588,,,15233,,,1
,CHEMBL626162,10667,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under curve at an iv dose of 1 mg/kg in rat,Intermediate,1,,N,50597,,,15233,,,1
,CHEMBL626163,10668,BAO_0000019,A,,,,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,Autocuration,0,,U,22224,,,12978,,,1
,CHEMBL626164,10669,BAO_0000019,A,,,,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,Autocuration,0,,U,22224,,,12978,,,1
,CHEMBL626165,10670,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve measured as conc vs time after intravenous administration to mice.,Intermediate,1,,N,50594,,,11355,,,1
,CHEMBL626166,10671,BAO_0000218,A,,,10090.0,,Mus musculus,,Area under curve measured as conc vs time after peroral administration to mice.,Intermediate,1,,N,50594,,,11355,,,1
,CHEMBL626167,10672,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,1,,N,50588,,,12923,,,1
,CHEMBL626168,10673,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Intermediate,1,,N,50588,,,12923,,,1
,CHEMBL877463,10674,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Intermediate,1,,N,50588,,,12923,,,1
,CHEMBL626169,10675,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Intermediate,1,,N,50588,,,12923,,,1
,CHEMBL626170,10676,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,948.0,,17738,In vivo,,1
,CHEMBL626171,10677,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,948.0,,17738,In vivo,,1
,CHEMBL626172,10678,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,948.0,,17738,In vivo,,1
,CHEMBL626173,10679,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,948.0,,17738,In vivo,,1
,CHEMBL626174,10680,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,1,,N,50597,2113.0,,17738,In vivo,,1
,CHEMBL626175,10681,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2113.0,,17738,In vivo,,1
,CHEMBL626176,10682,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2113.0,,17738,In vivo,,1
,CHEMBL626177,10683,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2113.0,,17738,In vivo,,1
,CHEMBL622499,10684,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2113.0,,17738,In vivo,,1
,CHEMBL622500,10685,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,1,,N,50597,2107.0,,17738,In vivo,,1
,CHEMBL622501,10686,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2107.0,,17738,In vivo,,1
,CHEMBL622502,10687,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2107.0,,17738,In vivo,,1
,CHEMBL622503,10688,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2107.0,,17738,In vivo,,1
,CHEMBL877614,10689,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2107.0,,17738,In vivo,,1
,CHEMBL624839,10690,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2048.0,,17738,In vivo,,1
,CHEMBL624840,10691,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2048.0,,17738,In vivo,,1
,CHEMBL624841,10692,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2048.0,,17738,In vivo,,1
,CHEMBL624842,10693,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2048.0,,17738,In vivo,,1
,CHEMBL624843,10694,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2385.0,,17738,In vivo,,1
,CHEMBL624844,10695,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Intermediate,1,,N,50597,2385.0,,17738,In vivo,,1
,CHEMBL624845,10696,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2385.0,,17738,In vivo,,1
,CHEMBL621904,10697,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Intermediate,1,,N,50597,2385.0,,17738,In vivo,,1
,CHEMBL621905,10698,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Intermediate,1,,N,50597,178.0,,11195,In vivo,,1
,CHEMBL874382,10699,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Intermediate,1,,N,50597,178.0,,11195,In vivo,,1
,CHEMBL621906,10700,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Intermediate,1,,N,50597,178.0,,11195,In vivo,,1
,CHEMBL621907,10701,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Intermediate,1,,N,50597,955.0,,11195,In vivo,,1
,CHEMBL622096,10702,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Intermediate,1,,N,50597,955.0,,11195,In vivo,,1
,CHEMBL622097,10703,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Intermediate,1,,N,50597,955.0,,11195,In vivo,,1
,CHEMBL622098,10704,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Intermediate,1,,N,50597,948.0,,11195,In vivo,,1
,CHEMBL622099,10705,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Intermediate,1,,N,50597,948.0,,11195,In vivo,,1
,CHEMBL622100,10706,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Intermediate,1,,N,50597,948.0,,11195,In vivo,,1
,CHEMBL622101,10707,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Intermediate,1,,N,50597,2113.0,,11195,In vivo,,1
,CHEMBL622102,10708,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Intermediate,1,,N,50597,2113.0,,11195,In vivo,,1
,CHEMBL622103,10709,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Intermediate,1,,N,50597,2113.0,,11195,In vivo,,1
,CHEMBL622104,10710,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Intermediate,1,,N,50597,2107.0,,11195,In vivo,,1
,CHEMBL622105,10711,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Intermediate,1,,N,50597,2107.0,,11195,In vivo,,1
,CHEMBL622106,10712,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Intermediate,1,,N,50597,2107.0,,11195,In vivo,,1
,CHEMBL622107,10713,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Intermediate,1,,N,50597,2048.0,,11195,In vivo,,1
,CHEMBL622108,10714,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Intermediate,1,,N,50597,2048.0,,11195,In vivo,,1
,CHEMBL622109,10715,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Intermediate,1,,N,50597,2048.0,,11195,In vivo,,1
,CHEMBL622110,10716,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Intermediate,1,,N,50597,2385.0,,11195,In vivo,,1
,CHEMBL622111,10717,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Intermediate,1,,N,50597,2385.0,,11195,In vivo,,1
,CHEMBL874383,10718,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Intermediate,1,,N,50597,2385.0,,11195,In vivo,,1
,CHEMBL622112,10719,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Intermediate,1,,N,50597,14.0,,11195,In vivo,,1
,CHEMBL622113,10720,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Intermediate,1,,N,50597,14.0,,11195,In vivo,,1
,CHEMBL622114,10721,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Intermediate,1,,N,50597,14.0,,11195,In vivo,,1
,CHEMBL622115,10722,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Intermediate,1,,N,50597,2106.0,,11195,In vivo,,1
,CHEMBL622116,10723,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Intermediate,1,,N,50597,2106.0,,11195,In vivo,,1
,CHEMBL622117,10724,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6193,In vivo,,1
,CHEMBL622118,10725,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6803,In vivo,,1
,CHEMBL622119,10726,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rats at 6 mg/kg,Intermediate,1,,N,50597,,,6647,In vivo,,1
,CHEMBL622120,10727,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 6 mg/kg),Intermediate,1,,N,50597,,,6647,In vivo,,1
,CHEMBL622121,10728,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Intermediate,1,,N,50597,,,6647,In vivo,,1
,CHEMBL622122,10729,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6640,In vivo,,1
,CHEMBL622123,10730,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL622124,10731,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6641,In vivo,,1
,CHEMBL622125,10732,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,6642,In vivo,,1
,CHEMBL622126,10733,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,5472,In vivo,,1
,CHEMBL620455,10734,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,1,,N,50597,,,6141,In vivo,,1
,CHEMBL620456,10735,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,4390,In vivo,,1
,CHEMBL620457,10736,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5472,In vivo,,1
,CHEMBL620458,10737,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was evaluated; Not tested,Intermediate,1,,N,50597,,,5472,In vivo,,1
,CHEMBL620459,10738,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,5438,In vivo,,1
,CHEMBL620460,10739,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat by oral dosing,Intermediate,1,,N,50597,,,4883,In vivo,,1
,CHEMBL620461,10740,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,1,,N,50597,,,1908,In vivo,,1
,CHEMBL620462,10741,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley),Intermediate,1,,N,50597,,,4853,In vivo,,1
,CHEMBL620463,10742,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,1,,N,50597,,,4853,In vivo,,1
,CHEMBL620464,10743,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,1,,N,50597,,,4853,In vivo,,1
,CHEMBL620465,10744,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,1,,N,50597,,,4853,In vivo,,1
,CHEMBL620466,10745,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Intermediate,1,,N,50597,,,4853,In vivo,,1
,CHEMBL620467,10746,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Intermediate,1,,N,50597,,,4853,In vivo,,1
,CHEMBL620468,10747,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Intermediate,1,,N,50597,,,4853,In vivo,,1
,CHEMBL620469,10748,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Intermediate,1,,N,50597,,,12873,In vivo,,1
,CHEMBL620470,10749,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Intermediate,1,,N,50597,,,12873,In vivo,,1
,CHEMBL620471,10750,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,3169,In vivo,,1
,CHEMBL620472,10751,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6305,In vivo,,1
,CHEMBL620473,10752,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Intermediate,1,,N,50597,,,4762,In vivo,,1
,CHEMBL620474,10753,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,17847,In vivo,,1
,CHEMBL620475,10754,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Intermediate,1,,N,50597,,,6211,In vivo,,1
,CHEMBL620476,10755,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6011,In vivo,,1
,CHEMBL620477,10756,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,6317,In vivo,,1
,CHEMBL620478,10757,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL618768,10758,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL618769,10759,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL618770,10760,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Intermediate,1,,N,50597,,,6644,In vivo,,1
,CHEMBL618771,10761,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability (dose 20 mg/kg p.o.),Intermediate,1,,N,50597,,,6113,In vivo,,1
,CHEMBL618772,10762,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,1,,N,50597,,,5937,In vivo,,1
,CHEMBL618773,10763,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat at 10 mg/kg of the compound,Intermediate,1,,N,50597,,,5711,In vivo,,1
,CHEMBL875842,10764,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL618774,10765,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL618775,10766,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL618776,10767,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,1,,N,50597,,,17717,In vivo,,1
,CHEMBL618777,10768,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent bioavailability (F) in rats after iv administration,Intermediate,1,,N,50597,,,4722,In vivo,,1
,CHEMBL618778,10769,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Intermediate,1,,N,50597,,,4722,In vivo,,1
,CHEMBL618779,10770,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 5 uM/kg p.o.),Intermediate,1,,N,50597,,,4353,In vivo,,1
,CHEMBL618780,10771,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability,Intermediate,1,,N,50597,,,15662,In vivo,,1
,CHEMBL618781,10772,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 2 mg/kg p.o.),Intermediate,1,,N,50597,,,4756,In vivo,,1
,CHEMBL618782,10773,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Intermediate,1,,N,50597,,,4756,In vivo,,1
,CHEMBL618783,10774,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,1,,N,50597,,,3436,In vivo,,1
,CHEMBL618784,10775,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,17800,In vivo,,1
,CHEMBL618785,10776,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent oral bioavailability evaluated in rat,Intermediate,1,,N,50597,,,15762,In vivo,,1
,CHEMBL618786,10777,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,5089,In vivo,,1
,CHEMBL618787,10778,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent oral bioavailability in rat; Not determined,Intermediate,1,,N,50597,,,5089,In vivo,,1
,CHEMBL618788,10779,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Intermediate,1,,N,50597,,,3185,In vivo,,1
,CHEMBL618789,10780,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Intermediate,1,,N,50597,,,5145,In vivo,,1
,CHEMBL618790,10781,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Intermediate,1,,N,50597,,,3457,In vivo,,1
,CHEMBL618791,10782,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Intermediate,1,,N,50597,,,3457,In vivo,,1
,CHEMBL875843,10783,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Intermediate,1,,N,50597,,,5983,In vivo,,1
,CHEMBL618792,10784,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,1,,N,50597,,,5739,In vivo,,1
,CHEMBL623395,10785,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax at a dose of 30 mg/kg in rat,Intermediate,1,,N,50597,,,3579,In vivo,,1
,CHEMBL623396,10786,BAO_0000218,A,,,314293.0,,Simiiformes,,Cmax in monkeys at a dose of 1 mg/kg,Autocuration,0,,U,22224,,,17788,In vivo,,1
,CHEMBL623397,10787,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat,Intermediate,1,,N,50597,,,14956,In vivo,,1
,CHEMBL623398,10788,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rats at a dose of 1 mg/kg,Intermediate,1,,N,50597,,,17788,In vivo,,1
,CHEMBL623399,10789,BAO_0000218,A,,,10090.0,,Mus musculus,,Cmax was measured in mice after an oral dose of 50 mg/kg.,Intermediate,1,,N,50594,,,9750,In vivo,,1
,CHEMBL623400,10790,BAO_0000218,A,,,,,,,"Cmax value at a dose of 12.7 uM/kg, po",Autocuration,0,,U,22224,,,12767,In vivo,,1
,CHEMBL623401,10791,BAO_0000218,A,,,,,,,"Cmax value at a dose of 6.3 uM/kg, iv",Autocuration,0,,U,22224,,,12767,In vivo,,1
,CHEMBL623402,10792,BAO_0000218,A,,,,,,,"Cmax value at a dose of 7.1 uM/kg, iv",Autocuration,0,,U,22224,,,12767,In vivo,,1
,CHEMBL623403,10793,BAO_0000218,A,,,,,,,Cmax value of compound was determined after 1 hr,Autocuration,0,,U,22224,,,12703,In vivo,,1
,CHEMBL623404,10794,BAO_0000218,A,,,,,,,Cmax value of the compound,Autocuration,0,,U,22224,,,15778,In vivo,,1
,CHEMBL625997,10795,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value administered intraintestinal in rats.,Intermediate,1,,N,50597,,,12818,In vivo,,1
,CHEMBL625998,10796,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value administered perorally was determined in rat; Not determined,Intermediate,1,,N,50597,,,14964,In vivo,,1
,CHEMBL625999,10797,BAO_0000218,A,,,,,,,Cmax value at the dose of 2.3 mg/kg,Autocuration,0,,U,22224,,,15808,In vivo,,1
,CHEMBL626000,10798,BAO_0000218,A,,,,,,,Cmax value at the dose of 5 mg/kg,Autocuration,0,,U,22224,,,15808,In vivo,,1
,CHEMBL626001,10799,BAO_0000218,A,,,,,,,Cmax value in the period of 8 hr after dosing. ,Autocuration,0,,U,22224,,,15778,In vivo,,1
,CHEMBL626002,10800,BAO_0000218,A,,,,,,,Cmax value at a oral dose of 20 mg/kg; Not tested,Autocuration,0,,U,22224,,,3715,In vivo,,1
,CHEMBL626003,10801,BAO_0000218,A,,,,,,,Cmax value at a oral dose of 20 mg/kg,Autocuration,0,,U,22224,,,3715,In vivo,,1
,CHEMBL626004,10802,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,1,,N,50597,,,1446,In vivo,,1
,CHEMBL626005,10803,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,1,,N,50512,,,15240,In vivo,,1
,CHEMBL626006,10804,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Intermediate,1,,N,50597,,,15240,In vivo,,1
,CHEMBL626007,10805,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Intermediate,1,,N,50597,1969.0,,14810,In vivo,,1
,CHEMBL626008,10806,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Intermediate,1,,N,50594,1969.0,,14239,In vivo,,1
,CHEMBL626009,10807,BAO_0000218,A,,,9615.0,Liver,Canis lupus familiaris,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Intermediate,1,,N,50588,2107.0,,12555,In vivo,,1
,CHEMBL626010,10808,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Intermediate,1,,N,50588,,,10754,In vivo,,1
,CHEMBL626011,10809,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Intermediate,1,,N,50594,178.0,,10754,In vivo,,1
,CHEMBL626012,10810,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Intermediate,1,,N,50594,178.0,,10754,In vivo,,1
,CHEMBL626013,10811,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Intermediate,1,,N,50594,178.0,,10754,In vivo,,1
,CHEMBL626014,10812,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Intermediate,1,,N,50594,178.0,,10754,In vivo,,1
,CHEMBL877496,10813,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Intermediate,1,,N,50594,178.0,,10754,In vivo,,1
,CHEMBL626015,10814,BAO_0000218,F,,,9615.0,,Canis lupus familiaris,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Intermediate,1,,N,50588,,,14600,In vivo,,1
,CHEMBL626016,10815,BAO_0000218,F,,,9615.0,,Canis lupus familiaris,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Intermediate,1,,N,50588,,,14600,In vivo,,1
,CHEMBL626017,10816,BAO_0000218,F,,,9615.0,,Canis lupus familiaris,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Intermediate,1,,N,50588,,,14600,In vivo,,1
,CHEMBL626018,10817,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Bioavailability as maximal plasma concentration in dogs,Intermediate,1,,N,50588,1969.0,,13543,In vivo,,1
,CHEMBL626692,10818,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Bioavailability as maximal plasma concentration in dogs,Intermediate,1,,N,50588,1969.0,,13543,In vivo,,1
,CHEMBL626693,10819,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Bioavailability as maximal plasma concentration in rats,Intermediate,1,,N,50597,1969.0,,13543,In vivo,,1
,CHEMBL626694,10820,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Bioavailability as maximal plasma concentration in rats,Autocuration,0,,U,22224,1969.0,,13543,In vivo,,1
,CHEMBL626695,10821,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,1,,N,50588,178.0,,14600,In vivo,,1
,CHEMBL626696,10822,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,1,,N,50588,178.0,,14600,In vivo,,1
,CHEMBL626697,10823,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,1,,N,50588,178.0,,14600,In vivo,,1
,CHEMBL626859,10824,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Intermediate,1,,N,50588,178.0,,14600,In vivo,,1
,CHEMBL626860,10825,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,1,,N,50588,178.0,,14600,In vivo,,1
,CHEMBL626861,10826,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,1,,N,50588,178.0,,14600,In vivo,,1
,CHEMBL626296,10827,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,1,,N,50597,,,14681,In vivo,,1
,CHEMBL626297,10828,BAO_0000218,A,,,,,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,Autocuration,0,,U,22224,,,15905,In vivo,,1
,CHEMBL626298,10829,BAO_0000218,A,,,,Plasma,,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,Autocuration,0,,U,22224,1969.0,,15905,In vivo,,1
,CHEMBL626299,10830,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Intermediate,1,,N,50597,1969.0,,13304,In vivo,,1
,CHEMBL626300,10831,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,In vivo,,1
,CHEMBL626301,10832,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,In vivo,,1
,CHEMBL626962,10833,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,In vivo,,1
,CHEMBL626963,10834,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,In vivo,,1
,CHEMBL626964,10835,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,In vivo,,1
,CHEMBL626965,10836,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Intermediate,1,,N,100710,1969.0,,14839,In vivo,,1
,CHEMBL626966,10837,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,1,,N,50594,1969.0,,14839,In vivo,,1
,CHEMBL626967,10838,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,1,,N,50594,1969.0,,14839,In vivo,,1
,CHEMBL626968,10839,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Intermediate,1,,N,100710,1969.0,,14839,In vivo,,1
,CHEMBL626969,10840,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL627126,10841,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631276,10842,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631277,10843,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631278,10844,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL874457,10845,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631279,10846,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631280,10847,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631281,10848,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631968,10849,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631969,10850,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631970,10851,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631971,10852,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL631972,10853,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL630435,10854,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL630436,10855,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL630437,10856,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL630438,10857,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL630439,10858,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Intermediate,1,,N,50597,948.0,,8418,,,1
,CHEMBL630440,10859,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL630441,10860,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL630442,10861,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL625234,10862,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL625235,10863,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL625236,10864,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL625237,10865,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626125,10866,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626126,10867,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626127,10868,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626128,10869,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626129,10870,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626130,10871,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626131,10872,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626132,10873,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626752,10874,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626753,10875,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626754,10876,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626755,10877,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Intermediate,1,,N,50597,2113.0,,8418,,,1
,CHEMBL626756,10878,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL626757,10879,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL626758,10880,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL626759,10881,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL626760,10882,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL626394,10883,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL626395,10884,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL626396,10885,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL626397,10886,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL626398,10887,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL626399,10888,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL874653,10889,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL626400,10890,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL626401,10891,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL626402,10892,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL626403,10893,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL626404,10894,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL626405,10895,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625529,10896,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625530,10897,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625531,10898,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625532,10899,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625533,10900,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL875474,10901,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625534,10902,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625535,10903,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625536,10904,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625537,10905,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625538,10906,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625539,10907,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625540,10908,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625541,10909,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625542,10910,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625543,10911,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625544,10912,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625545,10913,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625546,10914,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625547,10915,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625548,10916,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625549,10917,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625550,10918,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625551,10919,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL875475,10920,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625552,10921,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625553,10922,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625554,10923,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625555,10924,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625556,10925,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624986,10926,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624987,10927,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624988,10928,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624989,10929,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624990,10930,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL874391,10931,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624991,10932,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624992,10933,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624993,10934,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624994,10935,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624995,10936,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624996,10937,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624997,10938,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624998,10939,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624999,10940,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL882955,10941,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625000,10942,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625001,10943,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625089,10944,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625090,10945,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625091,10946,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625092,10947,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625093,10948,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625094,10949,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625095,10950,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL625096,10951,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for its bioavailability in the dogs,Intermediate,1,,N,50588,,,2249,In vivo,,1
,CHEMBL625097,10952,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for its bioavailability in the rats,Intermediate,1,,N,50597,,,2249,In vivo,,1
,CHEMBL882956,10953,BAO_0000218,A,,,,,,,Compound was evaluated for oral bioavailability,Autocuration,0,,U,22224,,,17515,In vivo,,1
,CHEMBL625098,10954,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for percentage of Oral bioavailability in rats,Intermediate,1,,N,50597,,,14541,In vivo,,1
,CHEMBL625099,10955,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Bioavailability in guinea pig,Autocuration,0,,U,22224,,,12797,In vivo,,1
,CHEMBL625100,10956,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the oral bioavailability in rat,Intermediate,1,,N,50597,,,12797,In vivo,,1
,CHEMBL625101,10957,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for the oral bioavailability in dog,Intermediate,1,,N,50588,,,12797,In vivo,,1
,CHEMBL874396,10958,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the oral bioavailability in rat,Intermediate,1,,N,50597,,,12797,In vivo,,1
,CHEMBL625102,10959,BAO_0000218,F,,,9615.0,,Canis lupus familiaris,,Bioavailability in dog (dosed i.v.),Autocuration,0,,U,22224,,,11727,In vivo,,1
,CHEMBL625103,10960,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was tested for in vivo bioavailability in dog,Intermediate,1,,N,50588,,,13249,In vivo,,1
,CHEMBL625104,10961,BAO_0000218,A,,,10026.0,,Cricetinae,,Compound was tested for in vivo bioavailability in hamsters,Intermediate,1,,N,100712,,,13249,In vivo,,1
,CHEMBL625105,10962,BAO_0000218,A,,,314293.0,,Simiiformes,,Compound was tested for in vivo bioavailability in monkey,Autocuration,0,,U,22224,,,13249,In vivo,,1
,CHEMBL625106,10963,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for in vivo bioavailability in rat,Intermediate,1,,N,50597,,,13249,In vivo,,1
,CHEMBL625107,10964,BAO_0000218,A,,,10090.0,,Mus musculus,,Oral bioavailability in mouse,Autocuration,0,,U,22224,,,9552,In vivo,,1
,CHEMBL625108,10965,BAO_0000218,A,,,10090.0,,Mus musculus,,Compound was tested for percent of oral bioavailability in mice; 56-74,Intermediate,1,,N,50594,,,9552,In vivo,,1
,CHEMBL625109,10966,BAO_0000218,A,,,10090.0,,Mus musculus,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Autocuration,0,,U,22224,,,14839,In vivo,,1
,CHEMBL625110,10967,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Autocuration,0,,U,22224,,,14839,In vivo,,1
,CHEMBL625111,10968,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Autocuration,0,,U,22224,,,14839,In vivo,,1
,CHEMBL625112,10969,BAO_0000218,A,,,10090.0,,Mus musculus,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Intermediate,1,,N,50594,,,14839,In vivo,,1
,CHEMBL875334,10970,BAO_0000218,A,,,10090.0,,Mus musculus,,Oral bioavailability in nude mice,Intermediate,1,,N,50594,,,14839,In vivo,,1
,CHEMBL628617,10971,BAO_0000218,A,,,9443.0,,Primates,,Bioavailability in monkey (i.d. dosing),Autocuration,0,,U,22224,,,11219,In vivo,,1
,CHEMBL628618,10972,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Autocuration,0,,U,22224,,,9552,In vivo,,1
,CHEMBL628619,10973,BAO_0000218,A,,,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,Autocuration,0,,U,22224,,,11732,In vivo,,1
,CHEMBL628620,10974,BAO_0000218,A,,,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,Autocuration,0,,U,22224,,,11732,In vivo,,1
,CHEMBL628621,10975,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,1,,N,100710,,,14839,In vivo,,1
,CHEMBL628622,10976,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,1,,N,100710,,,14839,In vivo,,1
,CHEMBL628623,10977,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,1,,N,100710,,,14839,In vivo,,1
,CHEMBL628624,10978,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Intermediate,1,,N,100710,1969.0,,14839,In vivo,,1
,CHEMBL628625,10979,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,1,,N,50594,1969.0,,14839,In vivo,,1
,CHEMBL628626,10980,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Intermediate,1,,N,100710,1969.0,,14839,In vivo,,1
,CHEMBL627041,10981,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,1,,N,50594,1969.0,,14839,In vivo,,1
,CHEMBL627042,10982,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,1,,N,50594,1969.0,,14839,In vivo,,1
,CHEMBL627043,10983,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,1,,N,50594,1969.0,,14839,In vivo,,1
,CHEMBL627044,10984,BAO_0000218,A,,,,Plasma,,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,Autocuration,0,,U,22224,1969.0,,13932,In vivo,,1
,CHEMBL627045,10985,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Cmax in mouse plasma,Intermediate,1,,N,50594,1969.0,,11637,In vivo,,1
,CHEMBL627046,10986,BAO_0000218,A,,,,Plasma,,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,Autocuration,0,,U,22224,1969.0,,11637,In vivo,,1
,CHEMBL627047,10987,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximal plasma concentration in rat,Intermediate,1,,N,50597,1969.0,,13960,In vivo,,1
,CHEMBL627048,10988,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Intermediate,1,,N,50597,1969.0,,15905,In vivo,,1
,CHEMBL627049,10989,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL627050,10990,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL627051,10991,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL627052,10992,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL627053,10993,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL627054,10994,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL627055,10995,BAO_0000218,A,,,10090.0,,Mus musculus,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,In vivo,,1
,CHEMBL627056,10996,BAO_0000218,A,,,10090.0,,Mus musculus,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,In vivo,,1
,CHEMBL627057,10997,BAO_0000218,A,,,10090.0,,Mus musculus,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,1,,N,50594,,,15011,In vivo,,1
,CHEMBL627058,10998,BAO_0000218,A,,,10090.0,,Mus musculus,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,In vivo,,1
,CHEMBL626211,10999,BAO_0000218,A,,,10090.0,,Mus musculus,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,1,,N,50594,,,15011,In vivo,,1
,CHEMBL626212,11000,BAO_0000218,A,,,,,,,Maximum Concentration of the compound.,Autocuration,0,,U,22224,,,10291,In vivo,,1
,CHEMBL626213,11001,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum Concentration was measured after iv administration into Beagle dog,Intermediate,1,,N,50588,,,14599,In vivo,,1
,CHEMBL626214,11002,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum Concentration was measured after iv administration into Beagle dog.,Intermediate,1,,N,50588,,,14599,In vivo,,1
,CHEMBL626215,11003,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum Concentration was measured after po administration into Beagle dog,Intermediate,1,,N,50588,,,14599,In vivo,,1
,CHEMBL626216,11004,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum Concentration was measured after po administration into Beagle dog.,Intermediate,1,,N,50588,,,14599,In vivo,,1
,CHEMBL626217,11005,BAO_0000218,A,,,,Blood,,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,Autocuration,0,,U,22224,178.0,,12767,In vivo,,1
,CHEMBL626218,11006,BAO_0000218,A,,,,Blood,,,Maximum blood level reached after an iv dose of 12.2 uM/kg,Autocuration,0,,U,22224,178.0,,12767,In vivo,,1
,CHEMBL626219,11007,BAO_0000218,A,,,,Blood,,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,Autocuration,0,,U,22224,178.0,,12767,In vivo,,1
,CHEMBL626220,11008,BAO_0000218,A,,,,Blood,,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,Autocuration,0,,U,22224,178.0,,12767,In vivo,,1
,CHEMBL626221,11009,BAO_0000218,A,,,,Blood,,,Maximum blood level reached after an oral dose of 5.0 mg/kg,Autocuration,0,,U,22224,178.0,,12767,In vivo,,1
,CHEMBL626222,11010,BAO_0000218,A,,,,Blood,,,Maximum blood level reached at dose of 10.6 uM/kg orally,Autocuration,0,,U,22224,178.0,,12767,In vivo,,1
,CHEMBL626223,11011,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Intermediate,1,,N,50512,,,14706,In vivo,,1
,CHEMBL626224,11012,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Intermediate,1,,N,50512,,,14706,In vivo,,1
,CHEMBL626225,11013,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,1,,N,50597,955.0,,14793,In vivo,,1
,CHEMBL626226,11014,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Intermediate,1,,N,50597,955.0,,14793,In vivo,,1
,CHEMBL626227,11015,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Intermediate,1,,N,50597,955.0,,14793,In vivo,,1
,CHEMBL626228,11016,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Intermediate,1,,N,50597,955.0,,14793,In vivo,,1
,CHEMBL626229,11017,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,14793,In vivo,,1
,CHEMBL626921,11018,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,14793,In vivo,,1
,CHEMBL876793,11019,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Intermediate,1,,N,50597,,,14793,In vivo,,1
,CHEMBL625309,11020,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,14793,In vivo,,1
,CHEMBL625310,11021,BAO_0000218,A,,,1423.0,,Bacillus subtilis,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,1,,N,50278,,,10524,In vivo,,1
,CHEMBL625311,11022,BAO_0000218,A,,,314293.0,,Simiiformes,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Autocuration,0,,U,22224,,,11871,In vivo,,1
,CHEMBL625312,11023,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Intermediate,1,,N,50597,,,11871,In vivo,,1
,CHEMBL625313,11024,BAO_0000218,A,,,,,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,Autocuration,0,,U,22224,,,3437,In vivo,,1
,CHEMBL625314,11025,BAO_0000218,A,,,10090.0,,Mus musculus,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Intermediate,1,,N,50594,,,12038,In vivo,,1
,CHEMBL625315,11026,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration in male rats after iv administration of 20 mg/kg,Intermediate,1,,N,50597,,,12038,In vivo,,1
,CHEMBL625316,11027,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625317,11028,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625318,11029,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625319,11030,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625320,11031,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625321,11032,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625322,11033,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL876801,11034,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625323,11035,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625324,11036,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625325,11037,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625326,11038,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625327,11039,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625328,11040,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Intermediate,1,,N,50597,2107.0,,8418,,,1
,CHEMBL625329,11041,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL625330,11042,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627774,11043,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627775,11044,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627949,11045,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627950,11046,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627951,11047,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627952,11048,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627953,11049,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627954,11050,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627955,11051,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627956,11052,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL876802,11053,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627957,11054,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627958,11055,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627959,11056,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627960,11057,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627961,11058,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627962,11059,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Intermediate,1,,N,50597,2048.0,,8418,,,1
,CHEMBL627963,11060,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,1,,N,50597,,,9796,,,1
,CHEMBL624759,11061,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,,,9796,,,1
,CHEMBL624760,11062,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,,,9796,,,1
,CHEMBL624761,11063,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,,,9796,,,1
,CHEMBL877607,11064,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,,,9796,,,1
,CHEMBL624762,11065,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,1,,N,50597,2107.0,,9796,,,1
,CHEMBL624763,11066,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,2107.0,,9796,,,1
,CHEMBL624764,11067,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,2107.0,,9796,,,1
,CHEMBL624765,11068,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,2107.0,,9796,,,1
,CHEMBL624766,11069,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,2107.0,,9796,,,1
,CHEMBL624767,11070,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624768,11071,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624769,11072,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624770,11073,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624771,11074,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624772,11075,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624773,11076,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624774,11077,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624775,11078,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624776,11079,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624777,11080,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624778,11081,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624779,11082,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624780,11083,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624781,11084,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL877608,11085,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624782,11086,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624783,11087,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624784,11088,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624785,11089,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624786,11090,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL624787,11091,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL628676,11092,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL621842,11093,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL621843,11094,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL623873,11095,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL623874,11096,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL623875,11097,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL623876,11098,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL623877,11099,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623878,11100,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623879,11101,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623880,11102,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623881,11103,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623957,11104,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623958,11105,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623959,11106,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623960,11107,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623961,11108,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL623962,11109,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624676,11110,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624677,11111,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624678,11112,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624679,11113,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624680,11114,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624849,11115,BAO_0000218,A,,,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,Autocuration,0,,U,22224,,,11732,In vivo,,1
,CHEMBL624850,11116,BAO_0000218,A,,,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,Autocuration,0,,U,22224,,,11732,In vivo,,1
,CHEMBL874399,11117,BAO_0000218,A,,,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,Autocuration,0,,U,22224,,,11732,In vivo,,1
,CHEMBL624851,11118,BAO_0000218,A,,,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,Autocuration,0,,U,22224,,,11732,In vivo,,1
,CHEMBL624852,11119,BAO_0000218,A,,,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,Autocuration,0,,U,22224,,,11732,In vivo,,1
,CHEMBL624853,11120,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (dose 10 mg/kg),Autocuration,0,,U,22224,,,13359,In vivo,,1
,CHEMBL624854,11121,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley),Autocuration,0,,U,22224,,,16618,In vivo,,1
,CHEMBL624855,11122,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Autocuration,0,,U,22224,,,13960,In vivo,,1
,CHEMBL624856,11123,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rats was determined in vivo,Autocuration,0,,U,22224,,,13917,In vivo,,1
,CHEMBL882957,11124,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability in dog,Autocuration,0,,U,22224,,,14266,In vivo,,1
,CHEMBL624857,11125,BAO_0000218,A,,,314293.0,,Simiiformes,,Oral bioavailability of compound in monkey,Autocuration,0,,U,22224,,,12359,In vivo,,1
,CHEMBL622202,11126,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound in rat,Intermediate,1,,N,50597,,,12359,In vivo,,1
,CHEMBL622203,11127,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat of PMEA prodrug,Autocuration,0,,U,22224,,,12359,In vivo,,1
,CHEMBL625522,11128,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Intermediate,1,,N,50597,,,12359,In vivo,,1
,CHEMBL622868,11129,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Serum conc at 3 hours following 25 mg/kg dose,Autocuration,0,,U,22224,,,10791,In vivo,,1
,CHEMBL622869,11130,BAO_0000218,A,,,9544.0,Urine,Macaca mulatta,,Urine conc 0-5 hours following 25 mg/kg dose,Autocuration,0,,U,22224,1088.0,,10791,In vivo,,1
,CHEMBL622870,11131,BAO_0000218,A,,,9544.0,Urine,Macaca mulatta,,Urine conc 0-24 hours following 25 mg/kg dose,Autocuration,0,,U,22224,1088.0,,10791,In vivo,,1
,CHEMBL622871,11132,BAO_0000218,A,,,9534.0,,Chlorocebus aethiops,,Oral bioavailability in African green monkeys; 20-25,Autocuration,0,,U,22224,,,138,In vivo,,1
,CHEMBL620560,11133,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Oral bioavailability in cynomolgus monkey.,Intermediate,1,,N,100710,,,14521,In vivo,,1
,CHEMBL620561,11134,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability in dog,Autocuration,0,,U,22224,,,13953,In vivo,,1
,CHEMBL620562,11135,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability in dog at 10 mg/kg oral dose,Intermediate,1,,N,50588,,,12836,In vivo,,1
,CHEMBL620563,11136,BAO_0000218,A,,,10026.0,,Cricetinae,,Oral bioavailability in hamster at 10 mg/kg oral dose,Intermediate,1,,N,100712,,,12836,In vivo,,1
,CHEMBL620564,11137,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat at 10 mg/kg oral dose,Intermediate,1,,N,50597,,,12836,In vivo,,1
,CHEMBL872265,11138,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Autocuration,0,,U,22224,,,14521,In vivo,,1
,CHEMBL620565,11139,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Autocuration,0,,U,22224,,,13953,In vivo,,1
,CHEMBL620566,11140,BAO_0000218,A,,,9347.0,,Eutheria,,Oral bioavailability,Autocuration,0,,U,22224,,,6799,In vivo,,1
,CHEMBL620567,11141,BAO_0000218,A,,,,,,,Oral bioavailability was determined; range 49-102%,Autocuration,0,,U,22224,,,11311,In vivo,,1
,CHEMBL620568,11142,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability was determined in dogs,Intermediate,1,,N,50588,,,4013,In vivo,,1
,CHEMBL620569,11143,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat,Autocuration,0,,U,22224,,,4013,In vivo,,1
,CHEMBL620570,11144,BAO_0000218,A,,,9347.0,,Eutheria,,Oral bioavailability,Autocuration,0,,U,22224,,,17591,In vivo,,1
,CHEMBL620571,11145,BAO_0000218,A,,,,,,,Oral bioavailability was determined; Not orally available,Autocuration,0,,U,22224,,,17591,In vivo,,1
,CHEMBL620572,11146,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,1,,N,50594,,,15011,In vivo,,1
,CHEMBL620573,11147,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Autocuration,0,,U,22224,,,15011,In vivo,,1
,CHEMBL620574,11148,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Autocuration,0,,U,22224,,,15011,In vivo,,1
,CHEMBL620575,11149,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Oral bioavailability in Rhesus monkey,Autocuration,0,,U,22224,,,9552,In vivo,,1
,CHEMBL620576,11150,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability in dog (female mongrel),Autocuration,0,,U,22224,,,9552,In vivo,,1
,CHEMBL875846,11151,BAO_0000218,A,,,,,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,Autocuration,0,,U,22224,,,3639,In vivo,,1
,CHEMBL620577,11152,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability in dog,Autocuration,0,,U,22224,,,13397,In vivo,,1
,CHEMBL620578,11153,BAO_0000218,A,,,,,,,Percentage Bioavailability was evaluated.,Autocuration,0,,U,22224,,,3031,In vivo,,1
,CHEMBL620579,11154,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat administered i.d.,Autocuration,0,,U,22224,,,12818,In vivo,,1
,CHEMBL621248,11155,BAO_0000218,A,,,9347.0,,Eutheria,,Bioavailability,Autocuration,0,,U,22224,,,4847,In vivo,,1
,CHEMBL625390,11156,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,0,,U,22224,,,12421,In vivo,,1
,CHEMBL625391,11157,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Autocuration,0,,U,22224,,,11966,In vivo,,1
,CHEMBL872266,11158,BAO_0000218,A,,,9443.0,,Primates,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Autocuration,0,,U,22224,,,11218,In vivo,,1
,CHEMBL625392,11159,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability in rat (Sprague-Dawley) (male),Autocuration,0,,U,22224,,,13129,In vivo,,1
,CHEMBL625393,11160,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The oral bioavailability was measured on rats after oral administration,Intermediate,1,,N,50597,,,12350,In vivo,,1
,CHEMBL625394,11161,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,1,,N,50597,,,2231,In vivo,,1
,CHEMBL625395,11162,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,1,,N,50797,,,2231,In vivo,,1
,CHEMBL625396,11163,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,0,,U,22224,,,12187,In vivo,,1
,CHEMBL625397,11164,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,0,,U,22224,,,12421,In vivo,,1
,CHEMBL625398,11165,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL625399,11166,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,178.0,,13256,In vivo,,1
,CHEMBL626074,11167,BAO_0000218,A,,,10090.0,Cerebellum,Mus musculus,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2037.0,,13256,In vivo,,1
,CHEMBL626075,11168,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL626076,11169,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,1,,N,50597,1969.0,,2231,In vivo,,1
,CHEMBL626077,11170,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,1,,N,50797,1969.0,,2231,In vivo,,1
,CHEMBL626078,11171,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Intermediate,1,,N,50597,178.0,,12178,In vivo,,1
,CHEMBL625846,11172,BAO_0000218,A,,,,Blood,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),Autocuration,0,,U,22224,178.0,,12178,In vivo,,1
,CHEMBL625847,11173,BAO_0000218,A,,,,Blood,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),Autocuration,0,,U,22224,178.0,,12178,In vivo,,1
,CHEMBL625848,11174,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Expert,1,,N,50597,,,15633,In vivo,,1
,CHEMBL625849,11175,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of compound in plasma administered orally to rats,Intermediate,1,,N,50597,1969.0,,14258,In vivo,,1
,CHEMBL626023,11176,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Intermediate,1,,N,50588,1969.0,,14224,In vivo,,1
,CHEMBL626024,11177,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Intermediate,1,,N,50588,1969.0,,14224,In vivo,,1
,CHEMBL626025,11178,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Intermediate,1,,N,50588,1969.0,,14224,In vivo,,1
,CHEMBL626026,11179,BAO_0000218,A,,,,,,,Maximum concentration after 10 mg/kg by oral administration,Autocuration,0,,U,22224,,,5566,In vivo,,1
,CHEMBL626027,11180,BAO_0000218,A,,,,,,,Maximum concentration at a dose of 1.5 mg/kg,Autocuration,0,,U,22224,,,16935,In vivo,,1
,CHEMBL626028,11181,BAO_0000218,A,,,,,,,Maximum concentration at a dose of 2.0 mg/kg,Autocuration,0,,U,22224,,,16935,In vivo,,1
,CHEMBL626029,11182,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum concentration in dog plasma,Intermediate,1,,N,50588,1969.0,,14224,In vivo,,1
,CHEMBL626030,11183,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,Autocuration,0,,U,22224,1969.0,,12536,In vivo,,1
,CHEMBL626031,11184,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,Autocuration,0,,U,22224,1969.0,,12536,In vivo,,1
,CHEMBL626032,11185,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,Autocuration,0,,U,22224,1969.0,,12536,In vivo,,1
,CHEMBL626033,11186,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,Autocuration,0,,U,22224,1969.0,,12536,In vivo,,1
,CHEMBL626034,11187,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,Autocuration,0,,U,22224,1969.0,,12536,In vivo,,1
,CHEMBL626035,11188,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Intermediate,1,,N,50588,1969.0,,9994,In vivo,,1
,CHEMBL626036,11189,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma at Tmax,Autocuration,0,,U,22224,1969.0,,1434,In vivo,,1
,CHEMBL626037,11190,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Expert,1,,N,50588,1969.0,,12836,In vivo,,1
,CHEMBL626038,11191,BAO_0000218,A,,,10026.0,Plasma,Cricetinae,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Intermediate,1,,N,100712,1969.0,,12836,In vivo,,1
,CHEMBL626039,11192,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,12836,In vivo,,1
,CHEMBL626040,11193,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Intermediate,1,,N,50597,1969.0,,12545,In vivo,,1
,CHEMBL626041,11194,BAO_0000218,A,,,9986.0,Plasma,Oryctolagus cuniculus,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Intermediate,1,,N,50592,1969.0,,13856,In vivo,,1
,CHEMBL626042,11195,BAO_0000218,A,,,,,,,Maximum concentration was calculated,Autocuration,0,,U,22224,,,3550,In vivo,,1
,CHEMBL626043,11196,BAO_0000218,A,,,,,,,Maximum concentration was calculated.,Autocuration,0,,U,22224,,,2632,In vivo,,1
,CHEMBL626044,11197,BAO_0000218,A,,,,,,,Maximum concentration at a peroral dose of 10 mg/kg,Autocuration,0,,U,22224,,,5566,In vivo,,1
,CHEMBL626045,11198,BAO_0000218,A,,,,,,,Maximum concentration of the drug at 10 uM/dg administered perorally,Autocuration,0,,U,22224,,,11883,In vivo,,1
,CHEMBL626046,11199,BAO_0000218,A,,,,,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,Autocuration,0,,U,22224,,,11883,In vivo,,1
,CHEMBL626047,11200,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Intermediate,1,,N,50588,1969.0,,14122,In vivo,,1
,CHEMBL626048,11201,BAO_0000218,A,,,10026.0,Plasma,Cricetinae,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Intermediate,1,,N,100712,1969.0,,14122,In vivo,,1
,CHEMBL626049,11202,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Intermediate,1,,N,50597,1969.0,,14122,In vivo,,1
,CHEMBL626050,11203,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,12542,In vivo,,1
,CHEMBL874541,11204,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Intermediate,1,,N,50588,1969.0,,12542,In vivo,,1
,CHEMBL622826,11205,BAO_0000218,A,,,10026.0,Plasma,Cricetinae,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Intermediate,1,,N,100712,1969.0,,12542,In vivo,,1
,CHEMBL622827,11206,BAO_0000218,A,,,10026.0,Plasma,Cricetinae,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Intermediate,1,,N,100712,1969.0,,12542,In vivo,,1
,CHEMBL622828,11207,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,12542,In vivo,,1
,CHEMBL622829,11208,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Intermediate,1,,N,50597,1969.0,,14080,In vivo,,1
,CHEMBL876806,11209,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration reached following intravenous administration in male rat,Intermediate,1,,N,50597,,,11911,In vivo,,1
,CHEMBL622830,11210,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Intermediate,1,,N,50588,,,13204,In vivo,,1
,CHEMBL622831,11211,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Intermediate,1,,N,50597,,,13204,In vivo,,1
,CHEMBL626794,11212,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Intermediate,1,,N,50588,,,14346,In vivo,,1
,CHEMBL626795,11213,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,,,14346,In vivo,,1
,CHEMBL626796,11214,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,,,14346,In vivo,,1
,CHEMBL626797,11215,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,,,14346,In vivo,,1
,CHEMBL626798,11216,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum drug concentration is determined after oral dosing in rats.,Intermediate,1,,N,50597,,,14127,In vivo,,1
,CHEMBL626799,11217,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Intermediate,1,,N,50588,,,14339,In vivo,,1
,CHEMBL626800,11218,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Maximum observed concentration in oral (5 mg/kg) fed dogs,Intermediate,1,,N,50588,,,14339,In vivo,,1
,CHEMBL626801,11219,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration,Autocuration,0,,U,22224,1969.0,,13494,In vivo,,1
,CHEMBL876816,11220,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Intermediate,1,,N,50597,1969.0,,14925,In vivo,,1
,CHEMBL626802,11221,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,14474,In vivo,,1
,CHEMBL626803,11222,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Intermediate,1,,N,50588,1969.0,,14474,In vivo,,1
,CHEMBL626804,11223,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration following oral administration of 30 umol/kg,Autocuration,0,,U,22224,1969.0,,13917,In vivo,,1
,CHEMBL626805,11224,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Intermediate,1,,N,50597,1969.0,,9796,,,1
,CHEMBL626309,11225,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,1,,N,50597,1969.0,,9796,,,1
,CHEMBL626310,11226,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,1969.0,,9796,,,1
,CHEMBL626311,11227,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,1969.0,,9796,,,1
,CHEMBL626312,11228,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,1969.0,,9796,,,1
,CHEMBL626313,11229,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,995.0,,9796,,,1
,CHEMBL626314,11230,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,1,,N,50597,995.0,,9796,,,1
,CHEMBL626315,11231,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,995.0,,9796,,,1
,CHEMBL626316,11232,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,995.0,,9796,,,1
,CHEMBL626317,11233,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,1,,N,50597,995.0,,9796,,,1
,CHEMBL626318,11234,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626319,11235,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626320,11236,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL875053,11237,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626321,11238,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626322,11239,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626323,11240,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626324,11241,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626325,11242,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626326,11243,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626327,11244,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626328,11245,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,1,,N,50597,,,8363,,,1
,CHEMBL626329,11246,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL626330,11247,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL626331,11248,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL626332,11249,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL626333,11250,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL626334,11251,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL626335,11252,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL624798,11253,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,178.0,,8684,,,1
,CHEMBL624799,11254,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624800,11255,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624801,11256,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624802,11257,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624803,11258,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624804,11259,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624805,11260,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624806,11261,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Intermediate,1,,N,50597,955.0,,8684,,,1
,CHEMBL624807,11262,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624808,11263,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624809,11264,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624810,11265,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL877618,11266,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624811,11267,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624812,11268,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624813,11269,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624814,11270,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624815,11271,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624816,11272,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624817,11273,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624818,11274,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624819,11275,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624820,11276,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624821,11277,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624822,11278,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624823,11279,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624824,11280,BAO_0000218,A,,,562.0,,Escherichia coli,,Observed diffusion coefficient in organic solvent for Escherichia coli,Intermediate,1,,N,50212,,,15599,,,1
,CHEMBL624825,11281,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,1,,N,50597,178.0,,9614,,,1
,CHEMBL624826,11282,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,1,,N,50597,178.0,,9614,,,1
,CHEMBL876817,11283,BAO_0000218,A,,,10116.0,Cardiac atrium,Rattus norvegicus,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,1,,N,50597,2081.0,,9614,,,1
,CHEMBL624827,11284,BAO_0000218,A,,,10116.0,Cardiac atrium,Rattus norvegicus,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,1,,N,50597,2081.0,,9614,,,1
,CHEMBL624828,11285,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,1,,N,50597,,,9614,,,1
,CHEMBL624829,11286,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,1,,N,50597,,,9614,,,1
,CHEMBL624830,11287,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,1,,N,50597,2107.0,,9614,,,1
,CHEMBL624831,11288,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,1,,N,50597,2107.0,,9614,,,1
,CHEMBL624832,11289,BAO_0000218,A,,,10116.0,Cardiac atrium,Rattus norvegicus,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,1,,N,50597,2081.0,,9614,,,1
,CHEMBL624833,11290,BAO_0000218,A,,,10116.0,Cardiac atrium,Rattus norvegicus,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,1,,N,50597,2081.0,,9614,,,1
,CHEMBL624834,11291,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,1,,N,50597,,,9614,,,1
,CHEMBL624835,11292,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,1,,N,50597,,,9614,,,1
,CHEMBL624836,11293,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,1,,N,50597,2106.0,,9614,,,1
,CHEMBL624837,11294,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,1,,N,50597,2106.0,,9614,,,1
,CHEMBL624838,11295,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Intermediate,1,,N,50597,178.0,,9071,,,1
,CHEMBL622188,11296,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Intermediate,1,,N,50597,178.0,,9071,,,1
,CHEMBL622189,11297,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Intermediate,1,,N,50597,948.0,,9071,,,1
,CHEMBL622190,11298,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Intermediate,1,,N,50597,948.0,,9071,,,1
,CHEMBL625170,11299,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Intermediate,1,,N,50597,948.0,,9071,,,1
,CHEMBL625171,11300,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,1,,N,50597,2113.0,,9071,,,1
,CHEMBL625172,11301,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,1,,N,50597,2113.0,,9071,,,1
,CHEMBL625173,11302,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Intermediate,1,,N,50597,2113.0,,9071,,,1
,CHEMBL625174,11303,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Intermediate,1,,N,50597,2107.0,,9071,,,1
,CHEMBL625175,11304,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Intermediate,1,,N,50597,2107.0,,9071,,,1
,CHEMBL625176,11305,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Intermediate,1,,N,50597,2107.0,,9071,,,1
,CHEMBL625177,11306,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,1,,N,50597,2048.0,,9071,,,1
,CHEMBL625178,11307,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Intermediate,1,,N,50597,2048.0,,9071,,,1
,CHEMBL625179,11308,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Intermediate,1,,N,50597,2048.0,,9071,,,1
,CHEMBL625180,11309,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,1,,N,50597,2048.0,,9071,,,1
,CHEMBL625181,11310,BAO_0000218,A,,,,,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",Autocuration,0,,U,22224,,,10677,,,1
,CHEMBL625182,11311,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Intermediate,1,,N,50594,1088.0,,9750,,,1
,CHEMBL625183,11312,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL875848,11313,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL622260,11314,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL622261,11315,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL622262,11316,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL622263,11317,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL622418,11318,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL622419,11319,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,1,,N,50597,2107.0,,8319,,,1
,CHEMBL623388,11320,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL623389,11321,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2107.0,,13256,In vivo,,1
,CHEMBL623390,11322,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL623391,11323,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL623392,11324,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,178.0,,13256,In vivo,,1
,CHEMBL623393,11325,BAO_0000218,A,,,10090.0,Cerebellum,Mus musculus,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2037.0,,13256,In vivo,,1
,CHEMBL623394,11326,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL618885,11327,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL618886,11328,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2107.0,,13256,In vivo,,1
,CHEMBL618887,11329,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL619535,11330,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL619536,11331,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,178.0,,13256,In vivo,,1
,CHEMBL619537,11332,BAO_0000218,A,,,10090.0,Cerebellum,Mus musculus,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2037.0,,13256,In vivo,,1
,CHEMBL619705,11333,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL619706,11334,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL619707,11335,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2107.0,,13256,In vivo,,1
,CHEMBL619708,11336,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL625219,11337,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL625220,11338,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,178.0,,13256,In vivo,,1
,CHEMBL625221,11339,BAO_0000218,A,,,10090.0,Cerebellum,Mus musculus,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2037.0,,13256,In vivo,,1
,CHEMBL625222,11340,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL625223,11341,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL625224,11342,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,2107.0,,13256,In vivo,,1
,CHEMBL625225,11343,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,1,,N,50594,,,13256,In vivo,,1
,CHEMBL625226,11344,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in Rat blood after 24 hours of iv administration,Intermediate,1,,N,50597,178.0,,8829,In vivo,,1
,CHEMBL625227,11345,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Intermediate,1,,N,50597,178.0,,8829,In vivo,,1
,CHEMBL625228,11346,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in Rat blood after 30 minutes of iv administration,Intermediate,1,,N,50597,178.0,,8829,In vivo,,1
,CHEMBL875354,11347,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,178.0,,8829,In vivo,,1
,CHEMBL625229,11348,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in Rat blood after 5 minutes of iv administration,Intermediate,1,,N,50597,178.0,,8829,In vivo,,1
,CHEMBL625230,11349,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,178.0,,8829,In vivo,,1
,CHEMBL625231,11350,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in Rat heart after 24 hours of iv administration,Intermediate,1,,N,50597,948.0,,8829,In vivo,,1
,CHEMBL625900,11351,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Intermediate,1,,N,50597,948.0,,8829,In vivo,,1
,CHEMBL625901,11352,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in Rat heart after 30 minutes of iv administration,Intermediate,1,,N,50597,948.0,,8829,In vivo,,1
,CHEMBL625902,11353,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,948.0,,8829,In vivo,,1
,CHEMBL625903,11354,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in Rat heart after 5 minutes of iv administration,Intermediate,1,,N,50597,948.0,,8829,In vivo,,1
,CHEMBL625904,11355,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,948.0,,8829,In vivo,,1
,CHEMBL625905,11356,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 24 hours of iv administration,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL627861,11357,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL627862,11358,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL627863,11359,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL627769,11360,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL627770,11361,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,1,,N,50588,1969.0,,13249,In vivo,,1
,CHEMBL627771,11362,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Cmax in cynomolgus monkey (PO dose),Intermediate,1,,N,100710,,,13622,In vivo,,1
,CHEMBL627772,11363,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat (PO dose),Intermediate,1,,N,50597,,,13622,In vivo,,1
,CHEMBL627773,11364,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax in rat (PO dose),Intermediate,1,,N,50597,,,13622,In vivo,,1
,CHEMBL621922,11365,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Intermediate,1,,N,50597,1969.0,,13494,In vivo,,1
,CHEMBL621923,11366,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax in rat plasma after oral dose (10 mg/kg),Intermediate,1,,N,50597,1969.0,,12170,In vivo,,1
,CHEMBL621924,11367,BAO_0000218,A,,,,Plasma,,,Cmax in plasma after oral dose (10 mg/kg),Autocuration,0,,U,22224,1969.0,,12170,In vivo,,1
,CHEMBL621925,11368,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Intermediate,1,,N,50588,1969.0,,17025,In vivo,,1
,CHEMBL621926,11369,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Autocuration,0,,U,22224,1969.0,,17025,In vivo,,1
,CHEMBL621927,11370,BAO_0000218,A,,,9986.0,Plasma,Oryctolagus cuniculus,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Intermediate,1,,N,50592,1969.0,,17025,In vivo,,1
,CHEMBL621928,11371,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Intermediate,1,,N,50597,1969.0,,17025,In vivo,,1
,CHEMBL621929,11372,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Intermediate,1,,N,50597,1969.0,,14187,In vivo,,1
,CHEMBL621930,11373,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Intermediate,1,,N,50594,1969.0,,14816,In vivo,,1
,CHEMBL621931,11374,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration after oral dosing in rat,Intermediate,1,,N,50597,1969.0,,17820,In vivo,,1
,CHEMBL621932,11375,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL621933,11376,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL621934,11377,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Intermediate,1,,N,50588,1969.0,,14691,In vivo,,1
,CHEMBL621935,11378,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Intermediate,1,,N,50588,1969.0,,14691,In vivo,,1
,CHEMBL621936,11379,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Intermediate,1,,N,50597,1969.0,,13375,In vivo,,1
,CHEMBL621937,11380,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was determined,Autocuration,0,,U,22224,1969.0,,6236,In vivo,,1
,CHEMBL621938,11381,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL621939,11382,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL621940,11383,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL621941,11384,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL621942,11385,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL626178,11386,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL626179,11387,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL626180,11388,BAO_0000218,A,,,,Plasma,,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,1969.0,,14380,In vivo,,1
,CHEMBL626181,11389,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma Cmax in rat (PO dose),Intermediate,1,,N,50597,1969.0,,13622,In vivo,,1
,CHEMBL626182,11390,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Intermediate,1,,N,50597,,,15372,In vivo,,1
,CHEMBL626183,11391,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Intermediate,1,,N,50597,,,15372,In vivo,,1
,CHEMBL626184,11392,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,1,,N,50597,,,15372,In vivo,,1
,CHEMBL626185,11393,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,1,,N,50597,,,15372,In vivo,,1
,CHEMBL626186,11394,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Intermediate,1,,N,50588,1969.0,,14925,In vivo,,1
,CHEMBL877589,11395,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Intermediate,1,,N,50588,1969.0,,14925,In vivo,,1
,CHEMBL626187,11396,BAO_0000218,A,,,,,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,Autocuration,0,,U,22224,,,11883,In vivo,,1
,CHEMBL626188,11397,BAO_0000218,A,,,,,,,Maximum concentration of the drug at 20 uM/dg administered perorally,Autocuration,0,,U,22224,,,11883,In vivo,,1
,CHEMBL626189,11398,BAO_0000218,A,,,,,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,Autocuration,0,,U,22224,,,13391,In vivo,,1
,CHEMBL626855,11399,BAO_0000218,A,,,,Blood,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,0,,U,22224,178.0,,13391,In vivo,,1
,CHEMBL623781,11400,BAO_0000218,A,,,,Blood,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,0,,U,22224,178.0,,13391,In vivo,,1
,CHEMBL623782,11401,BAO_0000218,A,,,,Blood,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,0,,U,22224,178.0,,13391,In vivo,,1
,CHEMBL623783,11402,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Intermediate,1,,N,50597,1969.0,,16360,In vivo,,1
,CHEMBL623784,11403,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Cmax in dog plasma after 1mg/kg oral dose,Intermediate,1,,N,50588,1969.0,,3673,In vivo,,1
,CHEMBL623785,11404,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Intermediate,1,,N,50588,1969.0,,14431,In vivo,,1
,CHEMBL623786,11405,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,14431,In vivo,,1
,CHEMBL623787,11406,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral maximum concentration in rat,Intermediate,1,,N,50597,,,14964,In vivo,,1
,CHEMBL623788,11407,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral maximum concentration in rat,Intermediate,1,,N,50597,,,14964,In vivo,,1
,CHEMBL623789,11408,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Intermediate,1,,N,50594,1969.0,,14209,In vivo,,1
,CHEMBL623790,11409,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Peak concentration in blood after intravenous administration to mice,Intermediate,1,,N,50594,178.0,,11355,In vivo,,1
,CHEMBL623791,11410,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Peak concentration in blood after peroral administration to mice,Intermediate,1,,N,50594,178.0,,11355,In vivo,,1
,CHEMBL623792,11411,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak concentration in rat plasma was determined,Intermediate,1,,N,50597,1969.0,,11966,In vivo,,1
,CHEMBL623793,11412,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,0,,U,22224,1969.0,,8918,In vivo,,1
,CHEMBL623794,11413,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,1,,N,50594,1969.0,,8918,In vivo,,1
,CHEMBL623795,11414,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,1,,N,50597,1969.0,,8918,In vivo,,1
,CHEMBL623796,11415,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623797,11416,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623798,11417,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623799,11418,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624490,11419,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL624491,11420,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL624492,11421,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL624493,11422,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL877595,11423,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL624494,11424,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL624495,11425,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL624681,11426,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,160.0,,8684,,,1
,CHEMBL624682,11427,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624683,11428,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624684,11429,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624685,11430,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624686,11431,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624687,11432,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624688,11433,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL627161,11434,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL622127,11435,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL622128,11436,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL874384,11437,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624898,11438,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624899,11439,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624900,11440,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624901,11441,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624902,11442,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624903,11443,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624904,11444,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624905,11445,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624906,11446,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624907,11447,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624908,11448,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624909,11449,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624910,11450,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL624911,11451,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL874388,11452,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL624912,11453,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL622930,11454,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL623121,11455,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL623122,11456,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL623123,11457,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL623124,11458,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2385.0,,8684,,,1
,CHEMBL623125,11459,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623126,11460,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623127,11461,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623128,11462,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623129,11463,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623130,11464,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623131,11465,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623132,11466,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL623133,11467,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,2107.0,,8319,,,1
,CHEMBL623134,11468,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL874389,11469,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL623135,11470,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL623136,11471,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL623137,11472,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL623138,11473,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL623139,11474,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL623140,11475,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL623141,11476,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,1,,N,50597,2107.0,,8319,,,1
,CHEMBL623142,11477,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,2107.0,,8319,,,1
,CHEMBL623143,11478,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL623144,11479,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Intermediate,1,,N,50594,1088.0,,14571,,,1
,CHEMBL623405,11480,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Intermediate,1,,N,50597,1088.0,,14571,,,1
,CHEMBL624074,11481,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624075,11482,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624076,11483,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624077,11484,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624078,11485,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624079,11486,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL624261,11487,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL624262,11488,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624263,11489,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624264,11490,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624265,11491,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624266,11492,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624267,11493,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624268,11494,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL875227,11495,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624269,11496,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL624270,11497,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,2113.0,,8319,,,1
,CHEMBL624271,11498,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624272,11499,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624273,11500,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,1,,N,50597,,,8319,,,1
,CHEMBL624274,11501,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Intermediate,1,,N,50597,1088.0,,12064,,,1
,CHEMBL624275,11502,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Intermediate,1,,N,50597,1088.0,,12064,,,1
,CHEMBL624276,11503,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Intermediate,1,,N,50597,1088.0,,12064,,,1
,CHEMBL624277,11504,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Intermediate,1,,N,50597,1088.0,,12038,,,1
,CHEMBL624278,11505,BAO_0000019,A,,,,,,,% dose converted to 2-amino-5-chlorophenyl sulfate,Autocuration,0,,U,22224,,,14314,,,1
,CHEMBL624279,11506,BAO_0000019,A,,,,,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),Autocuration,0,,U,22224,,,14314,,,1
,CHEMBL624280,11507,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,1,,N,50597,1988.0,,11488,,,1
,CHEMBL624281,11508,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,1,,N,50597,1988.0,,11488,,,1
,CHEMBL622933,11509,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,1,,N,50597,1988.0,,11488,,,1
,CHEMBL622934,11510,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,1,,N,50597,1988.0,,11488,,,1
,CHEMBL622935,11511,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL622936,11512,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 5 minutes of iv administration,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL875228,11513,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,2107.0,,8829,In vivo,,1
,CHEMBL622937,11514,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in Rat lung after 24 hours of iv administration,Intermediate,1,,N,50597,2048.0,,8829,In vivo,,1
,CHEMBL622938,11515,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Intermediate,1,,N,50597,2048.0,,8829,In vivo,,1
,CHEMBL619736,11516,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in Rat lung after 30 minutes of iv administration,Intermediate,1,,N,50597,2048.0,,8829,In vivo,,1
,CHEMBL625117,11517,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,2048.0,,8829,In vivo,,1
,CHEMBL625118,11518,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in Rat lung after 5 minutes of iv administration,Intermediate,1,,N,50597,2048.0,,8829,In vivo,,1
,CHEMBL625119,11519,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Intermediate,1,,N,50597,2048.0,,8829,In vivo,,1
,CHEMBL625120,11520,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Intermediate,1,,N,50597,2037.0,,14972,In vivo,,1
,CHEMBL625121,11521,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Intermediate,1,,N,50597,,,14972,In vivo,,1
,CHEMBL625122,11522,BAO_0000218,A,,,10116.0,Thalamus,Rattus norvegicus,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Intermediate,1,,N,50597,10000006.0,,14972,In vivo,,1
,CHEMBL622204,11523,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,178.0,,14608,In vivo,,1
,CHEMBL877503,11524,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,178.0,,14608,In vivo,,1
,CHEMBL627127,11525,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,178.0,,14608,In vivo,,1
,CHEMBL627128,11526,BAO_0000218,A,,,,Hippocampus,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,Autocuration,0,,U,22224,10000000.0,,14608,In vivo,,1
,CHEMBL627129,11527,BAO_0000218,A,,,,Hippocampus,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,Autocuration,0,,U,22224,10000000.0,,14608,In vivo,,1
,CHEMBL627130,11528,BAO_0000218,A,,,,Hippocampus,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,Autocuration,0,,U,22224,10000000.0,,14608,In vivo,,1
,CHEMBL627131,11529,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,955.0,,14608,In vivo,,1
,CHEMBL627132,11530,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,955.0,,14608,In vivo,,1
,CHEMBL627133,11531,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,955.0,,14608,In vivo,,1
,CHEMBL627134,11532,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2037.0,,14608,In vivo,,1
,CHEMBL627135,11533,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2037.0,,14608,In vivo,,1
,CHEMBL627136,11534,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2037.0,,14608,In vivo,,1
,CHEMBL628435,11535,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,,,14608,In vivo,,1
,CHEMBL628436,11536,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,,,14608,In vivo,,1
,CHEMBL628437,11537,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,,,14608,In vivo,,1
,CHEMBL628438,11538,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,948.0,,14608,In vivo,,1
,CHEMBL628439,11539,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,948.0,,14608,In vivo,,1
,CHEMBL628440,11540,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,948.0,,14608,In vivo,,1
,CHEMBL628441,11541,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,10000000.0,,14608,In vivo,,1
,CHEMBL628442,11542,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,10000000.0,,14608,In vivo,,1
,CHEMBL628443,11543,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,10000000.0,,14608,In vivo,,1
,CHEMBL628444,11544,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2113.0,,14608,In vivo,,1
,CHEMBL628445,11545,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2113.0,,14608,In vivo,,1
,CHEMBL877504,11546,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2113.0,,14608,In vivo,,1
,CHEMBL628446,11547,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2107.0,,14608,In vivo,,1
,CHEMBL626874,11548,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2107.0,,14608,In vivo,,1
,CHEMBL626875,11549,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2107.0,,14608,In vivo,,1
,CHEMBL626876,11550,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2048.0,,14608,In vivo,,1
,CHEMBL626877,11551,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2048.0,,14608,In vivo,,1
,CHEMBL626878,11552,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2048.0,,14608,In vivo,,1
,CHEMBL626879,11553,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2385.0,,14608,In vivo,,1
,CHEMBL626880,11554,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,0,,U,22224,1969.0,,8918,In vivo,,1
,CHEMBL626881,11555,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,1,,N,50594,1969.0,,8918,In vivo,,1
,CHEMBL626882,11556,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,1,,N,50597,1969.0,,8918,In vivo,,1
,CHEMBL626883,11557,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Peak plasma concentration was measured in dogs,Intermediate,1,,N,50588,1969.0,,14470,In vivo,,1
,CHEMBL626884,11558,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,1,,N,50597,,,14393,In vivo,,1
,CHEMBL626885,11559,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,1,,N,50597,,,14886,In vivo,,1
,CHEMBL626886,11560,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,1,,N,50597,,,14886,In vivo,,1
,CHEMBL626887,11561,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,1,,N,50597,,,14886,In vivo,,1
,CHEMBL626888,11562,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,1,,N,50597,,,14393,In vivo,,1
,CHEMBL626889,11563,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Intermediate,1,,N,50588,,,13465,In vivo,,1
,CHEMBL626761,11564,BAO_0000218,A,,,314293.0,,Simiiformes,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Autocuration,0,,U,22224,,,13465,In vivo,,1
,CHEMBL626762,11565,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Intermediate,1,,N,50588,,,13465,In vivo,,1
,CHEMBL626763,11566,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Intermediate,1,,N,50588,,,13465,In vivo,,1
,CHEMBL626764,11567,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Intermediate,1,,N,50597,,,13465,In vivo,,1
,CHEMBL626765,11568,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Intermediate,1,,N,50597,,,13465,In vivo,,1
,CHEMBL626766,11569,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Intermediate,1,,N,50588,,,13465,In vivo,,1
,CHEMBL626767,11570,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Intermediate,1,,N,50597,,,13465,In vivo,,1
,CHEMBL626768,11571,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Intermediate,1,,N,50597,,,13465,In vivo,,1
,CHEMBL626769,11572,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Intermediate,1,,N,50588,,,13465,In vivo,,1
,CHEMBL874463,11573,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Intermediate,1,,N,50588,,,13465,In vivo,,1
,CHEMBL626770,11574,BAO_0000218,A,,,314293.0,,Simiiformes,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Autocuration,0,,U,22224,,,13465,In vivo,,1
,CHEMBL626771,11575,BAO_0000218,A,,,314293.0,,Simiiformes,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Autocuration,0,,U,22224,,,13465,In vivo,,1
,CHEMBL626772,11576,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Intermediate,1,,N,50597,,,13465,In vivo,,1
,CHEMBL626773,11577,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,1,,N,100710,,,14731,In vivo,,1
,CHEMBL626774,11578,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Intermediate,1,,N,50594,,,14731,In vivo,,1
,CHEMBL626775,11579,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,1,,N,50588,,,13376,In vivo,,1
,CHEMBL626776,11580,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,1,,N,50588,,,13376,In vivo,,1
,CHEMBL626777,11581,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Maximum concentration (Cmax) in rat when administered orally,Intermediate,1,,N,50597,,,14443,In vivo,,1
,CHEMBL626778,11582,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Autocuration,0,,U,22224,1969.0,,13465,In vivo,,1
,CHEMBL626779,11583,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Autocuration,0,,U,22224,,,16359,In vivo,,1
,CHEMBL626780,11584,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Autocuration,0,,U,22224,,,16359,In vivo,,1
,CHEMBL626781,11585,BAO_0000218,A,,,,Plasma,,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,Autocuration,0,,U,22224,1969.0,,15618,In vivo,,1
,CHEMBL632164,11586,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic profile Cmax was evaluated in rats,Intermediate,1,,N,50597,,,14554,In vivo,,1
,CHEMBL632165,11587,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Intermediate,1,,N,50588,,,11537,In vivo,,1
,CHEMBL632166,11588,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Intermediate,1,,N,50594,,,11537,In vivo,,1
,CHEMBL632167,11589,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Intermediate,1,,N,50588,,,11537,In vivo,,1
,CHEMBL632168,11590,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Intermediate,1,,N,50594,,,11537,In vivo,,1
,CHEMBL632169,11591,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax in rat plasma,Autocuration,0,,U,22224,1969.0,,2021,In vivo,,1
,CHEMBL632170,11592,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Cmax in dog plasma after 30mg/kg oral dose,Intermediate,1,,N,50588,1969.0,,5932,In vivo,,1
,CHEMBL632171,11593,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,5932,In vivo,,1
,CHEMBL632172,11594,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma level in rats at 30 mg/kg,Intermediate,1,,N,50597,1969.0,,17320,In vivo,,1
,CHEMBL632173,11595,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Tested for maximum plasma concentration in mice,Intermediate,1,,N,50594,1969.0,,15831,In vivo,,1
,CHEMBL632174,11596,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,In vivo,,1
,CHEMBL632175,11597,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The Cmax values in female wistar rats.,Intermediate,1,,N,50597,,,14941,In vivo,,1
,CHEMBL632176,11598,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,1,,N,50588,1969.0,,15343,In vivo,,1
,CHEMBL632177,11599,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Intermediate,1,,N,50597,1969.0,,15343,In vivo,,1
,CHEMBL632178,11600,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Intermediate,1,,N,50597,1969.0,,14856,In vivo,,1
,CHEMBL632179,11601,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,1,,N,50597,,,13129,In vivo,,1
,CHEMBL632180,11602,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Intermediate,1,,N,50597,178.0,,13098,In vivo,,1
,CHEMBL632181,11603,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Intermediate,1,,N,50597,178.0,,13098,In vivo,,1
,CHEMBL632182,11604,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Intermediate,1,,N,50597,178.0,,13098,In vivo,,1
,CHEMBL632183,11605,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Autocuration,0,,U,22224,178.0,,15478,In vivo,,1
,CHEMBL632184,11606,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Intermediate,1,,N,50588,,,15341,In vivo,,1
,CHEMBL874470,11607,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Intermediate,1,,N,50597,,,15341,In vivo,,1
,CHEMBL631302,11608,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL631303,11609,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL631304,11610,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL631305,11611,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL631306,11612,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL631307,11613,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL631308,11614,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL625557,11615,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,,,8684,,,1
,CHEMBL625558,11616,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL625559,11617,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL625560,11618,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL625561,11619,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL625562,11620,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL875320,11621,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL625563,11622,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL625564,11623,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,2106.0,,8684,,,1
,CHEMBL625565,11624,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL625566,11625,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL625567,11626,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL625568,11627,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL628217,11628,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL628218,11629,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL628219,11630,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL628220,11631,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Intermediate,1,,N,50597,995.0,,8684,,,1
,CHEMBL628221,11632,BAO_0000019,A,,,,,,,Distribution in the blood after 120 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628222,11633,BAO_0000019,A,,,,,,,Distribution in the blood after 15 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628223,11634,BAO_0000019,A,,,,,,,Distribution in the blood after 30 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628224,11635,BAO_0000019,A,,,,,,,Distribution in the blood after 5 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628225,11636,BAO_0000019,A,,,,,,,Distribution in the blood after 60 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628226,11637,BAO_0000019,A,,,,,,,Distribution in the blood after 90 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628227,11638,BAO_0000019,A,,,,,,,Distribution in the bone after 120 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL875481,11639,BAO_0000019,A,,,,,,,Distribution in the bone after 15 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628228,11640,BAO_0000019,A,,,,,,,Distribution in the bone after 30 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628229,11641,BAO_0000019,A,,,,,,,Distribution in the bone after 5 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628230,11642,BAO_0000019,A,,,,,,,Distribution in the bone after 60 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628231,11643,BAO_0000019,A,,,,,,,Distribution in the bone after 90 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628232,11644,BAO_0000019,A,,,,,,,Distribution in the heart after 120 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628233,11645,BAO_0000019,A,,,,,,,Distribution in the heart after 15 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628234,11646,BAO_0000019,A,,,,,,,Distribution in the heart after 30 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628235,11647,BAO_0000019,A,,,,,,,Distribution in the heart after 5 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628236,11648,BAO_0000019,A,,,,,,,Distribution in the heart after 60 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628237,11649,BAO_0000019,A,,,,,,,Distribution in the heart after 90 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628238,11650,BAO_0000019,A,,,,,,,Distribution in the kidneys after 120 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628239,11651,BAO_0000019,A,,,,,,,Distribution in the kidneys after 15 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628240,11652,BAO_0000019,A,,,,,,,Distribution in the kidneys after 30 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628241,11653,BAO_0000019,A,,,,,,,Distribution in the kidneys after 5 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628242,11654,BAO_0000019,A,,,,,,,Distribution in the kidneys after 60 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL875482,11655,BAO_0000019,A,,,,,,,Distribution in the kidneys after 90 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628243,11656,BAO_0000019,A,,,,,,,Distribution in the liver after 120 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628244,11657,BAO_0000019,A,,,,,,,Distribution in the liver after 15 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628245,11658,BAO_0000019,A,,,,,,,Distribution in the liver after 30 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628246,11659,BAO_0000019,A,,,,,,,Distribution in the liver after 5 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628247,11660,BAO_0000019,A,,,,,,,Distribution in the liver after 60 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628248,11661,BAO_0000019,A,,,,,,,Distribution in the liver after 90 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628249,11662,BAO_0000019,A,,,,,,,Distribution in the lung after 120 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL625452,11663,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL625453,11664,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL625454,11665,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623844,11666,BAO_0000218,A,,,10090.0,,Mus musculus,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Intermediate,1,,N,50594,,,14839,,,1
,CHEMBL623845,11667,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,1,,N,50597,,,12178,,,1
,CHEMBL623846,11668,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,1,,N,50597,,,12178,,,1
,CHEMBL623847,11669,BAO_0000218,A,,,,,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,Autocuration,0,,U,22224,,,12178,,,1
,CHEMBL623848,11670,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,1,,N,100710,,,12186,,,1
,CHEMBL623849,11671,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,1,,N,100710,,,12186,,,1
,CHEMBL623850,11672,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,1,,N,100710,,,12186,,,1
,CHEMBL623851,11673,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,1,,N,100710,,,12186,,,1
,CHEMBL623852,11674,BAO_0000218,A,,,314293.0,,Simiiformes,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,0,,U,22224,,,12187,,,1
,CHEMBL624551,11675,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,1,,N,50506,,,12187,,,1
,CHEMBL624552,11676,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,1,,N,50506,,,12187,,,1
,CHEMBL624553,11677,BAO_0000218,A,,,314293.0,,Simiiformes,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,0,,U,22224,,,12187,,,1
,CHEMBL624554,11678,BAO_0000218,A,,,314293.0,,Simiiformes,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Autocuration,0,,U,22224,,,12187,,,1
,CHEMBL624555,11679,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,1,,N,50597,,,12187,,,1
,CHEMBL624741,11680,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,1,,N,50597,,,12187,,,1
,CHEMBL624742,11681,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,1,,N,50588,,,14122,,,1
,CHEMBL624743,11682,BAO_0000218,A,,,10026.0,,Cricetinae,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,1,,N,100712,,,14122,,,1
,CHEMBL877606,11683,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,1,,N,50597,,,14122,,,1
,CHEMBL624744,11684,BAO_0000218,A,,,,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,Autocuration,0,,U,22224,,,13391,,,1
,CHEMBL624745,11685,BAO_0000218,A,,,,Blood,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,0,,U,22224,178.0,,13391,,,1
,CHEMBL624746,11686,BAO_0000218,A,,,,Blood,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,0,,U,22224,178.0,,13391,,,1
,CHEMBL624747,11687,BAO_0000218,A,,,,Blood,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,0,,U,22224,178.0,,13391,,,1
,CHEMBL624748,11688,BAO_0000019,A,,,,,,,Oral absorption expressed as Area under curve was determined,Autocuration,0,,U,22224,,,16360,,,1
,CHEMBL622504,11689,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Intermediate,1,,N,50588,,,3673,,,1
,CHEMBL622505,11690,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,1,,N,50588,,,14122,,,1
,CHEMBL622506,11691,BAO_0000218,A,,,10026.0,,Cricetinae,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,1,,N,100712,,,14122,,,1
,CHEMBL622507,11692,BAO_0000218,A,,,10026.0,,Cricetinae,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,1,,N,100712,,,14122,,,1
,CHEMBL622508,11693,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,1,,N,50597,,,14122,,,1
,CHEMBL622509,11694,BAO_0000019,A,,,,,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,Autocuration,0,,U,22224,,,13889,,,1
,CHEMBL622510,11695,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL622511,11696,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Intermediate,1,,N,50597,,,17279,,,1
,CHEMBL622512,11697,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,1,,N,100710,,,14548,,,1
,CHEMBL622513,11698,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,1,,N,100710,,,14548,,,1
,CHEMBL622514,11699,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Intermediate,1,,N,100710,,,14548,,,1
,CHEMBL622515,11700,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,1,,N,50588,,,14548,,,1
,CHEMBL622516,11701,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Intermediate,1,,N,50588,,,14548,,,1
,CHEMBL622517,11702,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,1,,N,50597,,,14548,,,1
,CHEMBL622518,11703,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Intermediate,1,,N,50597,,,14548,,,1
,CHEMBL622519,11704,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Intermediate,1,,N,50597,,,14548,,,1
,CHEMBL622520,11705,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2385.0,,14608,In vivo,,1
,CHEMBL622521,11706,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2385.0,,14608,In vivo,,1
,CHEMBL625113,11707,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50594,14.0,,14608,In vivo,,1
,CHEMBL625114,11708,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,14.0,,14608,In vivo,,1
,CHEMBL874397,11709,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,14.0,,14608,In vivo,,1
,CHEMBL625115,11710,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2106.0,,14608,In vivo,,1
,CHEMBL625116,11711,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2106.0,,14608,In vivo,,1
,CHEMBL623932,11712,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2106.0,,14608,In vivo,,1
,CHEMBL623933,11713,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2435.0,,14608,In vivo,,1
,CHEMBL623934,11714,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2435.0,,14608,In vivo,,1
,CHEMBL623935,11715,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2435.0,,14608,In vivo,,1
,CHEMBL623936,11716,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,1,,N,50597,2046.0,,14608,In vivo,,1
,CHEMBL623937,11717,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,1,,N,50597,2046.0,,14608,In vivo,,1
,CHEMBL623938,11718,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,1,,N,50597,2046.0,,14608,In vivo,,1
,CHEMBL623939,11719,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL623940,11720,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL623941,11721,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL627216,11722,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL623942,11723,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL618793,11724,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,955.0,,15383,,,1
,CHEMBL618794,11725,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,955.0,,15383,,,1
,CHEMBL618795,11726,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,955.0,,15383,,,1
,CHEMBL618796,11727,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL618797,11728,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL618798,11729,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,1,,N,50594,2113.0,,15383,,,1
,CHEMBL618799,11730,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,2113.0,,15383,,,1
,CHEMBL618800,11731,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,1,,N,50594,2113.0,,15383,,,1
,CHEMBL618801,11732,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,1,,N,50594,2113.0,,15383,,,1
,CHEMBL618802,11733,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,2113.0,,15383,,,1
,CHEMBL618803,11734,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,2113.0,,15383,,,1
,CHEMBL618804,11735,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,1,,N,50594,2107.0,,15383,,,1
,CHEMBL618805,11736,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,2107.0,,15383,,,1
,CHEMBL618806,11737,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,1,,N,50594,2107.0,,15383,,,1
,CHEMBL618807,11738,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,1,,N,50594,2107.0,,15383,,,1
,CHEMBL618808,11739,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,2107.0,,15383,,,1
,CHEMBL618809,11740,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,2107.0,,15383,,,1
,CHEMBL618810,11741,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,2385.0,,15383,,,1
,CHEMBL618811,11742,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,1,,N,50594,2385.0,,15383,,,1
,CHEMBL875844,11743,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,1,,N,50594,2385.0,,15383,,,1
,CHEMBL618812,11744,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,2385.0,,15383,,,1
,CHEMBL618813,11745,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,2385.0,,15383,,,1
,CHEMBL618814,11746,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL618815,11747,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL618816,11748,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL618817,11749,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL620544,11750,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL626230,11751,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Intermediate,1,,N,50597,,,15341,In vivo,,1
,CHEMBL626231,11752,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,1,,N,50597,,,15341,In vivo,,1
,CHEMBL626232,11753,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Intermediate,1,,N,50597,,,15341,In vivo,,1
,CHEMBL626233,11754,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Intermediate,1,,N,50588,1969.0,,14906,In vivo,,1
,CHEMBL626234,11755,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Intermediate,1,,N,50597,1969.0,,14906,In vivo,,1
,CHEMBL875341,11756,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Intermediate,1,,N,50597,1969.0,,14906,In vivo,,1
,CHEMBL626235,11757,BAO_0000218,A,,,9606.0,Plasma,Homo sapiens,,The maximum plasma concentration (100 mg/kg) administered orally in human,Intermediate,1,,N,50587,1969.0,,14215,In vivo,,1
,CHEMBL626236,11758,BAO_0000218,A,,,9481.0,Plasma,Callithrix,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Autocuration,0,,U,22224,1969.0,,14215,In vivo,,1
,CHEMBL626237,11759,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Autocuration,0,,U,22224,1969.0,,14215,In vivo,,1
,CHEMBL626238,11760,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Intermediate,1,,N,50588,1969.0,,14215,In vivo,,1
,CHEMBL622412,11761,BAO_0000218,A,,,9606.0,Plasma,Homo sapiens,,The maximum plasma concentration (200 mg/kg) administered orally in human,Intermediate,1,,N,50587,1969.0,,14215,In vivo,,1
,CHEMBL623114,11762,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Intermediate,1,,N,50597,1969.0,,14215,In vivo,,1
,CHEMBL623115,11763,BAO_0000218,A,,,9481.0,Plasma,Callithrix,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Autocuration,0,,U,22224,1969.0,,14215,In vivo,,1
,CHEMBL623116,11764,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Autocuration,0,,U,22224,1969.0,,14215,In vivo,,1
,CHEMBL623117,11765,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,The maximum plasma concentration (30 mg/kg) administered orally in dog,Autocuration,0,,U,22224,1969.0,,14215,In vivo,,1
,CHEMBL623118,11766,BAO_0000218,A,,,9606.0,Plasma,Homo sapiens,,The maximum plasma concentration (400 mg/kg) administered orally in human,Intermediate,1,,N,50587,1969.0,,14215,In vivo,,1
,CHEMBL623119,11767,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Intermediate,1,,N,50597,1969.0,,14215,In vivo,,1
,CHEMBL623120,11768,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma concentration (50 mg/kg) administered orally in rat,Intermediate,1,,N,50597,1969.0,,14215,In vivo,,1
,CHEMBL623286,11769,BAO_0000218,A,,,9606.0,Plasma,Homo sapiens,,The maximum plasma concentration (800 mg/kg) administered orally in human,Intermediate,1,,N,50587,1969.0,,14215,In vivo,,1
,CHEMBL623287,11770,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma concentration was measured on rats,Intermediate,1,,N,50597,1969.0,,14067,In vivo,,1
,CHEMBL623288,11771,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The maximum plasma concentration was measured on rats after oral administration,Intermediate,1,,N,50597,1969.0,,12350,In vivo,,1
,CHEMBL623289,11772,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma drug Cmax in rat (PO dose),Intermediate,1,,N,50597,1969.0,,14813,In vivo,,1
,CHEMBL623290,11773,BAO_0000218,A,,,,,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,Autocuration,0,,U,22224,,,12536,In vivo,,1
,CHEMBL623291,11774,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,maximum Plasma concentration in Dog was determined after Peroral administration,Intermediate,1,,N,50588,1969.0,,14169,In vivo,,1
,CHEMBL623292,11775,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,maximum Plasma concentration in Rats was determined after Peroral administration,Intermediate,1,,N,50597,1969.0,,14169,In vivo,,1
,CHEMBL623293,11776,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,1,,N,50588,1969.0,,15604,In vivo,,1
,CHEMBL623294,11777,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,0,,U,22224,1969.0,,15604,In vivo,,1
,CHEMBL623295,11778,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,1,,N,50597,1969.0,,15604,In vivo,,1
,CHEMBL623296,11779,BAO_0000218,A,,,10090.0,,Mus musculus,,maximum concentration was measured when administered through oral route in mice,Intermediate,1,,N,50594,,,14387,In vivo,,1
,CHEMBL875349,11780,BAO_0000218,A,,,10090.0,,Mus musculus,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Intermediate,1,,N,50594,,,15115,,,1
,CHEMBL623297,11781,BAO_0000019,A,,,314293.0,,Simiiformes,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Autocuration,0,,U,22224,,,15115,,,1
,CHEMBL623298,11782,BAO_0000019,A,,,314293.0,,Simiiformes,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Autocuration,0,,U,22224,,,15115,,,1
,CHEMBL623299,11783,BAO_0000019,A,,,314293.0,,Simiiformes,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Autocuration,0,,U,22224,,,15115,,,1
,CHEMBL623300,11784,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter was evaluated in rats,Intermediate,1,,N,50597,,,16359,,,1
,CHEMBL623301,11785,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,1,,N,50594,,,12829,,,1
,CHEMBL623302,11786,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Intermediate,1,,N,50594,,,12829,,,1
,CHEMBL623303,11787,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,1,,N,50594,,,12829,,,1
,CHEMBL623304,11788,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Intermediate,1,,N,50594,,,12829,,,1
,CHEMBL623305,11789,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Intermediate,1,,N,50594,,,12829,,,1
,CHEMBL623306,11790,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,,,1
,CHEMBL623307,11791,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,,,1
,CHEMBL623308,11792,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Intermediate,1,,N,50597,1969.0,,15137,,,1
,CHEMBL623309,11793,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Intermediate,1,,N,50594,1969.0,,15137,,,1
,CHEMBL623310,11794,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma Concentration after 120 min of oral administration to mice,Intermediate,1,,N,50594,,,13509,,,1
,CHEMBL623311,11795,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma Concentration after 30 min of oral administration to mice,Intermediate,1,,N,50594,,,13509,,,1
,CHEMBL623312,11796,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Plasma Concentration after 60 min of oral administration to mice,Intermediate,1,,N,100710,,,13509,,,1
,CHEMBL875350,11797,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma Concentration after 60 min of oral administration to mice; Not determined,Intermediate,1,,N,50594,,,13509,,,1
,CHEMBL628635,11798,BAO_0000218,A,,,10090.0,,Mus musculus,,Plasma Concentration after 90 min of oral administration to mice,Intermediate,1,,N,50594,,,13509,,,1
,CHEMBL628636,11799,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Intermediate,1,,N,50597,,,12064,,,1
,CHEMBL628637,11800,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Intermediate,1,,N,50597,,,12064,,,1
,CHEMBL628058,11801,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Intermediate,1,,N,50597,,,12064,,,1
,CHEMBL628059,11802,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Intermediate,1,,N,50597,,,10677,,,1
,CHEMBL628060,11803,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Intermediate,1,,N,50597,,,10677,,,1
,CHEMBL628061,11804,BAO_0000019,A,,,,,,,Distribution in the lung after 15 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628062,11805,BAO_0000019,A,,,,,,,Distribution in the lung after 30 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628063,11806,BAO_0000019,A,,,,,,,Distribution in the lung after 5 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628064,11807,BAO_0000019,A,,,,,,,Distribution in the lung after 60 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628065,11808,BAO_0000019,A,,,,,,,Distribution in the lung after 90 min of intravenous administration,Autocuration,0,,U,22224,,,8926,,,1
,CHEMBL628066,11809,BAO_0000019,A,,,,Muscle tissue,,,Distribution in the muscle after 120 min of intravenous administration,Autocuration,0,,U,22224,2385.0,,8926,,,1
,CHEMBL628067,11810,BAO_0000019,A,,,,Muscle tissue,,,Distribution in the muscle after 15 min of intravenous administration,Autocuration,0,,U,22224,2385.0,,8926,,,1
,CHEMBL874646,11811,BAO_0000218,A,,,10090.0,Muscle tissue,Mus musculus,,Distribution in the muscle after 30 min of intravenous administration,Intermediate,1,,N,50594,2385.0,,8926,,,1
,CHEMBL628068,11812,BAO_0000019,A,,,,Muscle tissue,,,Distribution in the muscle after 5 min of intravenous administration,Autocuration,0,,U,22224,2385.0,,8926,,,1
,CHEMBL628069,11813,BAO_0000019,A,,,,Muscle tissue,,,Distribution in the muscle after 60 min of intravenous administration,Autocuration,0,,U,22224,2385.0,,8926,,,1
,CHEMBL628070,11814,BAO_0000019,A,,,,Muscle tissue,,,Distribution in the muscle after 90 min of intravenous administration,Autocuration,0,,U,22224,2385.0,,8926,,,1
,CHEMBL628071,11815,BAO_0000019,A,,,,Spleen,,,Distribution in the spleen after 120 min of intravenous administration,Autocuration,0,,U,22224,2106.0,,8926,,,1
,CHEMBL628072,11816,BAO_0000019,A,,,,Spleen,,,Distribution in the spleen after 15 min of intravenous administration,Autocuration,0,,U,22224,2106.0,,8926,,,1
,CHEMBL628073,11817,BAO_0000019,A,,,,Spleen,,,Distribution in the spleen after 30 min of intravenous administration,Autocuration,0,,U,22224,2106.0,,8926,,,1
,CHEMBL628074,11818,BAO_0000019,A,,,,Spleen,,,Distribution in the spleen after 5 min of intravenous administration,Autocuration,0,,U,22224,2106.0,,8926,,,1
,CHEMBL628075,11819,BAO_0000019,A,,,,Spleen,,,Distribution in the spleen after 60 min of intravenous administration,Autocuration,0,,U,22224,2106.0,,8926,,,1
,CHEMBL628076,11820,BAO_0000019,A,,,,Spleen,,,Distribution in the spleen after 90 min of intravenous administration,Autocuration,0,,U,22224,2106.0,,8926,,,1
,CHEMBL628077,11821,BAO_0000218,A,,,10116.0,Adrenal cortex,Rattus norvegicus,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,1,,N,50597,1235.0,,7570,,,1
,CHEMBL628078,11822,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Intermediate,1,,N,50597,178.0,,7570,,,1
,CHEMBL628079,11823,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Intermediate,1,,N,50597,2107.0,,7570,,,1
,CHEMBL628080,11824,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,1,,N,50597,992.0,,7570,,,1
,CHEMBL628081,11825,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,1,,N,50597,2046.0,,7570,,,1
,CHEMBL628082,11826,BAO_0000218,A,,,10116.0,Adrenal cortex,Rattus norvegicus,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,1,,N,50597,1235.0,,7570,,,1
,CHEMBL874647,11827,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Intermediate,1,,N,50597,178.0,,7570,,,1
,CHEMBL626406,11828,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Intermediate,1,,N,50597,2107.0,,7570,,,1
,CHEMBL626407,11829,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,1,,N,50597,992.0,,7570,,,1
,CHEMBL626408,11830,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,1,,N,50597,2046.0,,7570,,,1
,CHEMBL626409,11831,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL626410,11832,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL626411,11833,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL626412,11834,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL626413,11835,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL626414,11836,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL626415,11837,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL626416,11838,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL627062,11839,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL627063,11840,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL627064,11841,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL627227,11842,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL627228,11843,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL627229,11844,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL625792,11845,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL625793,11846,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL625794,11847,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL625795,11848,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Intermediate,1,,N,50597,178.0,,8608,,,1
,CHEMBL625796,11849,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Intermediate,1,,N,50594,,,13792,,,1
,CHEMBL625797,11850,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,1,,N,50588,,,13376,,,1
,CHEMBL625798,11851,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,1,,N,50588,,,13376,,,1
,CHEMBL875613,11852,BAO_0000218,A,,,,,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL625799,11853,BAO_0000218,A,,,,,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL625800,11854,BAO_0000218,A,,,,,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL625801,11855,BAO_0000218,A,,,,,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL625802,11856,BAO_0000218,A,,,,,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL625803,11857,BAO_0000218,A,,,,,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL625804,11858,BAO_0000019,A,,,,,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL622530,11859,BAO_0000218,A,,,,,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,0,,U,22224,,,14380,,,1
,CHEMBL622531,11860,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL622532,11861,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL623176,11862,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL623177,11863,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL623178,11864,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL623179,11865,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL623180,11866,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL623181,11867,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL624131,11868,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL624132,11869,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL624133,11870,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL624846,11871,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL624847,11872,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL624848,11873,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625012,11874,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625013,11875,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625014,11876,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625015,11877,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625016,11878,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625017,11879,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625018,11880,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625019,11881,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625020,11882,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625021,11883,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL625022,11884,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL625023,11885,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Intermediate,1,,N,50594,,,14731,,,1
,CHEMBL625024,11886,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Intermediate,1,,N,100710,,,14731,,,1
,CHEMBL627626,11887,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,1,,N,100710,,,14731,,,1
,CHEMBL627627,11888,BAO_0000218,A,,,,Brain,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,0,,U,22224,955.0,,13758,,,1
,CHEMBL627628,11889,BAO_0000218,A,,,,Serum,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,Autocuration,0,,U,22224,1977.0,,13758,,,1
,CHEMBL627629,11890,BAO_0000218,A,,,,Brain,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,0,,U,22224,955.0,,13758,,,1
,CHEMBL627630,11891,BAO_0000218,A,,,,Serum,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,Autocuration,0,,U,22224,1977.0,,13758,,,1
,CHEMBL627631,11892,BAO_0000019,A,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),Autocuration,0,,U,22224,,,16359,,,1
,CHEMBL629515,11893,BAO_0000218,A,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),Autocuration,0,,U,22224,,,16359,,,1
,CHEMBL629516,11894,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,2106.0,,15383,,,1
,CHEMBL629517,11895,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,2106.0,,15383,,,1
,CHEMBL629518,11896,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,2106.0,,15383,,,1
,CHEMBL877499,11897,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL629519,11898,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL629520,11899,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL629521,11900,BAO_0000218,A,,,10090.0,,Mus musculus,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,1,,N,50594,,,15383,,,1
,CHEMBL629522,11901,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629523,11902,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629524,11903,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629525,11904,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629526,11905,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629527,11906,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629528,11907,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629529,11908,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629530,11909,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL629531,11910,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL628656,11911,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL628657,11912,BAO_0000218,A,,,10090.0,,Mus musculus,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Intermediate,1,,N,50594,,,14439,,,1
,CHEMBL628658,11913,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL628659,11914,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL877500,11915,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL628660,11916,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL628661,11917,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL628662,11918,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL628663,11919,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL628664,11920,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL628665,11921,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,178.0,,13751,In vivo,,1
,CHEMBL628666,11922,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,178.0,,13751,In vivo,,1
,CHEMBL628667,11923,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,178.0,,13751,In vivo,,1
,CHEMBL628668,11924,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,178.0,,13751,In vivo,,1
,CHEMBL628669,11925,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,178.0,,13751,In vivo,,1
,CHEMBL628670,11926,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,178.0,,13751,In vivo,,1
,CHEMBL628671,11927,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,178.0,,13751,In vivo,,1
,CHEMBL628672,11928,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,10000001.0,,13751,In vivo,,1
,CHEMBL630300,11929,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,10000001.0,,13751,In vivo,,1
,CHEMBL629787,11930,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,10000001.0,,13751,In vivo,,1
,CHEMBL629788,11931,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,10000001.0,,13751,In vivo,,1
,CHEMBL629789,11932,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL629790,11933,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL629791,11934,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL629792,11935,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL629793,11936,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL629794,11937,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL874459,11938,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Intermediate,1,,N,50597,,,10677,,,1
,CHEMBL629795,11939,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Intermediate,1,,N,50597,,,10677,,,1
,CHEMBL629796,11940,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Intermediate,1,,N,50597,,,10677,,,1
,CHEMBL629797,11941,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Intermediate,1,,N,50597,,,10677,,,1
,CHEMBL629798,11942,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Intermediate,1,,N,50597,,,10677,,,1
,CHEMBL629799,11943,BAO_0000218,A,,,10116.0,Adrenal gland,Rattus norvegicus,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2369.0,,10911,In vivo,,1
,CHEMBL629800,11944,BAO_0000218,A,,,10116.0,Adrenal gland,Rattus norvegicus,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2369.0,,10911,In vivo,,1
,CHEMBL629801,11945,BAO_0000218,A,,,10116.0,Adrenal gland,Rattus norvegicus,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2369.0,,10911,In vivo,,1
,CHEMBL629802,11946,BAO_0000218,A,,,10116.0,Adrenal gland,Rattus norvegicus,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Intermediate,1,,N,50597,2369.0,,10911,In vivo,,1
,CHEMBL629803,11947,BAO_0000218,A,,,10116.0,Adrenal gland,Rattus norvegicus,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2369.0,,10911,In vivo,,1
,CHEMBL629804,11948,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,178.0,,10911,In vivo,,1
,CHEMBL629805,11949,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,178.0,,10911,In vivo,,1
,CHEMBL629806,11950,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,178.0,,10911,In vivo,,1
,CHEMBL629807,11951,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,178.0,,10911,In vivo,,1
,CHEMBL629808,11952,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,178.0,,10911,In vivo,,1
,CHEMBL629809,11953,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,955.0,,10911,In vivo,,1
,CHEMBL629810,11954,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,955.0,,10911,In vivo,,1
,CHEMBL629811,11955,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,955.0,,10911,In vivo,,1
,CHEMBL629812,11956,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,955.0,,10911,In vivo,,1
,CHEMBL629813,11957,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,955.0,,10911,In vivo,,1
,CHEMBL874460,11958,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,955.0,,10911,In vivo,,1
,CHEMBL629814,11959,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,,,10911,In vivo,,1
,CHEMBL629815,11960,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,,,10911,In vivo,,1
,CHEMBL629816,11961,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,,,10911,In vivo,,1
,CHEMBL629817,11962,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,,,10911,In vivo,,1
,CHEMBL626643,11963,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2113.0,,10911,In vivo,,1
,CHEMBL626644,11964,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2113.0,,10911,In vivo,,1
,CHEMBL626806,11965,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2113.0,,10911,In vivo,,1
,CHEMBL626807,11966,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2113.0,,10911,In vivo,,1
,CHEMBL627261,11967,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2107.0,,10911,In vivo,,1
,CHEMBL627262,11968,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2107.0,,10911,In vivo,,1
,CHEMBL627263,11969,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2107.0,,10911,In vivo,,1
,CHEMBL627264,11970,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2107.0,,10911,In vivo,,1
,CHEMBL627265,11971,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2048.0,,10911,In vivo,,1
,CHEMBL627266,11972,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2048.0,,10911,In vivo,,1
,CHEMBL627267,11973,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2048.0,,10911,In vivo,,1
,CHEMBL627268,11974,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2048.0,,10911,In vivo,,1
,CHEMBL627269,11975,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2385.0,,10911,In vivo,,1
,CHEMBL627270,11976,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2385.0,,10911,In vivo,,1
,CHEMBL627271,11977,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627946,11978,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL875472,11979,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627947,11980,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627948,11981,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628113,11982,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628114,11983,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628115,11984,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628116,11985,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628117,11986,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628118,11987,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628119,11988,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628120,11989,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628121,11990,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL628122,11991,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627297,11992,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627298,11993,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627299,11994,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627300,11995,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627301,11996,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627302,11997,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627303,11998,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627304,11999,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627305,12000,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL627306,12001,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623982,12002,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623983,12003,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623984,12004,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623985,12005,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623986,12006,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623987,12007,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623988,12008,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL623989,12009,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL622215,12010,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL622216,12011,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL877481,12012,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Intermediate,1,,N,50597,,,8608,,,1
,CHEMBL622217,12013,BAO_0000218,A,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),Autocuration,0,,U,22224,,,16359,,,1
,CHEMBL622218,12014,BAO_0000218,A,,,10090.0,,Mus musculus,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,1,,N,50594,,,13701,,,1
,CHEMBL622219,12015,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic profile AUC was evaluated in rats,Intermediate,1,,N,50597,,,14554,,,1
,CHEMBL622220,12016,BAO_0000019,A,,,,,,,Pharmacokinetic property (Area under curve),Autocuration,0,,U,22224,,,6241,,,1
,CHEMBL622221,12017,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Intermediate,1,,N,50588,,,11537,,,1
,CHEMBL622222,12018,BAO_0000218,A,,,10090.0,,Mus musculus,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Intermediate,1,,N,50594,,,11537,,,1
,CHEMBL622223,12019,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Intermediate,1,,N,50588,,,11537,,,1
,CHEMBL622224,12020,BAO_0000218,A,,,10090.0,,Mus musculus,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Intermediate,1,,N,50594,,,11537,,,1
,CHEMBL622225,12021,BAO_0000019,A,,,,,,,Plasma concentration (AUC) was determined,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622226,12022,BAO_0000019,A,,,,,,,Plasma concentration (AUC) was determined; Not detectable,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL624154,12023,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Intermediate,1,,N,50512,,,9562,,,1
,CHEMBL624155,12024,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Intermediate,1,,N,50597,,,10363,,,1
,CHEMBL624156,12025,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,1,,N,50597,,,10363,,,1
,CHEMBL624157,12026,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Intermediate,1,,N,50597,,,10363,,,1
,CHEMBL624158,12027,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Intermediate,1,,N,50597,,,10363,,,1
,CHEMBL624159,12028,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,1,,N,50597,,,12504,,,1
,CHEMBL624160,12029,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,1,,N,50597,,,12504,,,1
,CHEMBL624161,12030,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,1,,N,50597,,,12504,,,1
,CHEMBL624162,12031,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,1,,N,50597,,,12504,,,1
,CHEMBL624163,12032,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Intermediate,1,,N,50588,,,13317,,,1
,CHEMBL624164,12033,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL624165,12034,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The AUC(0-infinity) values in female wistar rats.,Intermediate,1,,N,50597,,,14941,,,1
,CHEMBL624166,12035,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL624167,12036,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL624168,12037,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The AUC(0-t)values in female wistar rats.,Intermediate,1,,N,50597,,,14941,,,1
,CHEMBL624169,12038,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The Area under the concentration time curve of compound was measured on rats,Intermediate,1,,N,50597,,,14067,,,1
,CHEMBL624170,12039,BAO_0000218,A,,,9606.0,,Homo sapiens,,The area under curve (100 mg/kg) administered orally in humans,Intermediate,1,,N,50587,,,14215,,,1
,CHEMBL624171,12040,BAO_0000218,A,,,9481.0,,Callithrix,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Autocuration,0,,U,22224,,,14215,,,1
,CHEMBL624172,12041,BAO_0000218,A,,,314293.0,,Simiiformes,,The area under curve (12.5 mg/kg) administered intravenously in monkey,Autocuration,0,,U,22224,,,14215,,,1
,CHEMBL624173,12042,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,The area under curve (15 mg/kg) administered intravenously in dog,Intermediate,1,,N,50588,,,14215,,,1
,CHEMBL877488,12043,BAO_0000218,A,,,9606.0,,Homo sapiens,,The area under curve (200 mg/kg) administered orally in humans,Intermediate,1,,N,50587,,,14215,,,1
,CHEMBL624174,12044,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The area under curve (25 mg/kg) administered intravenously in rat,Intermediate,1,,N,50597,,,14215,,,1
,CHEMBL624175,12045,BAO_0000218,A,,,9481.0,,Callithrix,,The area under curve (25 mg/kg) administered orally in marmoset,Autocuration,0,,U,22224,,,14215,,,1
,CHEMBL624176,12046,BAO_0000218,A,,,314293.0,,Simiiformes,,The area under curve (25 mg/kg) administered orally in monkey,Autocuration,0,,U,22224,,,14215,,,1
,CHEMBL624177,12047,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,The area under curve (30 mg/kg) administered orally in dog,Intermediate,1,,N,50588,,,14215,,,1
,CHEMBL624178,12048,BAO_0000218,A,,,9606.0,,Homo sapiens,,The area under curve (400 mg/kg) administered orally in humans,Intermediate,1,,N,50587,,,14215,,,1
,CHEMBL624179,12049,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The area under curve (50 mg/kg) administered orally in fasted rat,Intermediate,1,,N,50597,,,14215,,,1
,CHEMBL627689,12050,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The area under curve (50 mg/kg) administered orally in rat,Intermediate,1,,N,50597,,,14215,,,1
,CHEMBL627690,12051,BAO_0000218,A,,,9606.0,,Homo sapiens,,The area under curve (800 mg/kg) administered orally in humans,Intermediate,1,,N,50587,,,14215,,,1
,CHEMBL627691,12052,BAO_0000019,A,,,,,,,The compound was evaluated for area under the curve,Autocuration,0,,U,22224,,,11324,,,1
,CHEMBL627692,12053,BAO_0000019,A,,,9481.0,,Callithrix,,The compound was evaluated for area under the curve in marmosets,Autocuration,0,,U,22224,,,11324,,,1
,CHEMBL627693,12054,BAO_0000019,A,,,9481.0,,Callithrix,,The compound was evaluated for area under the curve in marmosets,Autocuration,0,,U,22224,,,11324,,,1
,CHEMBL627694,12055,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,1,,N,50597,,,13875,,,1
,CHEMBL627695,12056,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,1,,N,50597,,,13875,,,1
,CHEMBL627696,12057,BAO_0000218,A,,,,,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),Autocuration,0,,U,22224,,,13875,,,1
,CHEMBL627697,12058,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,1,,N,50597,,,13875,,,1
,CHEMBL627698,12059,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,1,,N,50597,,,13875,,,1
,CHEMBL627699,12060,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,1,,N,50597,,,13875,,,1
,CHEMBL627700,12061,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Intermediate,1,,N,50597,,,13807,,,1
,CHEMBL627701,12062,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total drug exposure is determined after oral dosing in rats.,Intermediate,1,,N,50597,,,14127,,,1
,CHEMBL627702,12063,BAO_0000218,A,,,,,,,Total drug exposure (5 mg/kg) when administered intravenously,Autocuration,0,,U,22224,,,15116,,,1
,CHEMBL627703,12064,BAO_0000218,A,,,,,,,Total drug exposure (5 mg/kg) when administered orally,Autocuration,0,,U,22224,,,15116,,,1
,CHEMBL626873,12065,BAO_0000218,A,,,314293.0,,Simiiformes,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,0,,U,22224,,,15604,,,1
,CHEMBL629583,12066,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,1,,N,50597,,,15604,,,1
,CHEMBL629584,12067,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,1,,N,50588,,,15604,,,1
,CHEMBL629585,12068,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,1,,N,50588,,,15604,,,1
,CHEMBL629586,12069,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL629587,12070,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,955.0,,13751,In vivo,,1
,CHEMBL629588,12071,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL629589,12072,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL629590,12073,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL629591,12074,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL629592,12075,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL629593,12076,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL629594,12077,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL629595,12078,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,948.0,,13751,In vivo,,1
,CHEMBL630290,12079,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,948.0,,13751,In vivo,,1
,CHEMBL627137,12080,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,948.0,,13751,In vivo,,1
,CHEMBL627138,12081,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,948.0,,13751,In vivo,,1
,CHEMBL627139,12082,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,948.0,,13751,In vivo,,1
,CHEMBL627140,12083,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,948.0,,13751,In vivo,,1
,CHEMBL627141,12084,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,948.0,,13751,In vivo,,1
,CHEMBL627142,12085,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2113.0,,13751,In vivo,,1
,CHEMBL627143,12086,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2113.0,,13751,In vivo,,1
,CHEMBL874449,12087,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2113.0,,13751,In vivo,,1
,CHEMBL627144,12088,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2113.0,,13751,In vivo,,1
,CHEMBL627145,12089,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2113.0,,13751,In vivo,,1
,CHEMBL627146,12090,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2113.0,,13751,In vivo,,1
,CHEMBL627147,12091,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2113.0,,13751,In vivo,,1
,CHEMBL627148,12092,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2107.0,,13751,In vivo,,1
,CHEMBL627149,12093,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2048.0,,13751,In vivo,,1
,CHEMBL632160,12094,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2048.0,,13751,In vivo,,1
,CHEMBL632161,12095,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2048.0,,13751,In vivo,,1
,CHEMBL632162,12096,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2048.0,,13751,In vivo,,1
,CHEMBL632163,12097,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2048.0,,13751,In vivo,,1
,CHEMBL874469,12098,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2048.0,,13751,In vivo,,1
,CHEMBL627182,12099,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2048.0,,13751,In vivo,,1
,CHEMBL627183,12100,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2385.0,,13751,In vivo,,1
,CHEMBL627184,12101,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2385.0,,13751,In vivo,,1
,CHEMBL627185,12102,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2385.0,,13751,In vivo,,1
,CHEMBL627186,12103,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2385.0,,13751,In vivo,,1
,CHEMBL627187,12104,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2385.0,,13751,In vivo,,1
,CHEMBL627188,12105,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2385.0,,13751,In vivo,,1
,CHEMBL627189,12106,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2385.0,,13751,In vivo,,1
,CHEMBL627190,12107,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,,,13751,In vivo,,1
,CHEMBL627191,12108,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2107.0,,13751,In vivo,,1
,CHEMBL627192,12109,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2107.0,,13751,In vivo,,1
,CHEMBL627193,12110,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2107.0,,13751,In vivo,,1
,CHEMBL874590,12111,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2385.0,,10911,In vivo,,1
,CHEMBL627194,12112,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2385.0,,10911,In vivo,,1
,CHEMBL627195,12113,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2385.0,,10911,In vivo,,1
,CHEMBL627196,12114,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,992.0,,10911,In vivo,,1
,CHEMBL627197,12115,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,992.0,,10911,In vivo,,1
,CHEMBL627198,12116,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,992.0,,10911,In vivo,,1
,CHEMBL627199,12117,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Intermediate,1,,N,50597,992.0,,10911,In vivo,,1
,CHEMBL627200,12118,BAO_0000218,A,,,10116.0,Female gonad,Rattus norvegicus,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,992.0,,10911,In vivo,,1
,CHEMBL627201,12119,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,1969.0,,10911,In vivo,,1
,CHEMBL627202,12120,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,1969.0,,10911,In vivo,,1
,CHEMBL627203,12121,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,1969.0,,10911,In vivo,,1
,CHEMBL627204,12122,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,1969.0,,10911,In vivo,,1
,CHEMBL627205,12123,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2106.0,,10911,In vivo,,1
,CHEMBL627206,12124,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2106.0,,10911,In vivo,,1
,CHEMBL627207,12125,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2106.0,,10911,In vivo,,1
,CHEMBL627208,12126,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2106.0,,10911,In vivo,,1
,CHEMBL627209,12127,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2046.0,,10911,In vivo,,1
,CHEMBL627210,12128,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2046.0,,10911,In vivo,,1
,CHEMBL627211,12129,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2046.0,,10911,In vivo,,1
,CHEMBL627212,12130,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,2046.0,,10911,In vivo,,1
,CHEMBL627213,12131,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,995.0,,10911,In vivo,,1
,CHEMBL626599,12132,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,995.0,,10911,In vivo,,1
,CHEMBL626600,12133,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,995.0,,10911,In vivo,,1
,CHEMBL626601,12134,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,1,,N,50597,995.0,,10911,In vivo,,1
,CHEMBL627484,12135,BAO_0000019,A,,,,,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,Autocuration,0,,U,22224,,,8081,,,1
,CHEMBL627485,12136,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Intermediate,1,,N,100710,1969.0,,17248,,,1
,CHEMBL628147,12137,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Intermediate,1,,N,100710,1969.0,,17248,,,1
,CHEMBL628148,12138,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Intermediate,1,,N,100710,1969.0,,17248,,,1
,CHEMBL628149,12139,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Intermediate,1,,N,50588,1969.0,,17248,,,1
,CHEMBL628150,12140,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Intermediate,1,,N,50588,1969.0,,17248,,,1
,CHEMBL628318,12141,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Intermediate,1,,N,50588,1969.0,,17248,,,1
,CHEMBL628319,12142,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Intermediate,1,,N,50588,1969.0,,17248,,,1
,CHEMBL875609,12143,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,1,,N,50588,,,15592,,,1
,CHEMBL628320,12144,BAO_0000019,A,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,Autocuration,0,,U,22224,,,7040,,,1
,CHEMBL628321,12145,BAO_0000019,A,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,Autocuration,0,,U,22224,,,7040,,,1
,CHEMBL628322,12146,BAO_0000019,A,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,Autocuration,0,,U,22224,,,7040,,,1
,CHEMBL628323,12147,BAO_0000019,A,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,Autocuration,0,,U,22224,,,7040,,,1
,CHEMBL628324,12148,BAO_0000019,A,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,Autocuration,0,,U,22224,,,7040,,,1
,CHEMBL628325,12149,BAO_0000019,A,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,Autocuration,0,,U,22224,,,7040,,,1
,CHEMBL628326,12150,BAO_0000019,A,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,Autocuration,0,,U,22224,,,7040,,,1
,CHEMBL628327,12151,BAO_0000218,A,,,9615.0,Adrenal medulla,Canis lupus familiaris,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Intermediate,1,,N,50588,1236.0,,9614,,,1
,CHEMBL628328,12152,BAO_0000218,A,,,9615.0,Adrenal medulla,Canis lupus familiaris,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Intermediate,1,,N,50588,1236.0,,9614,,,1
,CHEMBL628329,12153,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,"Concentration of compound in blood of dog 1, after administering intravenously",Intermediate,1,,N,50588,178.0,,9614,,,1
,CHEMBL628330,12154,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628331,12155,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628332,12156,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628333,12157,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628334,12158,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628335,12159,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628336,12160,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628337,12161,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628338,12162,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL875610,12163,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628339,12164,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628340,12165,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL628341,12166,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL622214,12167,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL623167,12168,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL623168,12169,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL623169,12170,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL623170,12171,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Intermediate,1,,N,50597,2107.0,,8608,,,1
,CHEMBL627224,12172,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL875634,12173,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL627225,12174,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL627226,12175,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626083,12176,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626084,12177,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626085,12178,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626086,12179,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626087,12180,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626088,12181,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626089,12182,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626090,12183,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626091,12184,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626092,12185,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626093,12186,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626094,12187,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626095,12188,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626096,12189,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Intermediate,1,,N,50597,2048.0,,8608,,,1
,CHEMBL626097,12190,BAO_0000218,A,,,314293.0,,Simiiformes,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,0,,U,22224,,,15604,,,1
,CHEMBL626098,12191,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,1,,N,50597,,,15604,,,1
,CHEMBL626099,12192,BAO_0000218,A,,,,Plasma,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,Autocuration,0,,U,22224,1969.0,,1806,,,1
,CHEMBL626100,12193,BAO_0000218,A,,,,Plasma,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,Autocuration,0,,U,22224,1969.0,,1806,,,1
,CHEMBL626101,12194,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,AUC 0-inf in dog,Intermediate,1,,N,50588,1969.0,,17237,,,1
,CHEMBL626102,12195,BAO_0000218,A,,,10141.0,Plasma,Cavia porcellus,,AUC 0-inf in guinea pig,Intermediate,1,,N,50512,1969.0,,17237,,,1
,CHEMBL626103,12196,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,AUC 0-t in dog,Intermediate,1,,N,50588,1969.0,,17237,,,1
,CHEMBL628391,12197,BAO_0000218,A,,,10141.0,Plasma,Cavia porcellus,,AUC 0-t in guinea pig,Intermediate,1,,N,50512,1969.0,,17237,,,1
,CHEMBL628392,12198,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for brain to plasma partition in rat,Intermediate,1,,N,50597,,,15194,,,1
,CHEMBL628393,12199,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for brain to plasma partition in rat.,Intermediate,1,,N,50597,,,15194,,,1
,CHEMBL628394,12200,BAO_0000019,A,,,,Blood,,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,Autocuration,0,,U,22224,178.0,,8787,,,1
,CHEMBL628395,12201,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,1,,N,50588,,,17025,,,1
,CHEMBL628396,12202,BAO_0000218,A,,,314293.0,,Simiiformes,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,0,,U,22224,,,17025,,,1
,CHEMBL628397,12203,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,1,,N,50592,,,17025,,,1
,CHEMBL628398,12204,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,1,,N,50597,,,17025,,,1
,CHEMBL628399,12205,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,1,,N,50797,,,4236,,,1
,CHEMBL628400,12206,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,1,,N,50588,,,15343,,,1
,CHEMBL874907,12207,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Intermediate,1,,N,50597,,,15343,,,1
,CHEMBL628401,12208,BAO_0000019,A,,,,,,,Area under curve of the compound was determined,Autocuration,0,,U,22224,,,17720,,,1
,CHEMBL628402,12209,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,AUC in monkeys at a dose of 1 mg/kg,Autocuration,0,,U,22224,1969.0,,17788,,,1
,CHEMBL628403,12210,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,AUC in rats at a dose of 1 mg/kg,Intermediate,1,,N,50597,1969.0,,17788,,,1
,CHEMBL628404,12211,BAO_0000019,A,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 2,Autocuration,0,,U,22224,,,8778,,,1
,CHEMBL628405,12212,BAO_0000019,A,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 4,Autocuration,0,,U,22224,,,8778,,,1
,CHEMBL628406,12213,BAO_0000019,A,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 7,Autocuration,0,,U,22224,,,8778,,,1
,CHEMBL628407,12214,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for its absorption in the rats,Intermediate,1,,N,50597,,,2249,,,1
,CHEMBL628408,12215,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,1,,N,50597,1088.0,,8881,,,1
,CHEMBL629171,12216,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Intermediate,1,,N,50597,1088.0,,8881,,,1
,CHEMBL629172,12217,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,1,,N,50597,1088.0,,8881,,,1
,CHEMBL629173,12218,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Intermediate,1,,N,50597,1088.0,,8881,,,1
,CHEMBL629174,12219,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL629175,12220,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 10-17,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL629176,12221,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 10-18,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL629177,12222,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 10-19,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL629178,12223,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 12-15,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631869,12224,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 13-19,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631870,12225,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 14-17,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631871,12226,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 15-18,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631872,12227,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 2-5,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL875775,12228,BAO_0000221,A,,,,Ileum,,,In vitro percent permeability into rat ileum; Range is 23-42,Autocuration,0,,U,22224,2116.0,,15286,,,1
,CHEMBL631873,12229,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 28-36,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631874,12230,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 29-35,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631875,12231,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 46-66,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631876,12232,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 50-68,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631877,12233,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; Range is 78-81,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631878,12234,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631879,12235,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; nd indicates not detected,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631880,12236,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; nt indicates not detected,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631881,12237,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro percent permeability into rat ileum; nt indicates not tested,Intermediate,1,,N,50597,,,15286,,,1
,CHEMBL631882,12238,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for oral absorption in bile-duct cannulated rats,Intermediate,1,,N,50597,,,13770,,,1
,CHEMBL630749,12239,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for oral absorption in bile-duct cannulated rats.,Intermediate,1,,N,50597,,,13770,,,1
,CHEMBL630750,12240,BAO_0000218,A,,,9606.0,,Homo sapiens,,Oral absorption using Caco-2 cell monolayers.,Intermediate,1,,N,50587,,,5202,,,1
,CHEMBL630253,12241,BAO_0000218,A,,,9606.0,,Homo sapiens,,Percent of the drug absorbed after administration to humans was determined,Intermediate,1,,N,50587,,,14920,,,1
,CHEMBL630254,12242,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL630255,12243,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL630256,12244,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL875781,12245,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,1,,N,50597,2107.0,,13751,In vivo,,1
,CHEMBL630257,12246,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2107.0,,13751,In vivo,,1
,CHEMBL630258,12247,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,1,,N,50597,2107.0,,13751,In vivo,,1
,CHEMBL630259,12248,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Intermediate,1,,N,50597,,,15807,,,1
,CHEMBL630260,12249,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,1,,N,50597,2435.0,,15807,,,1
,CHEMBL630261,12250,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,1,,N,50597,2435.0,,15807,,,1
,CHEMBL630262,12251,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630263,12252,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630264,12253,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630265,12254,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630266,12255,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630267,12256,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Intermediate,1,,N,50597,2113.0,,14950,,,1
,CHEMBL630268,12257,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Intermediate,1,,N,50597,2113.0,,14950,,,1
,CHEMBL630269,12258,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630270,12259,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630141,12260,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Intermediate,1,,N,50597,2048.0,,14950,,,1
,CHEMBL630142,12261,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Intermediate,1,,N,50597,2048.0,,14950,,,1
,CHEMBL630143,12262,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Intermediate,1,,N,50597,2385.0,,14950,,,1
,CHEMBL630144,12263,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Intermediate,1,,N,50597,2385.0,,14950,,,1
,CHEMBL630145,12264,BAO_0000218,A,,,10116.0,Prostate gland,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Intermediate,1,,N,50597,2367.0,,14950,,,1
,CHEMBL630146,12265,BAO_0000218,A,,,10116.0,Prostate gland,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Intermediate,1,,N,50597,2367.0,,14950,,,1
,CHEMBL630147,12266,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630148,12267,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630149,12268,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL630150,12269,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Intermediate,1,,N,50597,2106.0,,14950,,,1
,CHEMBL630151,12270,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Intermediate,1,,N,50597,2106.0,,14950,,,1
,CHEMBL632031,12271,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Intermediate,1,,N,50597,2046.0,,14950,,,1
,CHEMBL632032,12272,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Intermediate,1,,N,50597,2046.0,,14950,,,1
,CHEMBL632033,12273,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL632034,12274,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL632035,12275,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Intermediate,1,,N,50597,2385.0,,14950,,,1
,CHEMBL632036,12276,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Intermediate,1,,N,50597,,,14950,,,1
,CHEMBL632037,12277,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Intermediate,1,,N,50597,2046.0,,14950,,,1
,CHEMBL632038,12278,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL632039,12279,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL632040,12280,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL632041,12281,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL632042,12282,BAO_0000218,A,,,9615.0,Blood,Canis lupus familiaris,,"Concentration of compound in blood of dog 2, after administering intravenously",Intermediate,1,,N,50588,178.0,,9614,,,1
,CHEMBL632043,12283,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Intermediate,1,,N,50588,,,9614,,,1
,CHEMBL632044,12284,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Intermediate,1,,N,50588,,,9614,,,1
,CHEMBL632045,12285,BAO_0000218,A,,,9615.0,Liver,Canis lupus familiaris,,"Concentration of compound in liver of dog 1, after administering intravenously",Intermediate,1,,N,50588,2107.0,,9614,,,1
,CHEMBL632046,12286,BAO_0000218,A,,,9615.0,Liver,Canis lupus familiaris,,"Concentration of compound in liver of dog 2, after administering intravenously",Intermediate,1,,N,50588,2107.0,,9614,,,1
,CHEMBL632047,12287,BAO_0000218,A,,,9615.0,Lung,Canis lupus familiaris,,"Concentration of compound in lung of dog 1, after administering intravenously",Intermediate,1,,N,50588,2048.0,,9614,,,1
,CHEMBL632048,12288,BAO_0000218,A,,,9615.0,Lung,Canis lupus familiaris,,"Concentration of compound in lung of dog 2, after administering intravenously",Intermediate,1,,N,50588,2048.0,,9614,,,1
,CHEMBL632049,12289,BAO_0000218,A,,,9615.0,Muscle tissue,Canis lupus familiaris,,"Concentration of compound in muscle of dog 1, after administering intravenously",Intermediate,1,,N,50588,2385.0,,9614,,,1
,CHEMBL876418,12290,BAO_0000218,A,,,9615.0,Muscle tissue,Canis lupus familiaris,,"Concentration of compound in muscle of dog 2, after administering intravenously",Intermediate,1,,N,50588,2385.0,,9614,,,1
,CHEMBL632050,12291,BAO_0000218,A,,,9615.0,Spleen,Canis lupus familiaris,,"Concentration of compound in spleen of dog 1,after administering intravenously",Intermediate,1,,N,50588,2106.0,,9614,,,1
,CHEMBL632051,12292,BAO_0000218,A,,,9615.0,Spleen,Canis lupus familiaris,,"Concentration of compound in spleen of dog 2, after administering intravenously",Intermediate,1,,N,50588,2106.0,,9614,,,1
,CHEMBL632052,12293,BAO_0000218,F,,,,,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,Autocuration,0,,U,22224,,,10353,,,1
,CHEMBL632053,12294,BAO_0000218,F,,,,,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,Autocuration,0,,U,22224,,,10353,,,1
,CHEMBL632054,12295,BAO_0000218,A,,,,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,0,,U,22224,,,10353,,,1
,CHEMBL632055,12296,BAO_0000218,F,,,,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,0,,U,22224,,,10353,,,1
,CHEMBL631181,12297,BAO_0000218,F,,,,,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,Autocuration,0,,U,22224,,,10353,,,1
,CHEMBL631182,12298,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL631183,12299,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL631184,12300,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL629774,12301,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL629775,12302,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL876549,12303,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628172,12304,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628173,12305,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628174,12306,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628175,12307,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628176,12308,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628177,12309,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628178,12310,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628179,12311,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628180,12312,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628181,12313,BAO_0000218,A,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628182,12314,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628183,12315,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628184,12316,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628185,12317,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL875617,12318,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628186,12319,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628187,12320,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628188,12321,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628189,12322,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628190,12323,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628191,12324,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626513,12325,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626514,12326,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626515,12327,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626516,12328,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626517,12329,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626518,12330,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626519,12331,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626520,12332,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626521,12333,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626522,12334,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626523,12335,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626524,12336,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626688,12337,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626689,12338,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626690,12339,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL626691,12340,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL627319,12341,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL624052,12342,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL624053,12343,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Intermediate,1,,N,50597,2046.0,,8608,,,1
,CHEMBL624054,12344,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,,,8085,,,1
,CHEMBL624055,12345,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,,,8085,,,1
,CHEMBL624056,12346,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,,,8085,,,1
,CHEMBL624057,12347,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,995.0,,8085,,,1
,CHEMBL622281,12348,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,995.0,,8085,,,1
,CHEMBL622282,12349,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,995.0,,8085,,,1
,CHEMBL622283,12350,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,995.0,,8085,,,1
,CHEMBL622284,12351,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,995.0,,8085,,,1
,CHEMBL622285,12352,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,995.0,,8085,,,1
,CHEMBL622286,12353,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,1,,N,50597,995.0,,8085,,,1
,CHEMBL622287,12354,BAO_0000100,P,,,,,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,Autocuration,0,,U,22224,,,7657,,,1
,CHEMBL622288,12355,BAO_0000218,A,,,10090.0,,Mus musculus,,Partition coefficient (logD7.4),Intermediate,1,,N,50594,,,8935,,,1
,CHEMBL622289,12356,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,1,,N,50594,,,13792,,,1
,CHEMBL622290,12357,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL622291,12358,BAO_0000218,A,,,10090.0,,Mus musculus,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,1,,N,50594,,,13792,,,1
,CHEMBL622292,12359,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL622293,12360,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,1,,N,50594,,,13792,,,1
,CHEMBL622294,12361,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL622295,12362,BAO_0000218,A,,,10090.0,,Mus musculus,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,1,,N,50594,,,13792,,,1
,CHEMBL622296,12363,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,1,,N,50597,955.0,,13792,,,1
,CHEMBL874409,12364,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622297,12365,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622298,12366,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622299,12367,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622300,12368,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622301,12369,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622302,12370,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622303,12371,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622304,12372,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622305,12373,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL622306,12374,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626864,12375,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626865,12376,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626866,12377,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626867,12378,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626868,12379,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626869,12380,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626870,12381,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626871,12382,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL626872,12383,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL632185,12384,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL632186,12385,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Intermediate,1,,N,50597,1969.0,,14103,,,1
,CHEMBL629310,12386,BAO_0000019,A,,,,,,,Amount of acetic acid produced by the compound,Autocuration,0,,U,22224,,,12904,,,1
,CHEMBL629311,12387,BAO_0000019,A,,,,,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,Autocuration,0,,U,22224,,,12904,,,1
,CHEMBL629312,12388,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Log of (Cbrain/Cblood) in rats,Intermediate,1,,N,50597,,,9663,,,1
,CHEMBL629313,12389,BAO_0000221,A,,,,,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629314,12390,BAO_0000221,A,,,,,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629315,12391,BAO_0000221,A,,,,,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629316,12392,BAO_0000219,B,,,,,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629317,12393,BAO_0000221,A,,,,,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629318,12394,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL877497,12395,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629319,12396,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629320,12397,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629496,12398,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629497,12399,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629498,12400,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629499,12401,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629500,12402,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629501,12403,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629502,12404,BAO_0000019,A,,,,,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),Autocuration,0,,U,22224,,,7652,,,1
,CHEMBL629503,12405,BAO_0000218,F,,,,,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,Autocuration,0,,U,22224,,,8267,In vivo,,1
,CHEMBL629504,12406,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Intermediate,1,,N,50588,,,8267,,,1
,CHEMBL629505,12407,BAO_0000019,A,,,,,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,Autocuration,0,,U,22224,,,14479,,,1
,CHEMBL629506,12408,BAO_0000019,A,,,,,,,Compound was evaluated for total body clearance,Autocuration,0,,U,22224,,,17515,,,1
,CHEMBL629507,12409,BAO_0000019,A,,,,,,,Compound was evaluated for volume of distribution at steady state,Autocuration,0,,U,22224,,,17515,,,1
,CHEMBL877498,12410,BAO_0000019,A,,,,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,Autocuration,0,,U,22224,,,8142,,,1
,CHEMBL629508,12411,BAO_0000019,A,,,,,,,Percentage of the diamine which is monoprotonated at pH 7.4,Autocuration,0,,U,22224,,,14849,,,1
,CHEMBL629509,12412,BAO_0000019,A,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,Autocuration,0,,U,22224,,,7653,,,1
,CHEMBL629510,12413,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL629511,12414,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL629512,12415,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL629513,12416,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL629514,12417,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL628447,12418,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL628448,12419,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL628449,12420,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631119,12421,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631120,12422,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631121,12423,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL874458,12424,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631122,12425,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631123,12426,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631124,12427,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631125,12428,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631290,12429,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631291,12430,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631292,12431,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631293,12432,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631294,12433,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631295,12434,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631296,12435,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631297,12436,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,1,,N,50597,178.0,,8631,,,1
,CHEMBL631298,12437,BAO_0000218,A,,,,,,,Maximum biodistribution (Bmax) was determined.,Autocuration,0,,U,22224,,,10263,,,1
,CHEMBL631299,12438,BAO_0000218,A,,,10090.0,,Mus musculus,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Intermediate,1,,N,50594,,,12364,,,1
,CHEMBL631300,12439,BAO_0000218,A,,,10090.0,,Mus musculus,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Intermediate,1,,N,50594,,,12364,,,1
,CHEMBL631301,12440,BAO_0000218,A,,,10090.0,,Mus musculus,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Intermediate,1,,N,50594,,,12364,,,1
,CHEMBL630291,12441,BAO_0000218,A,,,10090.0,,Mus musculus,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Intermediate,1,,N,50594,,,12364,,,1
,CHEMBL630292,12442,BAO_0000218,A,,,,,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL630293,12443,BAO_0000218,A,,,,,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL630294,12444,BAO_0000218,A,,,,,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL630295,12445,BAO_0000218,A,,,,,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL630296,12446,BAO_0000218,A,,,,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626782,12447,BAO_0000218,A,,,,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626783,12448,BAO_0000218,A,,,,,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626784,12449,BAO_0000218,A,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626785,12450,BAO_0000218,A,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626786,12451,BAO_0000218,A,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626787,12452,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626788,12453,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625927,12454,BAO_0000218,A,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625928,12455,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625929,12456,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625930,12457,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625931,12458,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627230,12459,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627231,12460,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627232,12461,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627233,12462,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL875470,12463,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627234,12464,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627235,12465,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627236,12466,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627237,12467,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627238,12468,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627239,12469,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627240,12470,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627241,12471,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627242,12472,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627243,12473,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627244,12474,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627245,12475,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627246,12476,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627247,12477,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627248,12478,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627249,12479,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625569,12480,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625570,12481,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625571,12482,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625572,12483,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625573,12484,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL625574,12485,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL626245,12486,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL626246,12487,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL626247,12488,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626248,12489,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626249,12490,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626420,12491,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626421,12492,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626422,12493,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626423,12494,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626424,12495,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626425,12496,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Intermediate,1,,N,50588,,,12023,,,1
,CHEMBL875476,12497,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Intermediate,1,,N,50597,,,12023,,,1
,CHEMBL626426,12498,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Intermediate,1,,N,100710,,,12023,,,1
,CHEMBL626427,12499,BAO_0000100,P,,,,,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,0,,U,22224,,,10580,,,1
,CHEMBL626428,12500,BAO_0000100,P,,,,,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,0,,U,22224,,,10580,,,1
,CHEMBL626429,12501,BAO_0000019,A,,,,,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,Autocuration,0,,U,22224,,,16032,,,1
,CHEMBL625025,12502,BAO_0000019,A,,,,Urine,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,Autocuration,0,,U,22224,1088.0,,16032,,,1
,CHEMBL625026,12503,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625027,12504,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL874410,12505,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625028,12506,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625029,12507,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625030,12508,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625031,12509,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625032,12510,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625033,12511,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL625034,12512,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL624872,12513,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624873,12514,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624874,12515,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624875,12516,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624876,12517,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624877,12518,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624878,12519,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624879,12520,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624880,12521,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624881,12522,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624882,12523,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL624883,12524,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL624884,12525,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL624885,12526,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL624886,12527,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL624887,12528,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL624888,12529,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL624889,12530,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL624890,12531,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL621964,12532,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL621965,12533,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL621966,12534,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL621967,12535,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL622164,12536,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL623097,12537,BAO_0000019,A,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),Autocuration,0,,U,22224,,,7653,,,1
,CHEMBL623098,12538,BAO_0000019,A,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),Autocuration,0,,U,22224,,,7653,,,1
,CHEMBL623099,12539,BAO_0000019,A,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,Autocuration,0,,U,22224,,,7653,,,1
,CHEMBL623100,12540,BAO_0000019,A,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,Autocuration,0,,U,22224,,,7653,,,1
,CHEMBL628673,12541,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL628674,12542,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL628675,12543,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL627644,12544,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL627645,12545,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL627646,12546,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL627647,12547,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL627648,12548,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Intermediate,1,,N,50597,,,9104,,,1
,CHEMBL627649,12549,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Free level in rat plasma,Intermediate,1,,N,50597,,,12902,,,1
,CHEMBL628313,12550,BAO_0000019,A,,,,,,,Level reaching in blood plasma of rat or human was determined,Autocuration,0,,U,22224,,,6614,,,1
,CHEMBL628314,12551,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Log (Cbrain/Cblood) in rats,Intermediate,1,,N,50597,,,9663,,,1
,CHEMBL628315,12552,BAO_0000019,A,,,,,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,Autocuration,0,,U,22224,,,17658,,,1
,CHEMBL628316,12553,BAO_0000019,A,,,,,,,Mean percentage of compound transport through membrane; expressed as membrane transport,Autocuration,0,,U,22224,,,17658,,,1
,CHEMBL628317,12554,BAO_0000218,A,,,,,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,Autocuration,0,,U,22224,,,14314,,,1
,CHEMBL628473,12555,BAO_0000019,A,,,,,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,Autocuration,0,,U,22224,,,7385,,,1
,CHEMBL628474,12556,BAO_0000019,A,,,,,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",Autocuration,0,,U,22224,,,7385,,,1
,CHEMBL628475,12557,BAO_0000019,A,,,,,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,Autocuration,0,,U,22224,,,7385,,,1
,CHEMBL628476,12558,BAO_0000019,A,,,,,,,Net water uptake by a carrier mediated transport (%cm) mechanism,Autocuration,0,,U,22224,,,1329,,,1
,CHEMBL628477,12559,BAO_0000218,A,,,314293.0,,Simiiformes,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,0,,U,22224,,,12187,,,1
,CHEMBL628478,12560,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,1,,N,50506,,,12187,,,1
,CHEMBL628479,12561,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,1,,N,50506,,,12187,,,1
,CHEMBL628480,12562,BAO_0000218,A,,,314293.0,,Simiiformes,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,0,,U,22224,,,12187,,,1
,CHEMBL628481,12563,BAO_0000218,A,,,314293.0,,Simiiformes,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Autocuration,0,,U,22224,,,12187,,,1
,CHEMBL628482,12564,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,1,,N,50597,,,12187,,,1
,CHEMBL628483,12565,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,1,,N,50597,,,12187,,,1
,CHEMBL628484,12566,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,1,,N,50597,1969.0,,9278,,,1
,CHEMBL628485,12567,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,1,,N,50597,1969.0,,9278,,,1
,CHEMBL628486,12568,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Intermediate,1,,N,100710,1969.0,,9278,,,1
,CHEMBL628487,12569,BAO_0000218,A,,,9606.0,Plasma,Homo sapiens,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Intermediate,1,,N,50587,1969.0,,9278,,,1
,CHEMBL628488,12570,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,1,,N,50597,1969.0,,9278,,,1
,CHEMBL628489,12571,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,1,,N,50597,1969.0,,9278,,,1
,CHEMBL628490,12572,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,1,,N,50597,1969.0,,9278,,,1
,CHEMBL628491,12573,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,1,,N,100710,,,12186,,,1
,CHEMBL877507,12574,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,1,,N,100710,,,12186,,,1
,CHEMBL628492,12575,BAO_0000218,A,,,,,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Autocuration,0,,U,22224,,,12186,,,1
,CHEMBL628493,12576,BAO_0000019,A,,,314293.0,,Simiiformes,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Autocuration,0,,U,22224,,,12041,,,1
,CHEMBL628494,12577,BAO_0000019,A,,,314293.0,,Simiiformes,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Autocuration,0,,U,22224,,,12041,,,1
,CHEMBL628495,12578,BAO_0000019,A,,,314293.0,,Simiiformes,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Autocuration,0,,U,22224,,,12041,,,1
,CHEMBL628496,12579,BAO_0000218,A,,,9606.0,,Homo sapiens,,Permeability in Caco-2 assay at 10E-6,Intermediate,1,,N,50587,,,6737,,,1
,CHEMBL628497,12580,BAO_0000218,A,,,,Brain,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,0,,U,22224,955.0,,13758,,,1
,CHEMBL628498,12581,BAO_0000218,A,,,,Brain,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,0,,U,22224,955.0,,13758,,,1
,CHEMBL628499,12582,BAO_0000019,A,,,,,,,Plasma protein binding was determined,Autocuration,0,,U,22224,,,5676,,,1
,CHEMBL627656,12583,BAO_0000218,A,,,,,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL627657,12584,BAO_0000218,A,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626808,12585,BAO_0000218,A,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626809,12586,BAO_0000218,A,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626810,12587,BAO_0000218,A,,,,,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626811,12588,BAO_0000218,A,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL874465,12589,BAO_0000218,A,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626812,12590,BAO_0000218,A,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626813,12591,BAO_0000218,A,,,,,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626814,12592,BAO_0000218,A,,,,,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,Autocuration,0,,U,22224,,,14793,,,1
,CHEMBL626815,12593,BAO_0000019,A,,,,,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,Autocuration,0,,U,22224,,,14000,,,1
,CHEMBL628566,12594,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,5948,,,1
,CHEMBL628567,12595,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,0,,U,22229,,,13824,,,1
,CHEMBL628568,12596,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,10778,,,1
,CHEMBL628569,12597,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,C max in dog,Intermediate,1,,N,50588,,,17237,In vivo,,1
,CHEMBL628570,12598,BAO_0000218,A,,,10141.0,,Cavia porcellus,,C max in guinea pig,Intermediate,1,,N,50512,,,17237,In vivo,,1
,CHEMBL628571,12599,BAO_0000218,A,,,,,,,C max value was evaluated,Autocuration,0,,U,22224,,,2809,In vivo,,1
,CHEMBL628572,12600,BAO_0000218,A,,,,,,,Cmax value after oral dose of 0.1 mg//kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL628573,12601,BAO_0000218,A,,,,,,,Cmax value after oral dose of 0.3 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL628574,12602,BAO_0000218,A,,,,,,,Cmax value after oral dose of 1 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL628575,12603,BAO_0000218,A,,,,,,,Cmax value after oral dose of 10 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL628576,12604,BAO_0000218,A,,,,,,,Cmax value after oral dose of 23.4 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL628577,12605,BAO_0000218,A,,,,,,,Cmax value after oral dose of 3 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL628578,12606,BAO_0000218,A,,,,,,,Cmax value after oral dose of 3.87 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL874466,12607,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Cmax value in female Beagle dogs,Intermediate,1,,N,50588,,,12768,In vivo,,1
,CHEMBL628579,12608,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax value in male rats,Intermediate,1,,N,50597,,,12768,In vivo,,1
,CHEMBL628580,12609,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Cmax value in rat plasma when administered 20 mg/kg perorally,Intermediate,1,,N,50597,1969.0,,12780,In vivo,,1
,CHEMBL628581,12610,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,1,,N,50588,1969.0,,15592,In vivo,,1
,CHEMBL628582,12611,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,1,,N,50588,1969.0,,15592,In vivo,,1
,CHEMBL628583,12612,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Intermediate,1,,N,50588,,,17025,,,1
,CHEMBL625782,12613,BAO_0000218,A,,,314293.0,,Simiiformes,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,0,,U,22224,,,17025,,,1
,CHEMBL625783,12614,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,1,,N,50592,,,17025,,,1
,CHEMBL625784,12615,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Intermediate,1,,N,50597,,,17025,,,1
,CHEMBL625785,12616,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,1,,N,50797,1969.0,,4236,,,1
,CHEMBL625786,12617,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Intermediate,1,,N,50597,,,15791,,,1
,CHEMBL874467,12618,BAO_0000019,A,,,,,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,Autocuration,0,,U,22224,,,11149,,,1
,CHEMBL625787,12619,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,1,,N,50588,,,15592,,,1
,CHEMBL625964,12620,BAO_0000218,A,,,12721.0,,Human immunodeficiency virus,,cytotoxicity against HIV protease enzyme.,Intermediate,1,,N,50677,,,15778,,,1
,CHEMBL625965,12621,BAO_0000218,A,,,10090.0,,Mus musculus,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL625966,12622,BAO_0000218,A,,,10090.0,,Mus musculus,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Intermediate,1,,N,50594,,,12745,,,1
,CHEMBL625967,12623,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,The plasma clearance in dog.,Intermediate,1,,N,50588,1969.0,,13941,In vivo,,1
,CHEMBL625968,12624,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The plasma clearance in rat.,Intermediate,1,,N,50597,1969.0,,13941,In vivo,,1
,CHEMBL625969,12625,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Clearance from plasma in male Sprague-Dawley rats,Intermediate,1,,N,50597,1969.0,,16449,In vivo,,1
,CHEMBL625970,12626,BAO_0000218,A,,,9541.0,Plasma,Macaca fascicularis,,Clearance from plasma in male cynomolgus monkeys,Intermediate,1,,N,100710,1969.0,,16449,In vivo,,1
,CHEMBL625971,12627,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Intermediate,1,,N,50588,1969.0,,14224,In vivo,,1
,CHEMBL625972,12628,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Clearance of compound in dog plasma,Intermediate,1,,N,50588,1969.0,,14224,In vivo,,1
,CHEMBL625973,12629,BAO_0000218,A,,,9606.0,Plasma,Homo sapiens,,Clearance of compound in human plasma,Intermediate,1,,N,50587,1969.0,,14224,In vivo,,1
,CHEMBL625974,12630,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Intermediate,1,,N,50588,,,14317,In vivo,,1
,CHEMBL625975,12631,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Clearance of compound when administered intravenously as an individual dose to a single dog.,Intermediate,1,,N,50588,,,14317,In vivo,,1
,CHEMBL625976,12632,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,"Clearance (10 mg/kg, intravenously) in dog plasma",Intermediate,1,,N,50588,1969.0,,14224,In vivo,,1
,CHEMBL625977,12633,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Clearance value in dog,Intermediate,1,,N,50588,,,17237,In vivo,,1
,CHEMBL625978,12634,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Clearance value in guinea pig,Intermediate,1,,N,50512,,,17237,In vivo,,1
,CHEMBL874468,12635,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance values in rats after iv administration.,Intermediate,1,,N,50597,,,14187,In vivo,,1
,CHEMBL625421,12636,BAO_0000218,A,,,,Plasma,,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,Autocuration,0,,U,22224,1969.0,,4806,In vivo,,1
,CHEMBL625422,12637,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,In vivo clearance (5 mg/kg) was determined in rabbits,Intermediate,1,,N,50592,,,15025,In vivo,,1
,CHEMBL625423,12638,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma Clearance rate was determined for the compound in rats,Intermediate,1,,N,50597,,,13197,In vivo,,1
,CHEMBL625424,12639,BAO_0000218,A,,,9520.0,,Saimiri,,Plasma Clearance rate was determined for the compound in squirrel monkeys,Autocuration,0,,U,22224,,,13197,In vivo,,1
,CHEMBL625425,12640,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance in rat,Intermediate,1,,N,50597,,,13960,In vivo,,1
,CHEMBL625426,12641,BAO_0000218,A,,,,,,,Plasma clearance of the compound,Autocuration,0,,U,22224,,,17820,In vivo,,1
,CHEMBL625427,12642,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Intermediate,1,,N,50512,,,14706,In vivo,,1
,CHEMBL625428,12643,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Intermediate,1,,N,50512,,,14706,In vivo,,1
,CHEMBL625429,12644,BAO_0000218,A,,,,,,,Plasma clearance was determined,Autocuration,0,,U,22224,,,6504,In vivo,,1
,CHEMBL625430,12645,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Intermediate,1,,N,50588,,,14925,In vivo,,1
,CHEMBL625431,12646,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance rate was determined for the compound in rats,Intermediate,1,,N,50597,,,13197,In vivo,,1
,CHEMBL627307,12647,BAO_0000218,A,,,9520.0,,Saimiri,,Plasma clearance rate was determined for the compound in squirrel monkeys,Autocuration,0,,U,22224,,,13197,In vivo,,1
,CHEMBL627308,12648,BAO_0000218,A,,,,,,,Slow clearance (CL) was determined,Autocuration,0,,U,22224,,,3437,In vivo,,1
,CHEMBL627309,12649,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627310,12650,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627311,12651,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627312,12652,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627313,12653,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627314,12654,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627315,12655,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627316,12656,BAO_0000218,A,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627317,12657,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627318,12658,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL627999,12659,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628000,12660,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628001,12661,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL628002,12662,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625610,12663,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625611,12664,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625612,12665,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625613,12666,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL875479,12667,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625614,12668,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL625615,12669,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626302,12670,BAO_0000218,A,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,0,,U,22224,,,9196,,,1
,CHEMBL626303,12671,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627420,12672,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,1,,N,50597,178.0,,8374,,,1
,CHEMBL627421,12673,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL625695,12674,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL625696,12675,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL875606,12676,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of compound in mice brain was measured after 1 hr,Intermediate,1,,N,50594,955.0,,10009,,,1
,CHEMBL625697,12677,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of compound in mice brain was measured after 24 hr r,Intermediate,1,,N,50594,955.0,,10009,,,1
,CHEMBL625698,12678,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of compound in mice brain was measured after 2 hr,Intermediate,1,,N,50594,955.0,,10009,,,1
,CHEMBL625699,12679,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of compound in mice brain was measured after 3 hr,Intermediate,1,,N,50594,955.0,,10009,,,1
,CHEMBL625700,12680,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of compound in mice brain was measured after 6 hr,Intermediate,1,,N,50594,955.0,,10009,,,1
,CHEMBL625701,12681,BAO_0000218,A,,,10090.0,,Mus musculus,,Distribution of compound in mice liver was measured after 1 hr,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL625702,12682,BAO_0000218,A,,,10090.0,,Mus musculus,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL625703,12683,BAO_0000218,A,,,10090.0,,Mus musculus,,Distribution of compound in mice liver was measured after 2 hr,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL625704,12684,BAO_0000218,A,,,10090.0,,Mus musculus,,Distribution of compound in mice liver was measured after 3 hr,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL625705,12685,BAO_0000218,A,,,10090.0,,Mus musculus,,Distribution of compound in mice liver was measured after 6 hr,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL625706,12686,BAO_0000218,A,,,9615.0,Adrenal medulla,Canis lupus familiaris,,Distribution in dog adrenal medulla 30 min after administration.,Intermediate,1,,N,50588,1236.0,,8170,,,1
,CHEMBL625707,12687,BAO_0000218,A,,,9615.0,Adrenal medulla,Canis lupus familiaris,,Distribution in dog adrenal medulla 72 hours after administration.,Intermediate,1,,N,50588,1236.0,,8170,,,1
,CHEMBL625708,12688,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog Ovary 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL625709,12689,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog Ovary 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624180,12690,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog adipose 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624181,12691,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog adipose 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624182,12692,BAO_0000218,A,,,9615.0,Adrenal cortex,Canis lupus familiaris,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,1,,N,50588,1235.0,,8170,,,1
,CHEMBL624183,12693,BAO_0000218,A,,,9615.0,Adrenal cortex,Canis lupus familiaris,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,1,,N,50588,1235.0,,8170,,,1
,CHEMBL624184,12694,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL877489,12695,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL624185,12696,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL624186,12697,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL624187,12698,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL624188,12699,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL624189,12700,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624190,12701,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624191,12702,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624192,12703,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624193,12704,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624194,12705,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624891,12706,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624892,12707,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL624893,12708,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL627632,12709,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL627633,12710,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL627634,12711,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL627635,12712,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL627636,12713,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL626816,12714,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL626817,12715,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL626818,12716,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL626819,12717,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL626820,12718,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL626821,12719,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL626822,12720,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626823,12721,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626824,12722,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626825,12723,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626826,12724,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626827,12725,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626828,12726,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626829,12727,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL626830,12728,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL627150,12729,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL627151,12730,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL627152,12731,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL627153,12732,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL627154,12733,BAO_0000019,A,,,,,,,Rate of acetate production by the compound was determined,Autocuration,0,,U,22224,,,12904,,,1
,CHEMBL627155,12734,BAO_0000019,A,,,,,,,Rate of acetate production by the compound was determined; Not determined,Autocuration,0,,U,22224,,,12904,,,1
,CHEMBL627156,12735,BAO_0000019,A,,,,,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,Autocuration,0,,U,22224,,,3730,,,1
,CHEMBL627157,12736,BAO_0000019,A,,,,,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,Autocuration,0,,U,22224,,,3627,,,1
,CHEMBL627158,12737,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,1,,N,50592,,,13799,,,1
,CHEMBL627159,12738,BAO_0000218,A,,,9986.0,Plasma,Oryctolagus cuniculus,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,1,,N,50592,1969.0,,13799,,,1
,CHEMBL627160,12739,BAO_0000218,A,,,10090.0,,Mus musculus,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,1,,N,50594,,,13799,,,1
,CHEMBL628540,12740,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,1,,N,50597,,,13799,,,1
,CHEMBL628541,12741,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,1,,N,50597,1969.0,,13799,,,1
,CHEMBL628542,12742,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,1,,N,50597,1969.0,,13799,,,1
,CHEMBL628543,12743,BAO_0000100,P,,,,,,,Solubility after at a pH 1.2,Autocuration,0,,U,22229,,,6629,,,1
,CHEMBL628544,12744,BAO_0000100,P,,,,,,,Solubility after at pH 1.2,Autocuration,0,,U,22229,,,6629,,,1
,CHEMBL628545,12745,BAO_0000100,P,,,,,,,Solubility after injection of water,Autocuration,0,,U,22229,,,6629,,,1
,CHEMBL628546,12746,BAO_0000019,A,,,,,,,Statistical significance of IC 50 values; Expressed as R value,Autocuration,0,,U,22224,,,14000,,,1
,CHEMBL874455,12747,BAO_0000019,A,,,,,,,Systemic availability with respect to methyldopa was determined,Autocuration,0,,U,22224,,,8267,,,1
,CHEMBL628547,12748,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,1,,N,50597,,,13799,,,1
,CHEMBL628548,12749,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,1,,N,50597,1969.0,,13799,,,1
,CHEMBL628549,12750,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL628550,12751,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL628551,12752,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL628552,12753,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628553,12754,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628554,12755,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628555,12756,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628556,12757,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628557,12758,BAO_0000218,A,,,9986.0,Kidney,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,2113.0,,7132,,,1
,CHEMBL628558,12759,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL628559,12760,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL628560,12761,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL874456,12762,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628561,12763,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL628562,12764,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL628563,12765,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628564,12766,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL628565,12767,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL631248,12768,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL631249,12769,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL627214,12770,BAO_0000218,A,,,9986.0,Kidney,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,2113.0,,7132,,,1
,CHEMBL874591,12771,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL627215,12772,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL625471,12773,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL625472,12774,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Intermediate,1,,N,50592,,,7132,,,1
,CHEMBL625473,12775,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Intermediate,1,,N,50592,,,7132,,,1
,CHEMBL625474,12776,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Intermediate,1,,N,50588,,,13317,In vivo,,1
,CHEMBL625475,12777,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Intermediate,1,,N,50588,,,15341,In vivo,,1
,CHEMBL625476,12778,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Intermediate,1,,N,50597,,,15341,In vivo,,1
,CHEMBL625477,12779,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Intermediate,1,,N,50597,,,15341,In vivo,,1
,CHEMBL625478,12780,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,1,,N,50597,,,15341,In vivo,,1
,CHEMBL625479,12781,BAO_0000218,A,,,10116.0,esophageal tunica muscularis mucosae,Rattus norvegicus,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Intermediate,1,,N,50597,,,12801,In vitro,,1
,CHEMBL625480,12782,BAO_0000218,A,,,10116.0,esophageal tunica muscularis mucosae,Rattus norvegicus,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Intermediate,1,,N,50597,,,12801,In vitro,,1
,CHEMBL625481,12783,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Intermediate,1,,N,50597,1969.0,,14856,In vivo,,1
,CHEMBL625482,12784,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL625483,12785,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL625484,12786,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL625485,12787,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Intermediate,1,,N,50597,,,14062,In vivo,,1
,CHEMBL625486,12788,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Intermediate,1,,N,50588,1969.0,,14346,In vivo,,1
,CHEMBL625487,12789,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,1969.0,,14346,In vivo,,1
,CHEMBL625488,12790,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,1969.0,,14346,In vivo,,1
,CHEMBL625489,12791,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,1969.0,,14346,In vivo,,1
,CHEMBL625490,12792,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,1969.0,,14346,In vivo,,1
,CHEMBL625491,12793,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Intermediate,1,,N,50588,1969.0,,14346,In vivo,,1
,CHEMBL625492,12794,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,1,,N,50597,1969.0,,14346,In vivo,,1
,CHEMBL625493,12795,BAO_0000218,A,,,9606.0,Plasma,Homo sapiens,,plasma clearance in human,Intermediate,1,,N,50587,1969.0,,15711,In vivo,,1
,CHEMBL625494,12796,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,1,,N,50597,,,14886,In vivo,,1
,CHEMBL625495,12797,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,1,,N,50597,,,14886,In vivo,,1
,CHEMBL625496,12798,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,1,,N,50597,,,14886,In vivo,,1
,CHEMBL625497,12799,BAO_0000100,P,,,,,,,1-Octanol/water partition coefficient measured at 7.4,Autocuration,0,,U,22229,,,4115,,,1
,CHEMBL625498,12800,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13733,,,1
,CHEMBL625499,12801,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,12102,,,1
,CHEMBL625500,12802,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,12676,,,1
,CHEMBL625501,12803,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13733,,,1
,CHEMBL625502,12804,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13740,,,1
,CHEMBL625503,12805,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),Autocuration,0,,U,22229,,,12766,,,1
,CHEMBL625504,12806,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,2764,,,1
,CHEMBL625505,12807,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,12355,,,1
,CHEMBL625506,12808,BAO_0000100,P,,,,,,,Calculated partition coefficient of the compound,Autocuration,0,,U,22229,,,11314,,,1
,CHEMBL625507,12809,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,12706,,,1
,CHEMBL625508,12810,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,12645,,,1
,CHEMBL625509,12811,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13668,,,1
,CHEMBL625510,12812,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,12819,,,1
,CHEMBL883125,12813,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13668,,,1
,CHEMBL625511,12814,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13017,,,1
,CHEMBL874650,12815,BAO_0000019,A,,,,,,,Partition coefficient of the compound,Autocuration,0,,U,22224,,,2448,,,1
,CHEMBL625512,12816,BAO_0000019,A,,,,,,,Partition coefficient of the compound,Autocuration,0,,U,22224,,,11526,,,1
,CHEMBL625513,12817,BAO_0000019,A,,,,,,,Partition coefficient of compound was determined,Autocuration,0,,U,22224,,,12426,,,1
,CHEMBL625514,12818,BAO_0000019,A,,,,,,,Partition coefficient was determined,Autocuration,0,,U,22224,,,2448,,,1
,CHEMBL625515,12819,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,12001,,,1
,CHEMBL625516,12820,BAO_0000100,P,,,,,,,partition coefficient of compound was determined,Autocuration,0,,U,22229,,,12426,,,1
,CHEMBL625517,12821,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,The total body administered intravenously in dog,Intermediate,1,,N,50588,,,13204,In vivo,,1
,CHEMBL625518,12822,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The total body administered intravenously in rats,Intermediate,1,,N,50597,,,13204,In vivo,,1
,CHEMBL625519,12823,BAO_0000218,A,,,10090.0,,Mus musculus,,Time taken for the administration to female NIH mice weighing 25-30 g.,Intermediate,1,,N,50594,,,13889,,,1
,CHEMBL625520,12824,BAO_0000019,A,,,,,,,Time taken for the administration,Autocuration,0,,U,22224,,,13889,,,1
,CHEMBL874651,12825,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,1,,N,50588,,,17025,In vivo,,1
,CHEMBL625521,12826,BAO_0000218,A,,,314293.0,,Simiiformes,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,0,,U,22224,,,17025,In vivo,,1
,CHEMBL623171,12827,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,1,,N,50592,,,17025,In vivo,,1
,CHEMBL623853,12828,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,1,,N,50597,,,17025,In vivo,,1
,CHEMBL623854,12829,BAO_0000019,A,,,,,,,Plasma clearance for the compound was determined.,Autocuration,0,,U,22224,,,15067,,,1
,CHEMBL874405,12830,BAO_0000100,P,,,,,,,CLog P value of the compound,Autocuration,0,,U,22224,,,3091,,,1
,CHEMBL623855,12831,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,15592,,,1
,CHEMBL623856,12832,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,14738,,,1
,CHEMBL623857,12833,BAO_0000100,P,,,,,,,ClogP value of the compound; nd ='no data',Autocuration,0,,U,22224,,,14738,,,1
,CHEMBL623858,12834,BAO_0000100,P,,,,,,,ClogP value of the compound; nd ='not determined',Autocuration,0,,U,22224,,,14738,,,1
,CHEMBL623859,12835,BAO_0000100,P,,,,,,,CLog P was determined,Autocuration,0,,U,22224,,,6076,,,1
,CHEMBL839829,12836,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,17840,,,1
,CHEMBL623860,12837,BAO_0000019,A,,,,,,,CLogP was calculated,Autocuration,0,,U,22224,,,13589,,,1
,CHEMBL623861,12838,BAO_0000019,A,,,,,,,CLogP value was determined,Autocuration,0,,U,22224,,,17655,,,1
,CHEMBL623862,12839,BAO_0000019,A,,,,,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,Autocuration,0,,U,22224,,,5867,,,1
,CHEMBL874406,12840,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,5867,,,1
,CHEMBL623863,12841,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,10783,,,1
,CHEMBL624021,12842,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,14849,,,1
,CHEMBL624022,12843,BAO_0000218,A,,,9615.0,Adrenal medulla,Canis lupus familiaris,,Distribution in female dog adrenal medulla 24 hours after administration.,Intermediate,1,,N,50588,1236.0,,8170,,,1
,CHEMBL624023,12844,BAO_0000218,A,,,9615.0,Adrenal medulla,Canis lupus familiaris,,Distribution in female dog adrenal medulla 72 hours after administration.,Intermediate,1,,N,50588,1236.0,,8170,,,1
,CHEMBL624024,12845,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog bile 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624025,12846,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog bile 72 hr after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624026,12847,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog blood 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624027,12848,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog blood 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624028,12849,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog heart 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624029,12850,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog heart 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624030,12851,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog kidney 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624031,12852,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog kidney 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624032,12853,BAO_0000218,A,,,9615.0,Intestine,Canis lupus familiaris,,Distribution in female dog large intestine 24 hours after administration.,Intermediate,1,,N,50588,160.0,,8170,,,1
,CHEMBL874407,12854,BAO_0000218,A,,,9615.0,Intestine,Canis lupus familiaris,,Distribution in female dog large intestine 72 hours after administration.,Intermediate,1,,N,50588,160.0,,8170,,,1
,CHEMBL624033,12855,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog liver 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624034,12856,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog liver 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624035,12857,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog lung 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624036,12858,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog lung 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624037,12859,BAO_0000218,A,,,9615.0,Muscle tissue,Canis lupus familiaris,,Distribution in female dog muscle 24 hours after administration.,Intermediate,1,,N,50588,2385.0,,8170,,,1
,CHEMBL624038,12860,BAO_0000218,A,,,9615.0,Muscle tissue,Canis lupus familiaris,,Distribution in female dog muscle 72 hours after administration.,Intermediate,1,,N,50588,2385.0,,8170,,,1
,CHEMBL624039,12861,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog pancreas 24 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624040,12862,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Distribution in female dog pancreas 72 hours after administration.,Intermediate,1,,N,50588,,,8170,,,1
,CHEMBL624041,12863,BAO_0000218,A,,,9615.0,Intestine,Canis lupus familiaris,,Distribution in female dog small intestine 24 hours after administration.,Intermediate,1,,N,50588,160.0,,8170,,,1
,CHEMBL624042,12864,BAO_0000218,A,,,9615.0,Intestine,Canis lupus familiaris,,Distribution in female dog small intestine 72 hours after administration.,Intermediate,1,,N,50588,160.0,,8170,,,1
,CHEMBL624043,12865,BAO_0000218,A,,,9615.0,Spleen,Canis lupus familiaris,,Distribution in female dog spleen 24 hours after administration.,Intermediate,1,,N,50588,2106.0,,8170,,,1
,CHEMBL624044,12866,BAO_0000218,A,,,9615.0,Spleen,Canis lupus familiaris,,Distribution in female dog spleen 72 hours after administration.,Intermediate,1,,N,50588,2106.0,,8170,,,1
,CHEMBL624045,12867,BAO_0000218,A,,,9615.0,Stomach,Canis lupus familiaris,,Distribution in female dog stomach 24 hours after administration.,Intermediate,1,,N,50588,945.0,,8170,,,1
,CHEMBL624046,12868,BAO_0000218,A,,,9615.0,Stomach,Canis lupus familiaris,,Distribution in female dog stomach 72 hours after administration.,Intermediate,1,,N,50588,945.0,,8170,,,1
,CHEMBL624047,12869,BAO_0000218,A,,,9615.0,Thyroid gland,Canis lupus familiaris,,Distribution in female dog thyroid 24 hours after administration.,Intermediate,1,,N,50588,2046.0,,8170,,,1
,CHEMBL624048,12870,BAO_0000218,A,,,9615.0,Thyroid gland,Canis lupus familiaris,,Distribution in female dog thyroid 72 hours after administration.,Intermediate,1,,N,50588,2046.0,,8170,,,1
,CHEMBL874408,12871,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Distribution in female dog urine 24 hours after administration.,Intermediate,1,,N,50588,1088.0,,8170,,,1
,CHEMBL624049,12872,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Distribution in female dog urine 72 hr after administration.,Intermediate,1,,N,50588,1088.0,,8170,,,1
,CHEMBL624050,12873,BAO_0000218,A,,,,Plasma,,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,Autocuration,0,,U,22224,1969.0,,14283,,,1
,CHEMBL624051,12874,BAO_0000019,A,,,,,,,Plasma concentration at 7 hr after intravenous dosing,Autocuration,0,,U,22224,,,5623,,,1
,CHEMBL623278,12875,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623279,12876,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623280,12877,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623963,12878,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623964,12879,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623965,12880,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623966,12881,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL874415,12882,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623967,12883,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623968,12884,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL623969,12885,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL628409,12886,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL628410,12887,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL628411,12888,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL628412,12889,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Intermediate,1,,N,50597,,,13477,,,1
,CHEMBL628413,12890,BAO_0000019,A,,,,,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,Autocuration,0,,U,22224,,,12553,,,1
,CHEMBL628414,12891,BAO_0000019,A,,,,Plasma,,,The concentration in plasmat; Not determined,Autocuration,0,,U,22224,1969.0,,14548,,,1
,CHEMBL628415,12892,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue level at 10 mg/kg/po in wistar rats in blood,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL628416,12893,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL628417,12894,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue level at 10 mg/kg/po in wistar rats in heart,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL874908,12895,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Tissue level at 10 mg/kg/po in wistar rats in liver,Intermediate,1,,N,50597,2107.0,,14393,,,1
,CHEMBL628418,12896,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue level at 10 mg/kg/po in wistar rats in plasma,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL628419,12897,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Intermediate,1,,N,50597,2385.0,,14393,,,1
,CHEMBL628420,12898,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL628421,12899,BAO_0000019,A,,,,,,,Water solubility at 37 degree C.,Autocuration,0,,U,22224,,,1629,,,1
,CHEMBL626726,12900,BAO_0000100,P,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626727,12901,BAO_0000100,P,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626728,12902,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL626729,12903,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL626730,12904,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL626731,12905,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL626732,12906,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,178.0,,8594,,,1
,CHEMBL626733,12907,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL626734,12908,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL626735,12909,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL874909,12910,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL626736,12911,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,948.0,,8594,,,1
,CHEMBL626737,12912,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL630999,12913,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL631000,12914,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL631001,12915,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL631002,12916,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2113.0,,8594,,,1
,CHEMBL631003,12917,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL631004,12918,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL631005,12919,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL631006,12920,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL631007,12921,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2107.0,,8594,,,1
,CHEMBL631008,12922,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL631009,12923,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL631010,12924,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL631011,12925,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL631012,12926,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2048.0,,8594,,,1
,CHEMBL630271,12927,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL630272,12928,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL630273,12929,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL630274,12930,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL630275,12931,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,2046.0,,8594,,,1
,CHEMBL875782,12932,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL630276,12933,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL630277,12934,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL630278,12935,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL630279,12936,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Intermediate,1,,N,50597,,,8594,,,1
,CHEMBL630280,12937,BAO_0000019,A,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,Autocuration,0,,U,22224,,,8151,,,1
,CHEMBL630281,12938,BAO_0000019,A,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,0,,U,22224,,,8151,,,1
,CHEMBL630282,12939,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Intermediate,1,,N,50592,,,7132,,,1
,CHEMBL630283,12940,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Intermediate,1,,N,50592,,,7132,,,1
,CHEMBL630284,12941,BAO_0000019,A,,,,,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),Autocuration,0,,U,22224,,,5797,,,1
,CHEMBL630285,12942,BAO_0000019,A,,,,,,,Alkylating activity was determined,Autocuration,0,,U,22224,,,7849,,,1
,CHEMBL630286,12943,BAO_0000251,A,Microsomes,,,,,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Autocuration,0,,U,22224,,,14220,,,1
,CHEMBL630069,12944,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Intermediate,1,,N,50592,,,8650,,,1
,CHEMBL630070,12945,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Intermediate,1,,N,50592,,,8650,,,1
,CHEMBL630071,12946,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Intermediate,1,,N,50592,,,8650,,,1
,CHEMBL630072,12947,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Intermediate,1,,N,50592,,,8650,,,1
,CHEMBL875110,12948,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Intermediate,1,,N,50592,,,8650,,,1
,CHEMBL630073,12949,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for antidiuretic activity in rats,Intermediate,1,,N,50597,,,7116,,,1
,CHEMBL630074,12950,BAO_0000019,A,,,,,,,Compound was tested for inactivation kinetic values,Autocuration,0,,U,22224,,,14131,,,1
,CHEMBL630075,12951,BAO_0000218,A,,,,,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,Autocuration,0,,U,22224,,,7415,In vivo,,1
,CHEMBL630076,12952,BAO_0000019,A,,,,,,,Dissociation rate calculated from the first-order equation using the t1/2 value,Autocuration,0,,U,22224,,,13178,,,1
,CHEMBL630077,12953,BAO_0000100,P,,,,,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,Autocuration,0,,U,22229,,,8815,,,1
,CHEMBL630078,12954,BAO_0000100,P,,,,,,,Aqueous solubility was measured,Autocuration,0,,U,22229,,,1450,,,1
,CHEMBL630079,12955,BAO_0000100,P,,,,,,,Aqueous solubility was measured at a pH 4,Autocuration,0,,U,22229,,,1450,,,1
,CHEMBL630080,12956,BAO_0000100,P,,,,,,,Aqueous solubility (pH 7),Autocuration,0,,U,22229,,,1450,,,1
,CHEMBL630081,12957,BAO_0000100,P,,,,,,,Aqueous solubility was measured at a pH 9,Autocuration,0,,U,22229,,,1450,,,1
,CHEMBL630082,12958,BAO_0000019,A,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",Autocuration,0,,U,22224,,,12711,,,1
,CHEMBL630083,12959,BAO_0000019,A,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,0,,U,22224,,,12711,,,1
,CHEMBL630084,12960,BAO_0000019,A,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,0,,U,22224,,,12711,,,1
,CHEMBL629198,12961,BAO_0000100,P,,,,,,,Aqueous solubility of the compound,Autocuration,0,,U,22229,,,15032,,,1
,CHEMBL629199,12962,BAO_0000100,P,,,,,,,Aqueous solubility at 37 degree Celsius at pH 7.38,Autocuration,0,,U,22229,,,9964,,,1
,CHEMBL629200,12963,BAO_0000100,P,,,,,,,Aqueous solubility in pH 7.4 phosphate buffer,Autocuration,0,,U,22229,,,14962,,,1
,CHEMBL629201,12964,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,1,,N,50588,,,12487,,,1
,CHEMBL629202,12965,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Intermediate,1,,N,50588,,,12487,,,1
,CHEMBL875111,12966,BAO_0000218,A,,,9606.0,,Homo sapiens,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,1,,N,50587,,,10026,,,1
,CHEMBL629203,12967,BAO_0000218,A,,,9606.0,,Homo sapiens,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Intermediate,1,,N,50587,,,10026,,,1
,CHEMBL629204,12968,BAO_0000218,A,,,9606.0,,Homo sapiens,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,1,,N,50587,,,10026,,,1
,CHEMBL629205,12969,BAO_0000218,A,,,9606.0,,Homo sapiens,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,1,,N,50587,,,10026,,,1
,CHEMBL629206,12970,BAO_0000218,A,,,9606.0,,Homo sapiens,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,1,,N,50587,,,10026,,,1
,CHEMBL631185,12971,BAO_0000019,A,,,,,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,Autocuration,0,,U,22224,,,10026,,,1
,CHEMBL631186,12972,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the average bile flow rat in rats,Intermediate,1,,N,50597,,,7415,,,1
,CHEMBL631187,12973,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,1,,N,50592,,,17025,,,1
,CHEMBL631188,12974,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,1,,N,50592,,,17025,,,1
,CHEMBL876419,12975,BAO_0000019,A,,,,,,,Average half life period was determined,Autocuration,0,,U,22224,,,10184,,,1
,CHEMBL631189,12976,BAO_0000019,A,,,,,,,Average half life period was determined,Autocuration,0,,U,22224,,,10184,,,1
,CHEMBL631190,12977,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL631191,12978,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL631192,12979,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL632400,12980,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL630564,12981,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL630565,12982,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL630566,12983,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL631229,12984,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL631230,12985,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL876428,12986,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6030,,,1
,CHEMBL631231,12987,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6147,,,1
,CHEMBL631232,12988,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (MacLogP),Autocuration,0,,U,22229,,,14556,,,1
,CHEMBL631233,12989,BAO_0000019,A,,,,,,,Hydrophilicity was determined,Autocuration,0,,U,22224,,,768,,,1
,CHEMBL631234,12990,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,14452,,,1
,CHEMBL883126,12991,BAO_0000019,A,,,,,,,Increased absorption was determined,Autocuration,0,,U,22224,,,5237,,,1
,CHEMBL631235,12992,BAO_0000100,P,,,,,,,Lipophilicity value was evaluated,Autocuration,0,,U,22224,,,14378,,,1
,CHEMBL631236,12993,BAO_0000100,P,,,,,,,Log P value of the compound.,Autocuration,0,,U,22224,,,14418,,,1
,CHEMBL631237,12994,BAO_0000019,A,,,,,,,Partition coefficient of compound was determined,Autocuration,0,,U,22224,,,5249,,,1
,CHEMBL631238,12995,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,14621,,,1
,CHEMBL876429,12996,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,12542,,,1
,CHEMBL631414,12997,BAO_0000019,A,,,,,,,Partition coefficient was measured by medchem software; Not calculated,Autocuration,0,,U,22224,,,12542,,,1
,CHEMBL631415,12998,BAO_0000100,P,,,,,,,Partition coefficient was measured by octanol-water using standard shake-flask method,Autocuration,0,,U,22224,,,12542,,,1
,CHEMBL631416,12999,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,15462,,,1
,CHEMBL631417,13000,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,14884,,,1
,CHEMBL631418,13001,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,16526,,,1
,CHEMBL631419,13002,BAO_0000100,P,,,,,,,The Octanol/Water partition coefficient CLogP,Autocuration,0,,U,22229,,,13693,,,1
,CHEMBL631420,13003,BAO_0000019,A,,,,,,,The pharmacokinetic parameter C Log p was reported,Autocuration,0,,U,22224,,,13693,,,1
,CHEMBL631421,13004,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13779,,,1
,CHEMBL631422,13005,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,14772,,,1
,CHEMBL631423,13006,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,14393,,,1
,CHEMBL876430,13007,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,1,,N,50597,1969.0,,14793,In vivo,,1
,CHEMBL631424,13008,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,1,,N,50597,1969.0,,14793,In vivo,,1
,CHEMBL631425,13009,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Compound was administered intravenously in dog to evaluate plasma clearance values,Intermediate,1,,N,50588,1969.0,,13744,In vivo,,1
,CHEMBL631426,13010,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,Compound was administered intravenously in monkey to evaluate plasma clearance values,Autocuration,0,,U,22224,1969.0,,13744,In vivo,,1
,CHEMBL631427,13011,BAO_0000218,A,,,10090.0,Plasma,Mus musculus,,Compound was administered intravenously in mouse to evaluate plasma clearance values,Intermediate,1,,N,50594,1969.0,,13744,In vivo,,1
,CHEMBL631428,13012,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Intermediate,1,,N,50588,1969.0,,13207,In vivo,,1
,CHEMBL631429,13013,BAO_0000218,A,Microsomes,,9544.0,Liver,Macaca mulatta,,Intrinsic clearance in Rhesus liver microsome,Intermediate,1,,N,50797,2107.0,,5669,In vitro,,1
,CHEMBL631430,13014,BAO_0000218,A,Microsomes,,9615.0,Liver,Canis lupus familiaris,,Intrinsic clearance in dog liver microsome,Intermediate,1,,N,50588,2107.0,,5669,In vitro,,1
,CHEMBL631431,13015,BAO_0000218,A,Microsomes,,10116.0,Liver,Rattus norvegicus,,Intrinsic clearance in rat liver microsome,Intermediate,1,,N,50597,2107.0,,5669,In vitro,,1
,CHEMBL631432,13016,BAO_0000218,A,,,9544.0,Plasma,Macaca mulatta,,Low plasma clearance was calculated in rhesus monkey,Intermediate,1,,N,50797,1969.0,,4853,In vivo,,1
,CHEMBL631433,13017,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Intermediate,1,,N,50588,,,16452,In vivo,,1
,CHEMBL631434,13018,BAO_0000218,A,,,,,,,Plasma clearance after intravenous dose of 0.3 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL631435,13019,BAO_0000218,A,,,,,,,Plasma clearance after intravenous dose of 1 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL631436,13020,BAO_0000218,A,,,,,,,Plasma clearance after intravenous dose of 3 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL631437,13021,BAO_0000218,A,,,,,,,Plasma clearance after intravenous dose of 3.87 mg/kg,Autocuration,0,,U,22224,,,11954,In vivo,,1
,CHEMBL631438,13022,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after peroral administration at 10 mpk in Rat,Intermediate,1,,N,50597,,,5669,In vivo,,1
,CHEMBL876431,13023,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Plasma clearance after peroral administration at 10 mpk in Rhesus,Intermediate,1,,N,50797,,,5669,In vivo,,1
,CHEMBL631439,13024,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Plasma clearance after peroral administration at 10 mpk in dog,Intermediate,1,,N,50588,,,5669,In vivo,,1
,CHEMBL631440,13025,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Intermediate,1,,N,50597,,,13662,In vivo,,1
,CHEMBL631441,13026,BAO_0000019,A,,,,,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),Autocuration,0,,U,22224,,,8272,,,1
,CHEMBL631442,13027,BAO_0000019,A,,,,,,,Critical Micellar concentration was determined,Autocuration,0,,U,22224,,,13410,,,1
,CHEMBL626525,13028,BAO_0000019,A,,,,,,,Critical Micellar concentration of the compound. was determined,Autocuration,0,,U,22224,,,13410,,,1
,CHEMBL627168,13029,BAO_0000019,A,,,,,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,Autocuration,0,,U,22224,,,12628,,,1
,CHEMBL875618,13030,BAO_0000019,A,,,,,,,Critical micellar concentration was measured in water by the dye solubilization method,Autocuration,0,,U,22224,,,9675,,,1
,CHEMBL626612,13031,BAO_0000019,B,,,,,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,Autocuration,0,,U,22224,,,12628,,,1
,CHEMBL626613,13032,BAO_0000019,A,,,,,,,CMR value (relative to BAY K 8644),Autocuration,0,,U,22224,,,12766,,,1
,CHEMBL626614,13033,BAO_0000019,A,,,,,,,Carbamoylating activity was determined,Autocuration,0,,U,22224,,,7849,,,1
,CHEMBL626615,13034,BAO_0000218,A,,,314293.0,,Simiiformes,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Autocuration,0,,U,22224,,,12187,,,1
,CHEMBL626616,13035,BAO_0000019,A,,,,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,Autocuration,0,,U,22224,,,2040,,,1
,CHEMBL626617,13036,BAO_0000019,A,,,,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,Autocuration,0,,U,22224,,,2040,,,1
,CHEMBL626618,13037,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Intermediate,1,,N,50588,1969.0,,14180,In vivo,,1
,CHEMBL626619,13038,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Intermediate,1,,N,50597,1969.0,,14180,In vivo,,1
,CHEMBL626620,13039,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Clearance rate at 0.46 mg/kg, iv, in dogs",Intermediate,1,,N,50588,,,14474,In vivo,,1
,CHEMBL626621,13040,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Clearance rate at 5.5 mg/kg, iv, in rat",Intermediate,1,,N,50597,,,14474,In vivo,,1
,CHEMBL626622,13041,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,1,,N,100710,,,14548,In vivo,,1
,CHEMBL626623,13042,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,1,,N,100710,,,14548,In vivo,,1
,CHEMBL626624,13043,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,1,,N,50588,,,14548,In vivo,,1
,CHEMBL626625,13044,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,1,,N,50597,,,14548,In vivo,,1
,CHEMBL626626,13045,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,1,,N,50597,2107.0,,6125,Ex vivo,,1
,CHEMBL626627,13046,BAO_0000218,A,,,,,,,Tested for the total clearance of the compound,Autocuration,0,,U,22224,,,6874,In vivo,,1
,CHEMBL626628,13047,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Intermediate,1,,N,50588,,,15343,In vivo,,1
,CHEMBL626629,13048,BAO_0000218,A,,,,,,,Total body clearance was determined,Autocuration,0,,U,22224,,,6236,In vivo,,1
,CHEMBL626630,13049,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626631,13050,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626632,13051,BAO_0000100,P,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626633,13052,BAO_0000100,P,,,,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626634,13053,BAO_0000100,P,,,,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626635,13054,BAO_0000100,P,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626636,13055,BAO_0000100,P,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626637,13056,BAO_0000100,P,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,0,,U,22229,,,8194,,,1
,CHEMBL626638,13057,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL626639,13058,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL626640,13059,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL626641,13060,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL627272,13061,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL627273,13062,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL627441,13063,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL628355,13064,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL628356,13065,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL628357,13066,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL628358,13067,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL622307,13068,BAO_0000218,A,,,4754.0,,Pneumocystis carinii,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Intermediate,1,,N,50339,,,13273,,,1
,CHEMBL622527,13069,BAO_0000019,A,,,,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622528,13070,BAO_0000019,A,,,,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622529,13071,BAO_0000019,A,,,,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622992,13072,BAO_0000019,A,,,,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622993,13073,BAO_0000019,A,,,,,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622994,13074,BAO_0000019,A,,,,,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,Autocuration,0,,U,22224,,,13118,,,1
,CHEMBL622995,13075,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Intermediate,1,,N,50597,,,10633,,,1
,CHEMBL622996,13076,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Intermediate,1,,N,50597,,,10633,,,1
,CHEMBL622997,13077,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Intermediate,1,,N,50597,,,10633,,,1
,CHEMBL622998,13078,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Intermediate,1,,N,50597,,,10633,,,1
,CHEMBL622999,13079,BAO_0000218,A,,,,,,,Cp max following ip administration at 1 mg/kg,Autocuration,0,,U,22224,,,5767,,,1
,CHEMBL623000,13080,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma was reported at 0.5 hour,Autocuration,0,,U,22224,1969.0,,3302,In vivo,,1
,CHEMBL623001,13081,BAO_0000218,A,,,,Plasma,,,Maximum concentration in plasma was reported at 2 hour,Autocuration,0,,U,22224,1969.0,,3302,In vivo,,1
,CHEMBL623002,13082,BAO_0000218,A,,,10090.0,,Mus musculus,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Intermediate,1,,N,50594,,,12467,,,1
,CHEMBL623003,13083,BAO_0000100,P,,,,,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),Autocuration,0,,U,22229,,,11778,,,1
,CHEMBL623004,13084,BAO_0000019,A,,,,,,,Steady state concentration was evaluated,Autocuration,0,,U,22224,,,4321,,,1
,CHEMBL623005,13085,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,14884,,,1
,CHEMBL623006,13086,BAO_0000019,A,,,,,,,Partition coefficient (logD7.4),Autocuration,0,,U,22224,,,15234,,,1
,CHEMBL623007,13087,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,1,,N,50597,2107.0,,14198,In vivo,,1
,CHEMBL623008,13088,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,1,,N,50597,10000001.0,,14198,In vivo,,1
,CHEMBL876654,13089,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,1,,N,50597,2037.0,,14198,In vivo,,1
,CHEMBL623009,13090,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL623010,13091,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL623011,13092,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,1,,N,50597,948.0,,14198,In vivo,,1
,CHEMBL623012,13093,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,1,,N,50597,160.0,,14198,In vivo,,1
,CHEMBL623013,13094,BAO_0000019,A,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Autocuration,0,,U,22224,,,8151,,,1
,CHEMBL623014,13095,BAO_0000019,A,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,0,,U,22224,,,8151,,,1
,CHEMBL623015,13096,BAO_0000019,A,,,,Urine,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,Autocuration,0,,U,22224,1088.0,,8151,,,1
,CHEMBL623016,13097,BAO_0000019,A,,,,Urine,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Autocuration,0,,U,22224,1088.0,,8151,,,1
,CHEMBL624858,13098,BAO_0000019,A,,,,Urine,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,Autocuration,0,,U,22224,1088.0,,8151,,,1
,CHEMBL624859,13099,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL624860,13100,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL624861,13101,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL624862,13102,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL624863,13103,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL876655,13104,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,1,,N,50597,,,8151,,,1
,CHEMBL624864,13105,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624865,13106,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624866,13107,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL624867,13108,BAO_0000218,F,,,9615.0,,Canis lupus familiaris,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Expert,1,,N,50588,,,6996,,,1
,CHEMBL624868,13109,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628450,13110,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628451,13111,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628452,13112,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628453,13113,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628454,13114,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628455,13115,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628456,13116,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628457,13117,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL877505,13118,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628458,13119,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628459,13120,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628460,13121,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628461,13122,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL628462,13123,BAO_0000218,B,,,,,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",Autocuration,0,,U,22224,,,6996,,,1
,CHEMBL628463,13124,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL625666,13125,BAO_0000218,F,,,10116.0,,Rattus norvegicus,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Expert,1,,N,50597,,,6996,,,1
,CHEMBL625667,13126,BAO_0000218,B,,,,,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Autocuration,0,,U,22224,,,6996,,,1
,CHEMBL625668,13127,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Expert,1,,N,50597,,,6996,,,1
,CHEMBL625669,13128,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL625670,13129,BAO_0000019,A,,,,,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,Autocuration,0,,U,22224,,,7114,,,1
,CHEMBL625671,13130,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Intermediate,1,,N,50597,,,7114,,,1
,CHEMBL625672,13131,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL625673,13132,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL625674,13133,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL625675,13134,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL627637,13135,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL627638,13136,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL627639,13137,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL627640,13138,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL627641,13139,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL627642,13140,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL877506,13141,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL627275,13142,BAO_0000218,A,,,10090.0,,Mus musculus,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,1,,N,50594,,,8613,,,1
,CHEMBL627643,13143,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Intermediate,1,,N,50506,,,11219,,,1
,CHEMBL631246,13144,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,1,,N,50506,,,11219,,,1
,CHEMBL631247,13145,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,1,,N,50506,,,11219,,,1
,CHEMBL629532,13146,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,1,,N,50506,,,11219,,,1
,CHEMBL629533,13147,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Intermediate,1,,N,50506,,,11219,,,1
,CHEMBL629534,13148,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,1,,N,50506,,,11219,,,1
,CHEMBL629535,13149,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Intermediate,1,,N,50506,,,11219,,,1
,CHEMBL625932,13150,BAO_0000019,A,,,,,,,Pharmacokinetic parameter :drug bound to plasma was reported,Autocuration,0,,U,22224,,,14837,,,1
,CHEMBL625933,13151,BAO_0000019,A,,,,,,,compound was evaluated for drug bound in plasma,Autocuration,0,,U,22224,,,14837,,,1
,CHEMBL625934,13152,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Intermediate,1,,N,50597,,,15343,,,1
,CHEMBL625935,13153,BAO_0000218,A,,,9347.0,,Eutheria,,Bioavailability,Autocuration,0,,U,22224,,,13761,,,1
,CHEMBL625936,13154,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Intermediate,1,,N,50597,,,14810,,,1
,CHEMBL625937,13155,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Intermediate,1,,N,50597,,,14810,,,1
,CHEMBL625938,13156,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,1,,N,50588,,,13249,,,1
,CHEMBL625939,13157,BAO_0000218,A,,,10116.0,Bile,Rattus norvegicus,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Intermediate,1,,N,50597,1970.0,,9267,,,1
,CHEMBL625940,13158,BAO_0000218,A,,,10116.0,Bile,Rattus norvegicus,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Intermediate,1,,N,50597,1970.0,,9267,,,1
,CHEMBL874464,13159,BAO_0000218,A,,,10116.0,Bile,Rattus norvegicus,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Intermediate,1,,N,50597,1970.0,,9267,,,1
,CHEMBL625941,13160,BAO_0000218,A,,,10116.0,Bile,Rattus norvegicus,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Intermediate,1,,N,50597,1970.0,,9267,,,1
,CHEMBL625942,13161,BAO_0000218,A,,,10116.0,Bile,Rattus norvegicus,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Intermediate,1,,N,50597,1970.0,,9267,,,1
,CHEMBL625943,13162,BAO_0000218,A,,,10116.0,Bile,Rattus norvegicus,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Intermediate,1,,N,50597,1970.0,,9267,,,1
,CHEMBL625944,13163,BAO_0000218,A,,,9606.0,Serum,Homo sapiens,,In vitro protein binding in human serum at 5 ug/ml,Intermediate,1,,N,50587,1977.0,,15549,,,1
,CHEMBL625945,13164,BAO_0000019,A,,,,,,,Serum protein binding ability was measured,Autocuration,0,,U,22224,,,10929,,,1
,CHEMBL625946,13165,BAO_0000019,A,,,,,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),Autocuration,0,,U,22224,,,15444,,,1
,CHEMBL625947,13166,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral bioavailability in dog,Autocuration,0,,U,22224,,,12860,In vivo,,1
,CHEMBL625948,13167,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Intermediate,1,,N,50597,,,12170,In vivo,,1
,CHEMBL625949,13168,BAO_0000218,A,,,,,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL625950,13169,BAO_0000218,A,,,,,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL625951,13170,BAO_0000218,A,,,9347.0,,Eutheria,,Oral bioavailability (dose 15 mg/kg i.v.),Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL625952,13171,BAO_0000218,A,,,,,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL625953,13172,BAO_0000218,A,,,,,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL625954,13173,BAO_0000218,A,,,,,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL882959,13174,BAO_0000218,A,,,,,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL625955,13175,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Intermediate,1,,N,50588,,,11767,In vivo,,1
,CHEMBL625956,13176,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Bioavailability in ferret,Autocuration,0,,U,22224,,,11219,In vivo,,1
,CHEMBL625957,13177,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Intermediate,1,,N,100710,,,12186,In vivo,,1
,CHEMBL625958,13178,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL625959,13179,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626642,13180,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL631330,13181,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL631331,13182,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL631332,13183,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL631333,13184,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632018,13185,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632019,13186,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632020,13187,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632021,13188,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632022,13189,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632023,13190,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632024,13191,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL874472,13192,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632025,13193,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632026,13194,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632027,13195,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL632028,13196,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626430,13197,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626431,13198,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626432,13199,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626433,13200,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626434,13201,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627280,13202,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627281,13203,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627282,13204,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627283,13205,BAO_0000019,A,,,,,,,Total body clearance was measured at given dose,Autocuration,0,,U,22224,,,7199,,,1
,CHEMBL627284,13206,BAO_0000218,A,,,,,,,Total body clearance was measured at given dose.,Autocuration,0,,U,22224,,,7199,,,1
,CHEMBL627285,13207,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Metabolic clearance from the body in rat,Intermediate,1,,N,50597,,,7095,,,1
,CHEMBL627286,13208,BAO_0000218,A,,,,,,,Renal clearance from the body,Autocuration,0,,U,22224,,,7095,In vivo,,1
,CHEMBL875477,13209,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Renal clearance from the body in rat,Intermediate,1,,N,50597,,,7095,In vivo,,1
,CHEMBL627287,13210,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Intermediate,1,,N,50597,,,12528,In vivo,,1
,CHEMBL627288,13211,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Intermediate,1,,N,50588,,,12528,In vivo,,1
,CHEMBL627289,13212,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total clearance from the body in rat,Intermediate,1,,N,50597,,,7095,,,1
,CHEMBL627290,13213,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Clearance into cortex from rat plasma or PBS,Intermediate,1,,N,50597,1969.0,,14223,In vivo,,1
,CHEMBL627291,13214,BAO_0000218,A,,,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,Autocuration,0,,U,22224,,,13569,In vivo,,1
,CHEMBL627292,13215,BAO_0000218,A,,,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,Autocuration,0,,U,22224,,,13569,In vivo,,1
,CHEMBL627293,13216,BAO_0000218,A,,,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,Autocuration,0,,U,22224,,,13569,In vivo,,1
,CHEMBL627294,13217,BAO_0000218,A,,,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Autocuration,0,,U,22224,,,13569,In vivo,,1
,CHEMBL875478,13218,BAO_0000218,A,,,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,Autocuration,0,,U,22224,,,13569,In vivo,,1
,CHEMBL627295,13219,BAO_0000218,A,,,,,,,Clearance was determined,Autocuration,0,,U,22224,,,13979,In vivo,,1
,CHEMBL627296,13220,BAO_0000218,A,,,10090.0,,Mus musculus,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Intermediate,1,,N,50594,,,14315,In vivo,,1
,CHEMBL626119,13221,BAO_0000218,A,,,9986.0,,Oryctolagus cuniculus,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Intermediate,1,,N,50592,,,14315,In vivo,,1
,CHEMBL626120,13222,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Intermediate,1,,N,50597,,,14315,In vivo,,1
,CHEMBL626121,13223,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance in rat after iv dose (100 ug/kg),Intermediate,1,,N,50597,,,12174,In vivo,,1
,CHEMBL626122,13224,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Clearance in guinea pig,Autocuration,0,,U,22224,,,12797,In vivo,,1
,CHEMBL626123,13225,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for clearance in rat,Intermediate,1,,N,50597,,,12797,In vivo,,1
,CHEMBL623456,13226,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for the clearance in dog,Intermediate,1,,N,50588,,,12797,In vivo,,1
,CHEMBL623457,13227,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the clearance in rat,Intermediate,1,,N,50597,,,12797,In vivo,,1
,CHEMBL623458,13228,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested in vivo for clearance after iv administration in the rat,Intermediate,1,,N,50597,,,11500,In vivo,,1
,CHEMBL623459,13229,BAO_0000218,A,,,,,,,IV clearance determined at an iv dose of 14 mg/kg,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL875484,13230,BAO_0000218,A,,,,,,,IV clearance determined at an iv dose of 15.2 mg/kg,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL623460,13231,BAO_0000218,A,,,,,,,IV clearance determined at an iv dose of 15 mg/kg,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL623461,13232,BAO_0000218,A,,,,,,,IV clearance determined at an peroral dose of 30 mg/kg.,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL623462,13233,BAO_0000218,A,,,,,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL627386,13234,BAO_0000218,A,,,,,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL627387,13235,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,1,,N,50597,2113.0,,14198,In vivo,,1
,CHEMBL627388,13236,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,1,,N,50597,2107.0,,14198,In vivo,,1
,CHEMBL627389,13237,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,1,,N,50597,2048.0,,14198,In vivo,,1
,CHEMBL627390,13238,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,1,,N,50597,2385.0,,14198,In vivo,,1
,CHEMBL627391,13239,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,1,,N,50597,1969.0,,14198,In vivo,,1
,CHEMBL627392,13240,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL627393,13241,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,1,,N,50597,2106.0,,14198,In vivo,,1
,CHEMBL627394,13242,BAO_0000218,A,,,10116.0,Trachea,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,1,,N,50597,3126.0,,14198,In vivo,,1
,CHEMBL627395,13243,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,1,,N,50597,10000001.0,,14198,In vivo,,1
,CHEMBL875485,13244,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,1,,N,50597,2037.0,,14198,In vivo,,1
,CHEMBL627396,13245,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL627397,13246,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL627398,13247,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,1,,N,50597,948.0,,14198,In vivo,,1
,CHEMBL627399,13248,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Intermediate,1,,N,50597,10000001.0,,14198,In vivo,,1
,CHEMBL627400,13249,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,1,,N,50597,2113.0,,14198,In vivo,,1
,CHEMBL627401,13250,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,1,,N,50597,2107.0,,14198,In vivo,,1
,CHEMBL627402,13251,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,1,,N,50597,2048.0,,14198,In vivo,,1
,CHEMBL627403,13252,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,1,,N,50597,2385.0,,14198,In vivo,,1
,CHEMBL627404,13253,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,1,,N,50597,1969.0,,14198,In vivo,,1
,CHEMBL623101,13254,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL877480,13255,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,1,,N,50597,2106.0,,14198,In vivo,,1
,CHEMBL623102,13256,BAO_0000218,A,,,10116.0,Trachea,Rattus norvegicus,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,1,,N,50597,3126.0,,14198,In vivo,,1
,CHEMBL623103,13257,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,1,,N,50597,10000001.0,,14198,In vivo,,1
,CHEMBL623104,13258,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,1,,N,50597,2037.0,,14198,In vivo,,1
,CHEMBL623105,13259,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL623106,13260,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL623107,13261,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,1,,N,50597,948.0,,14198,In vivo,,1
,CHEMBL623108,13262,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,1,,N,50597,160.0,,14198,In vivo,,1
,CHEMBL623109,13263,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,1,,N,50597,2113.0,,14198,In vivo,,1
,CHEMBL623110,13264,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,1,,N,50597,2107.0,,14198,In vivo,,1
,CHEMBL623111,13265,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,1,,N,50597,2048.0,,14198,In vivo,,1
,CHEMBL625060,13266,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,1,,N,50597,2385.0,,14198,In vivo,,1
,CHEMBL625061,13267,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,1,,N,50597,1969.0,,14198,In vivo,,1
,CHEMBL625062,13268,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL625063,13269,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,1,,N,50597,2106.0,,14198,In vivo,,1
,CHEMBL625064,13270,BAO_0000218,A,,,10116.0,Trachea,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,1,,N,50597,3126.0,,14198,In vivo,,1
,CHEMBL625065,13271,BAO_0000218,A,,,10116.0,Bone,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,1,,N,50597,10000001.0,,14198,In vivo,,1
,CHEMBL625066,13272,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,1,,N,50597,2037.0,,14198,In vivo,,1
,CHEMBL625067,13273,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL625068,13274,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL622159,13275,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,1,,N,50597,948.0,,14198,In vivo,,1
,CHEMBL622160,13276,BAO_0000218,A,,,10116.0,Intestine,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Intermediate,1,,N,50597,160.0,,14198,In vivo,,1
,CHEMBL622161,13277,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,1,,N,50597,2113.0,,14198,In vivo,,1
,CHEMBL622162,13278,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,1,,N,50597,2048.0,,14198,In vivo,,1
,CHEMBL622163,13279,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,1,,N,50597,2385.0,,14198,In vivo,,1
,CHEMBL622313,13280,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,1,,N,50597,1969.0,,14198,In vivo,,1
,CHEMBL622314,13281,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,1,,N,50597,,,14198,In vivo,,1
,CHEMBL622315,13282,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,1,,N,50597,2106.0,,14198,In vivo,,1
,CHEMBL622316,13283,BAO_0000218,A,,,10116.0,Trachea,Rattus norvegicus,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,1,,N,50597,3126.0,,14198,In vivo,,1
,CHEMBL877486,13284,BAO_0000218,A,,,562.0,,Escherichia coli,,Normal diffusion coefficient in water for Escherichia coli,Intermediate,1,,N,50212,,,15599,,,1
,CHEMBL622317,13285,BAO_0000019,A,,,,,,,Average max percent decrease in RVR (renal vascular resistance) was determined,Autocuration,0,,U,22224,,,8204,,,1
,CHEMBL622318,13286,BAO_0000019,A,,,,,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,Autocuration,0,,U,22224,,,8204,,,1
,CHEMBL622319,13287,BAO_0000019,A,,,,,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL622320,13288,BAO_0000019,A,,,,,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL622321,13289,BAO_0000019,A,,,,,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL622322,13290,BAO_0000019,A,,,,,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL622323,13291,BAO_0000019,A,,,,,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,Autocuration,0,,U,22224,,,7114,,,1
,CHEMBL622324,13292,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Intermediate,1,,N,50597,,,7114,,,1
,CHEMBL622325,13293,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622326,13294,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL877487,13295,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622327,13296,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622328,13297,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622329,13298,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622330,13299,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622331,13300,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622332,13301,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL622333,13302,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL627658,13303,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL630428,13304,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL630429,13305,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL630430,13306,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL630431,13307,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL630432,13308,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL630433,13309,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL630434,13310,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629372,13311,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629553,13312,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629554,13313,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL874447,13314,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629555,13315,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629556,13316,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629557,13317,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629558,13318,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629559,13319,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629560,13320,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629561,13321,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629562,13322,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629563,13323,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629564,13324,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629565,13325,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629566,13326,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629567,13327,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629568,13328,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629569,13329,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629570,13330,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL629571,13331,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL629572,13332,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,0,,U,22224,,,12170,In vivo,,1
,CHEMBL629573,13333,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,0,,U,22224,,,12170,In vivo,,1
,CHEMBL629574,13334,BAO_0000218,A,,,9347.0,,Eutheria,,Bioavailability (dose 20 mg/kg),Autocuration,0,,U,22224,,,4985,In vivo,,1
,CHEMBL629575,13335,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Bioavailability in dog,Autocuration,0,,U,22224,,,15145,In vivo,,1
,CHEMBL874448,13336,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (Sprague-Dawley) (male),Autocuration,0,,U,22224,,,14080,In vivo,,1
,CHEMBL629576,13337,BAO_0000218,A,,,9443.0,,Primates,,Bioavailability in monkey (dose 10 mg/kg i.d.),Autocuration,0,,U,22224,,,11219,In vivo,,1
,CHEMBL629577,13338,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Autocuration,0,,U,22224,,,15145,In vivo,,1
,CHEMBL629578,13339,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Autocuration,0,,U,22224,,,15145,In vivo,,1
,CHEMBL629579,13340,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Bioavailability in dog (dose 3.0 mg/kg p.o.),Autocuration,0,,U,22224,,,1202,In vivo,,1
,CHEMBL882958,13341,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Autocuration,0,,U,22224,,,1202,In vivo,,1
,CHEMBL629580,13342,BAO_0000218,A,,,9598.0,,Pan troglodytes,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Intermediate,1,,N,50505,,,1202,In vivo,,1
,CHEMBL629581,13343,BAO_0000218,A,,,9347.0,,Eutheria,,Bioavailability,Autocuration,0,,U,22224,,,4026,In vivo,,1
,CHEMBL629582,13344,BAO_0000218,A,,,9520.0,,Saimiri,,Bioavailability in squirrel monkey,Autocuration,0,,U,22224,,,1492,In vivo,,1
,CHEMBL628522,13345,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Bioavailability was evaluated in dog,Intermediate,1,,N,50588,,,12793,In vivo,,1
,CHEMBL625432,13346,BAO_0000218,A,,,10026.0,,Cricetinae,,Bioavailability was evaluated in hamster,Intermediate,1,,N,100712,,,12793,In vivo,,1
,CHEMBL625433,13347,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat,Autocuration,0,,U,22224,,,12793,In vivo,,1
,CHEMBL625434,13348,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,1,,N,50597,1969.0,,14793,In vivo,,1
,CHEMBL625435,13349,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Intermediate,1,,N,50597,1969.0,,14793,In vivo,,1
,CHEMBL625436,13350,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 10 mg/kg p.o.),Autocuration,0,,U,22224,,,14793,In vivo,,1
,CHEMBL874588,13351,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Bioavailability was measured in cynomolgus monkeys.,Intermediate,1,,N,100710,,,14731,In vivo,,1
,CHEMBL625437,13352,BAO_0000218,A,,,10090.0,,Mus musculus,,Bioavailability was measured in nude mice.,Intermediate,1,,N,50594,,,14731,In vivo,,1
,CHEMBL625438,13353,BAO_0000218,A,,,9669.0,,Mustela putorius furo,,Bioavailability in ferret (dose 10 mg/kg i.d.),Autocuration,0,,U,22224,,,12187,In vivo,,1
,CHEMBL625439,13354,BAO_0000218,A,,,314293.0,,Simiiformes,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Autocuration,0,,U,22224,,,12187,In vivo,,1
,CHEMBL625440,13355,BAO_0000218,A,,,314293.0,,Simiiformes,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Autocuration,0,,U,22224,,,12187,In vivo,,1
,CHEMBL625441,13356,BAO_0000218,A,,,314293.0,,Simiiformes,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Autocuration,0,,U,22224,,,12187,In vivo,,1
,CHEMBL625442,13357,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,0,,U,22224,,,12187,In vivo,,1
,CHEMBL625443,13358,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,1,,N,50597,,,12187,In vivo,,1
,CHEMBL625444,13359,BAO_0000218,A,,,,,,,Bioavailability was determined; extremely poor,Autocuration,0,,U,22224,,,17431,In vivo,,1
,CHEMBL625445,13360,BAO_0000218,A,,,10090.0,,Mus musculus,,% bioavailability in mice after oral administration of prodrug,Intermediate,1,,N,50594,,,13318,In vivo,,1
,CHEMBL625446,13361,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL882960,13362,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625447,13363,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625448,13364,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625449,13365,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL874589,13366,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625450,13367,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625451,13368,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626584,13369,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626585,13370,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626586,13371,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626587,13372,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626588,13373,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626589,13374,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626590,13375,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626591,13376,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL627181,13377,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628083,13378,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628084,13379,BAO_0000218,A,,,,,,,IV clearance determined at an peroral dose of 15 mg/kg.,Autocuration,0,,U,22224,,,15173,In vivo,,1
,CHEMBL628085,13380,BAO_0000218,F,,,102285.0,,Hymenolepis nana,,Mouse oral clearance was measured against Hymenolepiasis nana.,Expert,1,,N,50064,,,7732,In vivo,,1
,CHEMBL628086,13381,BAO_0000218,F,,,6339.0,,Heligmosomoides polygyrus,,Mouse oral clearance was measured against Nematospiroides dubius,Expert,1,,N,50545,,,7732,In vivo,,1
,CHEMBL628087,13382,BAO_0000218,F,,,,,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,Autocuration,0,,U,22224,,,7732,In vivo,,1
,CHEMBL628088,13383,BAO_0000218,A,,,10090.0,,Mus musculus,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Intermediate,1,,N,50594,,,7732,In vivo,,1
,CHEMBL628089,13384,BAO_0000218,B,,,,,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Autocuration,0,,U,22224,,,7732,In vivo,,1
,CHEMBL628090,13385,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL628091,13386,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL628092,13387,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL628093,13388,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL875607,13389,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL625710,13390,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL625711,13391,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL625712,13392,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL625713,13393,BAO_0000218,A,,,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,0,,U,22224,,,8328,In vivo,,1
,CHEMBL625714,13394,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Intermediate,1,,N,50588,,,13376,In vivo,,1
,CHEMBL625715,13395,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Intermediate,1,,N,50797,,,13477,In vivo,,1
,CHEMBL625716,13396,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Intermediate,1,,N,50597,,,13477,In vivo,,1
,CHEMBL625717,13397,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Intermediate,1,,N,50597,,,13477,In vivo,,1
,CHEMBL625718,13398,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance was determined for the compound in rats,Intermediate,1,,N,50597,,,13313,In vivo,,1
,CHEMBL625719,13399,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,1,,N,50597,,,12504,In vivo,,1
,CHEMBL625720,13400,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,1,,N,50597,,,12504,In vivo,,1
,CHEMBL625721,13401,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,1,,N,50597,,,12504,In vivo,,1
,CHEMBL625722,13402,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,1,,N,50597,,,12504,In vivo,,1
,CHEMBL625723,13403,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,1,,N,50597,,,13129,In vivo,,1
,CHEMBL625724,13404,BAO_0000218,A,,,6339.0,,Heligmosomoides polygyrus,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Intermediate,1,,N,50545,,,7732,In vivo,,1
,CHEMBL625725,13405,BAO_0000218,A,,,6339.0,,Heligmosomoides polygyrus,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Intermediate,1,,N,50545,,,7732,In vivo,,1
,CHEMBL625726,13406,BAO_0000218,A,,,6339.0,,Heligmosomoides polygyrus,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Intermediate,1,,N,50545,,,7732,In vivo,,1
,CHEMBL875608,13407,BAO_0000218,A,,,6339.0,,Heligmosomoides polygyrus,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Intermediate,1,,N,50545,,,7732,In vivo,,1
,CHEMBL625727,13408,BAO_0000218,A,,,6339.0,,Heligmosomoides polygyrus,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Intermediate,1,,N,50545,,,7732,In vivo,,1
,CHEMBL625728,13409,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Autocuration,0,,U,22224,1088.0,,9278,In vivo,,1
,CHEMBL625729,13410,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,0,,U,22224,,,9278,In vivo,,1
,CHEMBL625730,13411,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Autocuration,0,,U,22224,,,9278,In vivo,,1
,CHEMBL625731,13412,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,0,,U,22224,1088.0,,9278,In vivo,,1
,CHEMBL626417,13413,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Urinary clearance was determined in rat at 25 mg/kg os dosage,Autocuration,0,,U,22224,1088.0,,9278,In vivo,,1
,CHEMBL626418,13414,BAO_0000218,A,,,9606.0,Urine,Homo sapiens,,Urinary clearance was determined at 100 mg/kg oral dosage in human,Intermediate,1,,N,50587,1088.0,,9278,In vivo,,1
,CHEMBL626419,13415,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Intermediate,1,,N,50588,1088.0,,9278,In vivo,,1
,CHEMBL626592,13416,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Intermediate,1,,N,50588,1969.0,,5932,In vivo,,1
,CHEMBL626593,13417,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,1,,N,50597,1969.0,,5932,In vivo,,1
,CHEMBL626594,13418,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,1,,N,50597,,,5182,In vivo,,1
,CHEMBL625035,13419,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Clearance rate in dogs,Intermediate,1,,N,50588,,,10499,In vivo,,1
,CHEMBL625036,13420,BAO_0000019,A,,,,,,,Compound was measured for intrinsic clearance,Autocuration,0,,U,22224,,,6051,In vitro,,1
,CHEMBL625037,13421,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,17508,,,1
,CHEMBL625038,13422,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6228,,,1
,CHEMBL625039,13423,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6231,,,1
,CHEMBL625040,13424,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,17740,,,1
,CHEMBL625041,13425,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6495,,,1
,CHEMBL625042,13426,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,2171,,,1
,CHEMBL874411,13427,BAO_0000019,A,,,,,,,Partition coefficient of the compound,Autocuration,0,,U,22224,,,3255,,,1
,CHEMBL625043,13428,BAO_0000019,A,,,,,,,Permeability,Autocuration,0,,U,22224,,,6821,,,1
,CHEMBL625044,13429,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,2685,,,1
,CHEMBL625045,13430,BAO_0000019,A,,,,,,,Partition coefficient (logD),Autocuration,0,,U,22224,,,17584,,,1
,CHEMBL625046,13431,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,0,,U,22229,,,13824,,,1
,CHEMBL625047,13432,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,0,,U,22229,,,13824,,,1
,CHEMBL625048,13433,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,16479,,,1
,CHEMBL625049,13434,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,11997,,,1
,CHEMBL625050,13435,BAO_0000100,P,,,,,,,Calculated logarithm of partition coefficient (P) was determined,Autocuration,0,,U,22229,,,2988,,,1
,CHEMBL625051,13436,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,931,,,1
,CHEMBL874412,13437,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,4381,,,1
,CHEMBL625052,13438,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,4397,,,1
,CHEMBL625053,13439,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,5889,,,1
,CHEMBL623250,13440,BAO_0000019,A,,,,,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL623251,13441,BAO_0000019,A,,,,,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL623252,13442,BAO_0000019,A,,,,,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL623253,13443,BAO_0000019,A,,,,,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL623254,13444,BAO_0000019,A,,,,,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL623255,13445,BAO_0000019,A,,,,,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,Autocuration,0,,U,22224,,,6154,,,1
,CHEMBL626831,13446,BAO_0000019,A,,,,,,,Percent degradation of compound at a pH of 1 over a 18 hr period,Autocuration,0,,U,22224,,,6887,,,1
,CHEMBL877494,13447,BAO_0000019,A,,,,,,,Percent degradation of compound at pH of 1 over an 18 hr period,Autocuration,0,,U,22224,,,6887,,,1
,CHEMBL626832,13448,BAO_0000019,A,,,,,,,Delta Logarithm of Partition Coefficient value was determined.,Autocuration,0,,U,22224,,,14116,,,1
,CHEMBL626833,13449,BAO_0000019,A,,,,,,,Delta logPoct-cyc,Autocuration,0,,U,22224,,,11137,,,1
,CHEMBL626834,13450,BAO_0000100,P,,,,,,,Lipophilicity estimated on reversed phase TLC,Autocuration,0,,U,22224,,,7230,,,1
,CHEMBL626835,13451,BAO_0000019,A,,,,,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,Autocuration,0,,U,22224,,,15741,,,1
,CHEMBL626836,13452,BAO_0000019,A,,,,,,,Delta logPoct-cyc,Autocuration,0,,U,22224,,,9663,,,1
,CHEMBL626837,13453,BAO_0000100,P,,,,,,,Change in logarithm of partition coefficient of the compound,Autocuration,0,,U,22229,,,9663,,,1
,CHEMBL626838,13454,BAO_0000019,A,,,,,,,Delta logD (pH 6.5),Autocuration,0,,U,22224,,,13807,,,1
,CHEMBL626839,13455,BAO_0000100,P,,,,,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",Autocuration,0,,U,22224,,,13807,,,1
,CHEMBL626840,13456,BAO_0000019,A,,,,,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,Autocuration,0,,U,22224,,,17425,,,1
,CHEMBL626841,13457,BAO_0000019,A,,,,,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),Autocuration,0,,U,22224,,,12143,,,1
,CHEMBL626842,13458,BAO_0000219,A,,,,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,Autocuration,0,,U,22224,,,12608,,,1
,CHEMBL626843,13459,BAO_0000219,A,,,,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,Autocuration,0,,U,22224,,,12608,,,1
,CHEMBL626844,13460,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Intermediate,1,,N,50597,,,8649,,,1
,CHEMBL877495,13461,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Amount of deuterium retained was reported after normal workup in rats,Intermediate,1,,N,50597,,,8649,,,1
,CHEMBL626845,13462,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Intermediate,1,,N,50597,,,8649,,,1
,CHEMBL626846,13463,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Intermediate,1,,N,50597,,,8649,,,1
,CHEMBL626847,13464,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,1,,N,50597,,,8649,,,1
,CHEMBL628677,13465,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,1,,N,50597,,,8649,,,1
,CHEMBL628678,13466,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Intermediate,1,,N,50597,,,8649,,,1
,CHEMBL628679,13467,BAO_0000019,A,,,,,,,Compound was subjected to electrochemical oxidation,Autocuration,0,,U,22224,,,9659,,,1
,CHEMBL628680,13468,BAO_0000019,A,,,,,,,Compound was subjected to photochemical oxidation,Autocuration,0,,U,22224,,,9659,,,1
,CHEMBL628681,13469,BAO_0000019,A,,,,,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,Autocuration,0,,U,22224,,,9659,,,1
,CHEMBL628682,13470,BAO_0000019,A,,,,,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,Autocuration,0,,U,22224,,,9659,,,1
,CHEMBL628683,13471,BAO_0000019,A,,,,,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,Autocuration,0,,U,22224,,,9659,,,1
,CHEMBL628684,13472,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Percent diffusion through fuzzy rat skin after 48 h of incubation,Intermediate,1,,N,50597,,,9607,,,1
,CHEMBL877501,13473,BAO_0000100,P,,,,,,,Dissociation constant (pKa),Autocuration,0,,U,22229,,,7057,,,1
,CHEMBL628685,13474,BAO_0000100,P,,,,,,,Dissociation constant value of the compound; ND means not determined.,Autocuration,0,,U,22224,,,7057,,,1
,CHEMBL628686,13475,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Intermediate,1,,N,50597,178.0,,7911,,,1
,CHEMBL628687,13476,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,1,,N,50597,178.0,,7911,,,1
,CHEMBL628688,13477,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Intermediate,1,,N,50597,,,7911,,,1
,CHEMBL628689,13478,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,1,,N,50597,,,7911,,,1
,CHEMBL628690,13479,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Intermediate,1,,N,50597,2107.0,,7911,,,1
,CHEMBL629363,13480,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,1,,N,50597,2107.0,,7911,,,1
,CHEMBL629364,13481,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Intermediate,1,,N,50597,2106.0,,7911,,,1
,CHEMBL629365,13482,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,1,,N,50597,2106.0,,7911,,,1
,CHEMBL629366,13483,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Intermediate,1,,N,50597,,,7911,,,1
,CHEMBL629367,13484,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Intermediate,1,,N,50597,1088.0,,7911,,,1
,CHEMBL629368,13485,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,1,,N,50597,1988.0,,7911,,,1
,CHEMBL877502,13486,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,1,,N,50597,1088.0,,7911,,,1
,CHEMBL629369,13487,BAO_0000218,A,,,10090.0,Cerebellum,Mus musculus,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Intermediate,1,,N,50594,2037.0,,13792,,,1
,CHEMBL629370,13488,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL629371,13489,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL626276,13490,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL626277,13491,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL631250,13492,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL631251,13493,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL631252,13494,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL631253,13495,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL631254,13496,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL631255,13497,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL631256,13498,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL631257,13499,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628009,13500,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628010,13501,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628011,13502,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628012,13503,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628013,13504,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628014,13505,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628015,13506,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628016,13507,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL874461,13508,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628017,13509,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628018,13510,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628019,13511,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628020,13512,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628021,13513,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628022,13514,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628023,13515,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,1,,N,50588,1088.0,,8133,,,1
,CHEMBL628024,13516,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL628025,13517,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL628026,13518,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL628027,13519,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL628028,13520,BAO_0000218,A,,,314293.0,Urine,Simiiformes,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,0,,U,22224,1088.0,,8133,,,1
,CHEMBL628029,13521,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628030,13522,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628031,13523,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628032,13524,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628033,13525,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628034,13526,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628035,13527,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628036,13528,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL874462,13529,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL628037,13530,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628123,13531,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628124,13532,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628125,13533,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628126,13534,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628127,13535,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628128,13536,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628129,13537,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628130,13538,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628131,13539,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628132,13540,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628133,13541,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628134,13542,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628135,13543,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628136,13544,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628137,13545,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628138,13546,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628139,13547,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628140,13548,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628141,13549,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628142,13550,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628143,13551,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628144,13552,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628145,13553,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL628146,13554,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625355,13555,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625356,13556,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625357,13557,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625527,13558,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL875473,13559,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL625528,13560,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Intermediate,1,,N,50588,,,9025,In vivo,,1
,CHEMBL626304,13561,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Intermediate,1,,N,50597,,,9025,In vivo,,1
,CHEMBL624138,13562,BAO_0000218,A,,,9615.0,Artery,Canis lupus familiaris,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Intermediate,1,,N,50588,1637.0,,9025,In vivo,,1
,CHEMBL624139,13563,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6448,,,1
,CHEMBL624140,13564,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,17221,,,1
,CHEMBL624141,13565,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6545,,,1
,CHEMBL624142,13566,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,577,,,1
,CHEMBL624143,13567,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6285,,,1
,CHEMBL624144,13568,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6500,,,1
,CHEMBL624145,13569,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6716,,,1
,CHEMBL624146,13570,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,13658,,,1
,CHEMBL624147,13571,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6549,,,1
,CHEMBL883123,13572,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (MacLogP),Autocuration,0,,U,22229,,,14685,,,1
,CHEMBL624148,13573,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,6893,,,1
,CHEMBL874416,13574,BAO_0000019,A,,,,,,,Kinetic parameter was determined,Autocuration,0,,U,22224,,,3687,,,1
,CHEMBL624149,13575,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,4207,,,1
,CHEMBL624150,13576,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,4626,,,1
,CHEMBL624151,13577,BAO_0000100,P,,,,,,,Lipophilicity was determined,Autocuration,0,,U,22224,,,1021,,,1
,CHEMBL624152,13578,BAO_0000100,P,,,,,,,Lipophilicity was determined,Autocuration,0,,U,22224,,,3777,,,1
,CHEMBL622139,13579,BAO_0000100,P,,,,,,,Lipophilicity was determined,Autocuration,0,,U,22224,,,17533,,,1
,CHEMBL622140,13580,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,6524,,,1
,CHEMBL622141,13581,BAO_0000100,P,,,,,,,Lipophilicity was determined,Autocuration,0,,U,22224,,,17533,,,1
,CHEMBL622142,13582,BAO_0000100,P,,,,,,,Lipophilicity in octanol-water,Autocuration,0,,U,22224,,,6480,,,1
,CHEMBL622143,13583,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,17606,,,1
,CHEMBL622144,13584,BAO_0000100,P,,,,,,,Octanol-water partition coefficient was determined,Autocuration,0,,U,22229,,,6863,,,1
,CHEMBL877473,13585,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,1356,,,1
,CHEMBL622145,13586,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,3326,,,1
,CHEMBL622146,13587,BAO_0000019,A,,,,,,,Partition coefficient was determined; ND means not determined,Autocuration,0,,U,22224,,,1356,,,1
,CHEMBL622147,13588,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP),Autocuration,0,,U,22229,,,12984,,,1
,CHEMBL622148,13589,BAO_0000019,A,,,,,,,Partition coefficient of the compound,Autocuration,0,,U,22224,,,17363,,,1
,CHEMBL883124,13590,BAO_0000019,A,,,,,,,Permeability was determined,Autocuration,0,,U,22224,,,6827,,,1
,CHEMBL622149,13591,BAO_0000100,P,,,,,,,The compound was evaluated for the partition coefficient,Autocuration,0,,U,22229,,,261,,,1
,CHEMBL622150,13592,BAO_0000019,A,,,,,,,Partition coefficient (logP),Autocuration,0,,U,22224,,,2685,,,1
,CHEMBL622151,13593,BAO_0000100,P,,,,,,,The lipophilicity was reported,Autocuration,0,,U,22224,,,414,,,1
,CHEMBL622152,13594,BAO_0000100,P,,,,,,,logarithm of the octanol-water partition coefficient for the compound,Autocuration,0,,U,22229,,,15769,,,1
,CHEMBL622153,13595,BAO_0000019,A,,,,,,,Clogp value was determined,Autocuration,0,,U,22224,,,17248,,,1
,CHEMBL877474,13596,BAO_0000218,A,,,,,,,Clp at a dose of 1.5 mg/kg,Autocuration,0,,U,22224,,,16935,In vivo,,1
,CHEMBL622154,13597,BAO_0000218,A,,,,,,,Clp at a dose of 2.0 mg/kg,Autocuration,0,,U,22224,,,16935,In vivo,,1
,CHEMBL622155,13598,BAO_0000218,A,,,,Plasma,,,"Clp, plasma clearance at a dose of 10 mg/kg",Autocuration,0,,U,22224,1969.0,,14832,In vivo,,1
,CHEMBL622156,13599,BAO_0000218,A,,,,Plasma,,,"Clp, plasma clearance at a dose of 50 mg/kg",Autocuration,0,,U,22224,1969.0,,14832,In vivo,,1
,CHEMBL622157,13600,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma clearance in rat,Intermediate,1,,N,50597,1969.0,,2399,In vivo,,1
,CHEMBL622158,13601,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Compound was tested for plasma clearance in rat; Not determined,Intermediate,1,,N,50597,1969.0,,2399,In vivo,,1
,CHEMBL622807,13602,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,1,,N,50597,,,6227,In vivo,,1
,CHEMBL622808,13603,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Intermediate,1,,N,50797,,,6227,In vivo,,1
,CHEMBL622809,13604,BAO_0000218,A,,,,,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,Autocuration,0,,U,22224,,,5623,In vivo,,1
,CHEMBL622810,13605,BAO_0000218,A,,,,,,,Plasma clearance determined,Autocuration,0,,U,22224,,,4854,In vivo,,1
,CHEMBL876653,13606,BAO_0000218,A,,,10026.0,,Cricetinae,,Plasma clearance after iv administration at 3 mg/kg in hamster,Intermediate,1,,N,100712,,,4493,In vivo,,1
,CHEMBL622811,13607,BAO_0000218,A,,,10026.0,,Cricetinae,,Plasma clearance after iv administration at 4 mg/kg in hamster,Intermediate,1,,N,100712,,,4493,In vivo,,1
,CHEMBL622986,13608,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Rate of clearance in rat was determined,Intermediate,1,,N,50597,,,14956,In vivo,,1
,CHEMBL622987,13609,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,15372,In vivo,,1
,CHEMBL622988,13610,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,15372,In vivo,,1
,CHEMBL622989,13611,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,15372,In vivo,,1
,CHEMBL622990,13612,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,1,,N,50597,1969.0,,15372,In vivo,,1
,CHEMBL622991,13613,BAO_0000218,A,,,314293.0,Plasma,Simiiformes,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,0,,U,22224,1969.0,,15604,In vivo,,1
,CHEMBL622227,13614,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,1,,N,50597,1969.0,,15604,In vivo,,1
,CHEMBL622228,13615,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,1,,N,50588,1969.0,,15604,In vivo,,1
,CHEMBL622229,13616,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Clpl value in rat,Intermediate,1,,N,50597,,,14964,In vivo,,1
,CHEMBL622230,13617,BAO_0000218,A,,,10141.0,,Cavia porcellus,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,1,,N,50512,,,15240,In vivo,,1
,CHEMBL622231,13618,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Intermediate,1,,N,50597,,,16449,In vivo,,1
,CHEMBL622232,13619,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Intermediate,1,,N,100710,,,16449,In vivo,,1
,CHEMBL622233,13620,BAO_0000218,A,,,,,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL622234,13621,BAO_0000218,A,,,,,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL622235,13622,BAO_0000218,A,,,,,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL622236,13623,BAO_0000218,A,,,,,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL622237,13624,BAO_0000218,A,,,,,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL877482,13625,BAO_0000218,A,,,,,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL622238,13626,BAO_0000218,A,,,,,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL622239,13627,BAO_0000218,A,,,,,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,Autocuration,0,,U,22224,,,12902,In vivo,,1
,CHEMBL622240,13628,BAO_0000218,A,,,,Blood,,,Cmax was calculated as maximum concentration reached in the blood,Autocuration,0,,U,22224,178.0,,11149,In vivo,,1
,CHEMBL622241,13629,BAO_0000218,A,,,,Blood,,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,Autocuration,0,,U,22224,178.0,,11149,In vivo,,1
,CHEMBL631013,13630,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax was determine after peroral administration at 10 mpk in Rat,Intermediate,1,,N,50597,,,5669,In vivo,,1
,CHEMBL631014,13631,BAO_0000218,A,,,9544.0,,Macaca mulatta,,Cmax was determine after peroral administration at 10 mpk in Rhesus,Intermediate,1,,N,50797,,,5669,In vivo,,1
,CHEMBL631015,13632,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Cmax was determine after peroral administration at 10 mpk in dog,Intermediate,1,,N,50588,,,5669,In vivo,,1
,CHEMBL631016,13633,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax was determine after peroral administration at 160 mpk in Rat,Intermediate,1,,N,50597,,,5669,In vivo,,1
,CHEMBL631017,13634,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax was determine after peroral administration at 20 mpk in Rat,Intermediate,1,,N,50597,,,5669,In vivo,,1
,CHEMBL631018,13635,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cmax was determine after peroral administration at 50 mpk in Rat,Intermediate,1,,N,50597,,,5669,In vivo,,1
,CHEMBL631019,13636,BAO_0000218,A,,,,,,,Cmax was determined,Autocuration,0,,U,22224,,,4236,In vivo,,1
,CHEMBL875761,13637,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL631020,13638,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL631669,13639,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL631670,13640,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Intermediate,1,,N,50594,955.0,,13792,,,1
,CHEMBL631671,13641,BAO_0000218,A,,,10090.0,Striatum,Mus musculus,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Intermediate,1,,N,50594,2435.0,,13792,,,1
,CHEMBL631672,13642,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631673,13643,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631856,13644,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631857,13645,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631858,13646,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631859,13647,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631860,13648,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631861,13649,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631862,13650,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631863,13651,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631864,13652,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631865,13653,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL631866,13654,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL629360,13655,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL629361,13656,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL629362,13657,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL630740,13658,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL630741,13659,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL630742,13660,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Intermediate,1,,N,50597,178.0,,8418,,,1
,CHEMBL630743,13661,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL630744,13662,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL630745,13663,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL630746,13664,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL630747,13665,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL630748,13666,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL632056,13667,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL632057,13668,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL632058,13669,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL632059,13670,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL632060,13671,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL632061,13672,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629207,13673,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629208,13674,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629209,13675,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629210,13676,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629211,13677,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629212,13678,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629213,13679,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Intermediate,1,,N,50597,,,8418,,,1
,CHEMBL629214,13680,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629215,13681,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL635154,13682,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Intermediate,1,,N,50597,1088.0,,8133,,,1
,CHEMBL629216,13683,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL629217,13684,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL629218,13685,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL629219,13686,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL629220,13687,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL629221,13688,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631127,13689,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631128,13690,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631129,13691,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631130,13692,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631131,13693,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631132,13694,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631133,13695,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631134,13696,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL875120,13697,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631135,13698,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631136,13699,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631137,13700,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631138,13701,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631139,13702,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631140,13703,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631141,13704,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631142,13705,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631143,13706,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631144,13707,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,1,,N,50597,,,6996,,,1
,CHEMBL631145,13708,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631146,13709,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631147,13710,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631148,13711,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631149,13712,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631150,13713,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631151,13714,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631152,13715,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631443,13716,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631444,13717,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631445,13718,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631446,13719,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631447,13720,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631448,13721,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631449,13722,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL631450,13723,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL629724,13724,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,1,,N,50588,,,6996,,,1
,CHEMBL629725,13725,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,14.0,,9716,In vivo,,1
,CHEMBL629726,13726,BAO_0000218,A,,,10090.0,Zone of skin,Mus musculus,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,14.0,,9716,In vivo,,1
,CHEMBL629727,13727,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,2106.0,,9716,In vivo,,1
,CHEMBL630404,13728,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,2106.0,,9716,In vivo,,1
,CHEMBL630405,13729,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,2106.0,,9716,In vivo,,1
,CHEMBL630406,13730,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,2106.0,,9716,In vivo,,1
,CHEMBL630407,13731,BAO_0000218,A,,,10090.0,Stomach,Mus musculus,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,945.0,,9716,In vivo,,1
,CHEMBL630573,13732,BAO_0000218,A,,,10090.0,Stomach,Mus musculus,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,945.0,,9716,In vivo,,1
,CHEMBL630574,13733,BAO_0000218,A,,,10090.0,Stomach,Mus musculus,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,945.0,,9716,In vivo,,1
,CHEMBL630575,13734,BAO_0000218,A,,,10090.0,Stomach,Mus musculus,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,945.0,,9716,In vivo,,1
,CHEMBL630576,13735,BAO_0000218,A,,,10090.0,,Mus musculus,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,,,9716,In vivo,,1
,CHEMBL630577,13736,BAO_0000218,A,,,10090.0,,Mus musculus,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,,,9716,In vivo,,1
,CHEMBL630578,13737,BAO_0000218,A,,,10090.0,,Mus musculus,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,,,9716,In vivo,,1
,CHEMBL630579,13738,BAO_0000218,A,,,10090.0,,Mus musculus,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,1,,N,50594,,,9716,In vivo,,1
,CHEMBL630580,13739,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Intermediate,1,,N,50594,2113.0,,12192,,,1
,CHEMBL630581,13740,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Intermediate,1,,N,50594,2113.0,,12192,,,1
,CHEMBL630582,13741,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Intermediate,1,,N,50594,2113.0,,12192,,,1
,CHEMBL630583,13742,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630584,13743,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630585,13744,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630586,13745,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630587,13746,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630588,13747,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630589,13748,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630590,13749,BAO_0000218,A,,,10090.0,,Mus musculus,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Intermediate,1,,N,50594,,,12192,,,1
,CHEMBL630591,13750,BAO_0000019,A,,,,Feces,,,Removal of 238-Plutonium(IV) in feces at 24 h,Autocuration,0,,U,22224,1988.0,,12192,,,1
,CHEMBL630592,13751,BAO_0000019,A,,,,Feces,,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),Autocuration,0,,U,22224,1988.0,,12192,,,1
,CHEMBL630593,13752,BAO_0000019,A,,,,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,Autocuration,0,,U,22224,,,12192,,,1
,CHEMBL630594,13753,BAO_0000019,A,,,,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),Autocuration,0,,U,22224,,,12192,,,1
,CHEMBL630595,13754,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630596,13755,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630597,13756,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine after 0-24 h,Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630598,13757,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630599,13758,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine after 0-4 h,Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630600,13759,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630601,13760,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine after 4-24 h,Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630602,13761,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630603,13762,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL630604,13763,BAO_0000019,A,,,,Urine,,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),Autocuration,0,,U,22224,1088.0,,12192,,,1
,CHEMBL624869,13764,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL624870,13765,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL623189,13766,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL623190,13767,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL623191,13768,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL623192,13769,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL623193,13770,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL623194,13771,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL623195,13772,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL623196,13773,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL623197,13774,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Intermediate,1,,N,50597,,,11836,,,1
,CHEMBL623198,13775,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,,,11836,,,1
,CHEMBL623199,13776,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,1,,N,50597,,,11836,,,1
,CHEMBL623200,13777,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623201,13778,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623202,13779,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623203,13780,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623204,13781,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623205,13782,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623206,13783,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623207,13784,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623208,13785,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623209,13786,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623210,13787,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,1,,N,50597,2385.0,,11836,,,1
,CHEMBL623211,13788,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,,,11836,,,1
,CHEMBL623212,13789,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,1,,N,50597,995.0,,11836,,,1
,CHEMBL623213,13790,BAO_0000019,A,,,,,,,Tested in vitro for intrinsic activity relative to quinpirole,Autocuration,0,,U,22224,,,12640,,,1
,CHEMBL623214,13791,BAO_0000019,A,,,,,,,"Relative ion enhancement, determined in pulsed ultrafiltration",Autocuration,0,,U,22224,,,14218,,,1
,CHEMBL623215,13792,BAO_0000019,A,,,,,,,% ionization at the pH 7.4 at 37 degree Centigrade,Autocuration,0,,U,22224,,,11296,,,1
,CHEMBL623216,13793,BAO_0000019,A,,,,,,,Percentage ionization was measured,Autocuration,0,,U,22224,,,10929,,,1
,CHEMBL623217,13794,BAO_0000218,A,,,9913.0,,Bos taurus,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Intermediate,1,,N,50591,,,13841,,,1
,CHEMBL623218,13795,BAO_0000019,A,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,Autocuration,0,,U,22224,,,10431,,,1
,CHEMBL623913,13796,BAO_0000019,A,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,Autocuration,0,,U,22224,,,10431,,,1
,CHEMBL623914,13797,BAO_0000019,A,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,Autocuration,0,,U,22224,,,10431,,,1
,CHEMBL623915,13798,BAO_0000100,P,,,,,,,Compound was evaluated for the partition coefficient in octanol/water,Autocuration,0,,U,22229,,,8826,,,1
,CHEMBL624080,13799,BAO_0000100,P,,,,,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),Autocuration,0,,U,22229,,,8826,,,1
,CHEMBL624081,13800,BAO_0000019,A,,,,,,,Equilibrium constant measured by the pulse radiolysis at pH 7,Autocuration,0,,U,22224,,,9884,,,1
,CHEMBL624082,13801,BAO_0000218,A,,,9606.0,,Homo sapiens,,In vitro hydrolytic rate constant determined in human blood,Intermediate,1,,N,50587,,,9827,,,1
,CHEMBL625054,13802,BAO_0000218,A,,,9606.0,,Homo sapiens,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Intermediate,1,,N,50587,,,10009,,,1
,CHEMBL877485,13803,BAO_0000019,A,,,,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,Autocuration,0,,U,22224,,,10009,,,1
,CHEMBL625055,13804,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL625056,13805,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL625057,13806,BAO_0000218,A,,,9606.0,,Homo sapiens,,In vitro oxidation of compound in presence of human plasma,Intermediate,1,,N,50587,,,10009,,,1
,CHEMBL625058,13807,BAO_0000019,A,,,,,,,In vitro oxidation of compound in presence of hydrogen peroxide,Autocuration,0,,U,22224,,,10009,,,1
,CHEMBL625059,13808,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro oxidation of compound in presence of mouse brain homogenate,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL629536,13809,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro oxidation of compound in presence of mouse liver homogenate,Intermediate,1,,N,50594,,,10009,,,1
,CHEMBL629537,13810,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629538,13811,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629539,13812,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL874445,13813,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629540,13814,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629541,13815,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629542,13816,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630243,13817,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630244,13818,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630245,13819,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630246,13820,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630247,13821,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630248,13822,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630249,13823,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood at 240 minutes after dose administration.,Intermediate,1,,N,50597,178.0,,13100,In vivo,,1
,CHEMBL630250,13824,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood at 30 minutes after dose administration.,Intermediate,1,,N,50597,178.0,,13100,In vivo,,1
,CHEMBL630251,13825,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood at 360 minutes after dose administration.,Intermediate,1,,N,50597,178.0,,13100,In vivo,,1
,CHEMBL630252,13826,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood at 3 hr after dose administration.,Intermediate,1,,N,50597,178.0,,13100,In vivo,,1
,CHEMBL630408,13827,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood at 60 minutes after dose administration.,Intermediate,1,,N,50597,178.0,,13100,In vivo,,1
,CHEMBL630409,13828,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL874446,13829,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL630410,13830,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL630411,13831,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL630412,13832,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL630413,13833,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL630414,13834,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 3 hr after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL630415,13835,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Intermediate,1,,N,50597,2037.0,,13100,In vivo,,1
,CHEMBL630416,13836,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 120 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630417,13837,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 1440 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630418,13838,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 15 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630419,13839,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 240 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630420,13840,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 30 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630421,13841,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 360 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630422,13842,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 3 hr after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630423,13843,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat cortex at 60 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL630424,13844,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart at 120 minutes after dose administration.,Intermediate,1,,N,50597,948.0,,13100,In vivo,,1
,CHEMBL630425,13845,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart at 15 minutes after dose administration.,Intermediate,1,,N,50597,948.0,,13100,In vivo,,1
,CHEMBL629462,13846,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart at 240 minutes after dose administration.,Intermediate,1,,N,50597,948.0,,13100,In vivo,,1
,CHEMBL630426,13847,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart at 30 minutes after dose administration.,Intermediate,1,,N,50597,948.0,,13100,In vivo,,1
,CHEMBL630427,13848,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart at 360 minutes after dose administration.,Intermediate,1,,N,50597,948.0,,13100,In vivo,,1
,CHEMBL625877,13849,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart at 3 hr after dose administration.,Intermediate,1,,N,50597,948.0,,13100,In vivo,,1
,CHEMBL625878,13850,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart at 60 minutes after dose administration.,Intermediate,1,,N,50597,948.0,,13100,In vivo,,1
,CHEMBL625879,13851,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Intermediate,1,,N,50597,10000000.0,,13100,In vivo,,1
,CHEMBL625880,13852,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Intermediate,1,,N,50597,10000000.0,,13100,In vivo,,1
,CHEMBL625881,13853,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Intermediate,1,,N,50597,10000000.0,,13100,In vivo,,1
,CHEMBL625882,13854,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Intermediate,1,,N,50597,10000000.0,,13100,In vivo,,1
,CHEMBL625883,13855,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Intermediate,1,,N,50597,10000000.0,,13100,In vivo,,1
,CHEMBL625884,13856,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney at 120 minutes after dose administration.,Intermediate,1,,N,50597,2113.0,,13100,In vivo,,1
,CHEMBL625885,13857,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney at 1440 minutes after dose administration.,Intermediate,1,,N,50597,2113.0,,13100,In vivo,,1
,CHEMBL628649,13858,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney at 15 minutes after dose administration.,Intermediate,1,,N,50597,2113.0,,13100,In vivo,,1
,CHEMBL628650,13859,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney at 240 minutes after dose administration.,Intermediate,1,,N,50597,2113.0,,13100,In vivo,,1
,CHEMBL628651,13860,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney at 30 minutes after dose administration.,Intermediate,1,,N,50597,2113.0,,13100,In vivo,,1
,CHEMBL628652,13861,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney at 360 minutes after dose administration.,Intermediate,1,,N,50597,2113.0,,13100,In vivo,,1
,CHEMBL628653,13862,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney at 60 minutes after dose administration.,Intermediate,1,,N,50597,2113.0,,13100,In vivo,,1
,CHEMBL628654,13863,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver at 120 minutes after dose administration.,Intermediate,1,,N,50597,2107.0,,13100,In vivo,,1
,CHEMBL628655,13864,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver at 1440 minutes after dose administration.,Intermediate,1,,N,50597,2107.0,,13100,In vivo,,1
,CHEMBL625238,13865,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver at 15 minutes after dose administration.,Intermediate,1,,N,50597,2107.0,,13100,In vivo,,1
,CHEMBL625239,13866,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver at 240 minutes after dose administration.,Intermediate,1,,N,50597,2107.0,,13100,In vivo,,1
,CHEMBL625240,13867,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver at 30 minutes after dose administration.,Intermediate,1,,N,50597,2107.0,,13100,In vivo,,1
,CHEMBL625241,13868,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver at 360 minutes after dose administration.,Intermediate,1,,N,50597,2107.0,,13100,In vivo,,1
,CHEMBL625242,13869,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver at 60 minutes after dose administration.,Intermediate,1,,N,50597,2107.0,,13100,In vivo,,1
,CHEMBL874587,13870,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung at 120 minutes after dose administration.,Intermediate,1,,N,50597,2048.0,,13100,In vivo,,1
,CHEMBL625405,13871,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung at 1440 minutes after dose administration.,Intermediate,1,,N,50597,2048.0,,13100,In vivo,,1
,CHEMBL625406,13872,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung at 15 minutes after dose administration.,Intermediate,1,,N,50597,2048.0,,13100,In vivo,,1
,CHEMBL625407,13873,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung at 240 minutes after dose administration.,Intermediate,1,,N,50597,2048.0,,13100,In vivo,,1
,CHEMBL625408,13874,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung at 30 minutes after dose administration.,Intermediate,1,,N,50597,2048.0,,13100,In vivo,,1
,CHEMBL625409,13875,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung at 360 minutes after dose administration.,Intermediate,1,,N,50597,2048.0,,13100,In vivo,,1
,CHEMBL625410,13876,BAO_0000218,A,,,10116.0,Thoracic aorta,Rattus norvegicus,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Intermediate,1,,N,50597,1515.0,,12361,,,1
,CHEMBL625411,13877,BAO_0000218,A,,,10116.0,Thoracic aorta,Rattus norvegicus,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Intermediate,1,,N,50597,1515.0,,12361,,,1
,CHEMBL625412,13878,BAO_0000218,A,,,10116.0,Thoracic aorta,Rattus norvegicus,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Intermediate,1,,N,50597,1515.0,,12361,,,1
,CHEMBL625413,13879,BAO_0000218,A,,,10116.0,Thoracic aorta,Rattus norvegicus,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Intermediate,1,,N,50597,1515.0,,12361,,,1
,CHEMBL625414,13880,BAO_0000218,A,,,10116.0,Thoracic aorta,Rattus norvegicus,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Intermediate,1,,N,50597,1515.0,,12361,,,1
,CHEMBL625415,13881,BAO_0000218,A,,,10116.0,Thoracic aorta,Rattus norvegicus,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,1,,N,50597,1515.0,,12361,,,1
,CHEMBL625416,13882,BAO_0000218,A,,,10116.0,Thoracic aorta,Rattus norvegicus,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,1,,N,50597,1515.0,,12361,,,1
,CHEMBL625417,13883,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Intermediate,1,,N,50597,1088.0,,12712,,,1
,CHEMBL625418,13884,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Intermediate,1,,N,50597,1988.0,,7415,,,1
,CHEMBL625419,13885,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Intermediate,1,,N,50597,1088.0,,7415,,,1
,CHEMBL625420,13886,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Intermediate,1,,N,50597,,,7415,,,1
,CHEMBL626996,13887,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Intermediate,1,,N,50597,,,7415,,,1
,CHEMBL626997,13888,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Intermediate,1,,N,50597,1988.0,,7415,,,1
,CHEMBL626998,13889,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Intermediate,1,,N,50597,1088.0,,7415,,,1
,CHEMBL626999,13890,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Intermediate,1,,N,50597,,,7415,,,1
,CHEMBL627000,13891,BAO_0000218,A,,,10090.0,,Mus musculus,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Intermediate,1,,N,50594,,,8050,,,1
,CHEMBL627001,13892,BAO_0000218,A,,,10090.0,,Mus musculus,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Intermediate,1,,N,50594,,,8050,,,1
,CHEMBL627002,13893,BAO_0000218,A,,,10090.0,,Mus musculus,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Intermediate,1,,N,50594,,,8050,,,1
,CHEMBL627003,13894,BAO_0000218,A,,,10090.0,,Mus musculus,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Intermediate,1,,N,50594,,,8050,,,1
,CHEMBL627004,13895,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627005,13896,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL874594,13897,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627006,13898,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627007,13899,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627884,13900,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627885,13901,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627886,13902,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627887,13903,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627888,13904,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL628057,13905,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627405,13906,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Intermediate,1,,N,50594,1088.0,,8050,,,1
,CHEMBL627406,13907,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627407,13908,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627408,13909,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627409,13910,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL875486,13911,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627410,13912,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627411,13913,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627412,13914,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627413,13915,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627414,13916,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627415,13917,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627416,13918,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627417,13919,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627418,13920,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627419,13921,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627320,13922,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627321,13923,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627322,13924,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL627323,13925,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL627491,13926,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL627492,13927,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL627493,13928,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL627494,13929,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL627495,13930,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL627496,13931,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL627497,13932,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL627498,13933,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL627499,13934,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL627500,13935,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL627501,13936,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL625616,13937,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL625617,13938,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL625618,13939,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL625619,13940,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL625620,13941,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL625621,13942,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL625622,13943,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL625788,13944,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL625789,13945,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL625790,13946,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL625791,13947,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL622334,13948,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL622335,13949,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2046.0,,12017,In vivo,,1
,CHEMBL622336,13950,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2046.0,,12017,In vivo,,1
,CHEMBL622337,13951,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2046.0,,12017,In vivo,,1
,CHEMBL622338,13952,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2046.0,,12017,In vivo,,1
,CHEMBL622339,13953,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2046.0,,12017,In vivo,,1
,CHEMBL624153,13954,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL628430,13955,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL628431,13956,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL628432,13957,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL628433,13958,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL628434,13959,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL626789,13960,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL626790,13961,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL626791,13962,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL626792,13963,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL626793,13964,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL627436,13965,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627437,13966,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627438,13967,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627439,13968,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627440,13969,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627602,13970,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627603,13971,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627604,13972,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627605,13973,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627606,13974,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627607,13975,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627608,13976,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627609,13977,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627610,13978,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627611,13979,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627612,13980,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL627613,13981,BAO_0000100,P,,,,,,,Octanol:water partition coefficient is evaluated,Autocuration,0,,U,22229,,,8362,,,1
,CHEMBL627614,13982,BAO_0000100,P,,,,,,,Partition coefficient in 1-octanol/water system,Autocuration,0,,U,22224,,,8257,,,1
,CHEMBL627615,13983,BAO_0000100,P,,,,,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,Autocuration,0,,U,22224,,,8257,,,1
,CHEMBL627616,13984,BAO_0000100,P,,,,,,,Partition coefficient in octanol/water system was determined,Autocuration,0,,U,22224,,,9468,,,1
,CHEMBL627617,13985,BAO_0000100,P,,,,,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,Autocuration,0,,U,22224,,,9468,,,1
,CHEMBL627618,13986,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,Autocuration,0,,U,22224,,,10568,,,1
,CHEMBL627619,13987,BAO_0000019,A,,,,,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",Autocuration,0,,U,22224,,,10568,,,1
,CHEMBL627620,13988,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant of the compound,Autocuration,0,,U,22224,,,15359,,,1
,CHEMBL627621,13989,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant with 1-min time point,Autocuration,0,,U,22224,,,15359,,,1
,CHEMBL627622,13990,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant without 1-min time point,Autocuration,0,,U,22224,,,15359,,,1
,CHEMBL627623,13991,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,Autocuration,0,,U,22224,,,10431,,,1
,CHEMBL627624,13992,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,Autocuration,0,,U,22224,,,10431,,,1
,CHEMBL627625,13993,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,Autocuration,0,,U,22224,,,10431,,,1
,CHEMBL628523,13994,BAO_0000019,A,,,,,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,Autocuration,0,,U,22224,,,15704,,,1
,CHEMBL628524,13995,BAO_0000019,A,,,,,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,Autocuration,0,,U,22224,,,15287,,,1
,CHEMBL628525,13996,BAO_0000019,A,,,,,,,The efflux rate constant of the compound,Autocuration,0,,U,22224,,,7516,,,1
,CHEMBL625732,13997,BAO_0000019,A,,,,,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,0,,U,22224,,,12973,,,1
,CHEMBL625733,13998,BAO_0000019,A,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,0,,U,22224,,,12973,,,1
,CHEMBL625734,13999,BAO_0000019,F,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,0,,U,22224,,,12973,,,1
,CHEMBL625913,14000,BAO_0000019,A,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,Autocuration,0,,U,22224,,,12973,,,1
,CHEMBL625914,14001,BAO_0000019,A,,,,,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,Autocuration,0,,U,22224,,,8696,,,1
,CHEMBL625915,14002,BAO_0000019,A,,,,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,Autocuration,0,,U,22224,,,15052,,,1
,CHEMBL625916,14003,BAO_0000019,A,,,,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,Autocuration,0,,U,22224,,,15052,,,1
,CHEMBL625917,14004,BAO_0000019,A,,,,,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),Autocuration,0,,U,22224,,,10503,,,1
,CHEMBL625918,14005,BAO_0000019,A,,,,,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL625919,14006,BAO_0000019,A,,,,,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL625920,14007,BAO_0000019,A,,,,,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL874453,14008,BAO_0000019,A,,,,,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL625921,14009,BAO_0000019,A,,,,,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL625922,14010,BAO_0000019,A,,,,,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,Autocuration,0,,U,22224,,,10503,,,1
,CHEMBL625923,14011,BAO_0000019,A,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL625924,14012,BAO_0000019,A,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL625925,14013,BAO_0000019,A,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL625926,14014,BAO_0000019,A,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL627704,14015,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung at 60 minutes after dose administration.,Intermediate,1,,N,50597,2048.0,,13100,In vivo,,1
,CHEMBL627705,14016,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL627706,14017,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL627707,14018,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL627708,14019,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL628361,14020,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL628362,14021,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Intermediate,1,,N,50597,,,13100,In vivo,,1
,CHEMBL628363,14022,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 120 minutes after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL628364,14023,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 1440 minutes after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL628365,14024,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 15 minutes after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL874454,14025,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 240 minutes after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL628531,14026,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 30 minutes after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL628532,14027,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 360 minutes after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL628533,14028,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 3 hr after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL628534,14029,BAO_0000218,A,,,10116.0,Striatum,Rattus norvegicus,,Biodistribution in rat striatum at 60 minutes after dose administration.,Intermediate,1,,N,50597,2435.0,,13100,In vivo,,1
,CHEMBL628535,14030,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in rat thyroid at 120 minutes after dose administration.,Intermediate,1,,N,50597,2046.0,,13100,In vivo,,1
,CHEMBL628536,14031,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Intermediate,1,,N,50597,2046.0,,13100,In vivo,,1
,CHEMBL628537,14032,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in rat thyroid at 15 minutes after dose administration.,Intermediate,1,,N,50597,2046.0,,13100,In vivo,,1
,CHEMBL628538,14033,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in rat thyroid at 240 minutes after dose administration.,Intermediate,1,,N,50597,2046.0,,13100,In vivo,,1
,CHEMBL628539,14034,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in rat thyroid at 30 minutes after dose administration.,Intermediate,1,,N,50597,2046.0,,13100,In vivo,,1
,CHEMBL630297,14035,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in rat thyroid at 360 minutes after dose administration.,Intermediate,1,,N,50597,2046.0,,13100,In vivo,,1
,CHEMBL630298,14036,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in rat thyroid at 60 minutes after dose administration.,Intermediate,1,,N,50597,2046.0,,13100,In vivo,,1
,CHEMBL630299,14037,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Intermediate,1,,N,50597,955.0,,13100,In vivo,,1
,CHEMBL628094,14038,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Intermediate,1,,N,50597,955.0,,13100,In vivo,,1
,CHEMBL628095,14039,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Intermediate,1,,N,50597,955.0,,13100,In vivo,,1
,CHEMBL874648,14040,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Intermediate,1,,N,50597,955.0,,13100,In vivo,,1
,CHEMBL628096,14041,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Intermediate,1,,N,50597,955.0,,13100,In vivo,,1
,CHEMBL628097,14042,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Intermediate,1,,N,50597,955.0,,13100,In vivo,,1
,CHEMBL628098,14043,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Intermediate,1,,N,50597,955.0,,13100,In vivo,,1
,CHEMBL628099,14044,BAO_0000019,A,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628100,14045,BAO_0000019,A,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628101,14046,BAO_0000019,A,,,,,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628102,14047,BAO_0000019,A,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628103,14048,BAO_0000019,A,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628104,14049,BAO_0000019,A,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628105,14050,BAO_0000019,A,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628106,14051,BAO_0000019,A,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",Autocuration,0,,U,22224,,,13331,,,1
,CHEMBL628107,14052,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Intermediate,1,,N,50597,1088.0,,10086,,,1
,CHEMBL628108,14053,BAO_0000218,F,,,,Urine,,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Autocuration,0,,U,22224,1088.0,,10086,,,1
,CHEMBL628109,14054,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Intermediate,1,,N,50597,1088.0,,10086,,,1
,CHEMBL625299,14055,BAO_0000218,F,,,,Urine,,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Autocuration,0,,U,22224,1088.0,,10086,,,1
,CHEMBL625300,14056,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Intermediate,1,,N,50597,1088.0,,10086,,,1
,CHEMBL625301,14057,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Intermediate,1,,N,50597,1088.0,,10086,,,1
,CHEMBL625302,14058,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Intermediate,1,,N,50597,1088.0,,10086,,,1
,CHEMBL874649,14059,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Intermediate,1,,N,50597,1088.0,,10086,,,1
,CHEMBL625303,14060,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Intermediate,1,,N,50597,,,13248,,,1
,CHEMBL625463,14061,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Intermediate,1,,N,50597,,,13248,,,1
,CHEMBL625464,14062,BAO_0000218,A,,,9606.0,Liver,Homo sapiens,,In vitro metabolism in human liver microsomes,Intermediate,1,,N,50587,2107.0,,14527,,,1
,CHEMBL625465,14063,BAO_0000218,A,,,9606.0,,Homo sapiens,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Intermediate,1,,N,50587,,,3008,,,1
,CHEMBL625466,14064,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625467,14065,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625468,14066,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625469,14067,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625470,14068,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL632418,14069,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627250,14070,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627251,14071,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627252,14072,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627253,14073,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627254,14074,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL875471,14075,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627255,14076,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627256,14077,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627257,14078,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627258,14079,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627259,14080,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627260,14081,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623256,14082,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL874413,14083,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623257,14084,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623258,14085,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623259,14086,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623260,14087,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623261,14088,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623262,14089,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623263,14090,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623264,14091,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623265,14092,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623266,14093,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623267,14094,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623268,14095,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623269,14096,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623270,14097,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623271,14098,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623272,14099,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623273,14100,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623274,14101,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL874414,14102,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623275,14103,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL629150,14104,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623276,14105,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623277,14106,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623112,14107,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623113,14108,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623800,14109,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623801,14110,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623802,14111,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL623803,14112,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,995.0,,12017,In vivo,,1
,CHEMBL623970,14113,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,995.0,,12017,In vivo,,1
,CHEMBL623971,14114,BAO_0000218,A,,,10116.0,Uterus,Rattus norvegicus,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,995.0,,12017,In vivo,,1
,CHEMBL623972,14115,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Intermediate,1,,N,50597,178.0,,14045,In vivo,,1
,CHEMBL623973,14116,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Intermediate,1,,N,50597,178.0,,14045,In vivo,,1
,CHEMBL623974,14117,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Intermediate,1,,N,50597,178.0,,14045,In vivo,,1
,CHEMBL623975,14118,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Intermediate,1,,N,50597,178.0,,14045,In vivo,,1
,CHEMBL623976,14119,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Intermediate,1,,N,50597,955.0,,14045,In vivo,,1
,CHEMBL623977,14120,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Intermediate,1,,N,50597,955.0,,14045,In vivo,,1
,CHEMBL623978,14121,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Intermediate,1,,N,50597,955.0,,14045,In vivo,,1
,CHEMBL623979,14122,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Intermediate,1,,N,50597,955.0,,14045,In vivo,,1
,CHEMBL623980,14123,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Intermediate,1,,N,50597,,,14045,In vivo,,1
,CHEMBL623981,14124,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Intermediate,1,,N,50597,,,14045,In vivo,,1
,CHEMBL626278,14125,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Intermediate,1,,N,50597,,,14045,In vivo,,1
,CHEMBL626279,14126,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Intermediate,1,,N,50597,,,14045,In vivo,,1
,CHEMBL626280,14127,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in mice bladder plus excreted urine was determined,Intermediate,1,,N,50594,,,14045,In vivo,,1
,CHEMBL626281,14128,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse blood, 10 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL626282,14129,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse blood, 30 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL626283,14130,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse blood, 5 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL626284,14131,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse blood, 60 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL626285,14132,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Percentage biodistribution in mouse brain, 10 minutes post injection",Intermediate,1,,N,50594,955.0,,14045,,,1
,CHEMBL626286,14133,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Percentage biodistribution in mouse brain, 30 minutes post injection",Intermediate,1,,N,50594,955.0,,14045,,,1
,CHEMBL626287,14134,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Percentage biodistribution in mouse brain, 5 minutes post injection",Intermediate,1,,N,50594,955.0,,14045,,,1
,CHEMBL626288,14135,BAO_0000218,A,,,10090.0,Brain,Mus musculus,,"Percentage biodistribution in mouse brain, 60 minutes post injection",Intermediate,1,,N,50594,955.0,,14045,,,1
,CHEMBL626289,14136,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse heart, 10 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL626290,14137,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse heart, 30 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL626291,14138,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse heart, 5 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL839888,14139,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse heart, 60 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL626292,14140,BAO_0000218,A,,,10090.0,Intestine,Mus musculus,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Intermediate,1,,N,50594,160.0,,14045,,,1
,CHEMBL626293,14141,BAO_0000218,A,,,10090.0,Intestine,Mus musculus,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Intermediate,1,,N,50594,160.0,,14045,,,1
,CHEMBL626294,14142,BAO_0000218,A,,,10090.0,Intestine,Mus musculus,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Intermediate,1,,N,50594,160.0,,14045,,,1
,CHEMBL626295,14143,BAO_0000218,A,,,10090.0,Intestine,Mus musculus,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Intermediate,1,,N,50594,160.0,,14045,,,1
,CHEMBL627659,14144,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,"Percentage biodistribution in mouse liver, 10 minutes post injection",Intermediate,1,,N,50594,2107.0,,14045,,,1
,CHEMBL627660,14145,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Intermediate,1,,N,50594,2107.0,,14045,,,1
,CHEMBL627661,14146,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,"Percentage biodistribution in mouse liver, 5 minutes post injection",Intermediate,1,,N,50594,2107.0,,14045,,,1
,CHEMBL627662,14147,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in mice liver at 60 minutes of post injection,Intermediate,1,,N,50594,2107.0,,14045,In vivo,,1
,CHEMBL627663,14148,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution in mice lungs at 10 min of post injection,Intermediate,1,,N,50594,2048.0,,14045,In vivo,,1
,CHEMBL627664,14149,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mouse lung, 30 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL627665,14150,BAO_0000218,A,,,10090.0,,Mus musculus,,"Percentage biodistribution in mousee lung, 5 minutes post injection",Intermediate,1,,N,50594,,,14045,,,1
,CHEMBL627666,14151,BAO_0000218,A,,,10090.0,Lung,Mus musculus,,Biodistribution in mice lungs at 60 min of post injection,Intermediate,1,,N,50594,2048.0,,14045,In vivo,,1
,CHEMBL627667,14152,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Percentage biodistribution in mouse spleen,Intermediate,1,,N,50594,2106.0,,14045,,,1
,CHEMBL627668,14153,BAO_0000218,A,,,10090.0,Stomach,Mus musculus,,Percentage biodistribution in mouse stomach,Intermediate,1,,N,50594,945.0,,14045,,,1
,CHEMBL627669,14154,BAO_0000218,A,,,10090.0,Urine,Mus musculus,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Intermediate,1,,N,50594,1088.0,,11745,,,1
,CHEMBL627670,14155,BAO_0000218,A,,,,Urinary bladder,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,Autocuration,0,,U,22224,1255.0,,13257,In vivo,,1
,CHEMBL627671,14156,BAO_0000218,A,,,,Blood,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,Autocuration,0,,U,22224,178.0,,13257,In vivo,,1
,CHEMBL627672,14157,BAO_0000218,A,,,,Bone element,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,Autocuration,0,,U,22224,1474.0,,13257,In vivo,,1
,CHEMBL627673,14158,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL627674,14159,BAO_0000218,A,,,,Kidney,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,Autocuration,0,,U,22224,2113.0,,13257,In vivo,,1
,CHEMBL627675,14160,BAO_0000218,A,,,,Liver,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,Autocuration,0,,U,22224,2107.0,,13257,In vivo,,1
,CHEMBL627676,14161,BAO_0000218,A,,,,Lung,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,Autocuration,0,,U,22224,2048.0,,13257,In vivo,,1
,CHEMBL627677,14162,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL627678,14163,BAO_0000019,A,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL627679,14164,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Affinity for protein binding expressed as association constant in fresh rat serum,Intermediate,1,,N,50597,1977.0,,7095,,,1
,CHEMBL627680,14165,BAO_0000019,A,,,,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,0,,U,22224,,,12185,,,1
,CHEMBL627681,14166,BAO_0000019,A,,,,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,0,,U,22224,,,12185,,,1
,CHEMBL627682,14167,BAO_0000019,A,,,,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,0,,U,22224,,,12185,,,1
,CHEMBL627683,14168,BAO_0000019,A,,,,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,0,,U,22224,,,12185,,,1
,CHEMBL627684,14169,BAO_0000019,A,,,,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,Autocuration,0,,U,22224,,,12686,,,1
,CHEMBL874441,14170,BAO_0000019,A,,,,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,0,,U,22224,,,12686,,,1
,CHEMBL627685,14171,BAO_0000019,A,,,,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,Autocuration,0,,U,22224,,,12686,,,1
,CHEMBL627686,14172,BAO_0000019,A,,,,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,0,,U,22224,,,12686,,,1
,CHEMBL627687,14173,BAO_0000019,A,,,,,,,Apparent rate constant Koff for inactivation of dTMP synthase.,Autocuration,0,,U,22224,,,8057,,,1
,CHEMBL627688,14174,BAO_0000019,A,,,,,,,The irreversible inhibitor activity by second order rate equation.,Autocuration,0,,U,22224,,,15778,,,1
,CHEMBL628038,14175,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Intermediate,1,,N,50597,,,12375,,,1
,CHEMBL628039,14176,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Intermediate,1,,N,50597,,,12375,,,1
,CHEMBL628040,14177,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Intermediate,1,,N,50597,,,12375,,,1
,CHEMBL628041,14178,BAO_0000019,A,,,,,,,Dissociation rate calculated from the first-order equation using t1/2 value,Autocuration,0,,U,22224,,,13588,,,1
,CHEMBL630226,14179,BAO_0000019,A,,,,,,,The compound was tested for Binding constant against DNA,Autocuration,0,,U,22224,,,15039,,,1
,CHEMBL628042,14180,BAO_0000019,A,,,,,,,First order rate constant for cyclization of the compound,Autocuration,0,,U,22224,,,9500,,,1
,CHEMBL625232,14181,BAO_0000019,A,,,,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,0,,U,22224,,,10014,,,1
,CHEMBL625233,14182,BAO_0000019,A,,,,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,0,,U,22224,,,10014,,,1
,CHEMBL625979,14183,BAO_0000019,A,,,,,,,Hydrolysis rate constant was determined,Autocuration,0,,U,22224,,,568,,,1
,CHEMBL625980,14184,BAO_0000019,A,,,,,,,Observed first order rate constant,Autocuration,0,,U,22224,,,10026,,,1
,CHEMBL625981,14185,BAO_0000019,A,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,0,,U,22224,,,10281,,,1
,CHEMBL625982,14186,BAO_0000019,A,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,0,,U,22224,,,10281,,,1
,CHEMBL625983,14187,BAO_0000019,A,,,,,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL625984,14188,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625985,14189,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625986,14190,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625987,14191,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625988,14192,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625989,14193,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625990,14194,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625991,14195,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625992,14196,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL625993,14197,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL631973,14198,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632143,14199,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632144,14200,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632145,14201,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632146,14202,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632147,14203,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632148,14204,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632149,14205,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632150,14206,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632151,14207,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL632152,14208,BAO_0000218,A,,,9606.0,,Homo sapiens,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Intermediate,1,,N,50587,,,3008,,,1
,CHEMBL632153,14209,BAO_0000218,A,,,9606.0,,Homo sapiens,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,1,,N,50587,,,4509,,,1
,CHEMBL632154,14210,BAO_0000218,A,,,9606.0,,Homo sapiens,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,1,,N,50587,,,4509,,,1
,CHEMBL632155,14211,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL632156,14212,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL632157,14213,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL632158,14214,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL632159,14215,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL626305,14216,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL626306,14217,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL626307,14218,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL626308,14219,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL626479,14220,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL626480,14221,BAO_0000218,A,,,10298.0,,Human herpesvirus 1,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Intermediate,1,,N,50602,,,8613,,,1
,CHEMBL626481,14222,BAO_0000100,P,,,,,,,Calculated partition coefficient (clogP) (MlogP),Autocuration,0,,U,22229,,,6021,,,1
,CHEMBL626482,14223,BAO_0000019,A,,,,,,,Equipotent potent ratio relative to carbachol (nicotinic activity),Autocuration,0,,U,22224,,,9348,,,1
,CHEMBL626483,14224,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Intermediate,1,,N,50588,,,15592,,,1
,CHEMBL626484,14225,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Intermediate,1,,N,50588,,,15592,,,1
,CHEMBL626485,14226,BAO_0000100,P,,,,,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,Autocuration,0,,U,22229,,,15592,,,1
,CHEMBL626486,14227,BAO_0000100,P,,,,,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,Autocuration,0,,U,22229,,,15592,,,1
,CHEMBL626487,14228,BAO_0000100,P,,,,,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,Autocuration,0,,U,22229,,,15592,,,1
,CHEMBL626488,14229,BAO_0000218,A,,,9615.0,Plasma,Canis lupus familiaris,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,1,,N,50588,1969.0,,15592,In vivo,,1
,CHEMBL626489,14230,BAO_0000218,A,,,10116.0,Serum,Rattus norvegicus,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Intermediate,1,,N,50597,1977.0,,7095,,,1
,CHEMBL626490,14231,BAO_0000019,A,,,,,,,Area under the MAP curve measured over 5 min; ND means Not determined,Autocuration,0,,U,22224,,,16618,,,1
,CHEMBL626491,14232,BAO_0000100,P,,,,,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,Autocuration,0,,U,22224,,,16835,,,1
,CHEMBL626492,14233,BAO_0000100,P,,,,,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,Autocuration,0,,U,22229,,,15284,,,1
,CHEMBL626493,14234,BAO_0000019,A,,,,,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,Autocuration,0,,U,22224,,,15750,,,1
,CHEMBL626494,14235,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,1,,N,50597,,,16618,In vivo,,1
,CHEMBL626495,14236,BAO_0000218,A,,,,,,,Half life after oral tested,Autocuration,0,,U,22224,,,16618,In vivo,,1
,CHEMBL626496,14237,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,Half life was determined in plasma of rat; NT indicates not tested,Intermediate,1,,N,50597,1969.0,,15812,,,1
,CHEMBL626497,14238,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,1,,N,50597,,,16618,In vivo,,1
,CHEMBL626498,14239,BAO_0000218,A,,,,,,,Oral bioavailability after oral tested,Autocuration,0,,U,22224,,,16618,In vivo,,1
,CHEMBL626499,14240,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Intermediate,1,,N,50597,,,13098,,,1
,CHEMBL626500,14241,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Intermediate,1,,N,50597,,,13098,,,1
,CHEMBL626501,14242,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,half life was determined in plasma of rat; NT indicates not tested,Intermediate,1,,N,50597,1969.0,,15812,,,1
,CHEMBL626502,14243,BAO_0000218,A,,,10116.0,Plasma,Rattus norvegicus,,half life was determined in plasma of rat; NT means not tested,Intermediate,1,,N,50597,1969.0,,15812,,,1
,CHEMBL626503,14244,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626504,14245,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626505,14246,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626506,14247,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626507,14248,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626508,14249,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626509,14250,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL875480,14251,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626510,14252,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626511,14253,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL626512,14254,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL628208,14255,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL628209,14256,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL628210,14257,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL628211,14258,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL628212,14259,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL628213,14260,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL628214,14261,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628215,14262,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628216,14263,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626595,14264,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626596,14265,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626597,14266,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626598,14267,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622242,14268,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622243,14269,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622244,14270,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622245,14271,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622246,14272,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622247,14273,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622248,14274,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL877483,14275,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622249,14276,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL622250,14277,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622251,14278,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622252,14279,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622253,14280,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622254,14281,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622255,14282,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622256,14283,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622257,14284,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622258,14285,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622259,14286,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622927,14287,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622928,14288,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL622929,14289,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL623182,14290,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL623183,14291,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL623184,14292,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623185,14293,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL877484,14294,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL627274,14295,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623186,14296,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623187,14297,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL623188,14298,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628055,14299,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628056,14300,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628200,14301,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628201,14302,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628202,14303,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628203,14304,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628204,14305,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628205,14306,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628206,14307,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628207,14308,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627220,14309,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627221,14310,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL627222,14311,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627223,14312,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL632062,14313,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL632063,14314,BAO_0000218,A,,,,Spleen,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,Autocuration,0,,U,22224,2106.0,,13257,In vivo,,1
,CHEMBL632064,14315,BAO_0000218,A,,,,Urinary bladder,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,Autocuration,0,,U,22224,1255.0,,13257,In vivo,,1
,CHEMBL632065,14316,BAO_0000218,A,,,,Blood,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,Autocuration,0,,U,22224,178.0,,13257,In vivo,,1
,CHEMBL632066,14317,BAO_0000218,A,,,,Bone element,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,Autocuration,0,,U,22224,1474.0,,13257,In vivo,,1
,CHEMBL632067,14318,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL629188,14319,BAO_0000218,A,,,,Kidney,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,Autocuration,0,,U,22224,2113.0,,13257,In vivo,,1
,CHEMBL629189,14320,BAO_0000218,A,,,,Liver,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,Autocuration,0,,U,22224,2107.0,,13257,In vivo,,1
,CHEMBL629190,14321,BAO_0000218,A,,,,Lung,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,Autocuration,0,,U,22224,2048.0,,13257,In vivo,,1
,CHEMBL629191,14322,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL629192,14323,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL629193,14324,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL629194,14325,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL629195,14326,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL629373,14327,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL629374,14328,BAO_0000218,A,,,,Spleen,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,Autocuration,0,,U,22224,2106.0,,13257,In vivo,,1
,CHEMBL629375,14329,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL629376,14330,BAO_0000218,A,,,,Urinary bladder,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,Autocuration,0,,U,22224,1255.0,,13257,In vivo,,1
,CHEMBL629377,14331,BAO_0000218,A,,,,Blood,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,Autocuration,0,,U,22224,178.0,,13257,In vivo,,1
,CHEMBL629378,14332,BAO_0000218,A,,,,Bone element,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,Autocuration,0,,U,22224,1474.0,,13257,In vivo,,1
,CHEMBL629379,14333,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL629151,14334,BAO_0000218,A,,,,Kidney,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,Autocuration,0,,U,22224,2113.0,,13257,In vivo,,1
,CHEMBL629152,14335,BAO_0000218,A,,,,Liver,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,Autocuration,0,,U,22224,2107.0,,13257,In vivo,,1
,CHEMBL629153,14336,BAO_0000218,A,,,,Lung,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,Autocuration,0,,U,22224,2048.0,,13257,In vivo,,1
,CHEMBL629154,14337,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL629155,14338,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL629156,14339,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL629157,14340,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL629158,14341,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL629159,14342,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL629160,14343,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL629161,14344,BAO_0000218,A,,,,Spleen,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,Autocuration,0,,U,22224,2106.0,,13257,In vivo,,1
,CHEMBL629162,14345,BAO_0000218,A,,,,Urinary bladder,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,Autocuration,0,,U,22224,1255.0,,13257,In vivo,,1
,CHEMBL629163,14346,BAO_0000218,A,,,,Blood,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,Autocuration,0,,U,22224,178.0,,13257,In vivo,,1
,CHEMBL629164,14347,BAO_0000218,A,,,,Bone element,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,Autocuration,0,,U,22224,1474.0,,13257,In vivo,,1
,CHEMBL629165,14348,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL629166,14349,BAO_0000218,A,,,,Liver,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,Autocuration,0,,U,22224,2107.0,,13257,In vivo,,1
,CHEMBL629167,14350,BAO_0000218,A,,,,Lung,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,Autocuration,0,,U,22224,2048.0,,13257,In vivo,,1
,CHEMBL629168,14351,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL629169,14352,BAO_0000019,A,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,Autocuration,0,,U,22224,,,2193,,,1
,CHEMBL629170,14353,BAO_0000019,A,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,Autocuration,0,,U,22224,,,2193,,,1
,CHEMBL631153,14354,BAO_0000019,A,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,Autocuration,0,,U,22224,,,2193,,,1
,CHEMBL875121,14355,BAO_0000019,A,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,Autocuration,0,,U,22224,,,2193,,,1
,CHEMBL631154,14356,BAO_0000019,A,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,Autocuration,0,,U,22224,,,2193,,,1
,CHEMBL631155,14357,BAO_0000019,A,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,Autocuration,0,,U,22224,,,2193,,,1
,CHEMBL631156,14358,BAO_0000019,A,,,,,,,Hydrolysis rate constant was determined,Autocuration,0,,U,22224,,,568,,,1
,CHEMBL631157,14359,BAO_0000019,A,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL631158,14360,BAO_0000019,A,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL631159,14361,BAO_0000019,A,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL631160,14362,BAO_0000019,A,,,,,,,Observed second order rate constant,Autocuration,0,,U,22224,,,10026,,,1
,CHEMBL631161,14363,BAO_0000019,A,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,0,,U,22224,,,10281,,,1
,CHEMBL631162,14364,BAO_0000019,A,,,,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,0,,U,22224,,,10014,,,1
,CHEMBL630313,14365,BAO_0000019,A,,,,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,0,,U,22224,,,10014,,,1
,CHEMBL630314,14366,BAO_0000019,A,,,,,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL630315,14367,BAO_0000019,A,,,,,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL630316,14368,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630986,14369,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630987,14370,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630988,14371,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630989,14372,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630990,14373,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630991,14374,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630992,14375,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630993,14376,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630994,14377,BAO_0000019,A,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,0,,U,22224,,,13028,,,1
,CHEMBL630995,14378,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Intermediate,1,,N,50597,,,10014,,,1
,CHEMBL629252,14379,BAO_0000019,A,,,,,,,Association constant for compound at 31 degree C was determined,Autocuration,0,,U,22224,,,9962,,,1
,CHEMBL629253,14380,BAO_0000019,A,,,,,,,Calculated antagonist equilibrium dissociation constant of the compound,Autocuration,0,,U,22224,,,12029,,,1
,CHEMBL629944,14381,BAO_0000019,A,,,,,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,Autocuration,0,,U,22224,,,12029,,,1
,CHEMBL629945,14382,BAO_0000218,A,,,10141.0,Trachea,Cavia porcellus,,Dissociation constants vs LTE4 on guinea pig trachea,Intermediate,1,,N,50512,3126.0,,10583,,,1
,CHEMBL629946,14383,BAO_0000019,A,,,,,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",Autocuration,0,,U,22224,,,568,,,1
,CHEMBL629947,14384,BAO_0000019,A,,,,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",Autocuration,0,,U,22224,,,568,,,1
,CHEMBL629948,14385,BAO_0000019,A,,,,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",Autocuration,0,,U,22224,,,568,,,1
,CHEMBL856024,14386,BAO_0000019,A,,,,,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",Autocuration,0,,U,22224,,,568,,,1
,CHEMBL629949,14387,BAO_0000019,A,,,,,,,Affinity constant KD value was derived from TMP,Autocuration,0,,U,22224,,,7493,,,1
,CHEMBL629950,14388,BAO_0000019,A,,,,,,,Apparent dissociation (binding) rate constant was evaluated,Autocuration,0,,U,22224,,,8371,,,1
,CHEMBL630127,14389,BAO_0000100,P,,,,,,,Dissociation constant (KD) of the compound,Autocuration,0,,U,22224,,,13114,,,1
,CHEMBL630128,14390,BAO_0000100,P,,,,,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,Autocuration,0,,U,22224,,,15515,,,1
,CHEMBL630129,14391,BAO_0000100,P,,,,,,,Dissociation constant from ESR titration experiments,Autocuration,0,,U,22224,,,522,,,1
,CHEMBL630130,14392,BAO_0000019,,,,,,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),Autocuration,0,,U,22224,,,13888,,,1
,CHEMBL875234,14393,BAO_0000100,P,,,,,,,Dissociation constant was evaluated.,Autocuration,0,,U,22224,,,2616,,,1
,CHEMBL630131,14394,BAO_0000100,P,,,,,,,Dissociation constant was reported,Autocuration,0,,U,22224,,,3798,,,1
,CHEMBL630132,14395,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Dissociation constant was determined in rat pituitary cells.,Intermediate,1,,N,50597,,,8731,,,1
,CHEMBL630133,14396,BAO_0000019,A,,,,,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,Autocuration,0,,U,22224,,,11892,,,1
,CHEMBL630134,14397,BAO_0000019,A,,,,,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,Autocuration,0,,U,22224,,,11892,,,1
,CHEMBL630135,14398,BAO_0000019,A,,,,,,,Equilibrium dissociation constant of the compound,Autocuration,0,,U,22224,,,2582,,,1
,CHEMBL630136,14399,BAO_0000019,A,,,,,,,Equilibrium dissociation constant was determined,Autocuration,0,,U,22224,,,11892,,,1
,CHEMBL630137,14400,BAO_0000019,A,,,,,,,Kinetic constant KD was evaluated,Autocuration,0,,U,22224,,,13396,,,1
,CHEMBL630138,14401,BAO_0000019,A,,,,,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,Autocuration,0,,U,22224,,,603,,,1
,CHEMBL630139,14402,BAO_0000019,A,,,,,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,Autocuration,0,,U,22224,,,15673,,,1
,CHEMBL630140,14403,BAO_0000019,A,,,,,,,Rate constant for hydrolysis in aqueous acetone.,Autocuration,0,,U,22224,,,10368,,,1
,CHEMBL875235,14404,BAO_0000019,A,,,,,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,Autocuration,0,,U,22224,,,14228,,,1
,CHEMBL876439,14405,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630605,14406,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630606,14407,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630607,14408,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630608,14409,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630609,14410,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630610,14411,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL630611,14412,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629552,14413,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629733,14414,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629734,14415,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629735,14416,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629736,14417,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629737,14418,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629738,14419,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629739,14420,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629740,14421,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629741,14422,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629742,14423,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629743,14424,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629744,14425,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629745,14426,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629746,14427,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629747,14428,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629748,14429,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629749,14430,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629750,14431,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629751,14432,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629752,14433,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629753,14434,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629754,14435,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629755,14436,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629756,14437,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629757,14438,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629758,14439,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629759,14440,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629760,14441,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL876443,14442,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,1,,N,50597,,,11510,,,1
,CHEMBL629761,14443,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,1,,N,50588,,,8310,,,1
,CHEMBL629762,14444,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Intermediate,1,,N,50588,,,8310,,,1
,CHEMBL629763,14445,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL629764,14446,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL629765,14447,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL629766,14448,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL629767,14449,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL629768,14450,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Intermediate,1,,N,50588,,,8310,,,1
,CHEMBL629769,14451,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL629770,14452,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,1,,N,50588,,,8310,,,1
,CHEMBL629771,14453,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Intermediate,1,,N,50588,,,8310,,,1
,CHEMBL629772,14454,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL629773,14455,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL625455,14456,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL625456,14457,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL625457,14458,BAO_0000218,A,,,10090.0,,Mus musculus,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Intermediate,1,,N,50594,,,8310,,,1
,CHEMBL625458,14459,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625459,14460,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL875483,14461,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL634779,14462,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625460,14463,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626117,14464,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626118,14465,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628342,14466,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628343,14467,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628344,14468,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628345,14469,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628346,14470,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628347,14471,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628348,14472,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628349,14473,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL875611,14474,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628350,14475,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628351,14476,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628352,14477,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628353,14478,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628354,14479,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626667,14480,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626668,14481,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626669,14482,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626670,14483,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626671,14484,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626672,14485,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626673,14486,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626674,14487,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626675,14488,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626676,14489,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626677,14490,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626678,14491,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626679,14492,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL875612,14493,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626680,14494,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626681,14495,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626682,14496,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626683,14497,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626684,14498,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626685,14499,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626686,14500,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626687,14501,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL624978,14502,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL624979,14503,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL624980,14504,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL624981,14505,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL624982,14506,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627564,14507,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627565,14508,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627566,14509,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL627567,14510,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL627568,14511,BAO_0000218,A,,,,Spleen,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,Autocuration,0,,U,22224,2106.0,,13257,In vivo,,1
,CHEMBL627569,14512,BAO_0000218,A,,,,Kidney,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,Autocuration,0,,U,22224,2113.0,,13257,In vivo,,1
,CHEMBL627570,14513,BAO_0000218,A,,,,Urinary bladder,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,Autocuration,0,,U,22224,1255.0,,13257,In vivo,,1
,CHEMBL627571,14514,BAO_0000218,A,,,,Blood,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,Autocuration,0,,U,22224,178.0,,13257,In vivo,,1
,CHEMBL627572,14515,BAO_0000218,A,,,,Bone element,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,Autocuration,0,,U,22224,1474.0,,13257,In vivo,,1
,CHEMBL627573,14516,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL627574,14517,BAO_0000218,A,,,,Kidney,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,Autocuration,0,,U,22224,2113.0,,13257,In vivo,,1
,CHEMBL627575,14518,BAO_0000218,A,,,,Liver,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,Autocuration,0,,U,22224,2107.0,,13257,In vivo,,1
,CHEMBL627576,14519,BAO_0000218,A,,,,Lung,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,Autocuration,0,,U,22224,2048.0,,13257,In vivo,,1
,CHEMBL627577,14520,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL627578,14521,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627579,14522,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627580,14523,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL627581,14524,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627582,14525,BAO_0000218,A,,,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,Autocuration,0,,U,22224,,,13257,In vivo,,1
,CHEMBL627583,14526,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL627584,14527,BAO_0000218,A,,,,Spleen,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,Autocuration,0,,U,22224,2106.0,,13257,In vivo,,1
,CHEMBL627585,14528,BAO_0000218,A,,,,Prostate gland,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,Autocuration,0,,U,22224,2367.0,,13257,In vivo,,1
,CHEMBL627586,14529,BAO_0000218,A,,,,Muscle tissue,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,Autocuration,0,,U,22224,2385.0,,13257,In vivo,,1
,CHEMBL627587,14530,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL627588,14531,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL628250,14532,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL628251,14533,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL628252,14534,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,1,,N,50597,10000000.0,,15413,In vivo,,1
,CHEMBL628253,14535,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,10000000.0,,15413,In vivo,,1
,CHEMBL628254,14536,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL877493,14537,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL628255,14538,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL628256,14539,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL628257,14540,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,10000000.0,,15413,In vivo,,1
,CHEMBL628258,14541,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL628259,14542,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL628429,14543,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL626862,14544,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,1,,N,50597,10000000.0,,15413,In vivo,,1
,CHEMBL626863,14545,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL625886,14546,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Intermediate,1,,N,50597,2037.0,,15413,In vivo,,1
,CHEMBL625887,14547,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Intermediate,1,,N,50597,2037.0,,15413,In vivo,,1
,CHEMBL625888,14548,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL625889,14549,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL625890,14550,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Intermediate,1,,N,50597,10000000.0,,15413,In vivo,,1
,CHEMBL625891,14551,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Intermediate,1,,N,50597,10000000.0,,15413,In vivo,,1
,CHEMBL625892,14552,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL625893,14553,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL625894,14554,BAO_0000218,A,,,10116.0,Cerebellum,Rattus norvegicus,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Intermediate,1,,N,50597,2037.0,,15413,In vivo,,1
,CHEMBL625895,14555,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Intermediate,1,,N,50597,,,15413,In vivo,,1
,CHEMBL625896,14556,BAO_0000019,A,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,0,,U,22224,,,12404,,,1
,CHEMBL625897,14557,BAO_0000019,A,,,,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",Autocuration,0,,U,22224,,,568,,,1
,CHEMBL625898,14558,BAO_0000019,A,,,,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,0,,U,22224,,,568,,,1
,CHEMBL625899,14559,BAO_0000019,A,,,,,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,0,,U,22224,,,568,,,1
,CHEMBL626124,14560,BAO_0000019,A,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,0,,U,22224,,,12404,,,1
,CHEMBL628500,14561,BAO_0000218,A,,,562.0,,Escherichia coli,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Intermediate,1,,N,50212,,,7624,,,1
,CHEMBL857856,14562,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Intermediate,1,,N,50597,,,7624,,,1
,CHEMBL628501,14563,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Intermediate,1,,N,50597,,,7624,,,1
,CHEMBL628502,14564,BAO_0000019,A,,,,,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",Autocuration,0,,U,22224,,,4643,,,1
,CHEMBL628503,14565,BAO_0000019,A,,,,,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,Autocuration,0,,U,22224,,,11532,,,1
,CHEMBL628504,14566,BAO_0000019,A,,,,,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,Autocuration,0,,U,22224,,,11018,,,1
,CHEMBL628505,14567,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL874452,14568,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL628506,14569,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL628507,14570,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL628508,14571,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL628509,14572,BAO_0000019,A,,,,,,,Michaelis constant (KM) was evaluated,Autocuration,0,,U,22224,,,8949,,,1
,CHEMBL628510,14573,BAO_0000019,A,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,0,,U,22224,,,12404,,,1
,CHEMBL628511,14574,BAO_0000019,B,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,Autocuration,0,,U,22224,,,7625,,,1
,CHEMBL628512,14575,BAO_0000019,B,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,Autocuration,0,,U,22224,,,7625,,,1
,CHEMBL628513,14576,BAO_0000019,B,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,Autocuration,0,,U,22224,,,7625,,,1
,CHEMBL628514,14577,BAO_0000019,B,,,,,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,Autocuration,0,,U,22224,,,7625,,,1
,CHEMBL628515,14578,BAO_0000019,A,,,,,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,Autocuration,0,,U,22224,,,12908,,,1
,CHEMBL628516,14579,BAO_0000019,A,,,,,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,Autocuration,0,,U,22224,,,10368,,,1
,CHEMBL628517,14580,BAO_0000019,A,,,,,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,0,,U,22224,,,13108,,,1
,CHEMBL628518,14581,BAO_0000019,A,,,,,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,0,,U,22224,,,13108,,,1
,CHEMBL628519,14582,BAO_0000019,A,,,,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,Autocuration,0,,U,22224,,,15217,,,1
,CHEMBL628520,14583,BAO_0000019,A,,,,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,Autocuration,0,,U,22224,,,15217,,,1
,CHEMBL628521,14584,BAO_0000019,A,,,,,,,Binding constant was determined,Autocuration,0,,U,22224,,,10933,,,1
,CHEMBL630443,14585,BAO_0000019,A,,,,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,Autocuration,0,,U,22224,,,2363,,,1
,CHEMBL630444,14586,BAO_0000019,A,,,,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,Autocuration,0,,U,22224,,,2363,,,1
,CHEMBL857732,14587,BAO_0000019,A,,,,,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL630445,14588,BAO_0000100,P,,,,,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,Autocuration,0,,U,22224,,,14915,,,1
,CHEMBL630446,14589,BAO_0000019,A,,,,,,,Catalytic rate constant of the compound,Autocuration,0,,U,22224,,,8847,,,1
,CHEMBL630447,14590,BAO_0000019,B,,,,,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,Autocuration,0,,U,22224,,,15357,,,1
,CHEMBL630448,14591,BAO_0000019,A,,,,,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),Autocuration,0,,U,22224,,,2869,,,1
,CHEMBL630449,14592,BAO_0000019,A,,,,,,,Catalytic rate constant against phospholipase A2 was determined,Autocuration,0,,U,22224,,,3484,,,1
,CHEMBL630450,14593,BAO_0000019,A,,,,,,,"Compound was evaluated for catalytic constant, Kcat",Autocuration,0,,U,22224,,,1373,,,1
,CHEMBL630451,14594,BAO_0000019,A,,,,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,Autocuration,0,,U,22224,,,8142,,,1
,CHEMBL630452,14595,BAO_0000019,A,,,,,,,Kcat calculated from 0.693/T1/2,Autocuration,0,,U,22224,,,14131,,,1
,CHEMBL630453,14596,BAO_0000019,A,,,,,,,Kcat was determined,Autocuration,0,,U,22224,,,17269,,,1
,CHEMBL630454,14597,BAO_0000019,A,,,,,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,Autocuration,0,,U,22224,,,3485,,,1
,CHEMBL630455,14598,BAO_0000019,A,,,,,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,Autocuration,0,,U,22224,,,3485,,,1
,CHEMBL631487,14599,BAO_0000019,A,,,,,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,Autocuration,0,,U,22224,,,3485,,,1
,CHEMBL631488,14600,BAO_0000019,A,,,,,,,Kcat value was determined,Autocuration,0,,U,22224,,,5962,,,1
,CHEMBL876440,14601,BAO_0000019,A,,,,,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,Autocuration,0,,U,22224,,,3133,,,1
,CHEMBL631489,14602,BAO_0000019,A,,,,,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,Autocuration,0,,U,22224,,,3133,,,1
,CHEMBL857742,14603,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL631490,14604,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL631491,14605,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL631492,14606,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL631493,14607,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL631494,14608,BAO_0000019,A,,,,,,,Kinetic parameter for rate of conversion to PABA was determined,Autocuration,0,,U,22224,,,4892,,,1
,CHEMBL631495,14609,BAO_0000019,A,,,,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,0,,U,22224,,,3133,,,1
,CHEMBL631496,14610,BAO_0000218,A,,,10116.0,Feces,Rattus norvegicus,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,1,,N,50597,1988.0,,11488,,,1
,CHEMBL631497,14611,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,1,,N,50597,1088.0,,11488,,,1
,CHEMBL631498,14612,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,1,,N,50597,1088.0,,11488,,,1
,CHEMBL629776,14613,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,1,,N,50597,1088.0,,11488,,,1
,CHEMBL629777,14614,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,1,,N,50597,1088.0,,11488,,,1
,CHEMBL629778,14615,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,1,,N,50597,1088.0,,11488,,,1
,CHEMBL630456,14616,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630457,14617,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630458,14618,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630459,14619,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630460,14620,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL876550,14621,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630461,14622,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630462,14623,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630463,14624,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630464,14625,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630465,14626,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630466,14627,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630467,14628,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630633,14629,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630634,14630,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630635,14631,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630636,14632,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630637,14633,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Intermediate,1,,N,50597,,,11488,,,1
,CHEMBL630638,14634,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL630639,14635,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL630640,14636,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL876551,14637,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL630641,14638,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL630642,14639,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL630643,14640,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL630644,14641,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL630645,14642,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL625599,14643,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL625600,14644,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL625601,14645,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL625602,14646,BAO_0000218,A,,,9986.0,Feces,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,1,,N,50592,1988.0,,7132,,,1
,CHEMBL627470,14647,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL627471,14648,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL627472,14649,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL627473,14650,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL627474,14651,BAO_0000218,A,,,9986.0,Urine,Oryctolagus cuniculus,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,1,,N,50592,1088.0,,7132,,,1
,CHEMBL627475,14652,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,178.0,,13925,In vivo,,1
,CHEMBL627476,14653,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,178.0,,13925,In vivo,,1
,CHEMBL627477,14654,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627478,14655,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627479,14656,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627480,14657,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627481,14658,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627482,14659,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL627483,14660,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL875636,14661,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625764,14662,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625765,14663,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625766,14664,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625767,14665,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625768,14666,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625769,14667,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625770,14668,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625771,14669,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625772,14670,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625773,14671,BAO_0000218,A,,,9615.0,Urine,Canis lupus familiaris,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,1,,N,50588,1088.0,,12582,,,1
,CHEMBL625774,14672,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625775,14673,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625776,14674,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625777,14675,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625778,14676,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625779,14677,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625780,14678,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL625781,14679,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL875637,14680,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626473,14681,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626474,14682,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626475,14683,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626476,14684,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL634397,14685,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL626477,14686,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631069,14687,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631070,14688,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631071,14689,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631072,14690,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631073,14691,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631074,14692,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631075,14693,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631725,14694,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631726,14695,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631727,14696,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631728,14697,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631729,14698,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631730,14699,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631731,14700,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631910,14701,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631911,14702,BAO_0000218,A,,,10116.0,Hippocampus,Rattus norvegicus,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Intermediate,1,,N,50597,10000000.0,,15413,In vivo,,1
,CHEMBL631912,14703,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL631913,14704,BAO_0000218,A,,,10116.0,Hypothalamus,Rattus norvegicus,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Intermediate,1,,N,50597,1898.0,,15413,In vivo,,1
,CHEMBL631914,14705,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631915,14706,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL875778,14707,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631916,14708,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631917,14709,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631918,14710,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631919,14711,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631920,14712,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631921,14713,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631922,14714,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631923,14715,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,178.0,,12017,In vivo,,1
,CHEMBL631924,14716,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630234,14717,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630235,14718,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630236,14719,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630237,14720,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630238,14721,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630239,14722,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630303,14723,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630304,14724,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630305,14725,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,,,12017,In vivo,,1
,CHEMBL630306,14726,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL630307,14727,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL630308,14728,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL630309,14729,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL629309,14730,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL629993,14731,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL629994,14732,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL629995,14733,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL631993,14734,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL631994,14735,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL631995,14736,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2113.0,,12017,In vivo,,1
,CHEMBL631996,14737,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL631997,14738,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL631998,14739,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL631999,14740,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL632000,14741,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL632001,14742,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL874424,14743,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL632002,14744,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL632003,14745,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL632004,14746,BAO_0000019,A,,,,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,0,,U,22224,,,3133,,,1
,CHEMBL632005,14747,BAO_0000019,A,,,,,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL632006,14748,BAO_0000019,A,,,,,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL632007,14749,BAO_0000019,A,,,,,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL632008,14750,BAO_0000019,A,,,,,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL632009,14751,BAO_0000019,A,,,,,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL632010,14752,BAO_0000019,A,,,,,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL857750,14753,BAO_0000019,A,,,,,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL632011,14754,BAO_0000019,A,,,,,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,Autocuration,0,,U,22224,,,2742,,,1
,CHEMBL632012,14755,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL632013,14756,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL632014,14757,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL629622,14758,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL629623,14759,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL629624,14760,BAO_0000019,A,,,,,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL629625,14761,BAO_0000019,A,,,,,,,Ratio of Kcat to that of Km was determined,Autocuration,0,,U,22224,,,17269,,,1
,CHEMBL629626,14762,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL629627,14763,BAO_0000019,A,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,0,,U,22224,,,2276,,,1
,CHEMBL629628,14764,BAO_0000019,A,,,,,,,"Compound was evaluated for constant, Kd",Autocuration,0,,U,22224,,,15917,,,1
,CHEMBL629629,14765,BAO_0000019,A,,,,,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,Autocuration,0,,U,22224,,,10933,,,1
,CHEMBL629630,14766,BAO_0000019,A,,,,,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,Autocuration,0,,U,22224,,,10933,,,1
,CHEMBL856030,14767,BAO_0000019,A,,,,,,,Dissociation Constant of compound determined,Autocuration,0,,U,22224,,,14293,,,1
,CHEMBL629631,14768,BAO_0000019,B,,,,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,Autocuration,0,,U,22224,,,6698,,,1
,CHEMBL629632,14769,BAO_0000019,B,,,,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,Autocuration,0,,U,22224,,,6698,,,1
,CHEMBL629633,14770,BAO_0000100,P,,,,,,,Dissociation constant of compound with Fructose was determined,Autocuration,0,,U,22224,,,4318,,,1
,CHEMBL629634,14771,BAO_0000100,P,,,,,,,Dissociation constant of compound with Fructose was determined; Not determined,Autocuration,0,,U,22224,,,4318,,,1
,CHEMBL629635,14772,BAO_0000100,P,,,,,,,Dissociation constant of compound with Lactulose was determined,Autocuration,0,,U,22224,,,4318,,,1
,CHEMBL629636,14773,BAO_0000100,P,,,,,,,Dissociation constant of compound with Lactulose was determined; Not determined,Autocuration,0,,U,22224,,,4318,,,1
,CHEMBL629637,14774,BAO_0000100,P,,,,,,,Dissociation constant of the Compound,Autocuration,0,,U,22224,,,14959,,,1
,CHEMBL629638,14775,BAO_0000100,P,,,,,,,Dissociation constant by non-linear regression analysis,Autocuration,0,,U,22224,,,5913,,,1
,CHEMBL629639,14776,BAO_0000100,P,,,,,,,Dissociation constant was determined,Autocuration,0,,U,22224,,,14218,,,1
,CHEMBL629640,14777,BAO_0000100,P,,,,,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,Autocuration,0,,U,22224,,,10689,,,1
,CHEMBL629641,14778,BAO_0000100,P,,,,,,,Dissociation constant was determined,Autocuration,0,,U,22224,,,13925,,,1
,CHEMBL631344,14779,BAO_0000100,P,,,,,,,Dissociation constant was determined,Autocuration,0,,U,22224,,,16359,,,1
,CHEMBL631345,14780,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Intermediate,1,,N,50597,2385.0,,10944,,,1
,CHEMBL631346,14781,BAO_0000019,A,,,,,,,The dissociation constant determined by fluorescence displacement assay,Autocuration,0,,U,22224,,,11080,,,1
,CHEMBL631524,14782,BAO_0000019,A,,,,,,,kd value surface plasmon resonance (SPR) method,Autocuration,0,,U,22224,,,17805,,,1
,CHEMBL631525,14783,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Intermediate,1,,N,50597,2385.0,,10944,,,1
,CHEMBL631526,14784,BAO_0000019,F,,,,,,,First dissociation constant of the binding of compound to V30M TTR,Autocuration,0,,U,22224,,,16645,,,1
,CHEMBL631527,14785,BAO_0000019,F,,,,,,,Second dissociation constant of the binding of compound to V30M TTR,Autocuration,0,,U,22224,,,16645,,,1
,CHEMBL631528,14786,BAO_0000019,A,,,,,,,"Compound was evaluated for equilibrium constant, Ke",Autocuration,0,,U,22224,,,7793,,,1
,CHEMBL631529,14787,BAO_0000019,A,,,,Hypothalamus,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,Autocuration,0,,U,22224,1898.0,,12199,,,1
,CHEMBL631530,14788,BAO_0000019,A,,,,Hypothalamus,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,Autocuration,0,,U,22224,1898.0,,12199,,,1
,CHEMBL631531,14789,BAO_0000019,A,,,,,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL631532,14790,BAO_0000019,A,,,,,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL631533,14791,BAO_0000019,A,,,,,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,0,,U,22224,,,9680,,,1
,CHEMBL876552,14792,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL631534,14793,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL631535,14794,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL631536,14795,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL631537,14796,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL631538,14797,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL631539,14798,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL631540,14799,BAO_0000218,A,,,10090.0,,Mus musculus,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,1,,N,50594,,,13758,,,1
,CHEMBL625637,14800,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL625638,14801,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,1,,N,50597,,,14393,,,1
,CHEMBL625639,14802,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,1,,N,50597,,,15078,,,1
,CHEMBL625640,14803,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,955.0,,13925,In vivo,,1
,CHEMBL625641,14804,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,955.0,,13925,In vivo,,1
,CHEMBL625642,14805,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,948.0,,13925,In vivo,,1
,CHEMBL625643,14806,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,948.0,,13925,In vivo,,1
,CHEMBL625644,14807,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2113.0,,13925,In vivo,,1
,CHEMBL625645,14808,BAO_0000218,A,,,10116.0,Kidney,Rattus norvegicus,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2113.0,,13925,In vivo,,1
,CHEMBL625646,14809,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2107.0,,13925,In vivo,,1
,CHEMBL625647,14810,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2107.0,,13925,In vivo,,1
,CHEMBL625648,14811,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2048.0,,13925,In vivo,,1
,CHEMBL625649,14812,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2048.0,,13925,In vivo,,1
,CHEMBL625650,14813,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2385.0,,13925,In vivo,,1
,CHEMBL625651,14814,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2385.0,,13925,In vivo,,1
,CHEMBL625652,14815,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,14.0,,13925,In vivo,,1
,CHEMBL625653,14816,BAO_0000218,A,,,10116.0,Zone of skin,Rattus norvegicus,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,14.0,,13925,In vivo,,1
,CHEMBL625654,14817,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2106.0,,13925,In vivo,,1
,CHEMBL625655,14818,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,1,,N,50597,2106.0,,13925,In vivo,,1
,CHEMBL625656,14819,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of Compound in rat blood after 15 minutes of administration,Intermediate,1,,N,50597,178.0,,9712,In vivo,,1
,CHEMBL625657,14820,BAO_0000218,A,,,10116.0,Blood,Rattus norvegicus,,Biodistribution of Compound in rat blood after 2 minutes of administration,Intermediate,1,,N,50597,178.0,,9712,In vivo,,1
,CHEMBL625658,14821,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of Compound in rat brain after 15 minutes of administration,Intermediate,1,,N,50597,955.0,,9712,In vivo,,1
,CHEMBL625659,14822,BAO_0000218,A,,,10116.0,Brain,Rattus norvegicus,,Biodistribution of Compound in rat brain after 2 minutes of administration,Intermediate,1,,N,50597,955.0,,9712,In vivo,,1
,CHEMBL625660,14823,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of Compound in rat heart after 15 minutes of administration,Intermediate,1,,N,50597,948.0,,9712,In vivo,,1
,CHEMBL625661,14824,BAO_0000218,A,,,10116.0,Heart,Rattus norvegicus,,Biodistribution of Compound in rat heart after 2 minutes of administration,Intermediate,1,,N,50597,948.0,,9712,In vivo,,1
,CHEMBL625662,14825,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of Compound in rat liver after 15 minutes of administration,Intermediate,1,,N,50597,2107.0,,9712,In vivo,,1
,CHEMBL625663,14826,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution of Compound in rat liver after 2 minutes of administration,Intermediate,1,,N,50597,2107.0,,9712,In vivo,,1
,CHEMBL875621,14827,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of Compound in rat lung after 15 minutes of administration,Intermediate,1,,N,50597,2048.0,,9712,In vivo,,1
,CHEMBL628382,14828,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution of Compound in rat lung after 2 minutes of administration,Intermediate,1,,N,50597,2048.0,,9712,In vivo,,1
,CHEMBL628383,14829,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of Compound in rat muscle after 15 minutes of administration,Intermediate,1,,N,50597,2385.0,,9712,In vivo,,1
,CHEMBL628384,14830,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution of Compound in rat muscle after 2 minutes of administration,Intermediate,1,,N,50597,2385.0,,9712,In vivo,,1
,CHEMBL628385,14831,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Intermediate,1,,N,50597,,,13925,,,1
,CHEMBL875753,14832,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Intermediate,1,,N,50597,,,13925,,,1
,CHEMBL628386,14833,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Intermediate,1,,N,50597,,,13925,,,1
,CHEMBL628387,14834,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat blood 2 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL628388,14835,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat blood 2 hr after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL628389,14836,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat blood 30 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL632756,14837,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat blood 30 min after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL628390,14838,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat brain 2 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631811,14839,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat brain 2 hr after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631812,14840,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat brain 30 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631813,14841,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat heart 2 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631814,14842,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat heart 2 hr after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631815,14843,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat heart 30 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631816,14844,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat kidney 2 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL875758,14845,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat kidney 2 hr after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631817,14846,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat kidney 30 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631818,14847,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Organ distribution in rat liver 2 minutes after intravenous injection,Intermediate,1,,N,50597,2107.0,,6941,,,1
,CHEMBL631819,14848,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Organ distribution in rat liver 2 hr after intravenous injection,Intermediate,1,,N,50597,2107.0,,6941,,,1
,CHEMBL631820,14849,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Organ distribution in rat liver 30 minutes after intravenous injection,Intermediate,1,,N,50597,2107.0,,6941,,,1
,CHEMBL631821,14850,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat lung 2 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631822,14851,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat lung 2 hr after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631823,14852,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Organ distribution in rat lung 30 minutes after intravenous injection,Intermediate,1,,N,50597,,,6941,,,1
,CHEMBL631824,14853,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Organ distribution in rat muscle 2 minutes after intravenous injection,Intermediate,1,,N,50597,2385.0,,6941,,,1
,CHEMBL631825,14854,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Organ distribution in rat muscle 2 hr after intravenous injection,Intermediate,1,,N,50597,2385.0,,6941,,,1
,CHEMBL631826,14855,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Organ distribution in rat muscle 30 minutes after intravenous injection,Intermediate,1,,N,50597,2385.0,,6941,,,1
,CHEMBL631827,14856,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL631828,14857,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL631829,14858,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL875759,14859,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631830,14860,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631831,14861,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631832,14862,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631833,14863,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631834,14864,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631835,14865,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631836,14866,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631837,14867,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631838,14868,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631839,14869,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631840,14870,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631841,14871,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631842,14872,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631843,14873,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631844,14874,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631845,14875,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631846,14876,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL875760,14877,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL632199,14878,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631847,14879,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL631848,14880,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628707,14881,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628708,14882,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628709,14883,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628710,14884,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628711,14885,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628712,14886,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628713,14887,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628714,14888,BAO_0000218,A,,,10116.0,Urine,Rattus norvegicus,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,1,,N,50597,1088.0,,12582,,,1
,CHEMBL628715,14889,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Intermediate,1,,N,50597,,,7415,,,1
,CHEMBL629179,14890,BAO_0000019,A,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,Autocuration,0,,U,22224,,,7313,,,1
,CHEMBL629180,14891,BAO_0000019,A,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,Autocuration,0,,U,22224,,,7313,,,1
,CHEMBL875108,14892,BAO_0000019,A,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,Autocuration,0,,U,22224,,,7313,,,1
,CHEMBL629181,14893,BAO_0000019,A,,,,Adrenal cortex,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,0,,U,22224,1235.0,,7570,,,1
,CHEMBL629182,14894,BAO_0000019,A,,,,Adrenal cortex,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,0,,U,22224,1235.0,,7570,,,1
,CHEMBL629183,14895,BAO_0000019,A,,,,,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629184,14896,BAO_0000019,A,,,,,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629185,14897,BAO_0000019,A,,,,Adrenal cortex,,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,0,,U,22224,1235.0,,7570,,,1
,CHEMBL629186,14898,BAO_0000019,A,,,,Adrenal cortex,,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,0,,U,22224,1235.0,,7570,,,1
,CHEMBL629187,14899,BAO_0000019,A,,,,,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629887,14900,BAO_0000019,A,,,,,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629888,14901,BAO_0000019,A,,,,,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629889,14902,BAO_0000019,A,,,,,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629890,14903,BAO_0000019,A,,,,Adrenal cortex,,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,Autocuration,0,,U,22224,1235.0,,7570,,,1
,CHEMBL629891,14904,BAO_0000019,A,,,,,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629892,14905,BAO_0000019,A,,,,,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629893,14906,BAO_0000019,A,,,,Adrenal cortex,,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,0,,U,22224,1235.0,,7570,,,1
,CHEMBL629894,14907,BAO_0000019,A,,,,,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL629895,14908,BAO_0000019,A,,,,,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,0,,U,22224,,,7570,,,1
,CHEMBL875109,14909,BAO_0000218,A,,,9615.0,,Canis lupus familiaris,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Autocuration,0,,U,22224,,,14122,In vivo,,1
,CHEMBL629896,14910,BAO_0000218,A,,,9541.0,,Macaca fascicularis,,Absolute bioavailability in male cynomolgus monkeys,Autocuration,0,,U,22224,,,16449,In vivo,,1
,CHEMBL629897,14911,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,Absolute bioavailability in maleSprague-Dawley rats,Autocuration,0,,U,22224,,,16449,In vivo,,1
,CHEMBL629898,14912,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL630057,14913,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL630058,14914,BAO_0000218,A,,,10116.0,Liver,Rattus norvegicus,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2107.0,,12017,In vivo,,1
,CHEMBL630059,14915,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630060,14916,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630061,14917,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630062,14918,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630063,14919,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630064,14920,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630065,14921,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630066,14922,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630067,14923,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL630068,14924,BAO_0000218,A,,,10116.0,Lung,Rattus norvegicus,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2048.0,,12017,In vivo,,1
,CHEMBL631113,14925,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL631114,14926,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL631115,14927,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL631116,14928,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL630528,14929,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL630529,14930,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL630530,14931,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL630531,14932,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL630532,14933,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL630533,14934,BAO_0000218,A,,,10116.0,Muscle tissue,Rattus norvegicus,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2385.0,,12017,In vivo,,1
,CHEMBL630534,14935,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution in normal mice blood after 120 hr,Intermediate,1,,N,50594,178.0,,15045,In vivo,,1
,CHEMBL630535,14936,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution in normal mice blood after 24 hr,Intermediate,1,,N,50594,178.0,,15045,In vivo,,1
,CHEMBL630536,14937,BAO_0000218,A,,,10090.0,Blood,Mus musculus,,Biodistribution in normal mice blood after 4 hr,Intermediate,1,,N,50594,178.0,,15045,In vivo,,1
,CHEMBL630537,14938,BAO_0000218,A,,,10090.0,Bone,Mus musculus,,Biodistribution in normal mice bone after 120 hr,Intermediate,1,,N,50594,10000001.0,,15045,In vivo,,1
,CHEMBL630538,14939,BAO_0000218,A,,,10090.0,Bone,Mus musculus,,Biodistribution in normal mice bone after 24 hr,Intermediate,1,,N,50594,10000001.0,,15045,In vivo,,1
,CHEMBL630539,14940,BAO_0000218,A,,,10090.0,Bone,Mus musculus,,Biodistribution in normal mice bone after 4 hr,Intermediate,1,,N,50594,10000001.0,,15045,In vivo,,1
,CHEMBL630540,14941,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution in normal mice heart after 120 hr,Intermediate,1,,N,50594,948.0,,15045,In vivo,,1
,CHEMBL630541,14942,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution in normal mice heart after 24 hr,Intermediate,1,,N,50594,948.0,,15045,In vivo,,1
,CHEMBL630542,14943,BAO_0000218,A,,,10090.0,Heart,Mus musculus,,Biodistribution in normal mice heart after 4 hr,Intermediate,1,,N,50594,948.0,,15045,In vivo,,1
,CHEMBL630543,14944,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution in normal mice kidney after 120 hr,Intermediate,1,,N,50594,2113.0,,15045,In vivo,,1
,CHEMBL630544,14945,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution in normal mice kidney after 24 hr,Intermediate,1,,N,50594,2113.0,,15045,In vivo,,1
,CHEMBL630545,14946,BAO_0000218,A,,,10090.0,Kidney,Mus musculus,,Biodistribution in normal mice kidney after 4 hr,Intermediate,1,,N,50594,2113.0,,15045,In vivo,,1
,CHEMBL630546,14947,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in normal mice liver after 120 hr,Intermediate,1,,N,50594,2107.0,,15045,In vivo,,1
,CHEMBL630547,14948,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in normal mice liver after 24 hr,Intermediate,1,,N,50594,2107.0,,15045,In vivo,,1
,CHEMBL630548,14949,BAO_0000218,A,,,10090.0,Liver,Mus musculus,,Biodistribution in normal mice liver after 4 hr,Intermediate,1,,N,50594,2107.0,,15045,In vivo,,1
,CHEMBL630549,14950,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution in normal mice spleen after 120 hr,Intermediate,1,,N,50594,2106.0,,15045,In vivo,,1
,CHEMBL630550,14951,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution in normal mice spleen after 24 hr,Intermediate,1,,N,50594,2106.0,,15045,In vivo,,1
,CHEMBL876426,14952,BAO_0000218,A,,,10090.0,Spleen,Mus musculus,,Biodistribution in normal mice spleen after 4 hr,Intermediate,1,,N,50594,2106.0,,15045,In vivo,,1
,CHEMBL630551,14953,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630552,14954,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630553,14955,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630554,14956,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630555,14957,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630556,14958,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630557,14959,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630558,14960,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630559,14961,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL630560,14962,BAO_0000218,A,,,10116.0,Spleen,Rattus norvegicus,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2106.0,,12017,In vivo,,1
,CHEMBL876427,14963,BAO_0000218,A,,,10116.0,Thyroid gland,Rattus norvegicus,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,1,,N,50597,2046.0,,12017,In vivo,,1
,CHEMBL630561,14964,BAO_0000218,A,,,10116.0,,Rattus norvegicus,,The Kel values in female wistar rats.,Intermediate,1,,N,50597,,,14941,,,1
,CHEMBL630562,14965,BAO_0000019,A,,,,,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,Autocuration,0,,U,22224,,,4646,,,1
,CHEMBL630563,14966,BAO_0000019,A,,,,,,,Hydrolysis rate constant of the compound,Autocuration,0,,U,22224,,,8847,,,1
,CHEMBL629673,14967,BAO_0000100,P,,,,,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,Autocuration,0,,U,22229,,,11778,,,1
,CHEMBL629674,14968,BAO_0000019,A,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",Autocuration,0,,U,22224,,,2363,,,1
,CHEMBL629675,14969,BAO_0000019,A,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",Autocuration,0,,U,22224,,,2363,,,1
,CHEMBL629676,14970,BAO_0000019,A,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",Autocuration,0,,U,22224,,,2363,,,1
,CHEMBL629677,14971,BAO_0000019,A,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",Autocuration,0,,U,22224,,,2363,,,1
,CHEMBL629678,14972,BAO_0000019,A,,,,,,,Apparent inactivation rate constant was evaluated,Autocuration,0,,U,22224,,,8371,,,1
,CHEMBL629679,14973,BAO_0000019,A,,,,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,Autocuration,0,,U,22224,,,14883,,,1
,CHEMBL629680,14974,BAO_0000019,A,,,,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,Autocuration,0,,U,22224,,,14883,,,1
,CHEMBL629681,14975,BAO_0000019,A,,,,,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,Autocuration,0,,U,22224,,,4643,,,1
,CHEMBL629682,14976,BAO_0000019,A,,,,,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,Autocuration,0,,U,22224,,,3519,,,1
,CHEMBL629683,14977,BAO_0000019,A,,,,,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,Autocuration,0,,U,22224,,,10600,,,1
,CHEMBL629684,14978,BAO_0000019,F,,,,,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,Autocuration,0,,U,22224,,,8501,,,1
,CHEMBL629685,14979,BAO_0000100,P,,,,,,,Dissociation constant was determined,Autocuration,0,,U,22224,,,8505,,,1
,CHEMBL629686,14980,BAO_0000100,P,,,,,,,Dissociation constant was determined,Autocuration,0,,U,22224,,,9778,,,1
,CHEMBL872932,14981,BAO_0000100,P,,,,,,,Dissociation constant at pH 7.4,Autocuration,0,,U,22224,,,9778,,,1
,CHEMBL629687,14982,BAO_0000100,P,,,,,,,Dissociation constant in presence of 1 mM dithiothreitol,Autocuration,0,,U,22224,,,9778,,,1
,CHEMBL872931,14983,BAO_0000019,A,,,,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,0,,U,22224,,,13007,,,1
,CHEMBL628151,14984,BAO_0000019,A,,,,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,0,,U,22224,,,13007,,,1
,CHEMBL628152,14985,BAO_0000019,A,,,,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,0,,U,22224,,,13007,,,1
,CHEMBL628153,14986,BAO_0000019,A,,,,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,0,,U,22224,,,13007,,,1
,CHEMBL628154,14987,BAO_0000019,A,,,,,,,Kinetic constant for aromatization of androstenedione,Autocuration,0,,U,22224,,,11482,,,1
,CHEMBL628155,14988,BAO_0000019,A,,,,,,,Kinetic constant for aromatization of testosterone,Autocuration,0,,U,22224,,,11482,,,1
,CHEMBL628156,14989,BAO_0000019,A,,,,,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,Autocuration,0,,U,22224,,,2303,,,1
,CHEMBL628157,14990,BAO_0000019,A,,,,,,,Local inhibition constant was determined,Autocuration,0,,U,22224,,,11964,,,1
,CHEMBL857533,14991,BAO_0000218,A,,,4932.0,,Saccharomyces cerevisiae,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Intermediate,1,,N,50347,,,3140,,,1
,CHEMBL628158,14992,BAO_0000100,P,,,,,,,Dissociation constant value of the compound,Autocuration,0,,U,22224,,,10650,,,1
,CHEMBL628159,14993,BAO_0000019,A,,,,Cornea,,,In vitro permeability through cornea without epithelium,Autocuration,0,,U,22224,964.0,,4667,,,1
,CHEMBL875616,14994,BAO_0000019,A,,,,Cornea,,,In vitro permeability through intact cornea,Autocuration,0,,U,22224,964.0,,4667,,,1
,CHEMBL628160,14995,BAO_0000218,A,,,9986.0,Cornea,Oryctolagus cuniculus,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Intermediate,1,,N,50592,964.0,,9199,,,1
,CHEMBL628161,14996,BAO_0000019,A,,,,,,,Rate of enzyme inactivation for the compound was determined,Autocuration,0,,U,22224,,,11966,,,1
,CHEMBL628162,14997,BAO_0000019,A,,,,Cornea,,,In vitro permeability through cornea without epithelium,Autocuration,0,,U,22224,964.0,,4667,,,1
,CHEMBL628163,14998,BAO_0000019,A,,,,Cornea,,,In vitro permeability through intact cornea,Autocuration,0,,U,22224,964.0,,4667,,,1
,CHEMBL628164,14999,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628165,15000,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628166,15001,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628167,15002,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628168,15003,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628169,15004,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628170,15005,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628171,15006,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL627434,15007,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL627435,15008,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628110,15009,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628111,15010,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628112,15011,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628260,15012,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628261,15013,BAO_0000019,A,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,0,,U,22224,,,8354,,,1
,CHEMBL628262,15014,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628263,15015,BAO_0000218,A,,,9606.0,,Homo sapiens,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,1,,N,50587,,,14439,In vivo,,1
,CHEMBL628264,15016,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628265,15017,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628266,15018,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628267,15019,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628268,15020,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628269,15021,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628270,15022,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628271,15023,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Intermediate,1,,N,50594,,,14439,In vivo,,1
,CHEMBL628272,15024,BAO_0000218,A,,,10090.0,,Mus musculus,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Intermediate,1,,N,50594,,,14439,In vivo,,1
